online final programme

Transcription

F
i
n
a
l
p
r
o
g
25th AnnuAl COnGRESS
13-17 october 2012
For physicians, nurses and other allied
healthcare professionals.
www.esicm.org
r
a
m
m
e
Acknowledgements
The European Society of Intensive Care Medicine would like to wholeheartedly thank the following
companies who are entitled to be recognised as
Major sponsors
Astute Medical
Gambro
Baxter
GE Healthcare
Covidien
Kimberly-Clark
Dräger
Maquet
Edwards
Nestlé Health Science
Fisher & Paykel
Orion Pharma
Fresenius Kabi
Philips
Pulsion
sponsors
Pfizer
CONTENTS
WELCOME FROM THE PRESIDENT & PRESIDENT ELECT
3
Welcome from the Congress Committee Chairman
5
Who’s who
6
Practical Information
19
MAP - CongreSs Center CCL LISBON
22
Summary poster CORNERS
24
POSTER CORNERS - REPLAY THEATRE - E-POSTERS
26
esicm activities
29
ESICM General Assembly
32
Pre-Congress Educational programme
43
PG Overview
44
Advanced haemodynamic monitoring
48
LUNG ABDOMINAL AND CEREBRAL ULTRASOUNDS IN ICU
50
Critical care refresher course
52
ECHOCARDIOGRAPHY
54
RENAL REPLACEMENT THERAPY
59
PERI-OPERATIVE CARE OF THE HIGH -RISK PATIENT: SIMULATION BASED
60
DESIGNING, CONDUCTING AND PUBLISHING INTENSIVE CARE RESEARCH
62
HOW TO WRITE A SYSTEMATIC REVIEW & META-ANALYSIS
64
Scientific Programme
67
Opening session
69
SESSIONS FORMAT
70
SESSIONS REFERENCES
72
Sessions of special interest for Nurses and AHP
73
Replay Theatre
75
Overview Monday 15 October
80
Overview Tuesday 16 October
132
Overview Wednesday 17 October
180
ESICm Faculty list
204
Industry SPONSORED sessions
207
FACULTY LIST - INDUSTRY SPONSORED SESSIONS
208
Industry sponsored sessions
209
Exhibition list & guide - List of exhibitors & Exhibition map
216
Guide to exhibition
218
L I V E S 2 012
L ink ing Inno vat ion Vi sion E xcel l ence & S cience
1
Our new identity _
As ESICM celebrates its 30th anniversary,
we wish to express new ambitions for our
society. Is there any better opportunity to
unveil the new ESICM identity?
this new logotype is clearly oriented towards the
future and is built on a graphic reinterpretation of
highly symbolic intensive care waveforms, Dna
strands, and digital connections. it conveys all the
values of a resourceful, dynamic, collaborative and
innovative scientific society: your eSicm.
The creation of a new brand slogan
Building the brand value of ESICM
With this complete redesign of the eSicm
graphic identity, we aim to capitalise on the work
accomplished over the past 30 years, and to foster
further worldwide recognition of eSicm for the
quality of its scientific research, professional events
and services.
to accompany this new eSicm identity, we
have launched a slogan that summarises our
commitment and mission: to provide all intensive
care professionals resources that will help them
advance care of critically ill patients and their
families, and create the conditions for the continued
progress for our specialty.
Download our new graphic logos
every eSicm member can download the new static
and animated logos after login on our website:
www.esicm.org. Feel free to add them to your site:
be part of the intensive connection!
liSbon 2012
wElCOME fROM THE PRESIDEnT
AnD PRESIDEnT ElECT.
DR. AnDREw RHODES,
eSicm president
PR. JEAn-DAnIEl CHICHE,
eSicm president elect
it gives us great pleasure to welcome you to liVeS 2012, the 25th annual congress of the european Society of intensive
care medicine (eSicm) in lisbon, portugal.
We have been delighted to oversee the continued growth of our annual congress, which now is the biggest and most
innovative critical care event held anywhere in the world. this continued success is richly deserved as the meeting
contains the highest quality of scientific and educational sessions, delivered by the world’s most eminent experts. as
important as the education is, however, we fully appreciate the importance of being able to meet up with colleagues
and old friends as well as having the time to network and forge new contacts in the field, so we have strived to create
an environment that is conducive to education, relaxation and fun.
this year, we will also be celebrating the 30th anniversary of eSicm. Standing on the shoulders of giants that have
made our discipline what it is today, it is easier to look at the future without fear and consider the next 30 years.
intensive care medicine has now become a mature specialty that is critical to the progress of all other disciplines. it
is anticipated that there will be a continued growth in the demand for intensive care services and therefore a need for
what we can offer and deliver. our Society will undoubtedly have a pivotal role to play in advancing biomedical sciences
that pertain to our discipline as well as in the continuous education of our workforces to guarantee the best possible
outcomes for our patients. We are ready for this challenge and have begun to prepare eSicm for its transformation into
a Society even more connected to its members and its root values. to mark this important milestone of eSicm turning
30, we are delighted to unveil a new visual identity as the first step of an evolution that will soon include a new digital
platform and membership offers with unprecedented benefits.
For those who are interested in getting involved in the activities of the eSicm, there has never been a better opportunity.
if you are already a member, ensure you take some time whilst you are at the congress to visit eSicm member’s
lounge. our staff will be pleased to welcome you and guide you through the benefits that you can receive from the
Society. if you are not yet an eSicm member, find a member to sponsor your application and get more rewards through
our “1+1=12,000” campaign. alone or with your sponsor, be sure to visit our booth where we will try to persuade you to
join us in our continual venture: to unite and collectively shape the future of our discipline — both for the homogeneity
of our profession and moreover, in the interest of improved quality of care and outcomes for our patients.
Join us to celebrate our 30th Anniversary and make lIVES 2012 the event where you finally become involved and
help to build the future of intensive care with us!
www.esicm.org / 3
RAPID AND SUSTAINED BENEFITS FOR THE FAILING HEART
Cardioprotective inodilator:
FIRST IN CLASS
SIMDAX is the first in class as cardioprotective
inodilator drug.1
ESC guidelines give levosimendan a class IIa
recommendation at level of evidence B for the
treatment of acute heart failure.2
The most recent meta-analysis shows reduction of
mortality and length of stay in hospital.3
These benefits are not obtained with other inodilators
such as dobutamine4 or milrinone.5
Papp et al. Int J Cardiol 2011 e-pub
Dickstein et al. Eur Heart J 2008;29:2388–442
3
Landoni et al. Crit Care Med 2011 e-pub
4
Tacon et al. Intensive Care Med 2011 e-pub
5
Zangrillo et al. J Cardiothor Vasc Anesth 2011 e-pub
1
2
PRODUCT INFORMATION: Simdax 2.5 mg/ml concentrate for solution for infusion.
Therapeutic indications
Simdax is indicated for the short-term treatment of acutely decompensated severe chronic heart failure (ADHF)
in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered
appropriate.
Dosage and administration
Simdax is for in-hospital use only. It should be administered in a hospital setting where adequate monitoring
facilities and expertise with the use of inotropic agents
are available.
Simdax is to be diluted prior to administration. The infusion is for intravenous use only and can be administered
by the peripheral or central route.
Dosage: The dose and duration of treatment should be
individualised according to the patient’s clinical condition and response.
The recommended duration of infusion in patients with
acute decompensation of severe chronic heart failure is
24 hours. No signs of development of tolerance or rebound phenomena have been observed following discontinuation of Simdax infusion. Haemodynamic effects
persist for at least 24 hours and may be seen up to 9
days after discontinuation of a 24-hour infusion.
Experience of repeated administration of Simdax is limited. Experience with concomitant use of vasoactive
agents, including inotropic agents (except digoxin) is
limited.
Monitoring of treatment: Consistent with current
medical practice, ECG, blood pressure and heart rate
must be monitored during treatment and the urine output measured. Monitoring of these parameters for at
least 3 days after the end of infusion or until the patient
is clinically stable is recommended. In patients with mild
to moderate renal or mild to moderate hepatic impairment monitoring is recommended for at least 5 days.
Elderly: No dose adjustment is required for elderly patients.
Renal impairment: Simdax must be used with caution
in patients with mild to moderate renal impairment.
Simdax should not be used in patients with severe renal
impairment (creatinine clearance <30 ml/min).
Hepatic impairment: Simdax must be used with caution in patients with mild to moderate hepatic impairment although no dose adjustment appears necessary
for these patients. Simdax should not be used in patients
with severe hepatic impairment.
Children: Simdax should not be administered to children and adolescents under 18 years of age.
Contraindications
Hypersensitivity to levosimendan or to any of the excipients. Severe hypotension and tachycardia. Significant
mechanical obstructions affecting ventricular filling or
outflow or both. Severe renal impairment (creatinine
clearance <30 ml/min) and severe hepatic impairment.
History of Torsades de Pointes.
Special warnings and special precautions for use
An initial haemodynamic effect of levosimendan may
be a decrease in systolic and diastolic blood pressure,
therefore, levosimendan should be used with caution
in patients with low baseline systolic or diastolic blood
pressure or those at risk for a hypotensive episode.
More conservative dosing regimens are recommended
for these patients. Physicians should tailor the dose and
duration of therapy to the condition and response of the
patient.
Severe hypovolaemia should be corrected prior to levosimendan infusion. If excessive changes in blood pressure
or heart rate are observed, the rate of infusion should be
reduced or the infusion discontinued.
The exact duration of all haemodynamic effects has not
been determined, however, the haemodynamic effects,
generally last for 7-10 days. This is partly due to the presence of active metabolites, which reach their maximum
plasma concentrations about 48 hours after the infusion
has been stopped. Non-invasive monitoring for at least
4-5 days after the end of infusion is recommended. Monitoring is recommended to continue until the blood
pressure reduction has reached its maximum and the
blood pressure starts to increase again, and may need to
be longer than 5 days if there are any signs of continuing
blood pressure decrease, but can be shorter than 5 days
if the patient is clinically stable. In patients with mild to
moderate renal or mild to moderate hepatic impairment
an extended period of monitoring maybe needed.
Simdax infusion should be used cautiously in patients
with tachycardia atrial fibrillation with rapid ventricular
response or potentially life-threatening arrhythmias.
Interaction with other medicinal products and
other forms of interaction
Consistent with current medical practice, levosimendan
should be used with caution when used with other intravenous vasoactive medicinal products due to a potentially increased risk of hypotension.
No pharmacokinetic interactions have been observed in
a population analysis of patients receiving digoxin and
Simdax infusion. Simdax infusion can be used in patients
receiving beta-blocking agents without loss of efficacy.
Co-administration of isosorbide mononitrate and levosimendan in healthy volunteers resulted in significant
potentiation of the orthostatic hypotensive response.
Undesirable effects
The most commonly (>1/10) reported adverse reactions
include headache, hypotension and ventricular tachycardia.
Overdose
Overdose of Simdax may induce hypotension and tachycardia. High doses (at or above 0.4 microgram/kg/min)
and infusions over 24 hours increase the heart rate and
are sometimes associated with prolongation of the QTc
interval. Simdax overdose leads to increased plasma concentrations of the active metabolite, which may lead to
a more pronounced and prolonged effect on heart rate
requiring a corresponding extension of the observation
period.
Storage
Store at 2°C-8°C (in a refrigerator). Do not freeze.
CONTACT INFORMATION: Orion Corporation, Orion Pharma, PO Box 65, FI-02101 ESPOO, FINLAND. Tel. +358 10 4261
liSbon 2012
wElCOME fROM THE COnGRESS
COMMITTEE CHAIRMAn
GIuSEPPE CITERIO
chairman, Division of eSicm
Scientific affairs and congress
committee
on behalf of the executive and congress committees of eSicm, i would like to welcome you to the 25th annual congress of
eSicm, liVeS 2012. the acronym liVeS: latest intensive care Views on education & Science, established last year, reflects
our congress’ brand as well as our Society’s core mission.
Updating clinicians, nursing staff, and allied health professionals on the latest and most relevant advances in critical care
and emergency medicine is the continual aim of our annual congress, and this years’ programme boasts an unprecedented
width and breadth: With 10 parallel sessions and more than 1000 lectures, presentations, debates, tutorials and interactive
educational sessions, this congress will surely once again not disappoint the participants – from more than 90 countries—
who will converge at ccl in lisbon.
the congress committee has worked closely with the Division of professional Development to propose a critical care
refresher and 7 postgraduate courses. these carefully selected courses have been adapted to suit potential european
Diploma in intensive care (eDic) candidates, as well as those more ‘senior’ intensive care professionals who would like to
refresh their knowledge and update crucial skills in a broad range of topics, such as haemodynamic monitoring, critical
care nephrology, ultrasound, management skills in intensive care medicine, research, systematic review creation and icU
practical skills.
this is a special anniversary year for the Society — be sure to join us at the opening ceremony to learn more about the
highlights of this year’s congress and to help us celebrate eSicm’s 30th anniversary. it is fitting that this is also a banner year
for cutting-edge original research. While presentations of original research has always been one of our central priorities,
we are pleased that this year, of the 1330 submitted, 1141 exemplary abstracts have been selected to be presented in
either oral or e-poster format. in keeping with the current climate of environmental conservatism and to lessen our own
carbon footprint, we have decided to eliminate paper posters. in addition to the environmental considerations, there are
added benefits for congress delegates in that there are no necessary printing and/or shipping costs, and rather than being
disposed of after the congress, electronic versions of all posters will be available online (indefinitely!) on the eSicm website.
e-poster corners, the replay theatre and an updated mobile app will empower you to optimise your selection of thematic
sessions or debates in an efficient, user-friendly and interactive fashion. the new liVeS 2012 app will have increased
functionality including a voting module (available in room rome), which utilises Wi-Fi (for smartphone users) and (along with
many other useful features) will allow participants to send questions to the session chairs. it may be somewhat paradoxical,
but while host city lisbon is one of the oldest cities, it has also been voted one of the most liveable cities in the world. it
boasts a moderate mediterranean climate, an expansive and reliable public transport network and is steeped in history and
culture. While you are here, be sure to take a stroll through the heart of the city — baixa (city centre) and for a little shopping,
visit chiado, a traditional shopping area that mixes old and modern shops with cafés, museums and theatres. also rich in
nightlife, lisbon offers traditional entertainment in the form of the nostalgic sounds of Fado at authentic Fado clubs (in
bairro alto and alfama), and for those with other pursuits, most locals would agree that with some 150 restaurants and
bars, the bairro alto is the most happening place after dark.
There is no better time or place to get involved! Join us for all of the lIVES 2012 programme and activities and take
advantage of all the perks this very multicultural city offers. we are pleased that you will be a part of ESICM’s 25th
Annual Congress in lisbon and we wholeheartedly wish you the best possible experience!
www.esicm.org / 5
Congress committee
Who’s who
CHAIR OF THE DIVISION
OF SCIENTIFIC AFFAIRS
Giuseppe Citerio
HEALTH SERVICES RESEARCH
AND OUTCOMES
Andreas Valentin
SYSTEMIC INFLAMMATION
AND SEPSIS
Susanne Toussaint
Monza, Italy
Vienna, Austria
Berlin, Germany
Acute Kidney Injury
Michael Joannidis
INFECTION
George Dimopoulos
Innsbruck, Austria
Athens, Greece
Trauma and Emergency
Medicine
Jacques Duranteau
ACUTE RESPIRATORY
FAILURE
Antonio Pesenti
METABOLISM, ENDOCRINOLOGY,
Nutrition
Jan Wernerman
Monza, Italy
Stockholm, Sweden
representative of the N&AHP
COMMITTEE
Stijn Blot
CARDIOVASCULAR
DYNAMICS
Maurizio Cecconi
NEURO-INTENSIVE CARE
Pedro Navarrete Navarro
Granada, Spain
London, United Kingdom
Kremlin-Bicetre, France
Ghent, Belgium
CHAIR OF THE RESEARCH
COMMITTEE
Richard Beale
ETHICS
Jozef Kesecioglu
PERIOPERATIVE INTENSIVE CARE
Rupert Pearse
Utrecht, Netherlands
CHAIR OF THE DIVISION
OF PROFESSIONAL DEVELOPMENT
Marco Maggiorini
Zurich, Switzerland
6
25th Annual Congress
13-17 October 2012
ccl - lisbon - PORTUGAL
L I V E S 2 012
SENATE
Executive committee
Who’s who
President
Andrew Rhodes
Peter Suter
1982-1986
Hilmar Burchardi
1998-2000
Cara-Presinge, Switzerland
Bovenden, Germany
PRESIDENT-ELECT
Jean-Daniel Chiche
Chair of the N&AHP committee
Christina Jones
Maurice Lamy
1986-1988
Jukka Takala
2000-2002
Paris, France
Liverpool, United Kingdom
Liège, Belgium
Bern, Switzerland
GENERAL SECRETARY
Philipp Metnitz
Editor-in-Chief Intensive Care
Medicine Journal
Massimo Antonelli
Luciano Gattinoni
1988-1990
Graham Ramsay
2002-2004
Milan, Italy
Chair of the Research Committee
Richard Beale
Iain Mc Ledingham
1990-1992
Julian Bion
2004-2006
Lisbon, Portugal
Perth, United Kingdom
Birmingham, United Kingdom
CHAIR of the division
of Scientific affairs
Giuseppe Citerio
CHAIR OF THE EDITORIAL &
PUBLISHING COMMITTEE
Salvatore Maggiore
Jean-Louis Vincent
1992-1994
Marco Ranieri
2006-2008
Vienna, Austria
Rome, Italy
Interim Treasurer
Rui Moreno
Brussels, Belgium
Turin, Italy
Monza, Italy
Rome, Italy
Chair of the division of
professional development
Marco Maggiorini
Past-President
Rui Moreno
Lambert G Thijs ✝
1994-1996
Rui Moreno
2008-2010
Lisbon, Portugal
Huizen, Netherlands
Lisbon, Portugal
Zurich, Switzerland
Espnic president
Jan Hazelzet
Rotterdam, Netherlands
L I V E S 2 012
Jean Carlet
1996-1998
La Plaine St-Denis, France
7
Chair Education and
training committee
Marco Maggiorini
Zurich, Switzerland
Research Committee
Education and Training Committee
Who’s who
CHAIR OF THE RESEARCH
COMMITTEE
Richard Beale
INF
Jordi Rello
Chair Congress Committee
Giuseppe Citerio
Barcelona, Spain
Monza, Italy
Chair Education and
Training Commitee
Marco Maggiorini
London , United Kingdom
Chair PACT Subcommittee
Dermot Phelan
AKI
Eric Hoste
MEN
Mette Berger
Dublin, Ireland
Ghent, Belgium
Lausanne, Switzerland
Zurich, Switzerland
ARF
John Laffey
NIC
Mauro Oddo
N&AHP Representative
Freda DeKeyser Ganz
Galway, Ireland
Jerusalem, Israel
Chair Congress Committee
Giuseppe Citerio
CD
Christoph Hofer
POIC
Michael Sander
Monza, Italy
Zurich, Switzerland
Berlin, Germany
N&AHP Representative
Katherina Iliopoulou
ETH
Andrej Michalsen
SIS
Ricard Ferrer Roca
Athens, Greece
Tuttlingen, Germany
Barcelona, Spain
HSRO
Akos Csomós
TEM
Martin Dünser
Budapest, Hungary
Salzburg, Austria
Chair Clinical Training
Subcommittee
Hans Flaatten
Bergen, Norway
8
13-17 October 2012
L I V E S 2 012
ESICM OFFICE STAFF
Who’s who
Executive Officer
Joël Alexandre
Brussels, Belgium
Administration Affairs Team
Administration
Stéphanie Khazzaka
Accounting
Oscar Serge Ndongo
Brussels, Belgium
Brussels, Belgium
IT & Website
Etienne Vander Elst
Brussels, Belgium
membership
Ghislaine Eenens
Brussels, Belgium
Scientific Affairs Team
Congress
Cindy Martinez
Congress
Elise Maquestiaux
Brussels, Belgium
(On maternity leave)
Brussels, Belgium
research
Dominique De Boom
research
Guy Marie François
Brussels, Belgium
Brussels, Belgium
Congress
Ana Freitas
Brussels, Belgium
Professional Development Team
EDUCATION & TRAINING
Estelle Flament
Brussels, Belgium
EDIC
Tania Kapu
Brussels, Belgium
(On maternity leave)
EDIC
Stephano Ridolfi
Brussels, Belgium
Editorial & Publishing
Sherry Scharff
Brussels, Belgium
L I V E S 2 012
9
TO be cOnTinued >
The intensive connection to…
A growing network of members_
BECOME An ESICM MEMBER
working to promote the highest standards of
multidisciplinary care of critically ill patients
through education, research and professional
development.
10 GOOD REASOnS_
1 Discount on registration fees at our annual
congress and at international meetings endorsed
by eSicm
2 Free access to the eSicm Flash-conferences
(slides & sound of the scientific sessions held
during the congress & regional meetings)
3 annual subscription to intensive care medicine –
electronic version of the Journal
(printed version optional)
4 Free access to the web-based 2nd edition
of the pact programme
5 participation in eSicm’s scientific activities:
including positions in Sections and Working
groups, annual congress, joint international
meetings, etc.
6 apply for research grants through the eccrn
(european critical care research network)
7 access to information about the development
of intensive care medicine in europe through
our monthly newsletter, annual report and
interactive website
8 participation in eSicm educational and training
activities: post-graduate courses, cobatrice, etc.
9 reduced fees as you apply for the eDic
(european Diploma in intensive care)
10 possibility of joint membership with the
european Society of paediatric and neonatal
intensive care - eSpnic (optional)
JOIn uS_
apply online at
www.esicm.org
www.esicm.org
DR.copyright©
TO be cOnTinued >
The new (magic) formula_
Today, the ESICM boasts slightly more than 6,000
members worldwide. Special thanks to all of you
that have contributed to make ESICM what it is
as we celebrate our 30th anniversary ! This is the
time for an open invitation: sponsor new ESICM
members!
with you, we can re-invent mathematics. with you,
1+1=12,000! If you are member of ESICM, sponsor
your friends, win… and help us win.
To thank you, we have imagined a simple principle
for rewards : discount on your registration to the
2013 regional conferences.
1 sponsorship = 10% additional discount
2 sponsorships = 15% additional discount
10 sponsorships = free registration
by introducing your Society to your friends, you will
allow eSicm to expand, progress and create the
resources necessary for better science and better
care, everywhere and for everyone.
to facilitate your connections with new members, we
offer you to wear this badge during liVeS 2012:
i’m eSicm connected and i am ready to sponsor you.
You are not yet an eSicm member: take advantage
of our exclusive offer during liVeS 2012. Find an
eSicm member to sponsor you and come together
to connect to the eSicm family.
You will benefit from the exclusive advantages of
eSicm membership in addition to an exceptional
offer made possible by your sponsor.
JOIn uS_
eSicm reception area
eSicm loUnge area
eSicm ForUm area
www.esicm.org
TO be cOnTinued >
become an ambassador_
you to…». You can help us set up the most amazing
network of individuals ready to speak up for those
who care for and cure the most critically ill patients.
BECOME A lIfE-PRIORITY AMBASSADOR
AnD HElP uS PuT InTEnSIVE CARE In
THE SPOTlIGHT.
To accelerate the development of our awareness
campaign about intensive care medicine, we are
looking for intensive care professionals that are
ready to become ambassadors of lIfE-PRIORITY,
the foundation that publicly represents ESICM
OuR AMBITIOn:
link intensive care to the human beings it serves,
beyond borders.
You stand at the bedside and work relentlessly to
save lives. You are the most legitimate ambassador
of liFe-prioritY as you breath our slogan. You can
state «because your life is our priority, we would like
JOIn uS_
Interested in becoming a lIfE-PRIORITY
ambassador? Come and meet us!
You are an intensive care professional?
• come and join us on the liFe-prioritY
connecting area located in front of the ccl
• or send us an email
ambassador@life-priority.com
We will be thrilled to tell you more about your role as
an ambassador and discuss how liFe-prioritY can
help you fulfill your most important mission:
SAVE lIVES.
www.life-priority.com
www.esicm.org
liSbon 2012
HOnORARY MEMBERS AnD
SOCIETY MEDAlS
Society Medal Holders
Honorary Members
eSicm awards a yearly medal, the Society medal, to one of
its most outstanding and long serving members.
every year, eSicm also awards honorary membership to
the society, to recognised professionals.
CRITERIA
CRITERIA
the eSicm medal is awarded to an individual who has
made an outstanding contribution to both the society and
the specialty over a prolonged period of time.
Honorary membership is awarded to an individual who
has made an outstanding contribution to the specialty of
intensive care medicine (Statutes - article 4.4).
PROCESS
PROCESS
the council nominates individuals they deem deserving
of this award in the Spring of each year. the executive
commmitee then shortlists the nominees and asks the
council to formally vote for the winner.
the council nominates individuals for this award
in the Spring of each year. the executive commmitee
then shortlists the nominees and (when necessary),
asks the council to formally vote for the most deserving
recipients(s).
RIGHTS
RIGHTS
the eSicm medal holders benefit from a life-long honorary
free membership of the society.
Honorary members benefit from a life-long free
membership of the society.
AWArded members
AWArded hOnOnAry membership
Peter Suter
Switzerland
2005
Konrad falke
germany
2006
françois lemaire
France
2007
Albert Osterhaus
netherlands
2009
Malcom fisher
australia
2010
Elias Knobel
brazil
2010
luciano Gattinoni
italy
2008
Jean-louis Vincent
belgium
2009
Jean-Roger le Gall
France
2010
David Bennett
United kingdom
2011
Andrés Esteban
Spain
2011
Antonio Artigas
Spain
2012
Charles Sprung
israel
2011
Julian Bion
United kingdom
2012
Mitchell levy
United States
2012
Michael Pinsky
United States
2012
warren Zapol
United States
2012
liSbon 2012
C IE
TY MED
AL
P
EA
N
RE
RO
ME
EU
DIC
THE
NE
SO
SO
CIE
TY OF INTENS
IV E
CA
Julian Bion
the european Society of intensive care medicine proudly
awards this citation of Honorary membership to professor
Julian bion, mD for his major contributions to the european
Society of intensive care medicine and to intensive care
medicine around the world, but foremost for his key role
in improving the quality of care of acutely, critically ill
patients and their relatives through the development of a
programme of high quality education and training.
Julian bion is professor of intensive care medicine at
the University of birmingham and honorary consultant in
intensive care medicine at the Queen elizabeth University
Hospital birmingham. as an active, dedicated and skilled
front-line physician and teacher, he is committed to full
clinical duties in one of the largest intensive care units in
europe.
Julian bion was president of the european Society of
intensive care medicine (2004-2006) and foundation
chairman of the european board of intensive care
medicine (2006-2009). He led the restructuring of the
european Society of intensive care medicine and he
was instrumental at establishing the european critical
care research network. most importantly however, he
conceived, led, and is now the research director of the
competency-based training programme for intensive
care medicine. cobatrice was established as an eU
leonardo da Vinci-funded collaboration and has now been
successfully adopted by a considerable number of national
training programmes worldwide. cobatrice has been
identified as an example of best practice by the european
commission, and the process has been emulated by the
United States.
His involvement in training and education goes back to
the late eighties. Julian bion has been responsible for
undergraduate training in resuscitation and intensive
care at the University of birmingham since 1987,
and he successfully developed national standards for
undergraduate training in the care of the acutely ill patient.
at the postgraduate level, he was the first regional advisor
in intensive care medicine for the West midlands. He has
been an elected council member of the royal college of
anaesthetists since 2007 and chair of the professional
Standards committee. in 2010, he was elected as the
first Dean of great britain’s new Faculty of intensive care
medicine. as a result of the strong collaborative efforts of
prof. bion and others, the United kingdom joined Spain
and Switzerland as the third european country with
intensive care medicine recognised as a primary medical
speciality. Hopefully, many more countries will follow in
the near future!
the research interests of Julian bion include sepsis
and multiple organ failure, quality management and
patients’ safety, and improving patient outcomes through
professional education and training. the sheer number
of prof. bion’s contributions limits the opportunity to
name them all, but to mention just a few: He established
an eU-funded european collaboration to determine
genetic predisposition to mortality from septic shock,
the genoSept project, and he is a member of the
national steering committee of the Hta-funded study on
protocolised management of sepsis, the promiSe study.
Julian bion is also senior clinical lead for a national
patient Safety programme, aiming at reducing blood
stream infections from central venous catheters in icUs.
Finally, he is leading a national approach that aims to
integrate clinical research and behavioural sciences with
education and professional development to improve the
quality and reliability of care of acutely ill hospitalised
patients.
in 2004 Julian bion received the Shubin-Weil international
award for excellence from the Society of critical care
medicine in the USa. He was awarded honorary life
memberships of the czech Society of intensive care
medicine in 2008 and of the Uk intensive care Society in
2009.
taking into account all these professional activities, it
may come as a surprise that “the man with the bow-tie”
still has some spare time to invite friends from all over
the world to his home, to browse through his collection
of more than 4000 books, or to attend to his collection of
excellent wines. Finally, with no less than three pianos at
his home in birmingham, you can be confident that even
though “cobatrice” may be a master keyword in Julian’s
life, his passion does not end there. be assured, it also
includes discussions of other aspects of life with his most
beloved wife nitaya, his family and his many friends.
HAnS u. ROTHEn
liSbon 2012
Antonio Artigas
the european Society of intensive care proudly awards this
citation of Honorary membership to antonio artigas, mD,
phD, for his major contributions to the european Society of
intensive care medicine and to intensive care around the
world. antonio is a founding member of the european Society
of intensive care medicine, and has devoted a huge amount
of time to this society, which he always considered as his
second family. He was a member of the executive committee
from 1982 to 1990. He has never missed missed one meeting
of the society, nor missed one general assembly. Fidelity
represents one of his numerous qualities. antonio has been
an outstanding clinician, and has always tried to balance
his activities between the clinical field, which remained his
absolute priority and many other activities, such as research,
teaching, and national or international activities. it is hard to
combine all those activities, but antonio made it.
antonio, 63, was born in barcelona, a splendid city that he
loves. He attended the French lycée in barcelona, which
explains why he speaks French so elegantly, and understands
French culture French culture. He was trained in barcelona
University (Spain), and became mD in 1973. He received his
phD in 1992. He his and was certified in internal medicine
in 1976 and intensive care medicine in 1982. He has been
appointed as the director of the chair of applied physiology,
parc tauli University institute, and professor at the medicine
department, autonomous University of barcelona in 2002.
From 1980 to 1988, he was the clinical chief of the general
icU in Hospital Santa creu i San pau, in barcelona. Since
1988, he has been director of the critical care centre at
Sabadell hospital. He has created an outstanding acute care
center, working with the emergency room, and also has
created a network with the icUs within the area. antonio is
very creative and interactive.
as a member of many international societies, including
eSicm and atS (critical care assembly and programme
committee), SrlF (vice president from 1991 to 1993), erS
(chairman of the critical care group) and chairman of
HermeS (respiratory critical care). He was also president
of the intensive care medicine Society from 1990 to
94, and his part of the european research group on
respiratory intensive care. antonio has proved his merits
on an international level. antonio likes the lungs. alongside
gordon bernard, he was involved in three american and
european consensus conferences on arDS, which led to the
publication of guidelines which have been cited thousands
of times. He is the director of the research programme on
acute respiratory failure and sepsis and active member
at the ciber de enfermedades respiratorias at instituto
carlos iii. He is also heavily involved in sepsis research,
and was part of the group who drafted the Surviving Sepsis
guidelines, which has shown that establishing bundles of
care in treatment can decrease mortality.
in addition to being an outstanding scientist, antonio is also
on the editorial boards of many critical care and respiratory
journals and reviews numerous papers. He published more
than 200 articles in national and international scientific
journals. He has published 20 books, and wrote chapters
in various others. He has presented at more than 200
conferences internationally. He has received 50 awards and
more than 30 research grants.
antonio also organises meetings. He chaired the
international Symposium on applied physiology of the
peripheral circulation, with michael pinsky and Jean
François Dhainaut, from 1994 to 2000. Since 1996, he has
lead the annual international Symposium on infections
in the critically ill patient with Jean carlet and michael
niederman. He was the president of the european congress
of intensive care medicine in barcelona, in 1992. antonio
has trained hundreds of students, residents, fellows and
nurses, many of whom remain very close to him.
on a more personal note, antonio is certainly one of
the kindest people that i know. He is one of the very few
people who is able to combine fidelity to people and
ideas, as well as maintain long lasting friendships and
impressive professionalism. He has a wonderful family, in
particular roser, his fantastic wife, who always supported
him throughout his career. He has seven wonderful, and
successful kids, including two medical doctors. they have
also inherited antonio’s love of travel. an avid mountain
climber, antonio also appreciates a good meal and wine with
friends. like many Spanish people, antonio likes football,
and considers, very logically that the barcelona football club
is the best of the world. (it might very well be true)
eSicm recognises how important prof. artigas’ contributions
to the Society and the field have been and are truly thankful
to this great physician and human being. i am personally
privileged to present antonio artigas this citation of Honorary
membership for his contributions to intensive care medicine
all around the world. i am especially proud to be one of
antonio’s colleagues and friends.
JEAn CARlET
liSbon 2012
Mitchell levy
awards this citation for Honorary membership to professor
mitchell m levy mD for his outstanding contributions to the
care of critically ill patients, especially those with severe
sepsis, and his unceasing efforts to build collaboration
and partnerships between professional societies as well as
individual critical care practitioners around the world and,
most notably, to build upon and further reinforce the crucial
relationship between the Society of critical care medicine
and the european Society of intensive care medicine.
Dr levy gained degrees in medicine and psychology from
the State University of new York in buffalo, before going on
to train in internal medicine at the University of colorado.
after positions in canada and Hawai, Dr mitchell came
to brown University, rhode island in 1997, where he
remains, having become professor of medicine in 2004, and
subsequently chief of the Division of pulmonary and critical
care medicine; positions he still holds. as a successful
academic, he has published in excess of 100 peer-reviewed
papers and chapters, and has served upon a number of
important bodies influential in the critical care arena, most
notably in the areas of quality initiatives, ethics and end of
life care. He played a particularly important role in 2000
– 2001 as chair of the niH arDSnet panel investigating
oHrp complaints against arDSnet.
Dr levy has been especially active within the Society of
critical care medicine, serving in a number of senior roles,
culminating in president-elect and president in 2008 –
2010. Dr levy is widely travelled, and is a europhile, and
it is perhaps this, together with his strong grounding in
the quality and process initiatives, that made him uniquely
suited to his role as a founding member of the Surviving
Sepsis campaign. originally conceived as a joint initiative
of the Society of critical care medicine, european Society
of intensive care medicine and the international Sepsis
Forum, and subsequently (and still) supported and
developed by Sccm and eSicm, the campaign has been
the product of an enormous amount of effort by many
dedicated people, but three extraordinary leaders have
played outstanding roles in its success. professor graham
ramsey (past president of eSicm led the First phase,
developing the narrative around why the campaign was
and remains necessary. professor r phillip Dellinger leads
the Second phase; the pivotal development and updating of
the guidelines that are distilled from the rapidly changing
evidence base, and which provide the most authoritative
statement of how best to treat severe sepsis and underpin
the third phase – the implementation phase, led by Dr levy.
this aspect of the campaign has been its most original
and transformative aspect, and is an initiative unique
within critical care, and arguably unequalled within any
major speciality area. building on the foundations of the
guidelines, and working with the institute for Healthcare
improvement (iHi), Dr levy championed the introduction
of the concept of bundles to critical care, at a time when
this was still an entirely new concept, allied with a formal
process improvement methodology and a database to allow
the effects of this initiative to be measured and reported.
as a consequence, there are now some 30,000 patients
with severe sepsis in whom the effects of this initiative have
been recorded, demonstrating a substantial improvement
in outcome, and establishing a new standard of care, both
clinically, and as a benchmark in research studies of new
therapies for this challenging patient group.
Dr levy has a formidable list of achievements and honours,
and his style and success has always been collaborative and
generous, in particular in the manner in which he reinforced
the importance of the fundamental relationship between
Sccm and the european Society. Ultimately, though, it
is his achievement through his leadership role in the
Surviving Sepsis campaign that will perhaps be regarded
as his greatest achievement to date. Very few can genuinely
claim to have changed fundamentally for the better the
way we treat our patients, and to have established a new
paradigm of care. Dr levy, through his personal leadership
and generous encouragement of others, together with Drs
ramsey and Deliinger, has been largely responsible for just
such a change.
i have been personally privileged to witness Dr levy
delivering the highest standard of care to his patients in
rhode island, but there are many more patients with severe
sepsis who will have survived in large part due to his efforts,
but without ever knowing his face or name. Ultimately it is
for this achievement that the european Society is proud to
recognise and honour Dr levy, and we are confident that
the full impact of the work he and his colleagues started
has yet to be completely realised. indeed, the finest tribute
we can pay will be to continue to work together to ensure
that, in the future, all patients with severe sepsis receive the
best possible standard of care, building on the foundation Dr
levy and his colleagues, and the campaign, have provided.
RICHARD BEAlE
liSbon 2012
Michael Pinsky
the european Society of intensive care medicine
proudly awards this citation of Honorary membership to
professor michael pinsky for his major contributions to
intensive care medicine around the world.
michael pinsky received his mD from mcgill University
in montreal in 1974, graduating with honours. after an
internal medicine residency and pulmonary medicine
fellowship at Stanford University with additional
cardiopulmonary physiology training at Johns Hopkins
medical institution, he joined the University of pittsburgh
faculty in 1981.
He is currently professor of critical care medicine with
secondary appointments in cardiovascular Diseases,
clinical & translational Science, anaesthesiology and
bioengineering at the University of pittsburgh.
prof. pinsky’s research over the years has mostly focused
on the fields of heart-lung interactions, cardiovascular
insufficiency, and haemodynamic monitoring. He has
published more than 230 peer-reviewed papers, many in
leading medical journals.
His expertise and knowledge are recognised
internationally as demonstrated by his regular invitations
to speak at national and international symposia and
his position on the editorial boards of several journals.
We were honoured to have him spend time with us as
a Visiting professor at erasme Hospital, University of
brussels in 1988/89, during which we formed a valuable
collaboration that has spanned the years. He continues
to join us in brussels every December as co-chairman
for our annual course on cardiovascular and respiratory
physiology applied to icm.
teaching is one of michael’s key interests and one of his
(many) fortes. When faced with an attentive audience,
michael seems to shine – transmitting his message
with enthusiasm and clarity. He has the innate ability to
adapt automatically to his listeners and always ensures
his presentations are ably illustrated with appropriate
images and diagrams.
michael’s dynamic approach to work spills over into most
other aspects of his life, or perhaps it’s the other way
round. either way, his sheer energy for life sometimes
makes it difficult to keep up with him and his exuberance
can, on occasion, get him into trouble! Whatever the
situation, you can be assured that michael’s heart is very
much in the right place and i am honoured to count him
among my friends.
michael has established himself as a leader in his
field, an inspired proponent of translation from basic
physiology to patient care. When someone mentions
“functional haemodynamic monitoring”, the name that
immediately springs to mind is: michael pinsky.
in 2012, michael’s contributions to the field of critical
care medicine were officially recognised as he became
one of the first 20 critical care physicians to become a
master of critical care medicine (mccm) of the Society
of critical care medicine.
in this citation of Honorary membership, the eSicm
recognises how important michael pinsky’s contributions
have been not only in the USa but also across europe. i
am privileged to be able to present him with this richly
deserved recognition of his service to intensive care
medicine.
JEAn-lOuIS VInCEnT
liSbon 2012
warren Zapol
awards this citation of Honorary membership to professor
Warren m. Zapol, mD, for his major contributions to the
european Society of intensive care medicine and to
intensive care medicine.
Warren m. Zapol, mD, is the emeritus anaesthetistin-chief at massachusetts general Hospital and the
reginald Jenney professor of anaesthesia at Harvard
medical School. He is currently the Director of the mgH
anaesthesia centre for critical care research. after
completing residency in anaesthesiology at mgH, in 1972
he joined and has remained on staff ever since. Supported
by the nHlbi, Dr. Zapol’s research efforts include studies
of extracorporeal membrane oxygenation (ecmo), acute
respiratory distress syndrome, and cardiopulmonary
physiology in animals and humans. His contributions
to the study of arDS and of pulmonary hypertension in
arDS include classic seminal papers. the randomised
controlled trial on ecmo he published in Jama in 1979
represented perhaps the first randomised multicentre
controlled clinical trial conducted in critical care. the
niH funded this trial, which can be considered the basis
of the current nHlbi arDS network (arDSnet).
one would be remiss to only focus on these aspects of
prof. Zapol professional achievements. His intellectual
curiosity knows no bounds, and over the years, he has
probed a wide range of fields, providing him with the
possibility to integrate knowledge and experiences
from very different sources. in addition to his roles as
an anaesthesiologist and intensive care physician,
supported by the national Science Foundation, prof.
Zapol has led nine antarctic expeditions.
His endeavours in this field have received the highest
recognition in the United States: in 2008, he was
appointed by president george W. bush and reappointed
by president barack obama in 2012 as an academic
representative to the U.S. arctic research commission.
in 2006, the United States board on geographic names
officially named a steep mountain glacier in antarctica
after prof. Zapol.
through his antarctic research his team learned how
marine mammals avoid compression/decompression
sickness and hypoxia during prolonged free diving. in the
early 90’s, he led research on the vasodilating effects of
inhaled nitric oxide and applied this knowledge to arDS
pathophysiology and management. in 2003, he was
awarded the ipo inventor of the Year award for his work
on an innovative treatment for hypoxic newborns utilising
inhaled nitric oxide. this technique, pioneered with his
mgH team, is now used to save the lives of over ten
thousand babies each year in the U.S. He has, throughout
his career and continues to, lead and mentor numerous
fellows and researchers – both in the experimental lab
and in the clinical investigation field.
eSicm recognises professor Warren Zapol as one of the
most important leaders and initiators of modern critical
care. His brilliant mind and broad vision of physiological
problems provide us in the field with an archetype of
what can be achieved.
personally, it is a great honour and privilege to be able
to present professor Warren Zapol this eSicm citation of
Honorary membership for his major contributions to our
understanding and treatment of critical illness.
moreover, i am extremely proud to have worked alongside
him, and to have been part of his ‘crew’.
AnTOnIO PESEnTI
Dates CME Credits
The Congress starts on Saturday 13 October 2012 with the PG Courses
at 08:30 and ends on Wednesday 17 October 2012 at 16:15 with the Hot
Topics Session.
Congress Venue The Congress takes place at the:
Centro de Congressos de Lisboa (CCL)
Praça das Indústrias
1300-307 Lisbon
Portugal
Tel: +(351) 213601400 - Fax: +(351) 213601499
www.lisboacc.pt
Congress Secretariat For all information regarding the Congress, please contact the
European Society of Intensive Care Medicine
ESICM
Rue Belliard 19
1040 Brussels - Belgium
Tel.: +32 (0)2 559 03 75 - Fax: +32 (0)2 559 03 79
Email: lisbon2012@esicm.org
www.esicm.org
The European Society of Intensive Care Medicine has chosen an
international contractor, K.I.T. Group GmbH, who will ensure a smooth
and efficient management of abstracts, e-Posters and industry
exhibition, registration and hotel accommodation linked to ESICM
LIVES 2012, the 25th Annual Congress. For any further information
regarding the Congress, do not hesitate to contact:
ESICM LIVES 2012
c/o K.I.T. Group GmbH
Association and Conference Management
Kurfürstendamm 71
10709 Berlin - Germany
Tel.: +49 30 24 603 319 - Fax: +49 30 24 603 200
Email: info@esicm-congress.org
www.kit-group.org
Congress Language The official language of the Congress is English. There will be no
simultaneous translation.
Non-Smoking Congress
LIVES 2012 is a non-smoking congress. Therefore, ESICM thanks
participants in advance for not smoking in the congress centre and
exhibition as well as during coffee breaks.
Registration to the Congress All Congress participants are required to personally check in at the
appropriate registration counter. The counters are open during the
following times:
Saturday 13 October Sunday 14 October Monday 15 October
Tuesday 16 October Wednesday 17 October 08:00 - 18:30
08:00 - 20:00
07:30 - 18:30
08:00 - 20:00
08:00 - 17:00
On-site registration will be accepted within the same time frame.
Group pick-ups will be handled by K.I.T. Group on an individual basis.
Please contact K.I.T. Group for further information.
L I V E S 2 012
The ESICM LIVES 2012, 25th Annual Congress is accredited by the
European Accreditation Council for Continuing Medical Education
(EACCME) to provide the following CME activity for medical specialists.
The EACCME is an institution of the European Union of Medical
Specialists (UEMS), www.uems.net
ESICM LIVES 2012, the 25th Annual Congresss is designated for a
maximum of 27 hours of European external CME credits. Each medical
specialist should claim only those hours of credit that he/she actually
spent in the educational activity.
Credits are divided as follows:
PG Courses: 12 credits (6 per day)
Congress: 15 credits (Monday and Tuesday: 6 per day, Wednesday: 3)
Through an agreement between the European Union of Medical
Specialists and the American Medical Association, physicians may
convert ACCME credits to an equivalent number of AMA PRA Category
1 Credits™. Information on the process to convert EACCME credit to
AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognised by
the UEMS-EACCME for ECMEC credits are deemed to be Accredited
Group Learning Activities (Section 1) as defined by the Maintenance of
Certification Program of The Royal College of Physicians and Surgeons
of Canada.
Congress WI-FI Free Wi-Fi is available in several locations throughout the CCL during
ESICM LIVES 2012. Signs willl indicate the hotspots and provide login
information.
Industry Exhibition LIVES 2012 will host an Industry Exhibition including the latest
technology, equipment, pharmaceutical products and literature.
To discuss sponsorship opportunities and rates, please contact the
Congress Department.
The Exhibition will be open during the following hours:
Sunday 14 October
18:45 - 20:15
Monday 15 October
09:00 - 17:00
Tuesday 16 October
09:00 - 17:00
Wednesday 17 October
09:00 - 14:00
Disclaimer
The Organising Committee and K.I.T. Group GmbH accept no liability
for injuries/losses of whatever nature incurred by participants and/or
accompanying persons, nor for loss or damage to their luggage and/
or personal belongings.
On-Site Facilities Restaurants: Lunches are not included in the registration fee.
There will be coffee and lunch areas in the Industry Exhibition.
Cloakroom: The cloakroom and baggage claim is located in the
entrance foyer. €1,70 will be charged for each piece of clothing and
€2,30 for each bag or suitcase.
Lost & Found: Lost items can be collected at the cloakroom during
the Congress and will remain at the CCL after the Congress.
19
Transportation Star Alliance™: Official airline of the Congress
The Lisboa International Airport is located 7km north of the city centre.
From the airport you can reach the city centre and the congress centre
either by taxis or public transportation.
Taxis: The transfer by taxi takes approximately 15 minutes depending
on the traffic and costs around €15. Taxis are always available in front
of the airport building.
Public transportation: From the airport participants can reach the
city centre by taking the AeroBus shuttle service, which leaves every
20 minutes between 7am and 9pm and stops at many hotels until it
reaches Cais do Sodré (downtown Lisbon).
Travel from Cais do Sodré (following busses and a tram) to the Lisbon
Congress Centre (station name: R. Junqueira/Centro de Congressos):
- Bus 732: Marquês Pombal / Caselas
- Tram 15E: Algés / Praça da Figueira
To travel from the Lisboa Congress Centre to other areas, the following
busses are available:
- Bus 714: Praça da Figueira / Outurela
- Bus 727: Estação Roma-Areeiro / Restelo - Av. Descobertas
- Bus 751: Estação Campolide / Linda-a-Velha
- Bus 756: Olaias / R. Junqueira
Detailed information regarding public transportation is available at:
www.carris.pt for trams and busses, and at: www.metrolisboa.pt for
metros.
Train: From Santa Apolónia terminal station, take the blue Metro line
to Baxia-Chiado station, and then change into the green Metro line to
terminus Cais do Sodré.
From Gare do Oriente, take the red Metro line to the station Alameda
and then change in the green Metro line to the terminus, Cais do
Sodré.
From here several busses and a tram travel to the Lisboa Congress
Centre (see Public Transportation).
Passport and Visa
For participants from EU countries, a national identity card is sufficient
to enter Portugal. For citizens of other countries, a valid passport is
required, and for some countries, a visa is required. Should you
have any doubt about the need of an entry visa, please contact the
Portuguese Embassy or Portuguese Consulate in your own country.
20
13-17 October 2012
Save up to 20% on travel with the Star Alliance network
The Star Alliance™ Members airlines are pleased to be appointed as the
Official airline Network for the 25th Congress of the European Society
of Intensive Care Medicine.
To obtain the Star Alliance™ Conventions Plus discounts, please call the
reservation office of a participating Star Alliance Member airline and
quote the following Convention Code: LH04A28.
Registered participants plus one accompanying person travelling
to the event are automatically granted a discount of up to 20%,
depending on fare and class of travel booked.
The participating airlines for this event are: Air Canada, bmi, Air
China, Spanair, Adria Airways, Lufthansa, LOT Polish airlines, SWISS
International air Lines, Egyptair, aNa, Austrian Airlines, Croatia Airlines,
Asiana Airlines, South African Airways, Scandinavian Airlines, Turkish
Airlines, TaP Portugal, United, US Airways
For booking office information please visit:
www.staralliance.com/conventionsplus.
Discounts are offered on published business and economy class fares,
excluding website/Internet fares, senior and youth fares, group fares
and Round the World fares.
Please note: for travel from Japan and New Zealand special fares
or discounts are offered by the participating airlines on their own
network.
When making your travel plans please present confirmation of your
registration or proof of attendance.
ESICM 2012 - SIGHTSEEING TOUR Tickets for hop-on hop-off tours with the company Cityrama will
be on sale in the registration area. The tickets are valid for 24 or 48
hours and allow participants to get on and off the bus at 30 minutes
intervals. Recorded descriptions are available in 14 languages with an
audioguide. Price: from € 10 to € 22 incl. VAT.
L I V E S 2 012
GENERAL Information
Climate
October temperatures in Lisbon average around 18°C (64°F). There is a
chance of rain, but average rainfull is low during this month.
Electricity
The electric current in Portugal is 220/380 volts at a frequency of 50
Hertz.
Language
The official language in Portugal is Portuguese.
Time Zone
Portugal is 1 hour behind Central European Standard Time [CET].
Currency
The Portuguese currency is the Euro.
Paying and tipping
Major credit cards are widely accepted. Prices in hotels and restaurants
as well as the price of taxi fares are calculated to include taxes and
service, but a tip of 5 to 10% for good service is appreciated.
Opening hours
Banks
Typically open from Monday to Friday from 08:30 to 15:00, closed on
Saturdays and Sundays. At other times, money can be exchanged at
the airport and in most hotels.
Shops
Generally open from Monday to Saturday, 10:00 to 13:00 and 15:00 to
19:00, closed on Sundays.
Post Offices
Usually open from Monday to Friday, 09:00 to 12:30 and 14:30 to 18:00
and closed on Saturdays and Sundays.
Telephone
From public call boxes, direct dialling abroad is possible. Phone cards
are commonly used. (available at post offices, kiosks and train stations).
Driving
Speed limit is according to the posted signs, typically 50 km/h in
towns, 90 km/h on major roads outside urban areas, and 120 km/h on
highways.
L I V E S 2 012
21
Map - Congress Centre CCL
MAP CONGRESS CENTRE CCL
LEVEL 0
Level 0
Conference & Meeting Rooms
Exhibition Area
Registration
Catering
Berlin
PG1
IM6
IM8
Stairs
Room Berlin
IM7
Berlin II
PG6
Lounge Area
Catering Area
Stairs
e-Posters &
Replay Theatre
Stairs
Internet Point
POSTER
CORNER
2x
POSTER
CORNER
First Aid
IM5
Exhibition Area A
2x
POSTER
CORNER
IM4
Exhibition
Area B
Geneva
POSTER
CORNER
IM1
POSTER
CORNER
Stairs
e-Posters
Stairs
Poster Corner
Check-in
Slide Preview
Stairs
Internet Point
Cloak
Room
Registration
IM3
ESICM Booth
2x
POSTER
CORNER
Catering Area
POSTER
CORNER
IM2
Glasgow
PG4
Stockholm
PG4
Main Entrance CCL
POSTER
CORNER
LIFE-PRIORITY Area
PG 5: How to write a systematic review & meta-analysis
PG 6: Lung abdominal and cerebral ultrasounds in ICU
22
PG 1: Advanced haemodynamic monitoring
PG 4: Echocardiography
PG 7: Peri-operative care of the high-risk patient: Simulation based
training in ventilation and haemodynamic management
PG 2: Critical care refresher course
PG 3: Designing, conducting and publishing intensive care research
PG 8: Renal replacement therapy
13-17 October 2012
L I V E S 2 012
Map - Congress Centre CCL
LEVEL 1
Level 1
Conference & Meeting Rooms
Exhibition Area
Registration
Catering
IM6
Berlin
IM7
IM8
Overflow 3
Replay
Theatre
Rome
TV
Studio
PG8
Walkway
Overflow 2
Vienna
PG3
e-Posters
Internet Point
Level
2
Exhibition Area
Barcelona
PG2
Lisbon
Members
Lounge
POSTER
CORNER
POSTER
CORNER
Slide Preview
Poster Corner
Check-in
Athens
PG7
Paris
PG7
POSTER
CORNER
Overflow 1
BM 1
BM 2
BM3 PG5
BM 4
Faculty
Lounge
BM 5
BM 6
Faculty
Restaurant
PG 5: How to write a systematic review & meta-analysis
PG 6: Lung abdominal and cerebral ultrasounds in ICU
PG 1: Advanced haemodynamic monitoring
PG 4: Echocardiography
PG 7: Peri-operative care of the high-risk patient: Simulation based
training in ventilation and haemodynamic management
PG 2: Critical care refresher course
PG 3: Designing, conducting and publishing intensive care research
PG 8: Renal replacement therapy
L I V E S 2 012
23
POSTER CORNERS
summary POSTER CORNERS
Area
Day
Time
Abstract Nr
Monday 15 oct.
Tuesday 16 oct.
Area Beja
0031 - 0044 VENTILATOR-INDUCED LUNG INJURY
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
Area Braga
14:00-15:50
Tuesday 16 oct.
10:10-12:00
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
Area Cascais
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Area Coimbra
Tuesday 16 oct.
Tuesday 16 oct.
10:10-12:00
Area Estoril
14:00-15:50
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
Area Evora
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
Area Faro
Tuesday 16 oct.
24
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
13-17 October 2012
0684 - 0697 CLINICAL OUTCOME PREDICTORS IN SEPSIS
0504 - 0517
NUTRITION & GLUCOSE CONTROL
0962 - 0975
RENAL REPLACEMENT THERAPY IN THE ICU
0238 - 0251
IMPROVING COMMUNICATION IN THE ICU
0698 - 0711
ELECTROLYTES & TRACE ELEMENTS
0059 - 0072
TRAUMA UPDATE
0518 - 0530
CARDIOVASCULAR FAILURE IN THE ICU
0976 - 0989
VENTILATORY SUPPORT 2
0252 - 0265
NON-INVASIVE VENTILATION: INDICATIONS & LIMITS
0712 - 0725
0531 - 0544
FLUID & HAEMODYNAMICS IN THE SURGICAL PATIENT
0990 - 1003 TECHNOLOGY FOR THE FAILING HEART & KIDNEY
Monday 15 oct.
Tuesday 16 oct.
TECHNOLOGY FOR VENTILATORY SUPPORT
0073 - 0086 ACUTE CORONARY SYNDROME IN THE ICU
Wednesday 17 oct.
Monday 15 oct.
0224 - 0237
0045 - 0058 SATISFYING METABOLIC DEMAND IN THE ICU
Wednesday 17 oct.
Monday 15 oct.
0490 - 0503 TECHNOLOGY ASSESSMENT IN ACUTE RESPIRATORY FAILURE
0948 - 0961 ARDS: NEW TRENDS IN TREATMENT 2
Monday 15 oct.
Tuesday 16 oct.
Session title
14:00-15:50
0266 - 0278
BEDSIDE ASSESSMENT OF HAEMODYNAMICS
0726 - 0739
FLUID RESPONSIVENESS & GOAL DIRECTED THERAPY
0087 - 0100
PREVENTION OF ICU-AQUIRED INFECTIONS
0545 - 0558
RISK FACTORS, PROPHYLAXIS & OUTCOME OF ICU INFECTIONS
1004 - 1017
BUNDLES FOR ICU INFECTIONS
0279 - 0292
ICU INFECTIONS: BIOMARKERS & ANTIMICROBIAL TREATMENT 1
0740 - 0752
AIRWAY CARE & INSTRUMENTATION
0101 - 0114
SEDATION, Analgaesia & DELIRIUM
0559 - 0572
MANAGEMENT OF CARDIOVASCULAR PATIENTS
1018 - 1031
0293 - 0306
INTENSIVE CARE IN SPECIFIC PATIENT POPULATIONS
0754 - 0764
SEDATION PRACTICES & DELIRIUM
0115 - 0126
ACUTE BRAIN INJURY: THERAPEUTIC COOLING & OUTCOME PREDICTION
0573 - 0585
VENTILATORY SUPPORT IN THE BRAIN-INJURED PATIENT
1032 - 1044
QUALITY & SAFETY IN THE ICU
0307 - 0319
EVALUATING SYSTEMIC & MICRO CIRCULATION
0765 - 0777
OPTIMISING TISSUE OXYGENATION
L I V E S 2 012
Day
Time
Monday 15 oct.
Tuesday 16 oct.
Area Fatima
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
10:10-12:00
Area Funchal Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
10:10-12:00
Area Guarda Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Area Porto
Tuesday 16 oct.
10:10-12:00
Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
10:10-12:00
Area Setubal Wednesday 17 oct.
Monday 15 oct.
Tuesday 16 oct.
14:00-15:50
Monday 15 oct.
Tuesday 16 oct.
Area Sintra
10:10-12:00
Tuesday 16 oct.
Monday 15 oct.
Tuesday 16 oct.
Life-Priority
Tuesday 16 oct.
0586 - 0599
ARDS: NEW TRENDS IN TREATMENT 1
1045 - 1058
TECHNOLOGY IN THE ICU
0320 - 0332
PHYSIOTHERAPY IN THE ICU
0778 - 0791
PNEUMONIA IN THE ICU: PREVENTION & TREATMENT
0141 - 0154
ACUTE KIDNEY INJURY: EVALUATION & TREATMENT
0600 - 0613
ABDOMINAL COMPLICATIONS IN THE ICU
1059 - 1072
0333 - 0346
POSTOPERATIVE MANAGEMENT OF CARDIO-SURGICAL PATIENTS
0792 - 0805
NEURO-EMERGENCIES & TRAUMA
0155 - 0167
IMPACT OF SPECIFIC ICU INTERVENTIONS
0614 - 0627
EMERGENCY MEDICINE
1073 - 1085
ACUTE KIDNEY INJURY: PATHOPHYSIOLOGY
0347 - 0360
EVALUATION OF SEPSIS BIOMARKERS
0806 - 0819
EVALUATION OF CARE IN TRAUMA & EMERGENCY MEDICINE
0168 - 0181
INFLAMMATORY RESPONSE IN SEPSIS: NEW INSIGHTS
0628 - 0641
END OF LIFE CARE - ETHICS OF RESEARCH
1086 - 1099
RE-EVALUATION OF SEPSIS THERAPIES
0361 - 0374
ORGAN DYSFUNCTION IN SEPSIS
0820 - 0833
INDICATORS OF COST, QUALITY & OUTCOME
0182 - 0195
PAEDIATRICS 1: NOT SMALL ADULTS!
0642 - 0655 ORGANISATION OF INTENSIVE CARE
1100 - 1113
SCORING & PROGNOSIS IN ICU PATIENTS
0375 - 0387
OUTCOME FROM INTENSIVE CARE
0834 - 0847 SEPTIC SHOCK: METABOLIC MARKERS, ORGAN DYSFUNCTION & THERAPY
10:10-12:00
14:00-15:50
IMPROVING ICU CARE & ORGANISATION
0656 - 0669 PAEDIATRICS 2: NOT SMALL ADULTS!
TRAINING ICU TEAMS
0388 - 0401 HAEMORRHAGIC STROKE: INTERVENTIONS & MARKERS
0848 - 0858 NURSING INTERVENTIONS
0210 - 0223
Wednesday 17 oct.
Monday 15 oct.
IMAGING TO GUIDE TREATMENT OF ACUTE RESPIRATORY FAILURE
1114 - 1127
14:00-15:50
Session title
0127 - 0140
0196 - 0209
Wednesday 17 oct.
Monday 15 oct.
Abstract Nr
POSTER CORNERS
Area
PNEUMONIA REVISITED
0670 - 0683 EPIDEMIOLOGY OF ICU-RELATED INFECTIONS
1128 - 1140
NURSING ASSESSMENT & TRAINING
0402 - 0415
OUTCOME PREDICTION AFTER CARDIAC ARREST
0859 - 0872
AUDIT & ASSESSMENT OF CRITICAL CARE PRACTICE
Try the
e-posters
experience in the
exhibition
area
L I V E S 2 012
25
POSTER CORNERS
Map - Poster Corners
LEVEL 0
Level 0
Try the
e-posters
experience in the
exhibition
area
Berlin
PG1
IM6
Stairs
Room Berlin
IM7
Berlin II
PG6
IM8
Lounge Area
Catering Area
Stairs
e-Posters &
Replay Theatre
Stairs
Internet Point
Fatima
Faro
First Aid
Evora
IM5
Guarda
Cascais
Geneva
Braga
IM3
Coimbra
ESICM Booth
Estoril
Catering Area
IM4
Funchal
IM1
IM2
Stairs
Poster Corners
Porto, Setubal, Sintra
Registration
Stairs
Poster Corner
Check-in
Stairs
e-Posters
Stairs
Internet Point
Beja
Cloak
Room
Glasgow
PG4
Stockholm
PG4
Main Entrance CCL
LIFEPRIORITY
26
13-17 October 2012
LIFE-PRIORITY Area
L I V E S 2 012
Map - Poster Corners
POSTER CORNERS
Level 1
LEVEL 1
30 minutes before the next session?
Visit the Replay theatre
Level 1 - Exhibition Area A - Gallery
IM6
Berlin
IM7
IM8
Replay
Theatre
Rome
TV
Studio
PG8
Walkway
Vienna
PG3
Exhibition Area
Exhibiti
e-Posters
Internet Point
Stairs
Level 2
Barcelona
PG2
Lisbon
Members
Lounge
Sintra
Poster Corner
Check-in
Slide Preview
Setubal
Athens
PG7
Paris
PG7
Porto
BM 1
BM 2
BM3 PG5
BM 4
L I V E S 2 012
Faculty
Lounge
BM 5
BM 6
Faculty
Restaurant
27
TO be cOnTinued >
The intensive connection for…
better performance_
Web-bAsed, e-leArning prOgrAmme
FOr inTensive cAre
Covers the Critical Care Medical curriculum
Quarterly, peer-reviewed, module updates
web-based access to
• pubmed abstracts and on-line resources
• Full text intensive care medicine references
• Selected eSicm ‘flash conference’ lectures
links to targeted Intensive / Critical Care
Medicine textbook extracts
• a concise textbook (Hinds and Watson - 2008)
• oxford Desk reference (Waldman, Soni,
rhodes editors - 2008)
EDIC-style self assessment
new ‘google-style’ programme search tool
fEES_
free for ESICM members
non-members - 395
(renewal 95 /yr)
Institutions/libraries - 800
(renewal 400 /yr)
Attractive introductory offers:
institutions/libraries will get a free access to 4 (of
44) modules for a 3-month free trial
JOIn uS_
pact@esicm.org
http://pact.esicm.org
www.esicm.org
esicm activities
TO BE CONTINUED >
The intensive connection as you…
Visit the ESICM members lounge_
AN EXCLUSIVE PLACE FOR ESICM
MEMBERS
Opening hours :
Saturday 13 October
Sunday 14 October
Monday 15 October
Tuesday 16 October
Wednesday 17 October
08:00 - 18:30
07:30 - 20:30
08:00 - 19:30
08:00 - 19:30
08:00 - 16:00
ENJOY_
ESICM members are welcome in a lounge where
they can relax and refresh, network with all the
members, access a meeting area, watch live
broadcasts from our hottest sessions or surf the
internet in the iPad bar.
NOT YET A MEMBER ?_
Come to our booth and join us!
www.esicm.org
ESICM activities
LIVES 2012 is a privileged time for ESICM members to meet. Most ESICM Committees, Sections and Working Groups will
take advantage of this opportunity to hold meetings and project planning sessions. ESICM also hosts its most important
annual meeting during the congress - the General Assembly for all ESICM members.
ESICM MEMBERS LOUNGE
ESICM members are welcome in the lounge where they can relax
and refresh, keep up to date with daily newspapers, chat with other
members or go online with free internet access.
The opening hours are:
Saturday 13th October
Sunday 14th October Monday 15th & Tuesday 16th October
Wednesday 17th October
08:00-18:30
07:30-20:30
08:00-19:30
08:00-16:00
This comfy place is located in Foyer D, on the 1st floor of the CCL.
ESICM BUSINESS MEETINGS
ESICM business meetings are scheduled from Saturday 13th October
until Wednesday 17th October from 09:00 to 12:00. For a detailed
schedule, please contact ESICM Staff (Exhibition Area).
PROFESSIONAL DEVELOPMENT ACTIVITIES
The Division of Professional Development via the Education & Training
committee (ETC) is in charge of developing and promoting the
educational and training strategy of ESICM. This entails coordinating
the efficient and effective work of EDIC, PACT and the Clinical Training
subcommittee. The Committee also has a role in advising on the
educational activities within the Society which includes collaborating
with the Congress Committee on the educational and competency
tracks of the Annual Congress. It will also continue to coordinate
developments in the roll-out of the CoBaTrICE programme.
EDIC
The written examination for the European Diploma in Intensive Care
(EDIC) will take place on
Monday 15th October 2012, 11:00 - 14:00
Pavilhão Atlântico - Rossio dos Olivais- Lote 2.13.01A
1190-231 Lisbon, Portugal
ESICM GENERAL ASSEMBLY
The annual General Assembly of the membership will take place in
room Stockholm on Tuesday 16th October 2012. A welcome cocktail
will be served at 17:30 before the assembly (18:15-19:30). All ESICM/
ESPNIC members are strongly encouraged to participate.
RESEARCH ACTIVITIES
Research is crucial to the Society, and we are continuing to increase
the level of resource we are devoting to its support. Acquiring an eCRF
capability to support our researchers is just one example of the type of
investment we are making. If you wish to become more involved, visit
our website www.esicm.org/research and please use the resources
of your section.
ESICM ON THE WEB
Website
Details regarding the Society and its various activities: Applications
for membership/EDIC, registration to the Congress, hotel booking,
submission of abstracts, flash conferences, the LIFE-PRIORITY fund
campaign, Web TV, events, news, and much more are available on
the website: http://www.esicm.org. Further information about
membership or ESICM activities can also be obtained from the
Secretariat based in Brussels via phone or email, please see About US/
Who we are on the ESICM website for contact details.
Social Media
ESICM keeps in touch with members and fans through their Facebook
page (http://www.facebook.com/pages/European-Societyof-Intensive-Care-Medicine-ESICM/218844214848666) and Twitter
account (https://twitter.com/ESICM). News, articles, notes, quotes,
photos, exam questions, and daily updates on ESICM and research in
the field - vital tools to the modern intensive care practitioner can be
found on these pages. ESICM also hosts a Twitter account especially for
our meetings: Check out https://twitter.com/LIVES_2012 to network
with other participants and “Tweet” about your favorite sessions at
LIVES 2012. Links to all our pages can be found on the ESICM website
and on the LIVES 2012 Smartphone App!
CONTINUING MEDICAL EDUCATION CREDITS
European / International Participants
The 25th ESICM LIVES Annual Congress is accredited by the European
Accreditation Council for Continuing Medical Education (EACCME) to
provide the following CME activity for medical specialists. The EACCME
is an institution of the European Union of Medical Specialists (UEMS),
www.uems.net.
The 25th ESICM LIVES Annual Congress is designated for a maximum of
27 hours of European external CME credits. Each medical specialist
should claim only those hours of credit that he/she actually spent in
the educational activity.
Last year the ESICM Systematic Review Group, led by Djillali Annane,
published its first handbook, entitled Clinical Evidence in Intensive
Care. It includes summaries of 60 systematic reviews containing expert
opinions organised into 14 topical sections, which are directly relevant for
intensive care practitioners. If you did not receive a free copy (provided
for all members), please visit the ESICM booth and pick one up.
Through an agreement between the European Union of Medical
Specialists and the American Medical Association, physicians may
convert EACCME credits to an equivalent number of AMA PRA
Category 1 Credits™. Information on the process to convert EACCME
credit to AMA credit can be found at www.ama-assn.org/go/
internationalcme.
The activities of the European Critical Care Research Network (ECCRN)
are flourishing, and in 2012 we received 76 high quality applications
for a total of 7 awards, including two industry-sponsored awards; one
from Dräger and a new one this year from Nestlé. The winners will be
announced during the Congress.
Live educational activities, occurring outside of Canada, recognised by
the UEMS-EACCME for ECMEC credits are deemed to be Accredited
Group Learning Activities (Section 1) as defined by the Maintenance of
Certification Program of The Royal College of Physicians and Surgeons
of Canada.
The clinical trials activities continue to develop with several studies
currently under discussion and for which meetings have been
organised. Two priority areas are SDD and SARI (Severe Acute
Respiratory Failure).
L I V E S 2 012
The credits are divided as follows:
- PG Courses: 12 credits (6 per day)
- Congress: 15 credits
(Monday and Tuesday: 6 per day, Wednesday: 3)
31
ESICM General Assembly
Tuesday 16 October 2012
18:15-19:30 Room Stockholm, LEVEL 0
A welcome cocktail will be served from 17:30 in front of Room Stockholm.
AGENDA
Welcome / Introduction (Andrew Rhodes)
Administrative Affairs
Membership; Elections (Philipp Metnitz)
Finances (Andrew Rhodes)
Division of Scientific Affairs
Giuseppe Citerio
Division of Professional Development
Marco Maggiorini
Other matters
Questions and answers from the membership
NB. All ESICM Members, Associates and Honorary members may attend.
32
13-17 October 2012
L I V E S 2 012
TO be cOnTinued >
Full interaction_
SMARTPHOnE APPlICATIOn
ESICM lIVES 2012
FOr An inTerAcTive pArTicipATiOn TO
The cOngress
ESICM releases its lIVES 2012 smartphone app
with even more interactivity!
With the eSicm liVeS 2012 smartphone app, all
the congress info you need to become an active
participant in congress sessions and activities will
be available at your ‘fingertips’.
The ESICM lIVES 2012 smartphone App gives you
access to:
• Scientific programme
• personal planner
• list of sponsors and exhibitors
• Floor plans
• abstracts of the 2012 congress
• Webcasts of the 2010 and 2011 congresses
• registration barcode for badge printing
nEw THIS YEAR!_
Take an active part in the congress via
the application by:
• Voting in the dedicated sessions
• Sending your questions to the chairmen
• rating the session
• taking part in the networking between
registered delegates
• Using the social media of the congress
Facebook and twitter
DOwnlOAD nOw_
on the app Store
iPhone user :
ESICM lIVES 2012
Smartphone user : app content can be accessed
through esicm2go.org
www.esicm.org
TO be cOnTinued >
success_
www.esicm.org
TO be cOnTinued >
cutting-edge research_
GET InVOlVED!
reseArch AT esicm
A JOinT eFFOrT!
ESICM aims to foster collaborative research
among its members and to promote European
Intensive Care Research
• We establish networks of investigators and
research teams
• We provide forums for discussion of research
projects
• We develop and implement clinical trials
• We provide access to methodological help
(e.g. meta-analysis group - Srg)
• We offer opportunities for education and collegial
support for emerging investigators
• We foster communication within the icU research
community
Join our Trials group and give more visibility to
your research projects
Join on-going research projects or submit
proposals for collaborative studies
JOIn uS_
To learn more, go to www.esicm.org and visit the
Research section
www.esicm.org
HOw ?_
tHe eUropean critical care
reSearcH netWork
ECCRn offers you, researcher in the field of ICM,
the opportunity to develop your studies and to
increase knowledge about how to improve care
for critically ill patients.
applY For eccrn enDorSement
for surveys at national or international level
endorsed surveys can be distributed to over 8000
intensive care professionals
for studies conducted by individual centres or by
research groups
applY For enDorSement or SUpport US!
JOIn uS_
For more information, please visit our website
www.esicm.org or write to
researchdept@esicm.org
eccrn: connecting you to research !
ESICM & industry
research awards 2013
share your ideas and promote your own research!
APPlICATIOn fOR THE 2013 AwARDS wIll
BE OPEn On fEBRuARY 1ST
> all memberS are Welcome to applY.
> more DetailS aVailable on www.ESICM.ORG
2012 RESEARCH AwARD wInnERS
APPlY In 2013
YOunG InVESTIGATOR
Headspace analysis of airway fluid samples for the prediction of ventilator-acquired pneumonia
lIEuwE D.J. BOS
amsterdam, netherlands
rapid and timely diagnosis of Vap by means of biological markers is very much needed, but not yet available. ideally, multiple
biomarkers originating from the lung should be sampled when assessing Vap. changes in volatile metabolic composition
of balF and/or tracheal aspirates (tas) may reflect bacterial metabolism, increasing number of pathogens in the airways,
and/or altered metabolism of the host due to inflammation. Volatile metabolites can be separated, detected and quantified
using gas–chromatography and mass–spectrometry (gc/mS) or fingerprinted using an electronic nose. the aim of this study
is to build a prediction model for (1) the development of Vap and (2) the causative pathogen using volatile metabolites in
headspace air of tas/balF. 200 mechanically ventilated patients were already included in Spain and 30 additional patients
with suspected pneumonia will be included as a validation cohort. tas were obtained every second day while a bal was
performed when a patient met clinical suspicion criteria for Vap. in this study the Voc in the tas and the balF is analyzed by
both gc/mS (amsterdam, the netherlands) and electronic nose analysis.
lEVI MOnTAlCInI
Effect of continuous haemofiltration on essential nutrients in critically ill patients with acute
kidney injury
DAnIEllE BEAR
london,
United kingdom
critically ill patients with acute kidney injury (aki) have a high mortality, especially if renal replacement therapy (rrt) is
needed. it remains uncertain whether trace elements, vitamins and amino acids are lost during rrt in sufficient amounts
to result in clinically significant deficiencies. We plan to serially measure plasma levels of micronutrients and essential
amino acids in 30 critically ill patients with severe aki for up to 6 days. the aim is to evaluate whether there are any losses
into the filtrate during continuous veno-venous haemofiltration at two different doses (25-35ml/kg/hr and >35ml/kg/hr)
and compare these with a control group of patients with aki not receiving rrt. We hope that the completion of this study
will further enhance our understanding of the nutritional management of these complex patients and ideally lead towards
a randomised controlled intervention trial in the near future.
ESTABlISHED InVESTIGATOR
use of contrast enhanced ultrasound echo (CEuS) to identify early renal microcirculatory
alterations associated with the development of AKI in critically ill patients: A validation study
CAn InCE
rotterdam, netherlands
current experimenta findings have led to the insight that renal microcirculatory flow alterations are key in the development
of acute kidney injury (aki). However, monitoring the renal microcirculation in critically ill patients at the bedside has been
impossible to date due to the unavailability of suitable technology. in this project we aim to introduce a new modality of
ultrasound that uses microbubbles for contrast enhancement (contrast-enhanced ultrasound; ceUS) imaging to identify
alterations in microcirculatory perfusion in the renal cortex non-invasively for the early clinical diagnosis and management
of aki in critically ill patients. in this project we aim to validate this new technique in porcine models of aki for monitoring
the microcirculatory blood flow distribution in the renal cortex as would done in patients. imaging of the cortical perfusion
will be done by ceUS imaging through the skin on one kidney (as would be the case in the clinic) and laser speckle
imaging (lSi) without skin on the other kidney. lSi is a technique we have previously validated for imaging renal cortical
microcirculatory perfusion by comparison to intravital microscopy and laser Doppler velocimetry. models of aki which
will be investigated include a normotensive and hypotensive model of septic aki with and without fluid resuscitation,
ischemia/reperfusion-induced aki and and isovolemic hemodilution. by performing this study we will validate and further
develop ceUS imaging for clinical use for the identification and monitoring alterations in renal microcirculatory perfusion
in critically ill patients. it is anticipated that ceUS imaging can be used to study the pathogenesis of aki at the bedside
and give real-time feedback on the effects of different resuscitation strategies, such as liberal or restrictive fluid therapy.
liSbon 2012
ClInICAl RESEARCH
Disproportionate care in the ICu: Impact for the patient, the family, healthcare providers and
the society
DOMInIQuE BEnOIT
ghent, belgium
the objective of this project is to assess the impact of postponed end of life decisions in the intensive care Unit on the patient,
the relatives, the doctors and nurses, and the society, and to identify the reasons why these decisions are postponed. For this
purpose objective and subjective data concerning the patient’s health status will be prospectively collected on a daily base
in 10 units in europe during 2 months. the subjective data consist of a daily assessment of the presence of disproportionate
(“too much” or “not enough”) care for a given patient as perceived by the doctors and nurses. by relating the time of onset
and duration of dis-, partial and full agreement of perception of disproportionate care among doctors and nurses with the
time of onset of official decisions to forego life sustaining treatments and the time of death, we will able to assess the
incidence and duration of postponed eol decisions and to assess its impact on the society through a health economic
analysis. Furthermore, in case of disproportionate care, the severity of the experienced moral distress will be asked as well
as the reasons why disproportionate care is still provided according to the health care provider. the impact of postponed eol
decisions on the relatives and health care providers will further be explored during one year through validated questionnaires
and in depth interviews in a single center. Finally, based upon these data an interventional trial aimed at decreasing the
likelihood of disproportionate care and its consequence(s) will be conducted.
Prevention of ventilator-associated pneumonia by continuous tracheal cuff pressure control
systems : the randomised control “noleak” Study
BEnOîT MISSET
paris, France
Ventilator associated pneumonia are mostly due to the leak of pharyngeal secretions around the tracheal tube and its
cuff. a control of the cuff pressure is recommended in most guidelines and usually performed with a manual system. a
continuous automated device have been proven better than a manual system in a single center study. We intend to perform
a multicenter randomized study testing 4 commercialized devices to control the cuff pressure, of which one is manual and
three are automated, either pneumatic or electronic. our primary goal is to objective a reduction in Vap incidence assessed
with broncho-alveolar lavage. our secondary goals are to assess the efficiency of the different devices on cuff pressure
control, incidence of trachea-bronchial colonization, length of mechanical ventilation, length of stay and mortality. We intend
to include 800 patients over 2 years. the tested devices will be provided by the industrials which commercialize them. the
funding of activities such as data collection, quality control, biostatistics, administrative issues and legal authorizations will
be achieved in part by the eccrn grant.
BASIC SCIEnCE
Renal microvascular and mitochondrial oxygenation assessed quantitatively during the
development of sepsis-induced acute kidney injury and fluid therapy
this project concerns the development of a setup for quantitative assessment of microvascular and mitochondrial oxygen
tensions in the kidney in vivo during sepsis and fluid resuscitation. Having completed this, pathophysiological animal
studies will be conducted to investigate the roles of renal microvascular and mitochondrial oxygen transport and utilization
in lipopolysaccharide-induced sepsis and acute kidney injury (aki). We anticipate that such innovative methodology will
provide novel insights regarding the role of mitochondrial dysfunction in critically ill patients and renal disease and
potentially identify therapeutic opportunities for the prevention and/or treatment of aki in the intensive care unit.
RICK BEZEMER
amsterdam, netherlands
Haemodynamics effects of lung function optimisation in Acute Respiratory Distress
Syndrome (HEARDS)
ARnAlDO SAnTOS
OVIEDO
madrid, Spain
this experimental research project aims at studying the hemodynamic response to different lung conditions and lung
protective ventilation strategies in a porcine model of acute respiratory Distress Syndrome. in particular, the project will
describe and explore how and to what extent these conditions and ventilation strategies affect right ventricular function,
pulmonary circulation and their coupling together with the resulting effects on systemic circulation. the hemodynamic
evaluation will be performed using advanced monitoring that include intra-vascular and transmural pressures monitoring,
continuous pulmonary blood flow and velocity, ventricular pressure-volume loops, regional distribution of perfusion by
means of electrical impedance tomography and echocardiography. this will allow us to perform a more comprehensive
analysis including ventricular-vascular coupling, pulmonary impedance analysis and right ventricular pressure-volume
relationships. the compared lung protective ventilation strategies will include the arDSnet strategy of low tidal volume
ventilation (permissive atelectasis and hypercapnia) and the open lung ventilation strategy re-expanding the lung and
stabilising it with high levels of peep.
With this study we intend to get a more in depth knowledge of the mechanisms involved in right ventricular failure and
ventricular-vascular coupling during mechanical ventilation and determine which ventilation strategies can, at the same
time, best protect the lung and the right ventricle.
THE ESICM InDuSTRY
reSearcH aWarDS
Bernhard Dräger Award for Advanced Treatment of
Acute Respiratory failure
the bernhard Dräger award allocates a grant of 15,000 to
research focusing on developing new knowledge
related to advanced non-invasive respiratory monitoring and
its application to the field of respiratory support.
wInnER 2012
“Stress raisers”
in acute respiratory Distress Syndrome
Ventilator induced lung injury (Vili) is a well recognised side effect of mechanical ventilation.
Volumes needed to induce Vili in healthy animals are in the range of the total lung capacity
(~38 ml/kg) while retrospective data from clinical studies suggest that ventilation with low tidal
volumes, even below 6 ml/kg, may be harmful. a possible explanation is that, in inhomogeneous
materials, forces are locally concentrated at discontinuities, which act as “stress raisers/pressure
multiplier”. We developed a software to quantify by ct scan the extent and intensity of the “stress
raisers”. We designed this study in order to demonstrate: (1) the time course of stress raisers
development during mechanical ventilation in a swine model (2) if the ”stress raisers” location is
associated with increased inflammation, as measured with 18-FDg pet (3) Determine a threshold
of stress raiser extent beyond which a safe mechanical ventilation is unfeasible.
MASSIMO CRESSOnI
milan, italY
THE PAST wInnERS ARE:
FUnctional reSiDUal capacitY
gUiDeD alVeolar recrUitment
StrategY in patientS WitH
acUte reSpiratorY FailUre
aFter carDiac SUrgerY
inVeStigation oF
carDioreSpiratorY coUpling,
Heart rate anD breatHto-breatH VariabilitY For
Weaning oUtcome aSSeSSment
in mecHanicallY VentilateD
patientS
DR VASIlIOS
PAPAIOAnnOu
greece 2009
DR HERMAnn HEInZE
germanY
2008
intra- anD poStoperatiVe
titration oF poSitiVe enDexpiratorY preSSUre (peep)
USing electrical impeDance
tomograpHY (eit)
clinical ValiDation oF
electrical impeDance
tomograpHY aS a beDSiDe
tool to aDJUSt mecHanical
Ventilation in arDS
DR JEAn-CHRISTOPHE
RICHARD
France 2010
THOMAS MuDERS
germanY
2011
liSbon 2012
THE ESICM InDuSTRY
reSearcH aWarDS
nestlé Award for Practice Improvement in ICu nutrition
the nestlé award allocates a grant amounting to 20,000
to research focusing on developing new knowledge related
to nutrition in intensive care units and its
applications.
wInnER 2012
Can ICu patients utilise extra amino acids to build
new proteins?
OlAV ROOYACKERS
StockHolm, SWeDen
the question to feed, or more accurate when and how to feed, icU patients is at the moment
very open. in the current sponsored project we will address the question whether icU patients
are able to utilize extra amino acids/proteins in the feeding for building new proteins or
whether they oxidize them. Stable isotope labelled amino acids will be used to measure in vivo
protein turnover and oxidation rates. icU patients will be studied during feeding according
to the clinic routines and during an increased amount of amino acids (1.5g/kg/24 h or 2.0g/
kg/24h) while the amount of sugar and fat will be kept the same. We hypothesize that the
patients will be able to utilize the extra amino acids/proteins to build new body protein and
thereby fight their catabolism.
ISf AwARD
The International Sepsis forum Research Award (ISf) is a
unique collaborative effort between industry and academia.
it is the first initiative to focus solely on management of patients with severe
sepsis. While sepsis and its sequelae are still associated with high morbidity
and mortality rates, new data on patient management are emerging that may
ultimately significantly improve the current situation. Such findings need to
be evaluated and incorporated, when appropriate, into existing treatment
protocols. Headed by a council of international experts and opinion leaders,
the iSF is focused exclusively on improving the management of sepsis and,
in particular, septic shock by developing an international consensus on the
latest understanding of key scientific and clinical issues, and disseminating
emerging practice guidelines to researchers, intensivists, and other critical
care professionals worldwide. one of their awarded selections is chosen
from abstracts submitted to liVeS 2012.
Winner 2012
Effects of statins on mitochondrial respiration and outcome
during experimental sepsis.
JéRôME MOREl
France
through their anti-oxidant and anti-inflammatory properties, statins may
positively impact upon mitochondrial function. However, on the other hand,
statins can inhibit ubiquinone, an electron carrier of the mitochondrial
respiratory chain and a mitochondrial antioxidant. We thus sought to study
the effects of statins on a long-term rat model of sepsis. Faecal peritonitis
was induced in instrumented male Wistar rats that were monitored and
fluid-resuscitated for 72h. Simvastatin 20mg/kg bd was administrated by
gavage, commencing either 3 days’ pre-sepsis [pre-treatment], or from 6h
post-sepsis [post-treatment]. a control group received vehicle but no active
drug [vehicle]. Survival at 72h (16 per group) was 43.7%, 25% and 12.5% for
pre-treatment, vehicle, and post-treatment groups, respectively, (p<0.05).
in a second set of experiments, heart and muscle ubiquinone (coQ9) levels
and ex vivo muscle oxygen consumption in permeabilized soleus muscle
fibres were measured at 24h post sepsis. Ubiquinone was significantly
decreased in hearts taken from statin pre-treated animals, however plasma
lipid levels were unaffected and organ function significantly improved. the
significant reduction in muscle oxygen consumption seen in the untreated
septic animals was prevented in both groups receiving simvastatin. We thus
confirm the beneficial effect of statins when given before the onset of sepsis.
this beneficial effect is likely to be multi-factorial but may be attributed in
part to protective effects on mitochondrial respiration.
liSbon 2012
THE STOuTEnBEEK AwARD
the Stoutenbeek award has been established in memory of professor c.p.
Stoutenbeek. He was an all-round clinician, driven by a deep interest to
understand the pathogenesis of critical disease. He advocated closed-format
intensive care, initiated the foundation of a national intensive care database
and the implementation of bedside patient data management systems, all
focused on the improvement of clinical treatment and use of intensive care
facilities. He died in 1998 at the age of 52.
The Stoutenbeek Award is granted to a candidate who:
• demonstrates excellence as an intensive care investigator
• presents the protocol of a clinical investigation (in preparation or under
way) that addresses an issue relevant for clinical practice in intensive care
medicine
• qualifies through published studies
the investigation must meet the requirements of good clinical practice, be
in line with the philosophy of chris Stoutenbeek and result in a publication in
an international journal.
Winner 2012
Tolerance and metabolic effects of a novel lactate buffered
dialysis and substitution fluid for citrate anticoagulated
continuous renal replacement therapy
MARTIn BAlIK
StatitUiS
We designed an original lactate buffered solution for citrate anticoagulated
rrt (“lactocitrate”), in response to the absence of data in current literature
and the unavailability of a similar solution. based on the pilot study (to be
presented at the 25th eSicm congress in lisbon) and our current continuing
research we aim to verify our 6 hypotheses. if they are proved we might
estimate that a single chamber polypropylene bag and lactate based fluid is
significantly cheaper than a two chamber bicarbonate buffered bag. these
findings, alongside our recent data may prove that citrate modality is cheaper
than heparin modality.
> Advanced haemodynamic monitoring
> Lung abdominal and cerebral ultrasounds in ICU
> Critical care refresher course
> echocardiography
> renal replacement therapy
> peri-operative care of the high-risk patient: simulation based
> Designing, conducting and publishing intensive care research
> How to write a systematic review & meta-analysis
10 october
saturday
pre-congress
educational programme
PG OVERVIEW
Saturday 13 October - PG
ROOM
Berlin
Berlin II
Barcelona
Glasgow
Stockholm
08:15
08:30
CRITICAL CARE
REFRESHER COURSE
08:45
09:00
09:15
ACUTE CIRCULATORY
FAILURE
09:30
09:45
10:00
10:15
10:30
CRITICAL CARE
REFRESHER COURSE
10:45
11:00
11:15
11:30
11:45
12:00
ADVANCED
HAEMODYNAMIC
MONITORING
ECHOCARDIOGRAPHY
ACUTE RESPIRATORY
FAILURE
PHYSIOLOGY AND
PATHOPHYSIOLOGY
12:15
saturday 13 OCTOBER
12:30
12:45
13:00
CRITICAL CARE
REFRESHER COURSE
13:15
13:30
13:45
14:00
14:15
14:30
ADVANCED
HAEMODYNAMIC
MONITORING
INFECTION AND
INFLAMMATION
THE TOOLS
14:45
15:00
15:15
15:30
15:45
16:00
16:15
16:30
16:45
ADVANCED
HAEMODYNAMIC
MONITORING
LUNG ABDOMINAL
AND CEREBRAL
ULTRASOUNDS IN ICU
ECHOCARDIOGRAPHY
GROUP A
NERVOUS SYSTEM
ECHOCARDIOGRAPHY
CRITICAL CARE
REFRESHER COURSE
17:00
LECTURES &
INTERACTIVE CLINICAL
CASES (ICC)
GROUP B
CRITICAL CARE
REFRESHER COURSE
CEREBRAL
ULTRASOUND
FROM THEORY TO
PRACTICE
ECHOCARDIOGRAPHY
LECTURES &
CASES (ICC)
GROUP A
ECHOCARDIOGRAPHY
GROUP B
NEPHROLOGY,
ELECTROLYTES, ACID
BASE AND FLUID
MANAGEMENT
17:15
17:30
17:45
18:00
PG titles
ADVANCED HAEMODYNAMIC MONITORING
CRITICAL CARE REFRESHER COURSE
ECHOCARDIOGRAPHY
44
13-17 October 2012
L I V E S 2 012
Paris
ROOM
Vienna
BM3
08:15
08:30
08:45
09:00
DESIGNING, CONDUCTING AND
PUBLISHING INTENSIVE CARE
RESEARCH
09:15
09:30
09:45
PG OVERVIEW
Saturday 13 October - PG
THE RIGHT DESIGN FOR YOUR
RESEARCH QUESTION
10:00
10:15
10:30
RESEARCH
10:45
11:00
11:15
FINANCIAL & REGULATORY
ASPECTS
11:30
11:45
12:00
12:15
12:45
13:00
13:15
RESEARCH
13:30
13:45
14:00
HOW TO WRITE A
SYSTEMATIC REVIEW
& META-ANALYSIS
THE ABC OF DATA ACQUISITION
AND ANALYSIS
14:15
14:30
14:45
15:00
15:15
15:30
15:45
16:00
saturday 13 OCTOBER
12:30
PERI-OPERATIVE CARE OF THE
HIGH-RISK PATIENT: SIMULATION DESIGNING, CONDUCTING AND
BASED
RESEARCH
TRAINING IN VENTILATION AND
HAEMODYNAMIC MANAGEMENT
STATISTICAL ANALYSIS
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
PG titles
PERI-OPERATIVE CARE OF THE HIGH-RISK PATIENT: SIMULATION BASED
Designing, conducting and publishing intensive care research
L I V E S 2 012
45
PG OVERVIEW
Sunday 14 October - PG
Room
Berlin
Berlin II
Barcelona
Rome
08:00
08:15
08:30
08:45
09:00
09:15
09:30
09:45
10:00
10:15
CRITICAL CARE
REFRESHER COURSE
ADVANCED
HAEMODYNAMIC
MONITORING
IMPROVING PATIENTS’
OUTCOME IN EVERYDAY
PRACTICE:
HOW TO DO IT
ABDOMEN
RENAL REPLACEMENT
THERAPY
ACUTE KIDNEY INJURY
LUNG ABDOMINAL
AND CEREBRAL
ULTRASOUNDS IN ICU
ECHOCARDIOGRAPHY
LECTURES &
CASES (ICC)
GROUP B
LUNG AND PLEURAL
10:30
ULTRASOUND
10:45
11:00
CRITICAL CARE
REFRESHER COURSE
NUTRITION,
METABOLISM,
ENDOCRINOLOGY,
INTOXICATION
11:15
11:30
RENAL REPLACEMENT
THERAPY
11:45
RRT
12:00
SUNDAY 14 OCTOBER
Glasgow
ECHOCARDIOGRAPHY
LECTURES &
CASES (ICC)
GROUP A
12:15
12:30
12:45
13:00
13:15
13:30
ADVANCED
HAEMODYNAMIC
MONITORING
INTERACTIVE CASE
BASED DISCUSSION
CRITICAL CARE
REFRESHER COURSE
13:45
TRAUMA AND SURGERY
14:00
RENAL REPLACEMENT
THERAPY
ANTICOAGULATION
MANAGEMENT
14:15
14:30
14:45
15:00
LUNG ABDOMINAL
AND CEREBRAL
ULTRASOUNDS IN ICU
15:15
ABDOMINAL
ULTRASOUND
15:30
15:45
16:00
CRITICAL CARE
REFRESHER COURSE
OTHERS (SEDATIONAnalgaesia,
PHARMACOLOGY,
MANAGEMENT, ETHICS)
RENAL REPLACEMENT
THERAPY
SPECIAL PROBLEMS IN
AKI PATIENTS
16:15
ECHOCARDIOGRAPHY
LECTURES &
CASES (ICC)
GROUP B
ECHOCARDIOGRAPHY
LECTURES &
CASES (ICC)
GROUP A
16:30
16:45
17:00
PG titles
ECHOCARDIOGRAPHY
46
13-17 October 2012
L I V E S 2 012
Room
Stockholm
Paris
Vienna
BM3
08:00
08:15
RESEARCH
08:30
08:45
CONDUCTING SINGLE CENTRE/
PATHOPHYSIOLOGICAL STUDIES
09:00
09:15
09:30
09:45
PG OVERVIEW
Sunday 14 October - PG
ECHOCARDIOGRAPHY
GROUP A
10:00
RESEARCH
10:15
10:30
CONDUCTING LARGE STUDIES
10:45
11:00
11:15
12:00
12:15
PERI-OPERATIVE CARE OF
THE HIGH-RISK PATIENT:
SIMULATION BASED
12:30
12:45
TRAINING IN VENTILATION
AND HAEMODYNAMIC
MANAGEMENT
13:00
13:15
RESEARCH
REPORTING & PUBLISHING
YOUR STUDY
HOW TO WRITE A
SYSTEMATIC REVIEW &
META-ANALYSIS
13:30
13:45
14:00
14:15
ECHOCARDIOGRAPHY
GROUP A
14:30
RESEARCH
14:45
15:00
DO IT YOURSELF
15:15
15:30
15:45
16:00
SUNDAY 14 OCTOBER
11:45
ECHOCARDIOGRAPHY
GROUP B
ECHOCARDIOGRAPHY
GROUP B
16:15
SUMMARY AND COURSE
EVALUATION
16:30
16:45
17:00
PG titles
TUESDAY 16 OCTOBER
11:30
ECHOCARDIOGRAPHY
PERI-OPERATIVE CARE OF THE HIGH-RISK PATIENT: SIMULATION BASED
Designing, conducting and publishing intensive care research
L I V E S 2 012
47
POSTGRADUATE COURSES
Course directors: Maurizio Cecconi, London, United Kingdom & Christoph Hofer, Zurich, Switzerland
Objectives:
To understand the importance of haemodynamics in critically ill patients.
To recognise and monitor haemodynamic instability in critically ill patients.
To understand the different principles and uses of different haemodynamic monitors.
ROOM Berlin
PHYSIOLOGY AND PATHOPHYSIOLOGY
Chair: Maurizio Cecconi, London, United Kingdom
10:50 - 11:00
Course overview
Maurizio Cecconi, London, United Kingdom
11:00 - 11:30
Cardiovascular pathophysiology: Understanding functional
haemodynamics
Michael Pinsky, Pittsburgh, United States
11:30 - 12:00
Venous return: Understanding preload
Jan Bakker, Rotterdam, Netherlands
12:00 - 12:30
Completing the picture: Integrating variables at the bedside
Jean-Louis Teboul, Kremlin-Bicetre, France
12:30 - 13:30
Lunch Time
ROOM Berlin
THE TOOLS
saturday 13 OCTOBER
Chair: Michael Pinsky, Pittsburgh, United States
13:30 - 14:00
Pulmonary artery catheter: Uses and limitations
Christoph Hofer, Zurich, Switzerland
14:00 - 14:30
Less invasive technologies: An overview
14:30 - 15:00
Monitoring the microcirculation
Can Ince, Rotterdam, Netherlands
15:00 - 15:30
Coffee Break
ROOM Berlin
FROM THEORY TO PRACTICE
Chair: Jean-Louis Teboul, Kremlin-Bicetre, France
15:30 - 16:00
How to give fluids
Jean-Louis Vincent, Brussels, Belgium
16:00 - 16:30
How to use vasoactive drugs
Daniel De Backer, Brussels, Belgium
16:30 - 17:00
Summary and open questions to the experts
48
13-17 October 2012
L I V E S 2 012
IMPROVING PATIENTS’ OUTCOME IN EVERYDAY PRACTICE: HOW TO DO IT
08:30 - 09:00
09:00 - 09:30
How to improve outcome in high risk surgical patients
How to improve outcome in patients with shock
Technology rotations
09:30 - 09:33
Rotation time
09:33 - 09:48
Technology rotation 1
09:48 - 09:51
Rotation time
09:51 - 10:06
10:06 - 10:09
Rotation time
10:09 - 10:24
10:24 - 10:27
Rotation time
10:27 - 10:42
10:42 - 10:45
Rotation time
10:45 - 11:00
11:00 - 11:30
Coffee Break
ROOM Berlin
11:30 - 12:00
Elias Knobel, Sao Paulo, Brazil
INTERACTIVE CASE BASED DISCUSSION
Rotation 1 - How to monitor fluid responsiveness
Xavier Monnet, Kremlin-Bicetre, France
12:00 - 12:30
Rotation 2 - Understanding volumes
Manu Malbrain, Antwerp, Belgium
12:30 - 13:00
Rotation 3 - Optimising the high risk surgical patient
ROOM Berlin
Chair: Maurizio Cecconi, London, United Kingdom
SUNDAY 14 OCTOBER
Max Jonas, Southampton, United Kingdom
13:00 - 13:30
Rotation 4 - Optimising the septic patient
13:30 - 14:00
Rotation 5 - Optimising the microcirculation
14:00 - 15:00
Lunch Time
L I V E S 2 012
TUESDAY 16 OCTOBER
49
Course directors: Mauro Oddo, Lausanne, Switzerland & Antonio Pesenti, Monza, Italy & Jacques Duranteau, Kremlin-Bicetre , France
Objectives:
Demonstrate the ability to properly operate an ultrasound machine and make adjustments to obtain adequate image quality.
Gain an understanding of how ultrasound can assist in the assessment, diagnosis and intervention in ICU.
Practise hands-on of lung, abdominal and cerebral ultrasound under the supervision of experts.
ROOM Berlin ii
CEREBRAL ULTRASOUND
Chairs: Mauro Oddo, Lausanne, Switzerland & Fabio Silvio Taccone, Brussels, Belgium
14:00 - 14:10
Course overview
14:10 - 14:45
Basic cerebral sonographic
Marek Czosnyka, Cambridge, United Kingdom
14:45 - 15:00
Vasospasm
Fabio Silvio Taccone, Brussels, Belgium
15:00 - 15:15
Coffee break
15:15 - 16:00
Autoregulation and high ICP
Frank Rasulo, Brescia, Italy
16:00 - 16:30
Brain death
Bernard Vigué, Kremlin-Bicetre, France
16:30 - 17:30
Ultrasound demonstration and technical advice
Bernard Vigué, Kremlin-Bicetre, France
Frank Rasulo, Brescia, Italy
saturday 13 OCTOBER
Marek Czosnyka, Cambridge, United Kingdom
50
13-17 October 2012
L I V E S 2 012
ROOM Berlin ii
LUNG AND PLEURAL ULTRASOUND
Chair: Antonio Pesenti, Monza, Italy
08:00 - 09:00
Basic thoracic sonographic
Antoine Vieillard-Baron, Boulogne, France
09:00 - 09:45
Pleural ultrasound (pneumothx, pleural effusion, emphymea)
Jean-Jacques Rouby, Paris, France
09:45 - 10:00
Coffee break
10:00 - 10:45
Lung ultrasound (consolidations, atelectasis)
Paul Mayo, New York, United States
10:45 - 12:45
Jean-Jacques Rouby, Paris, France
12:45 - 13:30
Lunch Time
ROOM Berlin ii
ABDOMINAL ULTRASOUND
13:30 - 14:15
Basic abdominal sonographic
Matthieu Legrand, Paris, France
14:15 - 15:00
Focused assessment by sonography for trauma
15:00 - 15:15
Coffee break
15:15 - 16:00
Kidney ultrasound
Jacques Duranteau, Kremlin-Bicetre, France
16:00 - 17:00
TUESDAY 16 OCTOBER
SUNDAY 14 OCTOBER
Chair: Jacques Duranteau, Kremlin-Bicetre, France
L I V E S 2 012
51
Course directors: Marco Maggiorini, Zurich, Switzerland & Hans Flaatten, Bergen, Norway
Objectives:
A two-day pre-congress course structured to cover almost all areas of the European Diploma in Intensive Care (EDIC) part 1 exam over a period of 3
years. To familiarise with the MCQ-type of exam at the end of each presentation a number of MCQs also will be discussed. Top international lecturers/
intensivists from all over Europe will give a 20 minutes overview of selected topics and conclude with a 10 minutes interactive discussion based on the
presentation of some key MCQs.
ROOM Barcelona
ACUTE CIRCULATORY FAILURE
Chair: Marco Maggiorini, Zurich, Switzerland
08:30 - 09:00
Cardiac arrest: Management including therapeutic hypothermia
Hans Friberg, Lund, Sweden
09:00 - 09:30
Myocardial infarction in the ICU setting
Marco Maggiorini, Zurich, Switzerland
09:30 - 10:00
Arrhythmias in the ICU
Alexandre Mebazaa, Paris, France
10:00 - 10:30
Coffee Break
ROOM Barcelona
ACUTE RESPIRATORY FAILURE
saturday 13 OCTOBER
10:30 - 11:00
Physiology of mechanical ventilation
Franco Valenza, Milan, Italy
11:00 - 11:30
ARDS epidemiology and pathophysiology
Claude Guérin, Lyon, France
11:30 - 12:00
ARDS and mechanical ventilation
Marco Ranieri, Turin, Italy
12:00 - 13:00
Lunch Time
ROOM Barcelona
INFECTION AND INFLAMMATION
Chair: Geoffrey Bellingan, London, United Kingdom
13:00 - 13:30
Catheter related infections
José Artur Paiva, Porto, Portugal
13:30 - 14:00
Ventilator associated pneumonia
Jacques-André Romand, Geneva, Switzerland
14:00 - 14:30
Fungal infections in the ICU
George Dimopoulos, Athens, Greece
ROOM Barcelona
NERVOUS SYSTEM
Chair: Geoffrey Bellingan, London, United Kingdom
14:30 - 15:00
Traumatic brain injury
Mauro Oddo, Lausanne, Switzerland
15:00 - 15:30
Brain death
Paulo Maia, Porto, Portugal
15:30 - 16:00
Organ donation
Pedro Navarrete Navarro, Granada, Spain
16:00 - 16:30
Coffee Break
ROOM Barcelona
NEPHROLOGY, ELECTROLYTES, ACID BASE AND FLUID MANAGEMENT
Chair: Brian Marsh, Dublin, Ireland
52
16:30 - 17:00
Electrolyte disturbances
Armand Girbes, Amsterdam, Netherlands
17:00 - 17:30
Acid-base disorders
Brian Marsh, Dublin, Ireland
17:30 - 18:00
Transfusions (RBC, platelets, FOP, synthetic coagulation factors)
Geoffrey Bellingan, London, United Kingdom
13-17 October 2012
L I V E S 2 012
ROOM Barcelona
ABDOMEN
Chair: Paulo Maia, Porto, Portugal
08:30 - 09:00
Acute liver failure
Pierre-François Laterre, Leuven, Belgium
09:00 - 09:30
Chronic liver diseases and transplantation
Julia Wendon, London, United Kingdom
09:30 - 10:00
Liver surgery
Christian Sitzwohl, Vienna, Austria
10:00 - 10:30
Coffee Break
ROOM Barcelona
NUTRITION, METABOLISM, ENDOCRINOLOGY, INTOXICATION
Chair: Paulo Maia, Porto, Portugal
10:30 - 11:00
Nutrition of the critically ill
Jan Wernerman, Stockholm, Sweden
11:00 - 11:30
Nutrition supplements and vitamins
Mette Berger, Lausanne, Switzerland
11:30 - 12:00
Complications of enteral and parenteral nutrition
Michaël Casear, Leuven, Belgium
12:00 - 13:00
Lunch Time
ROOM Barcelona
TRAUMA AND SURGERY
13:00 - 13:30
The polytrauma patients
Martin Dünser, Salzburg, Austria
13:30 - 14:00
Postoperative intensive care medicine
Rupert Pearse, London, United Kingdom
14:00 - 14:30
Transplantation and immunosuppression
Christian Sitzwohl, Vienna, Austria
14:00 - 14:30
Coffee Break
ROOM Barcelona
OTHERS (SEDATION-Analgaesia, PHARMACOLOGY, MANAGEMENT, ETHICS)
Chair: Hans Flaatten, Bergen, Norway
Ethics and communication with relatives
Hans Flaatten, Bergen, Norway
15:30 - 16:00
ICU-management
Pascale Gruber, London, United Kingdom
16:00 - 16:30
Paeditatric intensive care: The essentials
Mark Peters, London, United Kingdom
TUESDAY 16 OCTOBER
15:00 - 15:30
SUNDAY 14 OCTOBER
L I V E S 2 012
53
ECHOCARDIOGRAPHY
Course director: Bernard Cholley, Paris, France
Objectives:
To teach intensivists basic skills in echocardiography, lung and abdominal ultrasounds
ROOM Glasgow ECHOCARDIOGRAPHY
10:00 - 10:30
Basic views
Yanick Beaulieu, Montreal, Canada
10:30 - 12:30
Hands on
Nick Fletcher, London, United Kingdom
Gorazd Voga, Celje, Slovenia
Susanna Price, London, United Kingdom
Gwenaël Prat, Brest, France
Fernando Clau-Terré, Barcelona, Spain
Michelle Chew, Malmö, Sweden
Armand Mekontso Dessap, Creteil, France
Philippe Vignon, Limoges, France
Jan Poelaert, Brussels, Belgium
Jean-Luc Canivet, Liège, Belgium
saturday 13 OCTOBER
Eric Maury, Paris, France
12:30 - 13:30
Lunch Time
ROOM Stockholm
ECHOCARDIOGRAPHY - GROUP A
Chair: Jean-Luc Canivet, Liège, Belgium
13:30 - 15:00
Hands on
15:00 - 15:30
Coffee Break
ROOM Glasgow
LECTURES & INTERACTIVE CLINICAL CASES (ICC) - GROUP A
Chair: Jan Poelaert, Brussels, Belgium
54
15:30 - 15:45
How to recognise severe left ventricular dysfunction?
15:45 - 16:00
ICC 1: Clinical case severe LV dysfunction
16:00 - 16:15
How to recognise a dilated right ventricle?
16:15 - 16:30
ICC 2: Clinical cases showing images of normal and dilated RV
16:30 - 16:45
How to measure and interpret inferior vena cava diameter?
16:45 - 17:00
ICC 3: Clinical cases IVC: Spontaneous breathing and mechanical
ventilation
13-17 October 2012
L I V E S 2 012
Hands on
Gabriele Via, Paiva, Italy
Michel Slama, Amiens, France
Martin Balik, Prague, Czech Republic
Bernard Cholley, Paris, France
Antony McLean, Sydney, Australia
10:30 - 11:00
Coffee Break
ROOM Glasgow
Chair: Philippe Vignon, Limoges, France
11:00 - 11:15
Echo signs of pneumothorax
Roberto Copetti, Tolmezzo, Italy
11:15 - 11:30
ICC1: Clinical case pneumothorax (pleural sliding present and absent,
2D and M-mode, lung point)
11:30 - 11:45
Pleural effusion: How to detect it?
11:45 - 12:00
ICC2: Clinical cases of pleural effusion, various importances
12:00 - 12:15
Detection of abdominal effusion: How to do it? What should I look for?
12:15 - 12:30
ICC3: Examples of abdominal effusion
12:30 - 13:30
Lunch Time
ROOM Glasgow
LECTURES & INTERACTIVE CLINICAL CASES (ICC) - GROUP B
Chair: Armand Mekontso Dessap, Creteil, France
09:00 - 09:15
Echo signs of pneumothorax
09:15 - 09:30
ICC1: Clinical case pneumothorax (pleural sliding present and absent, 2D
and M-mode, lung point)
09:30 - 09:45
Pleural effusion: How to detect it?
09:45 - 10:00
ICC2: Clinical cases of pleural effusion, various importances
10:00 - 10:15
Detection of abdominal effusion: How to do it? What should I look for?
10:15 - 10:30
ICC3: Examples of abdominal effusion
ROOM Stockholm
11:00 - 12:30
ECHOCARDIOGRAPHY - GROUP B
Hands on
Enrico Storti, Milan, Italy
12:30 - 13:30
09:00 - 10:30
SUNDAY 14 OCTOBER
ROOM Stockholm
TUESDAY 16 OCTOBER
ECHOCARDIOGRAPHY
Lunch Time
L I V E S 2 012
55
ECHOCARDIOGRAPHY
Course director: Bernard Cholley, Paris, France
Objectives:
To teach intensivists basic skills in echocardiography, lung and abdominal ultrasounds
ROOM Glasgow
Chair: Martin Balik, Prague, Czech Republic
13:30 - 13:45
How to recognise severe left ventricular dysfunction?
13:45 - 14:00
ICC 1: Clinical case severe LV dysfunction
14:00 - 14:15
How to recognise a dilated right ventricle?
14:15 - 14:30
ICC 2: Clinical cases showing images of normal and dilated RV
14:30 - 14:45
How to measure and interpret inferior vena cava diameter?
14:45 - 15:00
ICC 3: Clinical cases IVC: Spontaneous breathing and mechanical
ventilation
15:00 - 15:30
Coffee break
ROOM Stockholm
Hands on
56
saturday 13 OCTOBER
15:30 - 17:00
13-17 October 2012
L I V E S 2 012
Hands on
15:00 - 15:30
Coffee Break
ROOM Glasgow
Chair: Bernard Cholley, Paris, France
15:15 - 15:25
Homogeneous/heterogeneous LV contraction
15:25 - 15:35
ICC 1: Regional wall motion abnormalities, obvious cases, major
territories (anterior, inferior, lateral)
15:35 - 15:45
Pericardial effusion and tamponade
15:45 - 15:55
ICC2: Clinical case of pericardial effusion. Criteria for tamponade or not
15:55 - 16:05
Massive valvular regurgitation: How to identify the problem?
16:05 - 16:15
ICC 3: Clinical cases of valvular regurgitation (TTE, 2D and color Doppler
only)
ROOM Glasgow
Chair: Antony McLean, Sydney, Australia
13:30 - 13:45
Homogeneous/heterogeneous LV contraction
13:45 - 14:00
ICC 1: Regional wall motion abnormalities, obvious cases, major
territories (anterior, inferior, lateral)
14:00 - 14:15
Pericardial effusion and tamponade
14:15 - 14:30
ICC2: Clinical case of pericardial effusion. Criteria for tamponade or not
14:30 - 14:45
Massive valvular regurgitation: How to identify the problem?
14:45 - 15:00
ICC 3: Clinical cases of valvular regurgitation (TTE, 2D and color Doppler
only)
15:00 - 15:30
Coffee Break
ROOM Stockholm
15:15 - 16:45
Hands on
13:30 - 15:00
SUNDAY 14 OCTOBER
ROOM Stockholm
TUESDAY 16 OCTOBER
ECHOCARDIOGRAPHY
L I V E S 2 012
57
The smarter way to check for AKI.
NOW AVAILABLE.
Stop by Exhibition Area A, Booth 19
to learn more about this revolutionary test.
The Astute140™ Meter and the NephroCheCk™ Test are not available in the United States. ©2012 Astute Medical, Inc. Astute Medical™, the AM logo, Astute140™, NephroCheCk™, and the NephroCheCk™ logo are trademarks of Astute Medical, Inc. PN 0088 Rev A 2012/08/13
Course directors: Michael Joannidis, Innsbruck, Austria & Arend Jan Woittiez, Almelo, Netherlands
Objectives:
To understand the definition epidemiology and risk factors of AKI.
To successfully apply preventive measures against AKI.
How to initiate, perform and terminate RRT treatment in the ICU.
ROOM Rome ACUTE KIDNEY INJURY
Chair: Lui Forni, Worthing, United Kingdom
09:00 - 09:30
Case simulation: Work-up
Lui Forni, Worthing, United Kingdom
09:30 - 10:00
Epidemiology of AKI
Eric Hoste, Ghent, Belgium
10:00 - 10:30
Prevention of AKI
Arie Bastiaan Johan Groeneveld, Amsterdam,
Netherlands
10:30 - 11:00
Coffee Break
ROOM Rome RRT
11:00 - 11:30
Case simulation: Treatment
Arend Jan Woittiez, Almelo, Netherlands
11:30 - 12:00
Timing and dosing
Anne-Cornelie de Pont, Amsterdam, Netherlands
12:00 - 12:30
Modality, membranes
Patrick Honoré, Brussels, Belgium
12:30 - 13:30
Lunch Time
ANTICOAGULATION MANAGEMENT
Chair: Michael Joannidis, Innsbruck, Austria
13:00 - 13:30
Case simulation: Clotting
Catherine Bouman, Amsterdam, Netherlands
13:30 - 14:00
Conventional anticoagulation
Frédérique Schortgen, Creteil, France
14:00 - 14:30
Citrate anticoagulation
Heleen Oudemans-van Straaten, Amsterdam,
Netherlands
14:30 - 15:00
Coffee break
ROOM Rome
SPECIAL PROBLEMS IN AKI PATIENTS
Chair: Olivier Joannes-Boyau, Pessac, France
15:00 - 15:30
Case simulation: Malnutrition
Olivier Joannes-Boyau, Pessac, France
15:30 - 16:00
Electrolytes
Wilfred Druml, Vienna, Austria
16:00 - 16:30
Nutrition
Catherine Bouman, Amsterdam, Netherlands
L I V E S 2 012
TUESDAY 16 OCTOBER
ROOM Rome
SUNDAY 14 OCTOBER
Chair: Arend Jan Woittiez, Almelo, Netherlands
59
PERI-OPERATIVE CARE OF THE HIGH-RISK PATIENT:
SIMULATION BASED
Course director: Torsten Schröder, Berlin, Germany
ROOM Paris
13:00 - 18:00
TRAINING IN VENTILATION AND HAEMODYNAMIC MANAGEMENT
Postoperative ventilation
José-Miguel Alonso-Iñigo, Alzira, Spain
Airway management
Michael Hiesmayr, Vienna, Austria
Haemodynamic management
Holger Köth, Berlin, Germany
Anders Larsson, Uppsala, Sweden
Susanne Marz, Berlin, Germany
Michael Sander, Berlin, Germany
Claudia Spies, Berlin, Germany
Steffen Weber-Carstens, Berlin, Germany
Willehad Boemke, Berlin, Germany
Torsten Schröder, Berlin, Germany
Christian Lojewski, Berlin, Germany
15:15 - 15:30
Coffee break
saturday 13 OCTOBER
LEGEND
Module A - Difficult airway management
Learning objectives:
- Know the incidence of, and recognise a difficult airway (including morbidly obese patients and immobilized cervical spine)
Skill stations:
- Practice supraglottic access with airway trainer in hands: Use videolaryngoscopy and flexible fibre scope
- Practice percutaneous and surgical cricothyrotomy with airway simulator
Module B - Difficult airway management: Decision making
- Know airway algorithms
Skill station:
- Practice airway algorithms with a full scale simulator
Module C - Application of haemodynamic monitoring
- Know the physiological basis of haemodynamic
- Know the different haemodynamic monitoring options
Skill stations:
- Practice to set up haemodynamic monitoring
- Practice extended haemodynamic monitoring
60
13-17 October 2012
L I V E S 2 012
ROOM Paris
09:00 - 16:45
TRAINING IN VENTILATION AND HAEMODYNAMIC MANAGEMENT
Postoperative ventilation
José-Miguel Alonso-Iñigo, Alzira, Spain
Airway management
Michael Hiesmayr, Vienna, Austria
Haemodynamic management
Holger Köth, Berlin, Germany
Susanne Marz, Berlin, Germany
Steffen Weber-Carstens, Berlin, Germany
PERI-OPERATIVE CARE OF THE HIGH-RISK PATIENT:
SIMULATION BASED
Willehad Boemke, Berlin, Germany
Torsten Schröder, Berlin, Germany
Christian Lojewski, Berlin, Germany
11:00 - 11:15
Coffee break
13:15 - 14:15
Lunch Time
Module D - Algorithm guided haemodynamic treatment - Simulation
Case: An 18 year old girl with scoliosis through spinal muscular athrophy, after spondylodesis Th3/S1
- Know algorithm guided haemodynamic treatment
Skill Station:
- Practice haemodynamic algorithms with a full scale simulator
Module E - Ventilation
SUNDAY 14 OCTOBER
LEGEND
- Know to set ventilator
- Know the different ventilator settings in ARDS or congestive heart failure
Skill stations:
- Practice ventilator setting in ARDS and congestive heart failure
Case: An 18 year old girl with colitis ulcerosa and CMV infection, transport via helicopter to hospital in prone position, acute ARDS with septic
shock - Simulation
- Know ventilator influence on haemodynamics and treatment options
Skill Station:
- Practice ventilator settings and learn what haemodynamic effects should be treated with a full scale simulator
L I V E S 2 012
TUESDAY 16 OCTOBER
Module F - Ventilator settings and effects on haemodynamic treatment
61
DESIGNING, CONDUCTING AND PUBLISHING INTENSIVE
CARE RESEARCH
Course directors: Jozef Kesecioglu, Utrecht, Netherlands & Richard Beale, London, United Kingdom
Objectives:
To understand the different steps inherent to clinical research.
To acquire the basic knowledge that is necessary to conduct clinical trials.
To learn the essential steps to present and publish results of clinical studies.
ROOM Vienna
THE RIGHT DESIGN FOR YOUR RESEARCH QUESTION
Chairs: Richard Beale, London, United Kingdom & Arjen Slooter, Utrecht, Netherland
09:00 - 09:20
Defining hypothesis (literature search: Critical analysis of the literature/
hypothesis reasonable to achieve)
09:20 - 09:40
Defining the right population
Richard Beale, London, United Kingdom
09:40 - 10:00
Study design: From observational studies to RCT’s
Christian Melot, Brussels, Belgium
10:00 - 10:20
Building the right team
Arjen Slooter, Utrecht, Netherlands
10:20 - 10:35
Coffee Break
ROOM Vienna
FINANCIAL & REGULATORY ASPECTS
saturday 13 OCTOBER
Chairs: Bertrand Guidet, Paris, France & Colin Ferguson, Plymouth, United Kingdom
10:35 - 10:55
Grant writing: What you should know
10:55 - 11:15
How realistic is your budget proposal?
Bertrand Guidet, Paris, France
11:15 - 11:35
Navigating the European regulation
Colin Ferguson, Plymouth, United Kingdom
11:35 - 11:55
IRB application
Jozef Kesecioglu, Utrecht, Netherlands
12:00 - 13:00
Lunch Time
ROOM Vienna
THE ABC OF DATA ACQUISITION AND ANALYSIS
Chairs: Daniel De Backer, Brussels, Belgium & Armand Girbes, Amsterdam, Netherlands
13:00 - 13:20
Establishing primary & secondary endpoints
Massimo Antonelli, Rome, Italy
13:20 - 13:40
Sample size calculation (why/how)
13:40 - 14:00
Data collection: What, how and when?
14:00 - 14:20
The role of Data Safety Monitoring Boards
14:20 - 14:40
Assessing protocol compliance & data quality
14:40 - 14:55
Coffee Break
ROOM Vienna
STATISTICAL ANALYSIS
Chairs: Kit Roes, Utrecht, Netherlands & Christian Melot, Brussels, Belgium
62
14:55 - 15:15
Planning statistical analysis
15:15 - 15:35
Randomisation strategies and alternatives
Kit Roes, Utrecht, Netherlands
15:35 - 15:55
Statistics for dummies
15:55 - 16:15
A Bayesian approach to interpreting clinical research
13-17 October 2012
L I V E S 2 012
ROOM Vienna
CONDUCTING SINGLE CENTRE/PATHOPHYSIOLOGICAL STUDIES
Chairs: Julie Benbenishty, Jerusalem, Israel & Gordon Doig, Sydney, Australia
08:15 - 08:35
What about the control group?
08:35 - 08:55
Sample size: A balance between power and feasibility
Gordon Doig, Sydney, Australia
08:55 - 09:15
Specificities of analytical plan
09:15 - 09:35
The role of research nurses
Julie Benbenishty, Jerusalem, Israel
09:35 - 09:50
Coffee Break
ROOM Vienna
CONDUCTING LARGE STUDIES
DESIGNING, CONDUCTING AND PUBLISHING INTENSIVE
CARE RESEARCH
09:50 - 10:10
Building and running networks
Laurent Brochard, Geneva, Switzerland
10:10 - 10:30
Research on databases
10:30 - 10:50
The concept of run-in trials
10:50 - 11:10
International studies: Avoiding pitfalls
11:10 - 11:55
Lunch Time
ROOM Vienna
REPORTING & PUBLISHING YOUR STUDY
Chairs: Jean-Daniel Chiche, Paris, France & Elie Azoulay, Paris, France
11:55 - 12:15
Report the data at congresses: Poster & oral presentations
Jean-Daniel Chiche, Paris, France
12:15 - 12:35
Publishing your research: What should you know?
12:35 - 12:55
How to write a paper?
Davide Chiumello, Milan, Italy
12:55 - 13:15
Answering reviewers comments
13:15 - 13:30
Coffee Break
ROOM Vienna
SUNDAY 14 OCTOBER
Chairs: Massimo Antonelli, Rome, Italy & Kit Roes, Utrecht, Netherlands
DO IT YOURSELF
13:30 - 14:00
Workshop A. Design your study
14:00 - 14:30
Workshop B. Interpret the results
14:30 - 15:00
Workshop C. Write the abstract
15:00 - 15:30
Workshop D. Prepare your presentation
15:30 - 16:30
4 group presentations
ROOM Vienna
16:30 - 16:45
TUESDAY 16 OCTOBER
Chairs: Richard Beale, London, United Kingdom & Massimo Antonelli, Rome, Italy
SUMMARY AND COURSE EVALUATION
Summary and course evaluation
L I V E S 2 012
63
Course directors: Djillali Annane, Garches, France & Mark Hamilton, London, United Kingdom & Gihan Abuella, London, United Kingdom
Objectives:
This course aims at providing attendees with sufficient knowledge to design and conduct a systematic review and meta-analysis. Attendees will be
coached by editors from the ESICM Systematic Review Group and write their own protocol for a systematic review and meta-analysis during the 2-day
course.
ROOM BM3
09:30 - 10:00
Welcome and introduction of the aim of the course
Djillali Annane, Garches, France
10:00 - 10:20
How to select a topic for SR
10:20 - 10:40
Problems & pitfalls of writing your first review
Gihan Abuella, London, United Kingdom
10:40 - 11:40
How to design a protocol for a systematic review
Mark Hamilton, London, United Kingdom
11:40 - 12:00
Candidates are divided into groups
12:00 - 13:00
Lunch Time
13:00 - 16:00
Group working on the protocol
16:00 - 16:15
Coffee Break
16:15 - 18:00
Group feedback: Presentation of the first draft of the protocol
saturday 13 OCTOBER
64
13-17 October 2012
L I V E S 2 012
ROOM BM3
08:30 - 09:30
How to search the literature?
09:30 - 10:45
Group working on protocol
10:45 - 11:00
Coffee Break
11:00 - 12:15
Group feedback: Presentation of the final protocol
12:15 - 13:00
Lunch Time
13:00 - 14:30
Start of literature search
14:30 - 15:30
Group feedback on first results of the literature search
15:30 - 15:45
Coffee Break
15:45 - 16:20
Designing data extraction forms
Gihan Abuella, London, United Kingdom
How to analyse & present the data
How to write up a high quality SR to maximise chances of publication
16:50 - 17:00
Conclusion of 2 days-course and next agenda
Mark Hamilton, London, United Kingdom
TUESDAY 16 OCTOBER
SUNDAY 14 OCTOBER
16:20 - 16:50
L I V E S 2 012
65
Up until now I wasn’t
informed early enough
to react.
Decide – for the better
From Reaction to Prevention
We offer solutions supporting your preventative care initiatives in the
ICU and beyond. Our IntelliVue Guardian Solution helps to detect patient
deterioration on the general floor earlier, to improve patients’ outcomes
sustainably. Decide for the better – IntelliVue
Join us at the Philips booth, Block 22 – Booth 54; and don’t miss our
symposium session on Monday, October 15, from 12:30-14:00.
TUESDAY 16 OCTOBER
1 october
saturday
SUNDAY 14 OCTOBER
scientific programme
For physicians, nurses and other
allied healthcare professionals.
> abStract SUbmiSSion DeaDline : 19 april 2013
for more information, contact
european society of intensive care medicine (esicm)
www.esicm.org
Congress Department
rue belliard 19 - 1040 brussels belgium
Tel: +32 (0)2 559 03 75 - Fax: +32 (0)2 559 03 79
paris2013@esicm.org
Thematic Session
Nurses
&
AHP
17:00 - 17:15
Welcome address
Andrew Rhodes, London, United Kingdom, ESICM President
17:15 - 17:35
Presentation of ESICM Honorary Memberships & Society Medal Award
Andrew Rhodes, London, United Kingdom, ESICM President
17:15
Presentation of Honorary Membership to Antonio Artigas
Citation to be read by Jean Carlet
17:20
Presentation of Honorary Membership to Warren Zapol
Citation to be read by Antonio Pesenti
17:25
Presentation of Honorary Membership to Michael Pinsky
Citation to be read by Jean-Louis Vincent
17:30
Presentation of Honorary Membership to Mitchell Levy
Citation to be read by Richard Beale
17:30 - 17:35
Presentation of ESICM Medal to Julian Bion
Citation to be read by Hans Ulrich Rothen
17:30 - 17:50
Saving Lives: Intensive Care in Evolution
Julian Bion, Birmingham, United Kingdom
17:50 - 18:10
Changing lives in the ICU: Doctors or designers?
Jozef Kesecioglu, Utrecht, The Netherlands
18:10 - 18:25
Living LIVES 2012 - the ESICM’s 25th Annual Congress
Giuseppe Citerio, Monza, Italy ESICM Chair of the Division of
Scientific Affairs
18:25 - 18:45
The next 30 years: The intensive connection
Jean-Daniel Chiche, Paris, France, ESICM President-Elect
SUNDAY 14 OCTOBER
room Lisbon
Sunday 14 October 2012
TUESDAY 16 OCTOBER
Opening session
Don’t miss this unique opportunity to get together.
Enjoy good food, beverages and have a good time!
L I V E S 2 012
69
SESSIONS FORMAT
ABSTRACT PRESENTATIONS
In total, 1330 abstracts have been submitted for the ESICM LIVES 2012, of which, 1140 have been accepted for oral presentations and thematic poster
corners sessions. The presentations of research studies and results by intensivists from around the world is an integral part of the ESICM’s Annual
Congress.
All accepted abstracts have been published in the September supplement issue of Intensive Care Medicine (ESICM’s official journal)
which is available online on our website www.esicm.org. Publication in the journal and presentation during the Congress requires registration by
one of the authors, and by the person making the presentation.
Abstract submitted and selected under the label ECCRN.
Abstract selected for the Abstract Award Winning Session.
ORAL PRESENTATIONS
These sessions include the oral presentation of 5 successive abstracts. Each presenter is allowed a 10-min presentation followed by a 5-min time
slot for comments and discussion by the audience and the chairpersons. There are 2 chairpersons for each session. The abstracts presented during
these sessions are not displayed as e-posters.
POSTER CORNERS
These sessions include the presentation of 14 successive e-posters at the Exhibition & Poster Corners Area. This year there will be 2 slots per day
(from 10:10 until 12:00 and from 14:00 until 15:50). Each presenter is allowed a 4-min presentation followed by a 3-min time slot for comments and
discussion by the audience and the chairpersons. There are 2 chairpersons for each session.
E-POSTERS AREA
Delegates, authors and chairs will be able to communicate and post comments on the data presented during the
Congress (poster corners) via a chat forum during and after the Congress on the ESICM website.
Try the
e-posters
experience in the
exhibition
area
CLINICAL CHALLENGES SESSIONS
Training sessions utlilise a “How do I …?” format and include an introductory talk on a specific clinical relevant problem or question followed by
illustrative cases/presentations which serve to stimulate interactive discussion. Interaction between the speakers and the audience is strongly
encouraged.
CONTINUOUS PROFESSIONAL EDUCATION SESSIONS
The Congress Committee has set up a full educational track throughout the congress. In these sessions, basic concepts are reviewed. For trainees
as well as professionals in the intensive care community (including physicians, nurses and technicians), this programme of educational sessions is an
excellent preparation for sitting the European Diploma in Intensive Care (EDIC) written examination on Monday October 15, 2012 (11:00-14:00) at the
Pavilhão Atlântico, Rossio dos Olivais, Lote 2.13.01A, 1190-231 Lisbon, Portugal.
70
13-17 October 2012
L I V E S 2 012
CONTROVERSIES SESSIONS
These are debate-style sessions surrounding an area of controversy. The total duration of each is 30 minutes, which allows 10 minutes for each side
of the argument and 10 minutes at the end for discussion.
FROM BENCH TO BEDSIDE SESSIONS
These unique sessions explore interactions between basic research and clinical medicine. They aim to update participants on new lab findings and
discuss possible future clinical applications.
HOT TOPICS SESSION
The Hot Topics Session at the end of the congress is devoted to the presentation of cutting edge research to a very large audience. During the
session, the 2012 ESICM/ECCRN Industry Research Awards, ISF and Stoutenbeek Awards will be presented to the winners.
INDUSTRY SPONSORED SESSIONS
Sessions organised in conjunction with Industry. The educational programme has been reviewed by ESICM.
JOINT SESSIONS
Sessions organised with other scientific societies on specific topics of interest.
The Congress Committee has organised 7 Postgraduate Courses and one Refresher Course that will be held on Saturday and/or Sunday prior to the
core congress programme.
STATE OF THE ART SESSIONS
State of the art sessions present and update participants on the highest level developments in the scientific field. Speakers are key experts on these
up-to-date topics.
THEMATIC SESSIONS
Key experts and well-known international speakers lecture on topical areas of interest and expertise.
L I V E S 2 012
71
Session references
This standard day planning serves as a basis for the structure of the scientific sessions. There are several simultaneous sessions in each
category.
The basic principle is that no overlap may occur between the Thematic Sessions and the Abstract Presentations (oral presentations
and poster corners).
Abstract Award Winning Session
09:40-11:00
Tuesday
Clinical Challenges Sessions 11:10-12:00 Monday & Tuesday Continuous Professional Education Sessions Monday until Wednesday
Controversies Sessions Monday until Wednesday
From Bench to Bedside Sessions Tuesday & Wednesday
Hot Topics Session
14:15-16:15 Wednesday
Industry Sponsored Sessions
12:30-14:00 18:15-19:15 Monday & Tuesday
Monday
Joint Sessions Monday until Wednesday
Oral presentations
09:40-11:00
10:10-11:30
14:15-15:50
Monday & Tuesday
Wednesday
Monday & Tuesday
Poster Corners
10:10-12:00 14:00-15:50 Monday until Wednesday
Monday & Tuesday
State of the Art Sessions Monday until Wednesday
Thematic Sessions Monday until Wednesday
The following final programme is subject to modification after printing.
72
13-17 October 2012
L I V E S 2 012
Sessions of special interest for Nurses and AHP
Nurses
If you are a nurse or allied health professional (physiotherapist, dietician, pharmacist, etc) working in critical care, there are a
number of sessions which may be of particular interest to you.
These are listed below and highlighted on each page with the following sign
Sunday 14 OCTOBER ROOM Lisbon Thematic Session
17:00-18:35 Opening Session
Monday 15 october Nurses
&
AHP
&
AHP
Tuesday 16 october
ROOM Stockholm Thematic Session
08:30-09:30PREPARING THE ICU NURSING WORKFORCE FOR
2020
ROOM Berlin
Oral PresentationS 09:40-11:00 PREVENTION OF INFECTIONS IN THE ICU SETTING
ROOM Rome Continuous Professional Education Session Area PORTO Poster Corner 10:10-12:00 END OF LIFE CARE - ETHICS OF RESEARCH
08:30-09:30 INTENSIVE CARE IS TEAM WORK!
ROOM Paris Thematic Session 08:30-09:30THE LIFE-PRIORITY SESSION. WHO CARES FOR
THOSE WHO CARE?
ROOM Glasgow Oral Presentations
ROOM Glasgow
Clinical Challenges Session
11:10-12:00
HOW DO I COUNSEL IN AND BEYOND THE ICU?
Area ESTORIL
Poster Corner 14:00-15:50 AIRWAY CARE & INSTRUMENTATION
09:40-11:00 COMMUNICATION IN THE ICU 1
ROOM Stockholm
Oral PresentationS
09:40-11:00 ASSESSING THE IMPACT OF INTERVENTIONS AND
ORGANISATIONS IN INTENSIVE CARE 1
Area ESTORIL Poster Corner 10:10-12:00 PREVENTION OF ICU-ACQUIRED INFECTIONS
ROOM Athens Poster Corner
14:00-15:50 IMPROVING COMMUNICATION IN THE ICU 2
ROOM Rome Oral PresentationS ROOM Stockholm Thematic Session 16:00-18:00
ACHIEVING A CULTURE OF SAFETY
11:10-12:00
HOW DO I REDUCE GUILT DURING FAMILY’S
MEETING
Area BRAGA
ROOM Stockholm
14:15-15:50 END OF LIFE CARE - ETHICS OF RESEARCH 2
Wednesday 17 october ROOM Athens Thematic Session 08:30-10:00
NURSING CARE FOR MY PATIENT WITH…
State of the Art Session 14:15-15:50 PATIENT SAFETY - “FIRST DO NO HARM”
ROOM Barcelona Thematic Session 16:00-18:00 AN UPDATE ON VAP
L I V E S 2 012
73
TO be cOnTinued >
sepsis FrOm bench TO bedside
REGIOnAl COnfEREnCE
MOnTREuX
JulY 4-5, 2013
JOIn uS_
Join us in montreux, just before the Jazz festival,
for a unique experience mixing cutting-edge
science and education in a relaxed and friendly
atmosphere.
for more information contact ESICM
tel: +32 2 559 03 75 - Fax: +32 2 559 03 79
email: montreux2013@esicm.org
Jointly organised with
www.esicm.org
Duration
Time
Session title
Presentation title
Speaker
09:15
ACUTE CIRCULATORY FAILURE
Cardiac arrest: Management including
therapeutic hypothermia
Hans Friberg
30
09:45
DESIGNING, CONDUCTING AND PUBLISHING
INTENSIVE CARE RESEARCH
THE RIGHT DESIGN FOR YOUR RESEARCH
QUESTION
Defining hypothesis (literature search:
Critical analysis of the literature/hypothesis reasonable to achieve)
Armand Girbes
20
10:05
ACUTE RESPIRATORY FAILURE
Physiology of mechanical ventilation
Franco Valenza
30
10:35
Cardiovascular pathophysiology: Understanding functional haemodynamics
Michael Pinsky
30
11:05
Venous return: Understanding preload
Jan Bakker
30
11:35
ECHOCARDIOGRAPHY - LECTURES &
INTERACTIVE CLINICAL CASES (ICC) - GROUP B
How to measure and interpret inferior
vena cava diameter?
Michel Slama
15
11:50
THE TOOLS
Pulmonary artery catheter: Uses and
limitations
Christoph Hofer
30
12:20
NERVOUS SYSTEM
Mauro Oddo
30
12:50
LUNG ABDOMINAL AND CEREBRAL
ULTRASOUNDS IN ICU
LUNG AND PLEURAL ultrasound
Basic thoracique sonographic
Antoine VieillardBaron
60
13:50
IMPROVING PATIENTS’ OUTCOME IN
EVERYDAY PRACTICE: HOW TO DO IT
How to improve outcome in patients with
shock
Jan Bakker
30
14:20
NUTRITION, METABOLISM, ENDOCRINOLOGY,
INTOXICATION
Nutrition of the critically ill
Jan Wernerman
30
14:50
Report the data at congresses: Poster &
oral presentations
Jean-Daniel Chiche
20
15:10
How to write a paper
Davide Chiumello
20
15:30
LUNG ABDOMINAL AND CEREBRAL
ULTRASOUNDS IN ICU
ABDOMINAL ultrasound
Basic abdominal sonographic
Matthieu Legrand
45
16:15
OTHERS (SEDATION-Analgaesia,
PHARMACOLOGY, MANAGEMENT, ETHICS)
Paediatric Intensive Care: The essentials
Mark Peters
30
L I V E S 2 012
Min.
MONDAY 15 OCTOBER
TUESDAY 16 OCTOBER
Could not attend the Critical Refresher Courses or the Postgraduate courses?
Could not make a choice between competing sessions?
Have some free time before the next session or are simply not in the mood for poster
viewing?
Then check out the programme of the Replay Theatre and come to experience a novel
way to optimise your time during the Congress. Be seated and follow the lectures that
have just been given on a large screen with high-fidelity audio. You are in your ESICM
lecture hall!
REPLAY THEATRE
75
Replay Theatre
75
REPLAY THEATRE
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
76
Time
Duration
Session title
Presentation title
Speaker
09:10
WEANING FROM MECHANICAL VENTILATION
How do I predict a successful weaning?
Massimo Antonelli
20
09:30
A NIGHTMARE: SEIZURES IN THE ICU
EEG monitoring: When, how, how long?
Jan Claassen
20
09:50
END-ORGAN CONSEQUENCES OF LIVER
FAILURE
Hepatorenal syndrome
John Kellum
20
10:10
SURVIVING SEPSIS CAMPAIGN: 2012 UPDATE
The Surviving Sepsis Campaign: What have
we achieved?
Mitchell Levy
20
10:30
The new guidelines and bundles
Richard Beale
20
10:50
How the new guidelines will impact your
practice?
Djillali Annane
20
11:10
HOW DO I EVALUATE AND MANAGE A
COMATOSE PATIENT?
Presentation
Tarek Sharshar
50
12:00
HOW DO I MANAGE THE BURN PATIENT?
Presentation
Philipp Metnitz
50
12:50
PULMONARY EMBOLISM
Diagnostic strategies
Alain Cariou
20
13:10
SCCM/ESICM - ACTIVATED PROTEIN
C: REVEALING THE DEFICITS IN OUR
TRANSLATIONAL PARADIGM
The rise and fall of a new drug
Marco Ranieri
20
13:30
Was there sufficient pre-clinical data for
the initial Xigris hopes?
Mervyn Singer
20
13:50
Was there sufficient clinical evidence for
the initial Xigris hype?
Derek Angus
20
14:10
THERAPEUTIC TARGETS SELECTION IN ACUTE
RESPIRATORY FAILURE
Targeting normal values in critical illness.
What is the rationale?
Brian Kavanagh
20
14:30
AN UPDATE ON VAP
Non-pharmacologic prevention
approaches
Stijn Blot
20
14:50
AN UPDATE ON VAP
SDD: Value and pitfalls
Marc Bonten
20
15:10
ERC/ESICM - POST-CARDIAC ARREST IN 2012
Recent important changes in resuscitation
Kjetil Sunde
20
15:30
Post-resuscitation bundle
Jerry Nolan
20
15:50
SHOCK REVISITED
From normal physiology to shock
Christoph Hofer
20
16:10
SHOCK REVISITED
Assessing perfusion and response to
treatment
Marco Maggiorini
20
16:30
ETHICAL DILEMMAS IN INTENSIVE CARE
Donation of organs
Beatriz Dominguez-Gil
20
13-17 October 2012
Min.
L I V E S 2 012
Presentation title
Speaker
09:10
MANIPULATING THE MICROCIRCULATION
Defining the best perfusion
Can Ince
20
09:30
RESPIRATORY MONITORING FOR DUMMIES
Presentation
Laurent Brochard
50
10:20
HOW DO I DIAGNOSE INTERSTITIAL
PNEUMONIA?
Presentation
Jean-Daniel Chiche
50
11:10
HOW DO I READ HEAD CT AND A MRI SCAN?
Presentation
Peter Horn
50
12:00
BLOOD SUGAR MONITORING
Clinical relevance of glucose control
Jean-Charles Preiser
25
12:25
CARDIOVASCULAR MONITORING UPDATE
From arterial pressure to cardiac output
Maurizio Cecconi
20
12:45
CARING FOR THE LUNGS OF THE
HAEMODYNAMICALLY CHALLENGED
PATIENT
Heart-lung interactions for dummies
Michael Pinsky
20
13:05
ASSESSMENT OF LUNG AERATION AND
COLLAPSE IN ARDS
Lung ultrasound - does it have a role?
Paul Mayo
20
13:25
ABC OF Paediatric INTENSIVE CARE FOR
THE ADULT INTENSIVIST
Paediatric respiratory insufficency
Brian Kavanagh
20
Min.
REPLAY THEATRE
Duration
Session title
WEDNSDAY 17 OCTOBERE
Time
L I V E S 2 012
77
Kimberly-Clark is proud to be a partner of
“Wheels of Life”, the European campaign of
, to promote emergency
life support skills.
Come and visit the
truck during the ESICM LIVES 2012 Congress
Helping You Improve
Patient Safety
For more information about the
Kimberly-Clark* KimVent*
Solutions please visit
www.VAP.kchealthcare.com
KimVent*
Oral Care Kits
KimVent*
Closed Suction
Systems
*Registered Trademark or Trademark of Kimberly-Clark Worldwide, Inc © 2012 KCWW. All rights reserved
KimVent* BAL CATH*
Bronchial Aspirate
Sampling Catheter
KimVent*
MicroCuff*
Endotracheal Tubes
TO be cOnTinued >
An amazing experience!
lIfE-PRIORITY COnnECTInG AREA
VISIT_
The dynamic connection to Intensive Care Medicine
has started!
Since last year, liFe-prioritY has toured europe
with «Wheels of life» and two respectable aims:
train the lay public to cpr and raise awareness
about your specialty. We have spotted major public
events to bring our event structure and attract
everyone’s attention for a day…or more…
as we wish you were there, we have decided to make
you live this experience again.
• come meet us in the 3D tecHno tent to travel
europe with Wheels of life. put your helmet, fasten
seat belts and find out where we have taken our
mobile icU in a mind-blowing 4-min 3D movie
• Visit the liFe-prioritY connecting area to
attend poster sessions, attend «meet the expert»
sessions in the truck, charge your devices or
simply relax and enjoy «petiscos». You are in
lisbon with eSicm and liFe-prioritY!
COnnECTInG AREA
2
1
3
1. 3D techno tent / 2. liFe-prioritY truck / 3. connecting lounge
live an amazing experience with the 3D Sony
helmet! with its two Oled screens right in your
eyes, the helmet offers you a truly amazing
immersion in the image!
JOIn uS_
Science, connection and fun guaranteed in our
Sony-powered 3D TECHnO TEnT, lIfE-PRIORITY
truck and Connecting lounge
With the support of
www.esicm.org
Scientific programme
MONDAY 15 OCTOBER
SCIENTIFIC programme
MONday 15 october
80
13-17 October 2012
L I V E S 2 012
Poster corners morning
Area Beja
Area Braga
Area Cascais
Area Coimbra
Ventilator-induced
lung injury
Satisfying
metabolic
demand in the
icu
Trauma update
Acute coronary
syndrome in the
icu
Area Faro
Area Fatima
Area Funchal
Area Guarda
Area Porto
Area Setubal
Acute kidney
injury: evaluation
& treatment
Impact of specific
icu interventions
Inflammatory
response in sepsis:
new insights
Paediatrics 1:
not small adults!
Acute brain injury:
therapeutic
Imaging to guide
cooling &
treatment of acute
outcome
respiratory failure
prediction
Area Sintra
Life-Priority
Improving
icu care &
organisation
Pneumonia
revisited
Area Estoril
Prevention of icuaquired infections
Nurses
&
AHP
Area Evora
Sedation,
analgaesia &
delirium
14:00 - 15:50
Poster corners afternoon
Area Beja
Area Cascais
Area Coimbra
Area Estoril
Area Evora
Nurses
&
AHP
Non-invasive
ventilation:
indications
& limits
Bedside
assessment of
haemodynamics
Icu infections:
biomarkers &
antimicrobial
treatment 1
Intensive care in
specific patient
populations
Area Faro
Area Fatima
Area Funchal
Area Guarda
Area Porto
Area Setubal
Evaluating
systemic & micro
circulation
Physiotherapy in
the icu
Postoperative
management of
cardio-surgical
patients
Evaluation of
sepsis biomarkers
Organ dysfunction
in sepsis
Outcome from
intensive care
Area Sintra
Life-Priority
Haemorrhagic
stroke:
interventions
& markers
Outcome
prediction after
cardiac arrest
Technology
for ventilatory
support
Area Braga
Improving
communication in
the icu
pOSTER overview
10:10 - 12:00
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
POSTER OVERVIEW - MONDAY 15 OCTOBER
View the poster corner plan on pages 26-27
L I V E S 2 012
81
programme OVERVIEW
Monday 15 October
Room
Lisbon
08:30
Weaning from
mechanical
ventilation
Acute heart failure in
icu: what’s new?
Therapeutic targets
in traumatic shock
Surviving sepsis
campaign: 2012
update
Crazy heart: rythm
disturbances in icu
Genetic and
molecular basis of
ards and vili
09:30
Berlin
Barcelona
Geneva
A nightmare:
seizures in the icu
Rome
Intensive care is
team work!
Nurses
&
AHP
09:30-09:40
09:40
11:00
New data on renal
replacement therapy
Systemic
complications of
acute brain damage
11:00-11:10
11:10
12:00
How do i prevent
ards in patients at
risk?
How do i evaluate
and manage a
comatose patient?
How do i manage
contact isolation
for multiresistant
bacterias?
How do i manage
the burn patient?
EDWARDS
Nestlé
FRESENIUS KABI
COVIDIEN
Good clinical
nutrition practice
Brain monitoring in
icu: Why and how?
Ethics of cost
containment
12:00-12:30
Gambro
12:30
14:00
New Clinical
Perspectives on the
Management of
Critically Ill Patients
with Acute Kidney
Injury
The future of glucose
Individualised
monitoring in the
nutritional strategies
icu
in ICU
14:00-14:15
MONDAY 15 OCTOBER
14:15
15:50
Pulmonary
embolism
Methods to optimise
infections outcome
in the icu
Therapeutic targets
selection in acute
respiratory failure
An update on vap
Csccm/esicm - aki
from diagnosis to
treatment
Assessing the impact
of interventions and
organisations in
intensive care 2
Patient safety
«First do no harm»
15:50-16:00
16:00
18:00
Sccm/esicm activated protein
c: revealing the
deficits in our
translational
paradigm
Erc/esicm
Post-cardiac arrest
in 2012
Shock revisited
Nurses
&
AHP
18:00-18:15
CONVATEC
Management of
intra-abdominal
hypertension: don’t
let the pressure take
control
18:15
19:00
Session references
82
Thematic session / JOINT SESSION
Controversies session
Clinical challenges session
STATE OF THE ART SESSION
Oral presentations
Poster corners
Continuous Professional Education Sessions
from bench to bedside
Industry sponsored session
13-17 October 2012
L I V E S 2 012
Stockholm
Isf controversies
session
Candida infections in
the icu
Communication in
the icu 1
Assessing the impact
of interventions and
organisations in
intensive care 1
Nurses
&
AHP
Paris
The life-priority
session. Who cares for
those who care?
Nurses
&
AHP
Vienna
End-organ
consequences of liver
failure
Athens
Inflammation
modulation by
nutrition
Brain injury
Shock
What junior ICU docs
already know
Nurses
&
AHP
How do i treat
hiv/aids in the
antiretroviral therapy
era
How do i manage
cancer patients in the
icu?
How do i treat muscle
weakness in the icu?
How do i improve
patient-ventilator
synchrony
How do i reduce
guilt during family’s
meeting
Baxter
MAQUET
ASTUTE MEDICAL
FISHER & PAYKEL
Philips
The role of
betablockers in sepsis
Optimising patientventilator interaction
and chance of success
in niv
New aki biomarkers:
a revolution in risk
assessment
Optiflow - Extending
the boundaries of
oxygen therapy:
latest trial results
and evolving clinical
experience
Philips
Outcomes for the
high-risk surgical
patient
Nutrition and
glycaemic control in
icu
The best in
neurointensive care:
acute brain injury
Sepsis therapy: new
hints from the lab
Peripheral perfusion
Sdd in my icu
Ethical dilemmas in
intensive care
L I V E S 2 012
Regional citrate
anticoagulation for
dummies
Intensive care in
resource-poor settings
Rapid response
systems revisited
FRESENIUS KABI
THERMO FISHER
Effective glycaemia
control
Guiding antibiotic
therapy to tackle
resistance formation
Recovery from
traumatic brain injury
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Glasgow
programme OVERVIEW
83
83
ROOM Lisbon
Thematic Session
WEANING FROM MECHANICAL VENTILATION
Chairs: Davide Chiumello, Milan, Italy & Anders Larsson, Uppsala, Sweden
08:30 - 08:50
How do I predict a successful weaning?
08:50 - 09:10
Protocol based weaning - does it work?
09:10 - 09:30
Can I minimise the extubation failure rate?
Jordi Mancebo, Barcelona, Spain
ROOM Berlin
Thematic Session
ACUTE HEART FAILURE IN ICU: WHAT’S NEW?
Chairs: Gorazd Voga, Celje, Slovenia & Alexandre Mebazaa, Paris, France
08:30 - 08:50
Cardiovascular dysfunction in sepsis
Alain Cariou, Paris, France
08:50 - 09:10
Cardiorenal syndrome
Claudio Ronco, Vicenza, Italy
09:10 - 09:30
Cardiogenic shock: From medical therapy to mechanical support
Alain Combes, Paris, France
ROOM Barcelona
Thematic Session
THERAPEUTIC TARGETS IN TRAUMATIC SHOCK
Chairs: Jacques Duranteau, Kremlin-Bicetre, France & Matthieu Legrand, Paris, France
08:30 - 08:50
Blood pressure targets
08:50 - 09:10
Haemoglobin and coagulation targets
09:10 - 09:30
Tissue oxygenation targets
ROOM Geneva
Thematic Session
A NIGHTMARE: SEIZURES IN THE ICU
MONDAY 15 OCTOBER
Chairs: Jan Claassen, New York, United States & Fabio Silvio Taccone, Brussels, Belgium
08:30 - 08:50
Initial approach
Tarek Sharshar, Paris, France
08:50 - 09:10
EEG monitoring: When, how, how long?
Jan Claassen, New York, United States
09:10 - 09:30
ICU management
ROOM Rome
Continuous Professional Education Session INTENSIVE CARE IS TEAM WORK!
Chairs: Francesca Rubulotta, London, United Kingdom & Christina Jones, Liverpool, United Kingdom
08:30 - 08:50
Basic principles of team building
Maurizia Capuzzo, Ferrara, Italy
08:50 - 09:10
Nurses and allied healthcare professionals: players, coaches or both?
Christina Jones, Liverpool, United Kingdom
09:10 - 09:30
Surviving life-long specialist practice in ICM
ROOM Glasgow
Nurses
&
AHP
Joint Session ISF CONTROVERSIES SESSION
Chairs: Jean-Paul Mira, Paris, France & Konrad Reinhart, Jena, Germany
84
08:30 - 08:40
Fluid resuscitation in septic shock - we should keep our patients wet: Pro
Charles Sprung, Jerusalem, Israel
08:40 - 08:50
Fluid resuscitation in septic shock - we should keep our patients wet:
Con
Konrad Reinhart, Jena, Germany
08:50 - 09:00
The type of haemodynamic monitoring matters: Pro
09:00 - 09:10
The type of haemodynamic monitoring matters: Con
Derek Angus, Pittsburgh, United States
13-17 October 2012
L I V E S 2 012
Welcome to the Gambro Lunch Symposium focusing on
NeW CLiNiCaL PerSPeCtiveS oN the
MaNaGeMeNt of CritiCaLLy iLL PatieNtS
With aCute KidNey iNjury
Program
Chair: Prof. Marco Maggiorini
(universitätsSpital, Zürich, Switzerland)
The KDIGO AKI Guideline: Implications for Clinical Practice
Prof. daniel de Backer (hôpital erasme, Brussels, Belgium)
Renal Recovery After Acute Kidney Injury: Clinical and Health Economic Considerations
dr. Max Bell (Karolinska university hospital, Stockholm, Sweden)
The evidence base pertaining to the management of critically ill patients with acute kidney injury
(AKI) continues to evolve. In this symposium, experts will focus on two recent developments
specifically in the area of renal replacement therapy (RRT) for AKI. First, RRT-related consensus
statements from the recently issued KDIGO AKI Guideline will be discussed, with particular
emphasis on modality choice and anticoagulation. In the second presentation, emerging data
which strongly suggest a benefit for CRRT over intermittent RRT modalities with respect to renal
recovery after AKI will be presented. Both the clinical and health economic implications of these
new data will be discussed.
Date: Monday, 15 October 2012
Time: 12.30–14.00
Venue: Room Lisbon
www.gambro.com
Gaining insight.
Magnifying results.
To see the complete patient picture, having accurate and timely oxygenation
information is essential. With a comprehensive portfolio of monitoring technologies,
Covidien allows caregivers to detect subtle, yet critical variations in patient status
for faster, more informed interventions.
BIS™
Brain Monitoring
The BIS™ Brain Monitoring System delivers:
• Customized titration and anesthesia using processed EEG signals
• Reduced anesthetic use for improved emergence and recovery time
1
The INVOS™ Cerebral/Somatic Oximeter facilitates:
• Real-time regional oxygen saturation (rSO ) measurement
• Reduced cognitive decline and major organ morbidity/mortality
• Enhanced detection of oxygen threats associated with neurologic damage
2
INVOS™
2,3
Cerebral/Somatic Oximetry
4,5
LEARN MORE ABOUT BRAIN MONITORING SOLUTIONS FROM COVIDIEN AT COVIDIEN.COM/RMS
THE SENSING SYSTEMS OF COVIDIEN
BIS™ Brain Monitoring | INVOS™ Cerebral/Somatic Oximetry | Nellcor™ Pulse Oximetry with OxiMax™ Technology
Come and visit our Booth
#28, Exhibition Area A
1. Gan TJ, Glass PS, Windsor A, et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group.
Anesthesiology. 1997;87(4):808-815.
2. Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.
3. Slater JP, Guarino T, Stack J, et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009;87(1):36-44.
4. Dent CL, Spaeth JP, Jones BV, et al. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2006;131(1):190-197.
5. Kussman BD, Wypij D, Laussen PC, et al. Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1 year of age in infants
undergoing biventricular repair. Circulation. 2010;122(3):245-254.
COVIDIEN, COVIDIEN with logo, Covidien logo and positive results for life are U.S. and internationally registered trademarks of Covidien AG.
Other brands are trademarks of a Covidien company.
©2012 Covidien. All rights reserved. 11-PM-0337e BRAIN GB
08:30 - 08:50
Candida biofilms
08:50 - 09:10
Immunogenicity of candida infections
Michael Bauer, Jena, Germany
09:10 - 09:30
Candida peritonitis: Prophylaxis and treatment
Jan De Waele, Ghent, Belgium
ROOM Paris
Thematic Session
THE LIFE-PRIORITY SESSION: WHO CARES FOR THOSE WHO CARE?
Chairs: Colin Ferguson, Plymouth, United Kingdom & Jean-Daniel Chiche, Paris, France
08:30 - 08:50
Understanding the concept and relevance
Margaret S. Herridge, Toronto, Canada
08:50 - 09:10
Risk factors for burnout: The individual/the environment/the institution
09:10 - 09:30
Caring for the family
Nancy Kentish-Barnes, Paris, France
ROOM Vienna
Thematic Session
END-ORGAN CONSEQUENCES OF LIVER FAILURE
Chairs: Julia Wendon, London, United Kingdom & John Kellum, Pittsburgh, United States
08:30 - 08:50
Liver-induced brain injury
08:50 - 09:10
Hepatopulmonary syndrome
09:10 - 09:30
Hepatorenal syndrome
John Kellum, Pittsburgh, United States
ROOM Athens
Thematic Session
INFLAMMATION MODULATION BY NUTRITION
Chairs: Mette Berger, Lausanne, Switzerland & Jean-Charles Preiser, Brussels, Belgium
08:30 - 08:50
Omega-3
08:50 - 09:10
Arginine
Olav Rooyackers, Stockholm, Sweden
09:10 - 09:30
Vitamin D and Selenium
Karin Amrein, Graz, Austria
ROOM Lisbon
Thematic Session
Chairs: Mitchell Levy, Providence, United States & Andrew Rhodes, London, United Kingdom
09:40 - 10:00
The Surviving Sepsis Campaign: What have we achieved?
Mitchell Levy, Providence, United States
10:00 - 10:20
The new guidelines and bundles
10:20 - 10:40
How will the new guidelines impact your practice?
10:40 - 11:00
What next for the Campaign?
ROOM Berlin
State of the Art Session
Nurses
&
AHP
Thematic Session CANDIDA INFECTIONS IN THE ICU
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Room Stockholm
Chairs: Jean-François Timsit, Grenoble, France & George Dimopoulos, Athens, Greece
CRAZY HEART: RYTHM DISTURBANCES IN ICU
Chairs: Antoine Vieillard-Baron, Boulogne, France & Gorazd Voga, Celje, Slovenia
09:40 - 10:00
Common rhythm challenges
10:00 - 10:20
Reducing heart rate in ICU: How?
10:20 - 10:40
AF and anticoagulation: When and how much?
10:40 - 11:00
Arrhythmia and intoxications: Nuts and bolts
L I V E S 2 012
87
ROOM Barcelona
Oral Presentations
GENETIC AND MOLECULAR BASIS OF ARDS AND VILI
Chairs: John Laffey, Galway, Ireland & Clifford Deutschman, Philadelphia, United States
09:40 - 09:55
HUMAN MESENCHYMAL STEM CELLS ENHANCE REPAIR FOLLOWING
VENTILATOR-INDUCED LUNG INJURY
M.B. Hayes, B. Ansari, G. Curley, S. Elliman,
D. O’Toole, J.G. Laffey, Galway, Ireland
0001
09:55 - 10:10
PATTERNS OF GENE EXPRESSION IN PATIENTS WITH SEPSIS AND ACUTE
RESPIRATORY DISTRESS SYNDROME
P. Cardinal-Fernández, A. Ferruelo, M. El-Assar,
A. Martín-Pellicer, F. Frutos-Vivar, O. Peñuelas,
N. Nin, A. Esteban, J.A. Lorente, Madrid, Spain
0002
10:10 - 10:25
BACTERIAL FLAGELLIN MAY LEAD TO LUNG FIBROSIS THROUGH
EPITHELIAL-MESENCHYMAL TRANSITION OF ALVEOLAR EPITHELIAL
CELLS
Y. Kondo, H. Yamamoto, I. Kukita, Okinawa,
Japan
0003
10:25 - 10:40
GENETIC PREDISPOSITION TO ACUTE RESPIRATORY DISTRESS
SYNDROME IN PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK
C. Santiago, F. Gómez, A. Martín-Pellicer,
F. Frutos-Vivar, O. Peñuelas, N. Nin, A. Esteban,
J.A. Lorente, Madrid, Spain
0004
10:40 - 10:55
THE ROLE OF ATF3 IN ALI AND VILI-INDUCED APOPTOSIS
Y. Shan, A. Gonzalez Lopez, T. Maron Gutierrez,
A. Akram, P.R. Rocco, G.M. Albaiceta, C.C. dos
Santos, Toronto, Canada
0005
ROOM Geneva
Oral Presentations
NEW DATA ON RENAL REPLACEMENT THERAPY
MONDAY 15 OCTOBER
Chairs: Wilfred Druml, Vienna, Austria & Eric Hoste, Ghent, Belgium
09:40 - 09:55
PARATHYROID HORMONE SECRETION DURING CITRATE-BASED RENAL
REPLACEMENT THERAPY
M. Raimundo, S. Crichton, K. Lei, C. McKenzie,
H. Dickie, M. Ostermann, Lisbon, Portugal
0006
09:55 - 10:10
CITRATE TREATMENT REDUCE ENDOTHELIAL DEATH AND
INFLAMMATION
A. Bryland, G. Godaly, A. Wieslander, O. Carlsson,
T. Hellmark, Lund, Sweden
0007
10:10 - 10:25
EARLY INITIATION OF RENAL REPLACEMENT THERAPY IS ASSOCIATED
WITH DECREASED RISK FOR HOSPITAL MORTALITY IN THE CRITICALLY
ILL
S.T. Vaara, A.-M. Korhonen, K.-M. Kaukonen,
S. Nisula, O. Inkinen, S. Hoppu, J.J. Laurila,
L. Mildh, M. Reinikainen, V. Lund, I. Parviainen,
V. Pettilä, Helsinki, Finland
0008
10:25 - 10:40
BLOOD PUMP ALARM ACTIVATION DURING CONTINUOUS RENAL
REPLACEMENT THERAPY: EFFECTS ON FILTER LIFESPAN
P.J. McCanny, H. Misran, E. O’Connor, Dublin,
Ireland
0009
10:40 - 10:55
RENAL REPLACEMENT THERAPY IN ICU- PATIENTS WITH LIVER CIRRHOSIS
K. Staufer, A. Drolz, K. Roedl, T. Horvatits, R. Saxa,
U. Holzinger, R. Brunner, C. Zauner, G. Heinz,
P. Schellongowski, M. Trauner, V. Fuhrmann,
Vienna, Austria
0010
ROOM Rome Continuous Professional Education Session
DAMAGE
SYSTEMIC COMPLICATIONS OF ACUTE BRAIN
Chairs: Elisa Zanier, Milan, Italy & Jan Claassen, New York, United States
09:40 - 10:00
The brain is the conductor, the organs are musicians…
Paolo Pelosi, Genova, Italy
10:00 - 10:20
Cardio-pulmonary dysfunction after acute brain damage
10:20 - 10:40
Water and electrolyte homeostasis
Jean-François Payen, Grenoble, France
10:40 - 11:00
Endocrine and immune dysfunction
Pedro Navarrete Navarro, Granada, Spain
ROOM Glasgow
Oral Presentations
Nurses
&
AHP
COMMUNICATION IN THE ICU 1
Chairs: Colin Ferguson, Plymouth, United Kingdom & Bob Truog, Boston, United States
88
09:40 - 09:55
THE ETHICAL CLIMATE IN EUROPEAN ICUS: RESULTS FROM THE
APPROPRICUS STUDY
R.D. Piers, E. Azoulay, B. Ricou, F. DeKeyser
Ganz, J. Decruyenaere, A. Max, A. Michalsen,
P. Depuydt, R. Owczuk, P. Maia, F. Rubulotta,
A.K. Reyners, A.-P. Meert, A. Aquilina,
D.D. Benoit, Gent, Belgium
0011
09:55 - 10:10
IMPROVING INTERPROFESSIONAL TEAMWORK IN THE ICU: A SINGLE
CENTRE INTERVENTION STUDY
B. Van den Bulcke, A. Vyt, E. Hoste, S. Oeyen,
H. Martens, V. Bosschem, J. Decruyenaere,
D. Benoit, Gent, Belgium
0012
13-17 October 2012
L I V E S 2 012
Unknowns
in Continuous
Glucose
Monitoring?
Join Edwards Lifesciences to find Clarity in Every Moment.
Attend our Lunch symposium:
The Future of Glucose Monitoring in the ICU
Monday, October 15 – 12.30-14.00, Room Berlin
Chairs: Carole Ichai, France & Jean-Charles Preiser, Belgium
Frequency of measurement and optimised glycaemic control in the ICU
Djillali Annane, France
Emerging technologies for automated glucose monitoring
Nigel Scawn, UK
Clinical experience with the GlucoClear* continuous
glucose monitoring system
Luc Foubert, Belgium
For professional use.
*GlucoClear System is not commercially available.
Edwards, Edwards Lifesciences, the stylized E logo, Clarity in Every Moment and GlucoClear are trademarks of Edwards Lifesciences
Corporation.
© 2012 Edwards Lifesciences Corporation. All rights reserved. E3150/08-12/CC
Edwards Lifesciences
Irvine, USA I Nyon, Switzerland
edwards.com
I Tokyo, Japan I Singapore, Singapore I São Paulo, Brazil
Nestlé Nutrition Institute
Is Pleased to invite You to Our Satellite Symposium
Individualized Nutritional Strategies in ICU
Monday, 15th October • Room Barcelona • 12.30 - 14.00
Chairman: Prof. Jukka Takala, MD, PhD, Switzerland
Co-Chair: Martin Dünser, MD, Salzburg, Austria
Welcome and Introduction
Adequate nutrition: Did we learn enough to change the practice?
Prof. Jean-Daniel Chiche, MD, PhD, France
Energy requirement: Do we need to measure?
Prof. Jan Wernerman, MD, PhD, Sweden
Barriers to Enteral Nutrition: GI dysfunction in ICU patients
Prof. Stephan Jakob, MD, PhD, Switzerland
Can Early Enteral Nutrition prevent gut dysfunction?
A/Prof. Gordon Doig, PhD, Australia
Question & Answer Session
Held in conjunction with the European Society of Intensive Care Medicine
Lisbon, October 13-17th
In collaboration with
M. de Vos, A. Bos, F. Plötz, M. van Heerde,
B. de Graaff, K. Tates, D. Willems, Amsterdam,
Netherlands
0013
10:25 - 10:40
SPOKEN LANGUAGE DISCORDANCE AND ALL CAUSE MORTALITY IN
CRITICALLY ILL PATIENTS: A COHORT STUDY
K.B. Christopher, M. Mendu, S. Zager,
F.K. Gibbons, Boston, United States
0014
10:40 - 10:55
HOW ARE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY
DISEASE (COPD) PREPARED TO THE EVENTUALITY OF AN INTENSIVE
CARE UNIT (ICU) ADMISSION?
M. Schmidt, T. Similowski, M. Chaize, S. de
Miranda, N. Belle, N. Roche, E. Azoulay,
A. Demoule, Paris, France
0015
ROOM Stockholm Oral Presentations
IN INTENSIVE CARE 1
ASSESSING THE IMPACT OF INTERVENTIONS & ORGANISATIONS
Chairs: Maurizia Capuzzo, Ferrara, Italy & Marco Maggiorini, Zurich, Switzerland
Nurses
&
AHP
09:40 - 09:55
THE EFFECT OF THREE INTERVENTIONS TO REDUCE ICU DELAYED
DISCHARGE IN A CENTRAL LONDON TEACHING HOSPITAL AND TRAUMA
CENTRE
C. Ruse, C. Bell, A. Feehan, K. Peters, A. Skorko,
Z. Ratansi, D. Green, P.A. Hopkins, London,
United Kingdom
0016
09:55 - 10:10
MEASURING FAMILY AND PATIENT SATISFACTION IN THE INTENSIVE
CARE UNIT. DOES A CORRELATION EXIST BETWEEN THE ANSWERS OF
THE RELATIVES AND THE ANSWERS OF PATIENTS?
M.S. Holanda Peña, R. Walkman,
M.J. Dominguez Artiga, E. Ots Ruiz, A. García
Miguelez, F. Ortiz Melón, Á. Castellanos Ortega,
Santander, Spain
0017
10:10 - 10:25
ICU ORGANISATION, VIEWS AND PRACTICES OF CAREGIVERS TO
IMPROVE PATIENT’S COMFORT: A FRENCH SURVEY
A. Roch, I. Bourgeon-Ghittori, S. Dray, F. Meziani,
B. Souweine, I. Vinatier, Paris, France
0018
10:25 - 10:40
INSTRUMENTS TO MEASURE FAMILY SATISFACTION WITH INTENSIVE
CARE, A SYSTEMATIC REVIEW
J.M. van den Broek, S. Arbous, E. de Jonge,
Leiden, Netherlands
0019
10:40 - 10:55
IMPROVING PATIENT SAFETY: USEFULNESS OF REAL TIME AUDITS TO
DETECT MEDICAL ERRORS IN CRITICAL CARE UNIT
M.J. Asensio Martín, E. Herrero, E. Perales,
M. Sanchez, B. Galvan, M. Jiménez, A. García-De
Lorenzo, Madrid, Spain
0020
ROOM Paris Oral Presentations
BRAIN INJURY
Chairs: Giuseppe Citerio, Monza, Italy & Thomas Geeraerts, Toulouse, France
09:40 - 09:55
SODIUM LACTATE INFUSION PREVENTS INTRACRANIAL HYPERTENSIVE
EPISODES IN SEVERE TRAUMATIC BRAIN INJURY: A DOUBLE-BLIND
RANDOMISED CONTROLLED STUDY
C. Ichai, J. C. Orban, H. Quintard, M. Legrand,
G. Francony, J.-F. Payen, X. Leverve, Nice, France
0021
09:55 - 10:10
CONTRALATERAL EXTRAAXIAL HAEMATOMAS AFTER URGENT
NEUROSURGERY OF A MASS LESION IN PATIENTS WITH TRAUMATIC
BRAIN INJURY (TBI). CLINICAL FEATURES AND RISK FACTOR ANALYSIS
J.L. Flordelís Lasierra, C. García Fuentes,
E. Alted López, M. Chico Fernández, D. Toral
Vázquez, R. Lesmes Gómez, S. Bermejo Aznárez,
L.D. Umezawa Makikado, I. Sáez de la Fuente,
J.C. Montejo González, Madrid, Spain
0022
10:10 - 10:25
IMPACT OF PROGESTERONE ADMINISTRATION ON OUTCOME OF
PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY
H. Abokhabar, A. Abouelela, S. Mousa,
Alexandria, Egypt
0023
10:25 - 10:40
LATE DECOMPRESSIVE CRANIECTOMY AFTER TRAUMATIC BRAIN INJURY:
NEUROLOGICAL OUTCOME AT 6 MONTHS AFTER ICU DISCHARGE
G. Cianchi, M. Bonizzoli, M.L. Migliaccio, G. Zagli,
S. di Valvasone, S. Biondi, G. Cappuccini,
M. Ciapetti, R. Spina, F. Mariotti, A. Peris,
Florence, Italy
0024
10:40 - 10:55
SEVERE TRAUMATIC BRAIN INJURY IN A HIGH INCOME COUNTRY: A
POPULATION-BASED PROSPECTIVE COHORT STUDY
B. Walder, G. Haller, E. Bottequin, P. Schoettker,
P. Ravussin, M. Brodmann, M. Zuercher,
J. Stover, J. Osterwalder, A. Haller, A. Waeckerlin,
C. Haberthur, J. Fandino, C. Haller, Geneva,
Switzerland
0025
91
DOCTORS, NOT PARENTS, DECIDE TO FORGO LIFE SUSTAINING
TREATMENT IN PAEDIATRIC INTENSIVE CARE
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
10:10 - 10:25
Try the
e-posters
experience in the
exhibition
area
L I V E S 2 012
91
ROOM Vienna
Oral Presentations
SHOCK
Chairs: Can Ince, Rotterdam, Netherlands & Jan Bakker, Rotterdam, Netherlands
09:40 - 09:55
SYSTEMIC AND MICROCIRCULATORY EFFECTS OF DOBUTAMINE IN
SEPTIC SHOCK PATIENTS
C. Enrico, V.S. Kanoore Edul, A. Risso Vazquez,
M.C. Pein, R.A. Pérez de la Hoz, C. Ince, A. Dubin,
Buenos Aires, Argentina
0026
09:55 - 10:10
EFFECTS OF NOREPINEPHRINE ON MEAN SYSTEMIC PRESSURE AND
VENOUS RETURN IN HUMAN SEPTIC SHOCK
R. Persichini, S. Silva, J.-L. Teboul, M. Jozwiak,
D. Chemla, C. Richard, X. Monnet, Le Kremlin
Bicetre, France
0027
10:10 - 10:25
RELATIONSHIP OF SYSTEMIC, HEPATOSPLANCHNIC AND
MICROCIRCULATORY PERFUSION PARAMETERS WITH SIX-HOUR
LACTATE CLEARANCE IN HYPERDYNAMIC SEPTIC SHOCK PATIENTS: AN
ACUTE CLINICAL-PHYSIOLOGICAL PILOT STUDY
G. Hernandez, T. Regueira, A. Bruhn, R. Castro,
M. Rovegno, A. Fuentealba, E. Veas, E. Kattan,
C. Martin, D. Berrutti, C. Ince, Santiago, Chile
0028
10:25 - 10:40
SERIAL EVALUATION OF PERIPHERAL PERFUSION TO PREDICT OUTCOME
IN CRITICALLY ILL PATIENTS
M.E. van Genderen, T. Boerstra, A. Lima,
J. Bakker, J. van Bommel, Rotterdam,
Netherlands
0029
10:40 - 10:55
VENOUS-ARTERIAL CO2 GAP (DCO2) CAN BE COMPLEMENTARY TO
CENTRAL VENOUS OXYGEN SATURATION (SCVO2) AS TARGET END
POINTS DURING FLUID RESUSCITATION
M. Nemeth, G. Demeter, J. Kaszaki, D. Erces,
N. Oveges, N. Frei, L. Matusek, Z. Molnar, Szeged,
Hungary
0030
ROOM ATHENS
THEMATIC SESSION
What junior ICU docs already know
Chairs: Mervyn Singer, London, United Kingdom & Antonio Artigas, Sabadell, Spain
09:40 - 10:00
Marco Giani
09:50 - 09:55 Speaker:
Peter Schellongowski
09:55 - 10:00
10:00 - 10:20
Katia Donadello
Discussion
The best way to foster mobility of ICM trainees in Europe is…
10:00 - 10:05 Speaker:
10:05 - 10:10 Speaker:
Oliver Wernet
10:10 - 10:15 Speaker:
Bernardo Bollen Pinto
10:15 - 10:20
MONDAY 15 OCTOBER
The biggest change needed in ICM training is…
09:40 - 09:45 Speaker:
09:45 - 09:50 Speaker:
Daniele Bonacina
Discussion
To improve ICM research prospects in Europe, we must …
10:20 - 10:25 Speaker:
10:25 - 10:30 Speaker:
10:30 - 10:35 Speaker:
10:20 - 10:40
10:35 - 10:40
10:40 - 11:00
Katie Lane
Jean-Francois Llitjos
Katharina Chalk
Discussion
To ensure a bright future for ICM in Europe we need to…
10:40 - 10:45 Speaker:
10:45 - 10:50 Speaker:
Julia Werner
10:50 - 10:55 Speaker:
Lara Prisco
10:55 - 11:00
Area Beja
Matthias Hilty
Discussion
Poster Corner
VENTILATOR-INDUCED LUNG INJURY
Chairs: Patricia Rocco, Rio de Janeiro, Brazil & Franco Valenza, Milan, Italy
10:10 - 12:00
92
TPL2 KINASE CONTRIBUTES TO VENTILATOR-INDUCED LUNG INJURY IN
A MOUSE MODEL
E. Kaniaris, K. Vaporidi, E. Vergadi, E. Kondili,
D. Georgopoulos, Heraklio, Greece
0031
CONVENTIONAL DENDRITIC CELLS INITIATE AND CONTROL ACUTE
LUNG INFLAMMATION BY REGULATING NEUTROPHIL INFILTRATION AND
BALANCE OF TH1/TH2 RESPONSE IN ACUTE LUNG INJURY
L. Dong, J. Xu, X. Lu, Y. Yang, H. Qiu, Nanjing,
China
0032
ANTIOXIDANT EFFECT OF HUMAN ADIPOSE-DERIVED MESENCHYMAL
STEM CELLS IN STRETCH-INDUCED ALVEOLAR EPITHELIAL CELL INJURY
O. Peñuelas, C. Sanchez Rodriguez, I. Sanchez
Muñoz, E. Melo, R. Farré, D. Navajas, N. Nin,
A. Esteban, J.A. Lorente, Getafe, Spain
0033
13-17 October 2012
L I V E S 2 012
Visit us
at boot
h
17
Lunch Symposium
Good Clinical
Nutrition Practice
Monday, 15th October 2012
12:30 – 14:00h, Room Geneva
Moderator
Prof. Pierre Déchelotte, France
Effective Glycaemia Control
Is it worth adapting the energy and
protein intake to the patient‘s
individual requirements?
Monday, 15 October 2012
18:15 – 19:15h
Room Stockholm
Glutamine for the intensivist
Satellite Symposium
Prof. Mette Berger, Switzerland
Prof. John Stover, Switzerland
Lunch Symposium
Volume Therapy
in Surgery and ICU
Tuesday, 16 October 2012
12:30 – 14:00h
Room Geneva
www.fresenius-kabi.com
BAXTER SATELLITE SYMPOSIUM, ESICM ANNUAL CONGRESS - LISBON 2012
The role of betablockers in sepsis
MONDAY 15TH OCTOBER 2012, 12.30 -14.00
ROOM GLASGOW – GROUND FLOOR
Chairmen: Prof. Mervyn Singer and Prof. Jean-François Timsit
12.30 – 12.40 Opening remarks
Prof. Mervyn Singer and Prof. Jean-François Timsit
12.40 – 13.00 The physiologic basis of hemodynamic treatment
in sepsis and septic shock
Prof. Walter Hasibeder
13.00 – 13.20 Preclinical data supporting beta-blockers rationale in sepsis
Dr .Alain Rudiger
13.20 – 13.40 Beta-blocker use in septic patient: experience
of a single center pilot
Dr. Andrea Morelli
13.40 – 13.50 Panel question session
13.50 – 14.00 Concluding comments
Pr. Mervyn Singer and Prof. Jean-François Timsit
MD AN 306, date of preparation August 2012.
0034
PROTECTIVE EFFECT OF URINARY TRYPSIN INHIBITOR ON SEPTIC RAT
LUNGS
D.W. Wu, C. Chen, H.N. Lu, H.P. Guo, Jinan, China
0035
HIGH FREQUENCY OSCILLATION AND PRONE POSITION VENTILATION
IN EXPERIMENTAL MODEL OF ARDS - HAEMODYNAMIC PARAMETERS
CHANGES
P. Kosut, J. Zurek, P. Dominik, M. Klimovic,
M. Seda, M. Fedora, Brno, Czech Republic
0036
MICRORNA-146A CONTRIBUTES TO VENTILATOR-INDUCED LUNG INJURY
K. Vaporidi, E. Vergadi, E. Ieronimaki,
C. Tsatsanis, D. Georgopoulos, Heraklio, Greece
0037
EFFECT OF PROTECTIVE VENTILATION ON THE INFLAMMATORY
RESPONSE AND NEURONAL ACTIVATION, IN AN EXPERIMENTAL
MODEL OF ACUTE LUNG INJURY INDUCED BY INSTILLATION OF
LIPOPOLYSACCHARIDE
M.E. Quílez, J. López-Aguilar, F. Puig, I. Ferrer,
L. Blanch, Madrid, Spain
0038
STUDY ON THE EFFECT OF PACO2 ON PULMONARY ARTERY PRESSURE
OF MECHANICALLY VENTILATED RABBITS
A. Triantaris, D. Makris, I. Aidonidis,
A. Hatziefthimiou, E. Zakynthinos, Larissa,
Greece
0039
BAL FLUID (BALF) ACTIVIN A (ACTA) LEVELS IN ARDS PATIENTS
VENTILATED WITH CONVENTIONAL MECHANICAL VENTILATION (CMV)
VS HIGH FREQUENCY OSCILLATORY VENTILATION (HFOV)
C.S. Vrettou, K. Stavrakaki-Kallergi,
S.D. Mentzelopoulos, C. Glynos, V. Karavana,
S. Zakynthinos, Athens, Greece
0040
TAK-1 SIRNA NORMALISES AUTOPHAGY AND APOPTOSIS IN SEPTIC
MOUSE LUNG
N. Matsuda, J. Tochikubo, T. Tamura, M. Tsuzuki,
K. Murase, Y. Adachi, Nagoya, Japan
0041
ACTIVATION OF CANONICAL WNT PATHWAY PROMOTES MICE BONE
MARROW DERIVED MSCS DIFFERENTIATING INTO TYPE II ALVEOLAR
EPITHELIAL CELLS, SURVIVAL AGAINST OXIDATIVE STRESS, AND
MIGRATING TOWARDS INJURED LUNG TISSUE IN VITRO
A. Liu, L. Liu, S. Chen, Y. Yang, L. Liu, F. Guo, X. Lu,
H. Qiu, Nanjing, China
0042
PHYSIOLOGIC EFFECTS OF HIGH FREQUENCY POSITIVE PRESSURE
VENTILATION (HFPPV) USING A CONVENTIONAL VENTILATOR IN A
SEVERE ARDS ANIMAL MODEL
R.L. Cordioli, M.B.P. Amato, E.L.V. Costa, M. Park,
L.C.P. Azevedo, Sao Paulo, Brazil
0043
CO2 DIALYSIS IN THE TREATMENT OF PATIENT WITH ARDS AND BRAIN
TRAUMA: A CASE REPORT
A.N. Cracchiolo, D.M. Palma, M.F. Sapuppo,
S. Ardizzone, R. Tetamo, Palermo, Italy
0044
Poster Corner
SATISFYING METABOLIC DEMAND IN THE ICU
Chairs: Annika Reintam Blaser, Tallin, Estonia & Olivier Joannes-Boyau, Pessac, France
10:10 - 12:00
METABOLIC MODULATION BY TETRATHIOMOLYBDATE, A SLOW-RELEASE
SULPHIDE DONOR
A. Dyson, K. Moore, N. Mongardon, L. Andreeva,
J. Martin, M. Singer, London, United Kingdom
0045
CAN INTRAVENOUS N-3 FATTY ACIDS, AS PHARMACONUTRITION,
MODIFY PLASMA PHOSPHOLIPIDS COMPOSITION AND CLINICAL
OUTCOME IN CRITICALLY ILL ELDERLY?
K. Barros, A.P. Cassulino, L. Schalch,
E.D.V. Munhoz, J.A. Manetta, M. Rogero,
P. Noakes, E.A. Miles, P.C. Calder, V.L.F. Silveira,
São Paulo, Brazil
0046
COMPARISON OF DIFFERENT METHODS OF ENERGY EXPENDITURE
DETERMINATION IN CRITICALLY ILL PATIENTS WITH INTRACRANIAL
HAEMORRHAGE
J. Titova, S. Petrikov, A. Ryk, A. Solodov,
E. Karapetyan, V. Krylov, Moscow, Russian
Federation
0047
LEAKAGE OF ALBUMIN IN MAJOR ABDOMINAL SURGERY
Å. Norberg, O. Rooyackers, J. Wernerman,
Stockholm, Sweden
0048
PREDICTING ENERGY EXPENDITURE IN SEPSIS - A COMPARATIVE STUDY
OF HARRIS-BENEDICT AND SCHOFIELD EQUATIONS VERSUS WEIR
DERIVATION IN SEPTIC PATIENTS
R. Nagappan, A. Subramaniam, M. McPhee,
Melbourne, Australia
0049
ARE THE LEVELS OF GLUCOSE ESTIMATED BY HBA1C THE TRUE GOAL OF
GLYCAEMIC CONTROL IN CRITICALLY ILL PATIENTS?
R. Chaires Gutiérrez, E. Monares Zepeda,
M. Poblano Morales, J. Aguirre Sánchez,
J. Franco Granillo, México, Mexico
0050
RESPIRATORY, METABOLIC AND HAEMODYNAMIC EFFECTS OF
DEXMEDETOMIDINE IN AGITATED, VENTILATED PATIENTS: PRELIMINARY
REPORT
V. Tsapas, C. Chaintoutis, E. Koco, A. Pitsoulis,
D. Matamis, Thessaloniki, Greece
0051
L I V E S 2 012
95
K. Timmermans, S.E.I. van der Wal, M. Vaneker,
M. Kox, G.J.J. Braak, J.A.W.M. van der Laak,
M.G. Netea, J.G. van der Hoeven, L.A.B. Joosten,
G.J. Scheffer, Nijmegen, Netherlands
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Braga
BYPASSING THE INFLAMMASOME: CRUCIAL ROLE FOR NEUTROPHIL
SERINE PROTEASES IN VENTILATOR-INDUCED LUNG INJURY
95
PREDICTORS OF OUTCOME AND COSTS OF ACUTE PANCREATITIS:
RESULTS FROM THE EAGLE-TRIAL-GROUP
W. Huber, A.-B. Roos, S. Mair, J. Hoellthaler,
V. Phillip, A. Herrmann, B. Saugel, R.M. Schmid,
C. Trautwein, A. Koch, Munich, Germany
0052
ENERGY TARGET BASED ON ACTUAL OR IDEAL WEIGHT: THE
NUTRITIONDAY ICU EXPERIENCE
M.J. Hiesmayr, M. Mouhieddine, P. Singer,
Vienna, Austria
0053
ARE WE MEETING THE NUTRITIONAL REQUIREMENTS OF OUR
CARDIOTHORACIC ADULT ICU PATIENTS?
A. Kulendran, S. Patel, J. Mutuyimana, E. Lum,
S. Price, London, United Kingdom
0054
THE CALORIC INTAKE OF PATIENTS UNDERGOING CARDIAC SURGERY,
HOW MUCH IS IT AND DOES IT COVER THE NEEDS?
E. De Waele, K. De Bondt, K. De Brabandere,
S. Mattens, D. Nguyen, F. Wellens, L. Huyghens,
Jette, Belgium
0055
COMPLIANCE WITH GUIDELINES ON NUTRITION IN SEVERE ACUTE
PANCREATITIS
K. Girgirah, S. Ghabina, A. Krige, Blackburn,
United Kingdom
0056
PREDICTED VS MEASURED ENERGY EXPENDITURE IN CRITICALLY ILL
A.D. Marinho, N. Costa, Porto, Portugal
0057
RELATIONSHIP BETWEEN BMI AND O/E RATIO IN CRITICALLY ILL
PATIENTS: DATA FROM NUTRITIONDAY
B. Mora, P. Singer, S. Ruiz-Santana, A. DÁrienzo,
M. Hiesmayr, Vienna, Austria
0058
FIBRINOGEN SYNTHESIS IN A CHRONIC PIG MODEL OF BLUNT LIVER
INJURY AFTER FIBRINOGEN SUBSTITUTION
C. Zentai, T. Braunschweig, H. Spronk,
R. Rossaint, O. Grottke, Aachen, Germany
0059
TACHOSIL IN A PIG MODEL WITH BLUNT LIVER INJURY UNDER SEVERE
HYPOTHERMIA
C. Zentai, T. Braunschweig, R. Rossaint, R. Tolba,
O. Grottke, Aachen, Germany
0060
EFFICACY AND SAFETY OF UNCROSS-MATCHED TYPE-O RED BLOOD
CELLS FOR RESUSCITATION OF TRAUMA PATIENTS: AN OBSERVATIONAL
STUDY AND PROPENSITY ANALYSIS
K. Maekawa, K. Kato, H. Mizuno, K. Sawamoto,
S. Uemura, K. Tanno, K. Mori, Sapporo, Japan
0061
TRAUMA RESUSCITATION USING ECHOCARDIOGRAPHY IN A DEPLOYED
MILITARY INTENSIVE CARE UNIT
P.S.C. Rees, S.D. Hutchings, London, United
Kingdom
0062
LOW RATIO OF INTRAVENOUS FLUID ADMINISTRATION TO PACKED RED
BLOOD CELL IS ASSOCIATED WITH IMPROVED SURVIVAL IN TRAUMA
PATIENTS: AN OBSERVATIONAL STUDY AND PROPENSITY ANALYSIS
K. Maekawa, K. Kato, H. Mizuno, K. Sawamoto,
S. Uemura, K. Tanno, K. Mori, Sapporo, Japan
0063
TERLIPRESSIN IS SUPERIOR TO LACTATED RINGER SOLUTION FOR
CEREBRAL PERFUSION PRESSURE DURING RESUSCITATION IN A MODEL
OF HAEMORRHAGIC SHOCK
K.K. Ida, D.A. Otsuki, A.T.C. Sasaki, J.O.C. Auler Jr,
L.M.S. Malbouisson, São Paulo, Brazil
0064
RESUSCITATION WITH FLUID OR TERLIPRESSIN DOES NOT INFLUENCE
COAGULATION STATUS IN A MODEL OF SEVERE CONTROLLED
HAEMORRHAGIC SHOCK
A.T.C. Sasaki, D.A. Otsuki, K.K. Ida, J.O.C. Auler Jr,
L.M.S. Malbouisson, São Paulo, Brazil
0065
THE SURGICAL MANAGEMENT OF SEVERE PENETRATING LIVER TRAUMA:
A DYNAMIC APPROACH ACCORDING TO INITIAL RESPONSE TO THERAPY
C.A. Ordoñez, M. Badiel, J. Salamea, M. Cepeda,
J.H. Loaiza, J.C. Puyana, L. Pino, D. Scavo,
W. Botache, Cali, Colombia
0066
PREDICTIVE PERFORMANCE OF A PREHOSPITAL ACTIVATION CODE TO
IDENTIFY PATIENTS IN HAEMORRHAGIC SHOCK
T. Gauss, S. Hamada, L. Oumakhlouf, A. Harrois,
J. Duranteau, J. Mantz, C. Paugam-Burtz, Clichy,
France
0067
POLYTRAUMA PATIENTS IN EMERGENCY OF A TERTIARY HOSPITAL. HAVE
THEY CHANGED THEIR CHARACTERISTICS?
M. Quintana, A.M. Borobia, M. Martí,
M.A. Rivera, S. Fabra, M. Sánchez Casado,
A.M. Martinez Virto, Madrid, Spain
0068
EFFECT OF PARTIAL BRAIN ISCHAEMIA ON THE METABOLIC AND
HAEMODYNAMIC RESPONSES TO HAEMORRHAGE HYPOTENSION
MEASURED IN THE BRAIN AND SMALL INTESTINE
M. Mandelbaum-Livnat, E. Barbiro-Michaely,
A. Mayevsky, Ramat-Gan, Israel
0069
PREHOSPITAL CONTROL OF SYSTOLIC ARTERIAL PRESSURE IN
HAEMORRHAGIC SHOCK
S. Hamada, T. Gauss, A. Harrois, J. Duranteau,
J. Mantz, C. Paugam-Burtz, Clichy, France
0070
PREVENTION OF HYPOTHERMIA IN PRE-HOSPITAL SEVERELY INJURED
TRAUMA PATIENTS. A SIMPLE SYSTEM
M. Croci, M.F. Panzeri, S. Fracassi, E. Lepera,
S. Hudecova, S. Greco, Busto Arsizio, Italy
0071
DEGREE OF NECK IMMOBILISATION, INFLUENCE ON JUGULAR VENOUS
PRESSURE AND PATIENT COMFORT: COMPARISON OF FOUR TYPES OF
NECK COLLARS
S. Karason, K. Reynisson, K. Gunnsteinsson,
A.G. Ludviksdottir, K. Sigvaldason,
G.H. Sigurdsson, T. Ingvarsson, Reykjavik, Iceland
0072
Area Cascais
Poster Corner
TRAUMA UPDATE
Chairs: Bernard Vigué, France & Rupert Pearse, London, United Kingdom
MONDAY 15 OCTOBER
10:10 - 12:00
96
13-17 October 2012
L I V E S 2 012
SYMPOSIUM 1
OPTIMIZING PATIENT-VENTILATOR INTERACTION
AND CHANCE OF SUCCESS IN NIV
Welcome to the MAQUET sponsored symposium.
Program:
Together we will explore the latest development within
An overview of NIV ventilation.
non-invasive ventilation and Neurally Adjusted Ventilatory
Paolo Navalesi, MD, S. Andrea hospital Vercelli, Piemonte
Assist (NAVA ).
Orientale, Novara, Italy
Optimizing patient-ventilator interaction and chance
Why does NIV fail? Is there a role for NIV NAVA?
of success in NIV
Leo M.A. Heunks, MD, UMC St Radboud, Nijmegen,
®
Time: Monday October 15, 12:00–14:30
Place: Room Stockholm
Chairpersons: Massimo Antonelli, MD, Università Cattolica
del Sacro Cuore, Rome, Italy and Paolo Navalesi, MD,
S. Andrea hospital Vercelli, Piemonte Orientale, Novara, Italy
Maquet Critical Care AB | maquet.com The Netherlands
NIV NAVA in the post-operative setting.
Mathieu Raux, MD, PhD, Groupe Hospitalier Pitié
Salpêtrière, Paris, France
An Educational Satellite Symposium at the 25th ESICM LIVES Annual Congress
Monday, October 15, 2012 • 12:30 hrs to 14:00 hrs • Paris Room • Centro de Congressos de Lisboa (CCL) • Lisbon, Portugal
Register at AKILisbon.com to stay connected and receive updates about the program.
There will be additional resources on the website following ESICM.
Come visit Astute in Exhibition Area A, Booth 19 to learn more or visit astutemedical.com
@ACuteKidneyMan
Sponsored by Astute Medical
San Diego, CA, USA 92121
Phone: (858) 792-3544
astutemedical.com
The NEPHROCHECK™ Test and the ASTUTE140™ Meter are not available in the United States. ©2012 Astute Medical, Inc. Astute Medical™, the AM logo,
ASTUTE140™, NEPHROCHECK™ and the NEPHROCHECK™ logo are trademarks of Astute Medical, Inc. PN 0079 Rev A 2012/08/14
New
AKI
Biomarkers:
a revolution in risk assessment
10:10 - 12:00
MYOCARDIAL INFARCTION AND PERCUTANEOUS REVASCULARISATION:
SHORT-TERM PROGNOSIS IN > 75 YEARS OLD
M. Cano Garcia, D. Gaitan Roman, B. Perez
Villardon, I. Vegas Vegas, M.A. Ramirez Marrero,
J. Cano Nieto, M. De Mora Martin, Malaga, Spain
0073
STUDY ABOUT SURVIVAL AND QUALITY OF LIFE IN > 75 YEARS OLD
WITH ACUTE CORONARY SYNDROME
D. Gaitan Roman, B. Perez Villardon,
M.A. Ramirez Marrero, I. Vegas Vegas,
G. Ballesteros Derbenti, J. Cano Nieto, M. De
Mora Martin, Malaga, Spain
0074
INITIAL RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION
MYOCARDIAL INFARCTION BY ECG PATTERN AND TIMI SCORE
T. Garcia-Paredes, D. Arias-Verdú, J. MoraOrdóñez, R. Rivera-Fernández, G. Jiménez-Pérez,
L. Olivencia-Peña, E. Agular-Alonso, Málaga,
Spain
0075
DOES PATIENT GENDER INFLUENCE IN MANAGEMENT OF ACUTE
CORONARY SYNDROME WITH ST ELEVATION IN OUR FIELD?
M. Colomo Gonzalez, M.R. Diaz Contreras,
R. de la Chica Ruiz Ruano, S. Nogueras
Guijarro, P. Castan Ribas, L.I. Rodriguez Peralta,
A. Sanchez Gonzalez, M.E. Poyatos Aguilera,
E. Aguayo de Hoyos, A. Reina Toral, Granada,
Spain
0076
BENEFICIAL EFFECTS OF THE PRESCRIPTION OF FIXED DOSE
COMBINATION OF BETA-BLOCKER AND DIURETIC IN PATIENTS WITH
RENAL FAILURE AND HISTORY OF NON-ST-SEGMENT-ELEVATION ACUTE
CORONARY SYNDROME
M.A. Ramirez-Marrero, I. Vegas-Vegas, B. PerezVillardon, D. Gaitan-Roman, M. Cano-Garcia,
M. de Mora-Martin, Malaga, Spain
0077
DIFFERENCE DIAGNOSIS OF ACUTE ISCHAEMIC STROKE WITH LEFT
HEMIPARALSIS AND ACUTE AORTIC DISSOCIATION
S.-I. Nihei, H. Arai, K. Nagata, Y. Isa, T. Shinjyo,
K. Goto, N. Harayama, K. Aibara, M. Kamochi,
Kitakyushu, Japan
0078
PREDICTORS OF INOTROPIC DRUGS UTILISATION IN ADULT CARDIAC
SURGERY WITH CARDIOPULMONARY BYPASS
G. Raimondi, G. Juliano, S. Gregu, P. Suriano,
E. Sisillo, Milan, Italy
0079
QT INTERVAL IN PATIENTS WITH ST-ELEVATION MYOCARDIAL
INFARCTION. RELATION WITH MORTALITY AND COMPLEMENTARITY
WITH THE TIMI AND APACHE II
M. Arias-Verdú, R. Rivera-Fernádez, E. AguilarAlonso, T. García-Paredes, M. Fenández-Zamora,
A. Vera-Almazán, G. Quesada-Garcia, Málaga,
Spain
0080
FACTORS ASSOCIATED WITH THE DEVELOPMENT OF AN EPISODE OF
ACUTE CORONARY SYNDROME IN PATIENTS EVALUATED BY A CHEST
PAIN UNIT
M.A. Ramirez-Marrero, D. Gaitan-Roman,
I. Vegas-Vegas, M. Cano-Garcia, B. LuqueAguirre, G. Ballesteros-Derbenti, M. de MoraMartin, Malaga, Spain
0081
GRACE SCORE AND CARDIAC MAGNETIC RESONANCE FOR PREDICTING
CARDIAC EVENTS AFTER HOSPITAL DISCHARGE IN PATIENTS WITH ST
SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
L. Palacios Gamir, V. Bodí, R. Oltra, C. Bonanad,
J. Sanchis, J. Nuñez, R. Huerta, Valencia, Spain
0082
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS WITH
ACUTE HEART FAILURE: GENDER-ASSOCIATED DIFFERENCES
V. Degoricija, I. Potočnjak, T. Bodrožić-Džakic,
I. Šmit, M. Milošević, Zagreb, Croatia
0083
FUNCTIONAL OUTCOME AFTER OUT OF HOSPITAL CARDIAC ARREST: A
ONE YEAR FOLLOW-UP
A. Peskine, E. Bayen, P. Pradat-Diehl, C.-E. Luyt,
Paris, France
0084
LONG-TERM PROGNOSIS IN PATIENTS WITH ANGINA WITHOUT
CORONARY LESSIONS
I. Vegas Vegas, B. Perez Villardon, M.A. Ramirez
Marrero, G. Ballesteros Derbenti, J.L. Delgado
Prieto, J.M. Perez Ruiz, M. De Mora Martin,
Malaga, Spain
0085
IMPROVEMENTS IN THE PROGNOSIS OF PATIENTS WITH HYPERTENSION
DISCHARGED FOR NSTEACS WITH THE USE OF FIXED DOSE
COMBINATION OF ACE INHIBITOR AND CALCIUM CHANNEL BLOCKER
M.A. Ramirez-Marrero, B. Perez-Villardon,
D. Gaitan-Roman, I. Vegas-Vegas, M. CanoGarcia, J.L. Delgado-Prieto, M. de Mora-Martin,
Malaga, Spain
0086
Area Estoril
Poster Corner
PREVENTION OF ICU-AQUIRED INFECTIONS
Chairs: Otgon Baatar, Ulaanbaatar, Mongolia (TBC) & Francesca Rubulotta, London, United Kingdom
10:10 - 12:00
SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT IN A MIXED
ICU IN A UNIVERSITY TERTIARY-CARE HOSPITAL: INITIAL 6 MONTHS
IMPACT
L I V E S 2 012
C. Sánchez Ramírez, M. Cabrera Santana,
S. Hípola Escalada, M.A. Hernández Viera,
N. Sangil Monroy, A. Bordes Benitez, J.J. Díaz
Díaz, J.L. Romero luján, V. Peña Morant,
P. Saavedra Santana, S. Ruiz-Santana, Las
Palmas de Gran Canaria, Spain
Poster Corner ACUTE CORONARY SYNDROME IN THE ICU
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Coimbra
Chairs: Alexandre Mebazaa, Paris, France & Susanna Price, London, United Kingdom
Nurses
&
AHP
0087
99
MONDAY 15 OCTOBER
Area Evora
R.K. Pande, V. Maurya, P. Khanna, M. Puri,
S. Sengupta, New Delhi, India
0088
EARLY INVASIVE FUNGAL INFECTIONS (IFI) AND UNIVERSAL
ANTIFUNGAL PROPHYLAXIS (UAP) AFTER LIVER TRANSPLANTATION
(LTX): CHANGING THE APPROACH ACCORDING TO THE RISK
A. De Gasperi, L. Petrò, M. Prosperi, E. Mazza,
L. Perrone, Milan, Italy
0089
THE IMPACT OF GLUTAMINE ON ORGAN FUNCTION AND MORTALITY OF
PATIENTS WITH SEVERE SEPSIS
G. Xiangdong, L. Xiaoyue, Guangzhou, China
0090
TOWARDS ZERO CENTRAL LINE ASSOCIATED BLOOD STREAM
INFECTION (CLABSI) - A SINGLE CENTRE EXPERIENCE
K. Krishnareddy, K. Smiley, A. Samuel, S. Weber,
H. Hon, A. Khallaf, Abu Dhabi, United Arab
Emirates
0091
TIME LAPSE TO IMPLEMENTATION OF ANTIMICROBIAL ADVICE
K. Ganeswaran, M. Staber, F. de Villiers,
Greenock, United Kingdom
0092
INFLUENCE OF INFECTION DURING THE POSTOPERATIVE PERIOD AFTER
HEART TRANSPLANTATION IN IN-HOSPITAL MORTALITY
R. Gómez-López, P. Fernández-Ugidos, P. VidalCortés, M.T. Bouza Vieiro, A.V. Aller Fernandez,
L. Seoane Quiroga, J. Muñiz, M.A. Solla Buceta,
S. Fojon Polanco, J.M. López Pérez, E. Rodriguez
Garcia, M.J. Paniagua Martin, E. Barge
Caballero, R. Marzoa Rivas, M.G. Crespo Leiro,
Ourense, Spain
0093
CHANGING ICU MICROBIOLOGICAL ECOLOGY IN RESPONSE TO
NATIONWIDE INFECTION CONTROL CAMPAIGNS
R. O’Leary, S. Fletcher, M. Emmott, P. Marsh,
L. Campbell, P. Stonelake, Bradford, United
Kingdom
0094
A FIVE YEAR STUDY OF COAGULASE NEGATIVE STAPHYLOCCOCUS
RESISTANCE PROFILE IN AN ICU OF A GREEK TERTIARY-TRAUMA
HOSPITAL
P. Sarafidou, A. Stylianakis, V. Kaldis, K. Tsopelas,
E. Chatziandreou, D. Argyris, I. Papadakis,
K. Mouta, I. Pavlou, Athens, Greece
0095
THE GENE EXPRESSION ANALYSIS OF BLOOD REVEALS S100A11 AND
AQP9 AS POTENTIAL BIOMARKERS OF INFECTIVE ENDOCARDITIS
J. Textoris, F. Thuny, A. Ben Amara, A. El Filali,
C. Capo, G. Habib, D. Raoult, J.-L. Mège, Marseille
Cedex, France
0096
EFFECT OF LIPOPOLYSACCHARIDE ON THE MITOCHONDRIAL FUNCTION
OF ISOLATED HUMAN MONOCYTES AND PLATELETS
T.M. Merz, A.J. Pereira, V. Jeger,
V. Madhusudanarao, S.M. Jakob, J. Takala,
S. Djafarzadeh, Bern, Switzerland
0097
BACTEREMIA DUE TO ESKAPE MICRORGANISMS: CLINICAL FEATURES
AND IMPACT ON OUTCOME
J.M. Pereira, J. Cortez, J.A. Paiva, Oporto,
Portugal
0098
CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA IN CRITICAL CARE
L.C. Blackbourn, M. Read, M.P. Wise, Cardiff,
United Kingdom
0099
BEDSIDE CHEST ULTRASONOGRAPHY COMBINED WITH INTRAPLEURAL
UROKINASE FOR TREATING MULTILOCULATED PARAPNEUMONIC
EMPYEMA IN CRITICALLY ILL CHILDREN
E. Vasilaki, E. Blevrakis, A.M. Spanaki,
E. Geromarkaki, S. Ilia, E. Tavladaki,
M.D. Fitrolaki, G. Briassoulis, Heraklion, Greece
0100
SEDATION, ANALGAESIA AND DELIRIUM RELATED PRACTICES IN
PORTUGUESE INTENSIVE CARE UNITS - NATIONAL SURVEY
F.F. Pinto, P.A. Maia, P.P.C. Amorim, Porto,
Portugal
0101
EFFECT OF SEDATIVES ON COLON MOTILITY IN VITRO
M. Schörghuber, E. Tatzl, P. Holzer, W. Toller,
S. Fruhwald, Graz, Austria
0102
EFFECT OF PIRITRAMIDE VS. TRAMADOL ON GUINEA PIG’S SMALL
BOWEL MOTILITY IN VITRO
M. Schörghuber, E. Tatzl, P. Holzer, W. Toller,
S. Fruhwald, Graz, Austria
0103
SEDATION PRACTICE IN NORDIC AND NON-NORDIC ICUS: A EUROPEAN
SURVEY
I. Egerod, J.W. Albarran, M. Ring, B. Blackwood,
Copenhagen, Denmark
0104
EVALUATION OF AN ALGORITHM ASSOCIATED WITH A DAILY ARREST OF
SEDATION COMPARED WITH A SINGLE ALGORITHM IN ICU
S. Wiramus, M. Haddam, J. Textoris, V. Paone,
B. Ragonnet, E. Hammad, F. Antonini, C.D. Martin, M. Leone, Marseille, France
0105
ADVANTAGE OF REMIFENTANIL VS COMBINATION MORPHINE/
PROPOFOL SEDATION OF MECHANICAL VENTILATED PATIENTS
V.M. Malenkovic, Belgrade, Serbia
0106
Poster Corner
SEDATION, Analgaesia & DELIRIUM
Chairs: Claudia Spies, Berlin, Germany & Christina Jones, Liverpool, United Kingdom
10:10 - 12:00
100
HAND HYGIENE COMPLIANCE TOWARDS WHO 5 MOMENTS OF HAND
HYGIENE AMONG NURSES & PHYSICIANS IN HIGH RISK AREAS IN A
TERTIARY HOSPITAL IN NEW DELHI, INDIA
13-17 October 2012
L I V E S 2 012
Simply Better Oxygen Therapy
Extending the boundaries of oxygen therapy
Latest trial results and evolving clinical experience
> Recent advances in Nasal High Flow
with Optiflow
J.D. Ricard (Colombes)
25th annual congress
– ESICM LIVES 2012
Scientific Symposium
> Latest trial results and clinical
experience in the cardiothoracic
population
R. Parke and S. McGuinness (Auckland)
> Optiflow during bronchoscopy
J. Wink (Porto)
Chairmen :
S. Maggiore, J. Laffey
Monday | October 15
12:30 - 14:00
Lisbon CCL | 1st floor | room Vienna
supported by
Visit us
at boot
h
17
Satellite Symposium
Effective Glycaemia
Control
Monday, 15th October 2012
18:15 – 19:15h, Room Stockholm
Moderator
Prof. Jean-Charles Preiser, Belgium
Glycaemia in ICU: State-of-the-art
Lunch Symposium
Good Clinical
Nutrition Practice
12:30 – 14:00h
Room Geneva
Lunch Symposium
Volume Therapy
in Surgery and ICU
Tuesday, 16 October 2012
12:30 – 14:00h
Room Geneva
Prof. Björn Ellger, Germany
Patient-specific glycaemic control
software in the ICU setting
Alexandre Guerrini, France
Computer-assisted glucose regulation
in critically ill patients:
a proof of concept study
Dr. Pierre Kalfon, France
0107
EXPERIENCE IN SEDOANALGAESIA IN CRITICALLY ILL PATIENTS
ADMITTED TO AN INTENSIVE CARE UNIT (ICU) IN NEED FOR
NONINVASIVE MECHANICAL VENTILATION
J.L. Martinez Melgar, E. Moreno Lopez, A. Ortega
Montes, T. Sanchez de Dios, A. Pais Almozara,
J.I. Cenoz Osinaga, S. Freita Ramos, E. Alemparte
Pardavila, C. Galban Rodriguez, Ferrol, Spain
0108
MINIMAL SEDATION PROTOCOL DIMINISHES RATES OF USE OF INVASIVE
DEVICES AND DEVICE ASSOCIATED INFECTION IN A GENERAL ICU
S.B. Cappi, E.S. Pacheco, L.D. Camargo,
S.S. Moura, M. Yoshida, D.T. Noritomi, São Paulo,
Brazil
0109
RAMDOMISED CLINICAL TRIAL ON SEDATION FOR ENDOSCOPIC
PROCEDURES: KETAMINE VERSUS PROPOFOL
A. Quintano, A. Vallejo, B. Fernández-Miret,
S. Cabañes, S. Castaño, A. Manzano, E. Corral,
J. Maynar, F. Fonseca, Vitoria-Gazteiz, Spain
0110
PROSPECTIVE, RANDOMISED STUDY TO ASSESS THE ROLE OF
DEXMEDETOMIDINE IN PATIENTS WITH POSTERIOR FOSSA TUMORS
UNDERGOING CRANIOTOMY AND REQUIRING POST OPERATIVE
VENTILATION IN ICU
S. Mishra, Bhubaneswar, India
0111
TRANSFORMATION IN SEDATION PRACTICE WITH 24-HOUR INTENSIVIST
LED CARE FOLLOWING MERGER OF A CARDIAC AND A GENERAL
INTENSIVE CARE
G. Lau, D. O’Neil, C. Allsager, Leicester, United
Kingdom
0112
SLEEP IN THE INTENSIVE CARE UNIT: CHANGING THE CULTURE
M.E. Lugarinho, L. Peixoto, P. Castro, Duque de
Caxias, Brazil
0113
VALUE OF THE EFFECTIVE ANALGAESIA IN NEAREST POSTOPERATIVE
PERIOD SURGERY OF OESOPHAGUS
A.S. Arifjanov, L.A. Nazirova, R.A. Ibadov,
N.A. Strijkov, Tashkent, Uzbekistan
0114
Poster Corner
ACUTE BRAIN INJURY: THERAPEUTIC COOLING & OUTCOME PREDICTION
Chairs: Hans Friberg, Lund, Sweden & Alain Cariou, Paris, France
10:10 - 12:00
THERAPEUTIC MILD HYPOTHERMIA AFTER CARDIAC ARREST IN
SHOCKABLE AND NONSHOCKABLE RHYTHMS: DOES IT IMPROVE BOTH
SURVIVAL AND NEUROLOGICAL OUTCOME?
M. Talegaonkar, A.K. Gupta, S. Dewan, A. Varma,
New Delhi, India
0115
A COMPARISON OF 2 THERAPEUTIC HYPOTHERMIA COOLING DEVICES
ON NEURO INTENSIVE CARE
H. Jones, W. Loh, Liverpool, United Kingdom
0116
THE RESULTS OF AN INTERNAL PILOT FOR THE EUROPEAN STUDY OF
THERAPEUTIC HYPOTHERMIA (32-35°C) FOR INTRACRANIAL PRESSURE
REDUCTION AFTER TRAUMATIC BRAIN INJURY (EUROTHERM3235TRIAL)
ISRCTN 34555414
P. Andrews, Edinburgh, United Kingdom
0117
ELECTROCARDIOGRAM AND ELECTROLYTE DISTURBANCES INDUCED BY
SURFACE COOLING AFTER CARDIAC ARREST
M.C. de Waard, R. de Groot, L.P. Smits,
R.H. Driessen, A.R. Girbes, Amsterdam,
Netherlands
0118
NEUROPROTECTIVE PROPERTIES OF HYPOTHERMIA
A. Butrov, O. Shevelyov, D. Bilibin, N. Hodorovich,
I. Kalenova, I. Sharinova, Moscow, Russian
Federation
0119
RISK FACTORS ASSOCIATED TO MORBID-MORTALITY PREVIOUS TO
STARTING HYPOTHERMIA TREATMENT IN ICU PATIENTS AFTER CARDIAC
ARREST
J. Cabrera-Arrocha, E. Martín-Sánchez,
O. Fariñas-Roman, P. Ravelo-Hernández,
P. Saavedra, S. Ruiz-Santana, Las Palmas de
Gran Canaria, Spain
0120
NSE FOR ASSESSMENT OF OUTCOME AFTER CARDIAC ARREST- THE
IMPACT OF THE ANALYSIS METHOD
M. Rundgren, I. Dragancea, T. Cronberg,
H. Friberg, A. Isacsson, Lund, Sweden
0121
THE FEASIBILITY OF USING SERUM PROTEOMICS TO IDENTIFY NOVEL
BIOMARKERS THAT PREDICT NEUROLOGICAL RECOVERY AFTER
CARDIAC ARREST: A PILOT STUDY
J.G. Boyd, L. Smithson, C. Petrie, J. Muscedere,
D. Howes, M.D. Kawaja, Kingston, Canada
0122
OPTIC NERVE ULTRASOUND TO ASSESS INTRACRANIAL PRESSURES IN
CARDIAC ARREST SURVIVORS: A FEASIBILITY STUDY
E. Golan, Toronto, Canada
0123
CEREBRAL OXYGEN DESATURATION IS ASSOCIATED WITH NEUROLOGIC
COMPLICATIONS AND LONGER INTENSIVE CARE UNIT STAY IN HIGH-RISK
CARDIAC SURGERY PATIENTS
S. Scolletta, F. Franchi, M. Sampieri, C. Guarino,
V. Ialongo, E. Maglioni, L. Marchetti, B. Biagioli,
Siena, Italy
0124
L I V E S 2 012
S. Caroleo, D. Vuoto, F. Tropea, V. Brescia,
B. De Leonardis, G. Maltese, G. Alvaro,
C. Spaccarotella, C. Indolfi, B. Amantea,
Catanzaro, Italy
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Faro
PROPOFOL VERSUS REMIFENTANIL FOR THE MANAGEMENT OF
ANALGO-SEDATION DURING THE PERCUTANEOUS TRANSCATHETER
AORTIC VALVE IMPLANTATION
103
MONDAY 15 OCTOBER
REDUCTION OF ISCHAEMIC BRAIN DAMAGE AFTER XENON
ADMINISTRATION IN A RAT MODEL OF GLOBAL CEREBRAL ISCHAEMIA
V. Metaxa, R. Lagoudaki, L. Oikonomou,
S. Meditskou, O. Thomareis, A. Sakantamis,
0125
ROLE OF THYROID HORMONE IN HAEMODYNAMIC MANAGEMENT OF
ORGAN DONOR
A. Sánchez Allueva, C. Prat Llimargas, L. García
Huete, E. Oliver Juan, M.E. Décoste, A. Sabaté
Pes, Hospitalet de Llobregat, Spain
0126
Area Fatima
Poster Corner
IMAGING TO GUIDE TREATMENT OF ACUTE RESPIRATORY FAILURE
Chairs: Elie Azoulay, Paris, France (TBC) & Luciano Gattinoni, Milan, Italy
10:10 - 12:00
REGIONAL VENTILATION DELAY INHOMOGENEITY MEASURED BY
ELECTRICAL IMPEDANCE TOMOGRAPHY DURING PEEP TITRATION IN
HEALTHY LUNGS AND DIFFERENT MODELS OF LUNG INJURY
T. Muders, S. Huckauf, A. Reske, M. Lutterkord,
D. Buchloh, H. Luepschen, C. Putensen,
H. Wrigge, Leipzig, Germany
0127
ASSESSMENT OF PULMONARY PERFUSION WITH FLUORODESOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY: A
VALIDATION STUDY
J.-C. Richard, C. Pouzot, A. Gros, D. Le Bars,
N. Costes, F. Lavenne, C. Tourvieille, C. Guérin,
Lyon, France
0128
EFFECTS OF CYCLIC SHORT RECRUITMENT MANEUVERS (SIGH) IN ACUTE
RESPIRATORY FAILURE PATIENTS UNDERGOING PRESSURE SUPPORT
VENTILATION: AN ELECTRICAL IMPEDANCE TOMOGRAPHY STUDY
T. Mauri, G. Bellani, M. Turella, V. Sala, F. Leone,
A. Perri, A. Coppadoro, R. Marcolin, G. Citerio,
N. Patroniti, A. Pesenti, Monza, Italy
0129
TOPOGRAPHIC DISTRIBUTION OF LUNG COMPLIANCE ASSESSED BY
COMPUTER TOMOGRAPHY IN MECHANICALLY VENTILATED PATIENTS
G. Perchiazzi, A. Stabile Ianora, S. Derosa,
D. Polieri, L. Pitagora, A. Tannoia, M. Pellegrini,
A. Sindaco, N. D’Onghia, G. Altamura,
G. Hedenstierna, N. Brienza, Bari, Italy
0130
EFFECT OF HIGH FLOW NASAL CANNULA AND BODY POSITION ON
END-EXPIRATORY LUNG VOLUME. A COHORT STUDY OF HEALTHY
INDIVIDUALS USING ELECTRICAL IMPEDANCE TOMOGRAPHY
J. Riera, P. Pérez, O. Roca, J.R. Masclans, J. Rello,
Barcelona, Spain
0131
COMPARISON OF THREE DIFFERENT PEEP TITRATION STRATEGIES IN
EXPERIMENTAL ACUTE LUNG INJURY OVER A PERIOD OF 24 HOURS
J. Pochert, T. Muders, A. Reske, A. Rau, A. Beilicke,
C. Putensen, H. Wrigge, Leipzig, Germany
0132
MAPPING LUNG MECHANICS BY ELECTRICAL IMPEDANCE TOMOGRAPHY
M. Bodenstein, S. Boehme, S. Bierschock,
A. Vogt, C. Bletz, K. Markstaller, M. David, Mainz,
Germany
0133
EFFECTS OF PLEURAL EFFUSION DRAINAGE ON OXYGENATION,
RESPIRATORY MECHANICS AND HAEMODYNAMICS: A PHYSIOLOGICAL
STUDY
K. Razazi, A.W. Thille, A. Mekontso-Dessap,
O. Beji, C. Brun Buisson, L. Brochard, Creteil,
France
0134
LUNG PATHOLOGY EXTENSION DOES NOT SIGNIFICANTLY INFLUENCE
ACCURACY OF QUANTITATIVE COMPUTED TOMOGRAPHY ON TEN
SECTION EXTRAPOLATION
L. Ball, F. Corradi, C. Brusasco, A. Garlaschi,
S. Bazurro, A. De Ferrari, M. Millone,
P. Herrmann, P. Pelosi, Genoa, Italy
0135
EFFECTS OF ACUTE HYPOVOLEMIA ON INTRAPULMONARY SHUNT IN A
PIG MODEL OF ACUTE RESPIRATORY DISTRESS SYNDROME
N. Siegenthaler, R. Giraud, D. Courvoisier,
D. Morel, C. Wiklund, L. Brochard, K. Bendjelid,
Geneva, Switzerland
0136
BEDSIDE DETECTION OF TIDAL RECRUITMENT BY LUNG ULTRASOUND
M. Muñoz, J.B. Borges, A. Santos, G. Tusman,
A. Larsson, G. Hedenstierna, F. Suarez-Sipmann,
Madrid, Spain
0137
VENTILATION DISTRIBUTION DURING DIFFERENT PRESSURE SUPPORT
AND NAVA LEVELS
P. Blankman, D. Hasan, D. Gommers, Rotterdam,
Netherlands
0138
VENTILATION AREA MEASURED WITH EIT IN ORDER TO OPTIMISE PEEP
SETTINGS IN MECHANICALLY VENTILATED PATIENTS
P. Blankman, E. Groot Jebbink, C. Preis, I. Bikker,
D. Gommers, Rotterdam, Netherlands
0139
Try the
e-posters
experience in the
exhibition
area
104
13-17 October 2012
L I V E S 2 012
Poster Corner
0140
ACUTE KIDNEY INJURY: EVALUATION & TREATMENT
Chairs: Marlies Ostermann, London, United Kingdom & Heleen Oudemans-van Straaten, Amsterdam, Netherlands
10:10 - 12:00
EMPLOYING ADVANCED ALGORITHMIC METHODS TO PREDICT FUTURE
CREATININE
P. Singer, E. Grozowski, J. Cohen, O. Fabian,
S. Lev, Y. Kiner, Petah Tikva, Israel
0141
EVALUATING THE EFFECT OF INTRAVENOUS CONTRAST ON RENAL
FUNCTION IN CRITICALLY ILL PATIENTS UNDERGOING RADIOLOGICAL
INVESTIGATIONS - A RETROSPECTIVE COHORT STUDY
D.J. Silcock, R. Sundaram, S. Koteeswaran,
G. Fletcher, Paisley, United Kingdom
0142
TRAMADOL AS A CYTOCHROME P450 2D6 DRUG PROBE IN THE
CRITICALLY ILL: PHARMACOLOGIC AND GENETIC EVIDENCE
K. Lane, J.J. Dixon, C.J. Kirwan, D. Mckeown,
R. van Schaik, I.A. Macphee, B.J. Philips, London,
United Kingdom
0143
A PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF CONTINUOUS
RENAL REPLACEMENT THERAPY USING A COMMERCIAL CITRATE
CONTAINING REPLACEMENT FLUID
Y.Y.N. Leung, W.M. Chan, N.W. Tsai, M.F. Lam,
Hong Kong, Hong Kong
0144
ACUTE KIDNEY INJURY ASSOCIATED WITH ACETIC ACID POISONING:
FIVE YEAR REVIEW
K. Brusin, I. Leyderman, Yekaterinburg, Russian
Federation
0145
TIME COURSE OF URINARY INDICES AFTER ICU ADMISSION MAY HELP IN
DIFFERENTIATING TRANSIENT FROM PERSISTENT AKI
B. Pons, F. Vincent, B. Tardy, A. Lautrette,
J. Dellamonica, C. Mariat, B. Souweine, Y. Cohen,
F. Zeni, M. Darmon, Saint Etienne, France
0146
RISK FACTORS IN THE DEVELOPMENT OF ACUTE RENAL FAILURE AFTER
CARDIAC SURGERY
T. Akarsu Ayazoğlu, A. Candan, I. Eseoğlu,
A. Özensoy, Istanbul, Turkey
0147
INCIDENCE AND PREVENTION OF CONTRAST INDUCED NEPHROPATHY
(CIN) IN THE ICU: PREVENTIVE ADMINISTRATION OF NA+BICARBONATE
IS NOT EFFECTIVE. SINGLE DOSE AMINO-GLYCOSIDE IS A MAJOR RISK
FACTOR
J. Juch, J. Le Noble, N. Foudraine, Venlo,
Netherlands
0148
ONE YEAR OUTCOME OF ACUTE KIDNEY INJURY IN CRITICALLY ILL
SEPTIC PATIENTS ADMITTED TO MEDICAL INTENSIVE CARE UNIT
D. Agrawal, W.K. Wong, H. Tay,
V. Anantharaman, A. Mukhopadhyay,
Singapore, Singapore
0149
COMPARING AKIN AND RIFLE CRITERIA IN DIAGNOSING ACUTE KIDNEY
INJURY: A SERUM LACTATE HYPOTHESIS?
M. Kompoti, E. Diogou, V. Salma, P. Plantza,
M. Michalia, P.-M. Clouva-Molyvdas, Athens,
Greece
0150
INCIDENCE OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH
ACUTE CARDIAC DISEASE
E. Torres, A. Jurado, J.A. Sanchez Izquierdo,
L.D. Umezawa, J.L. Flordelis, J.J. Parra, R. Martin,
J. Rodriguez, J.C. Montejo, Madrid, Spain
0151
CYSTATINE-C AND NGAL FOR THE EVALUATION OF EARLY KIDNEY
INJURY IN SEVERE SEPSIS
R. Lozano-Saez, M. Herrera Gutierrez, M.M. Arrebola-Ramirez, M.-J. Diez-de-los-RiosCarrasco, E. Aguiar-Flores, G. Seller-Perez,
Malaga, Spain
0152
A COMPARISON OF THE RIFLE AND AKIN CRITERIA FOR ACUTE KIDNEY
INJURY IN CRITICALLY ILL PATIENTS
A.D. Marinho, R.M. Gil, Porto, Portugal
0153
SIDE EFFECTS OF HYDROXYETHYL STARCH FORMULATIONS: PROBABLY
NOT SO EQUAL AT ALL
J. Vandeweghe, C. Danneels, J. Decruyenaere,
E. Hoste, Gent, Belgium
0154
+
L I V E S 2 012
Area Funchal
J.M. Lomelí Teran, E. Deloya Tomas, J.J. Martinez
Mazariegos, G. Magdaleno Lara, J.S. Leco
Romero, F. Jímenez, F. Tendillo, M. Poblano,
Mexico City, Mexico
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ANALYSIS OF ALVEOLAR VENTILATION WITH DIFFERENT DEGREES OF
INTRAABDOMINAL HYPERTENSION IN PORCINE MODEL
Visit us at the
ESICM Members Lounge
Level 1
105
MONDAY 15 OCTOBER
106
Area Guarda
Poster Corner
IMPACT OF SPECIFIC ICU INTERVENTIONS
Chairs: Bertrand Guidet, Paris, France & Michael Hiesmayr, Vienna, Austria
10:10 - 12:00
Area Porto
OPTIMISATION OF EMERGENCY MANAGEMENT IN PATIENTS WITH
ACUTE CORONARY SYNDROMES IN BIG URBAN DISTRICT
M. Milanova, M. Matveev, K. Atanassov,
V. Atanassova, R. Prokopova, Sofia, Bulgaria
0155
BENEFICIAL EFFECTS OF THE PRESCRIPTION OF FIXED DOSE
COMBINATION OF BETA-BLOCKER AND DIURETIC IN ELDERLY PATIENTS
WITH A HISTORY OF NON-ST-SEGMENT-ELEVATION ACUTE CORONARY
SYNDROME
M.A. Ramirez-Marrero, D. Gaitan-Roman,
M. Cano-Garcia, I. Vegas-Vegas, B. PerezVillardon, B. Luque-Aguirre, G. BallesterosDerbenti, M. de Mora-Martin, Malaga, Spain
0156
A COMPARISON OF CLINICAL AND COST- EFFECTIVENESS OF PRE–
VERSUS POSTOPERATIVE GOAL DIRECTED THERAPY
C. Ebm, M. Cecconi, A. Rhodes, London, United
Kingdom
0157
EFFECTIVENESS OF INSPIRATORY PRESSURE-LIMITED APPROACH TO
MECHANICAL VENTILATION IN SEPTIC PATIENTS
I. Martin-Loeches, C. de Haro, P. Dellinger,
R. Ferrer, G. Phillips, M. Levy, A. Artigas, Sabadell,
Spain
0158
ASSESSMENT OF AUTOMATED BLOOD GAS ALERT SYSTEM (REAL TIME
AUTOMATED PATIENT ALERT)
H. McMillan, S. Bracey, P. Macnaughton,
Plymouth, United Kingdom
0159
OUTBREAK OF CA-MRSA IN PATIENTS WITH NEURO-DEVELOPMENT
DISORDERS REQUIRING ICU ADMISSION
D. Molano, M. Villabon, J. Escobar, N. Vanegas,
R. Jordi, Bogota, Colombia
0160
IMPLEMENTATION AND EVALUATION OF A COMMUNICATION PLAN IN
AN INTENSIVE CARE UNIT
M.C.I. Valdovinos Mahave, J.M. Montón Dito,
J.C. Torralba Allué, M.J. Santed Andrés, J. Luz
Gómez de Travecedo, Teruel, Spain
0161
ACUTE BRAIN DYSFUNCTION IS A MAJOR PREDICTOR OF HOSPITAL
MORTALITY IN MECHANICALLY VENTILATED CANCER PATIENTS
I.C. Almeida, M. Soares, C. Shinotsuka,
R. Bujokas, V.C. Dantas, J.I. Salluh, Rio de Janeiro,
Brazil
0162
ICU STAFF LEVEL OF DEPRESSION DURING ECONOMIC CRISIS
A. Vakalos, M. Petkopoulou, D. Jannussis, Xanthi,
Greece
0163
INVESTIGATION ON THE QUALITY OF MANAGEMENT FOR THE PATIENTS
SUFFERED WITH POST CARDIAC ARREST SYNDROME
L. Li-Jun, Z. Yan, Z. Jian-Liang, Suzhou, China
0164
THE USE OF INHALED NITRIC OXIDE IN A TERTIARY PAEDIATRIC
INTENSIVE CARE UNIT (PICU)
C.L. Durand, S. Mahoney, S. Kerr, N. Shetty,
D. Buckley, Liverpool, United Kingdom
0165
SURVEILLANCE OF ICU-ACQUIRED INFECTION IN A TERTIARY HOSPITAL
BY ANALYSIS OF A DATABASE BUILT THROUGH A WORKFLOWINTEGRATED SOFTWARE APPLICATION
G. Diet, L. De Bus, B. Gadeyne, G. Claeys,
P. Vosters, D. Benoit, J. Decruyenaere, F. De Turck,
P. Depuydt, Ghent, Belgium
0166
NEGATIVE FLUID BALANCE 48 HOURS AFTER ADMISSION IMPROVES
SURVIVAL AT 28 DAYS IN CRITICALLY ILL PATIENTS
M. Cuartero, M.V. Nievas, A.J. Betbesé, K. Núñez,
J. Baldirà, L. Zapata, Barcelona, Spain
0167
Poster Corner
INFLAMMATORY RESPONSE IN SEPSIS: NEW INSIGHTS
Chairs: Jean-Paul Mira, Paris, France & Herwig Gerlach, Berlin, Germany
10:10 - 12:00
PROCALCITONIN (PROCT) INDUCES PRO-INFLAMMATORY MEDIATORS
AND APOPTOSIS IN MESANGIAL CELLS (MCS) IN VITRO
M. Araujo, S.Q. Doi, C.E. Palant,
B.C. Bandyopadhyay, E.S. Nylen, K.L. Becker,
Washington, DC, United States
0168
PLATELET, BUT NOT SKELETAL MUSCLE, MITOCHONDRIAL FUNCTION IS
ALTERED IN PATIENTS WITH SEPTIC SHOCK
A. Protti, F. Fortunato, M. Pluderi, L.P. Solimeno,
N. Grimoldi, V. Lucchini, P. Tecchio, G.P. Comi,
M.L. Caspani, L. Gattinoni, Milan, Italy
0169
ROLE OF IL-10 IN INCREASED S100A8/A9 MRNA EXPRESSIONS DURING
ENDOTOXIN-TOLERANCE
M. Fontaine, S. Planel, E. Peronnet, V. Barbalat,
E. Cerrato, C. Arnaud, F. Wallet, C. Tassin,
V. Piriou, A. Pachot, G. Monneret, A. Lepape,
F. Venet, Lyon, France
0170
THE GLUCOCORTICOID RECEPTOR EXPRESSION AND FUNCTION IS
DECREASED DURING EXPERIMENTAL STAPHYLOCOCCUS AUREUS SEPSIS
- A MECHANISM OF STEROID RESISTANCE?
M. Bergquist, C. Rylander, G. Hedenstierna,
C. Lindholm, Uppsala, Sweden
0171
BACTERIAL CLEARANCE IN SEPTIC MICE IS MODULATED BY MCP-1/CCL2
AND NITRIC OXIDE
R.N. Gomes, M.G.A. Teixeira-Cunha,
R.T. Figueiredo, P.E. Almeida, S.C. Alves,
F.A. Bozza, P.T. Bozza, G.A. Zimmerman,
M.T. Bozza, H.C. Castro-Faria-Neto, Rio de
Janeiro, Brazil
0172
13-17 October 2012
L I V E S 2 012
0173
ORGAN-SPECIFIC ALTERATIONS IN MITOCHONDRIAL RESPIRATION IN A
PORCINE MODEL OF SEPSIS-INDUCED MULTIPLE ORGAN FAILURE
V. Jeger, T.D. Correa, A.J. Pereira, M. Vuda,
J. Takala, S. Djafarzadeh, S.M. Jakob, Bern,
Switzerland
0174
EXPRESSION OF MONOCYTE PHOSPHODIESTERASES AT THE ICU
ADMISSION OF SEPTIC PATIENTS: AN MRNA STUDY
C. Lelubre, K. Zouaoui Boudjeltia, M. Piagnerelli,
A. Rousseau, P. Biston, M. Vanhaeverbeek, J.L. Vincent, Bruxelles, Belgium
0175
EARLY GENOMIC TSUNAMI IS OBSERVED AT THE ONSET OF SEPTIC
SHOCK
M.-A. Cazalis, F. Frager, E. Peronnet, A. Pachot,
A. Lepape, G. Monneret, F. Venet, Lyon, France
0176
LOW IMMUNOGLOBULIN G LEVELS AT ADMISSION REDUCES THE ODDS
FOR 28 DAY MORTALITY COMPARED TO NORMAL LEVELS: PROSPECTIVE
COHORT STUDY IN SEVERE SEPSIS
M. Shankar-Hari, M. Singer, V. Cornelius,
B. Sanderson, A. Gordon, M. Terblanche,
K. Rowan, R. Beale, J. Spencer, London, United
Kingdom
0177
NEURAMINIDASE MRNA EXPRESSION IS MODIFIED IN MONOCYTES
FROM SEPTIC PATIENTS
C. Lelubre, K. Zouaoui Boudjeltia, P. Biston,
A. Rousseau, M. Vanhaeverbeek, J.-L. Vincent,
M. Piagnerelli, Bruxelles, Belgium
0178
EARLY IMPORTANT ROLE OF B LYMPHOCYTES IN PATIENTS WITH SEPTIC
SHOCK
R. de Pablo, J. Monserrat, A. Prieto, M. Martín,
E. Reyes, M. Alvarez-Mon, Alcala de Henares,
Spain
0179
PLASMA FROM SEPTIC PATIENTS ENHANCES BACTERIAL PHAGOCYTOSIS
BUT IMPAIRS CHEMOTAXIS BY NEUTROPHIL-LIKE HL-60 CELLS
C.R.A. Oliveira, V. Nobre, I. Dunn, J. Pugin, Belo
Horizonte, Brazil
0180
IMMUNITY IN SEVERE SEPSIS
F. Valenzuela-Sanchez, R. Bohollo-Austria,
B. Valenzuela-Méndez, J.F. Rodríguez-Gutierrez,
M. Recuerda-Núñez, S. Garzón-López, Jerez de la
Frontera, Spain
0181
EVALUATION OF THE EFFECT OF THREE DIFFERENT INOTROPIC SUPPORT
STRATEGIES IN THE NORMAL AND STUNNED NEWBORN PIGLET HEART
ON HAEMODYNAMICS AND MYOCARDIAL METABOLISM
J.A. Hyldebrandt, L.M. Kolstrup, P.D. Colding,
C.A. Frederiksen, J. Heiberg, S. Rothmann,
M.R. Schmidt, H.B. Ravn, Aarhus, Denmark
0182
MODULATION OF THE SYSTEMIC INFLAMMATORY RESPONSE
IN CRITICAL ILL CHILDREN AFTER PARENTERAL GLUTAMINE
SUPPLEMENTATION. PRELIMINARY RESULTS
I. Jordan, M. Balaguer, A. Felipe, E. Esteban,
L. Hernandez, M. Villaronga, M. Molero,
F.J. Cambra, Barcelona, Spain
0183
PROGNOSIS VALUE OF ADRENOMEDULLIN IN SERIOUS BACTERIAL
INFECTION IN CHILDREN ADMITTED AT Paeditatric INTENSIVE CARE
UNIT
I. Jordan, P. Corniero, J. Ortiz, D. Vila, J. Velasco,
M. Balaguer, E. Esteban, F.J. Cambra, Barcelona,
Spain
0184
OUTCOMES ANALYSIS OF CHILDREN WITH SEVERE ADENOVIRAL
RESPIRATORY INFECTION
M.C. Spaeder, Washington, DC, United States
0185
COST ATTRIBUTABLE TO VENTILATOR-ASSOCIATED PNEUMONIAE IN
Paeditatric CRITICAL CARE
E. Esteban, I. Jordan, G. Gelabert, M. Urrea,
D. Suarez, F.J. Cambra, M. Balaguer, R. Ferrer,
Esplugues de Llobregat, Spain
0186
UTILISATION OF INO USING A NOVEL VENTILATOR CIRCUIT CONNECTOR
UNDER SIMULATED NEONATAL MECHANICAL VENTILATION
CONDITIONS AN IN VITRO STUDY
J. Mazela, K. Chmura, C. Henderson, T.J. Gregory,
M. Keszler, J. Gadzinowski, Poznan, Poland
0187
ACUTE NEUROLOGIC INJURY IN NEONATES SUPPORTED WITH
EXTRACORPOREAL MEMBRANE OXYGENATION: AN ANALYSIS OF ELSO
REGISTRY DATA
A. Polito, C.S. Barrett, R.T. Peter, R. Netto,
P.E. Cogo, R.R. Thiagarajan, Roma, Italy
0188
ANAEMIA AMONG PAEDIATRIC CRITICAL CARE SURVIVORS PREVALENCE AND RESOLUTION
Q.N. Ngo, D. Matsui, R. Singh, S. Zelcer,
A. Kornecki, London, Canada
0189
ORGANISATION AND TRAINING OF THE ACUTE CARE OF CRITICALLY ILL
CHILDREN IN GENERAL HOSPITALS IN THE SOUTHEAST NETHERLANDS;
WE CAN DO BETTER
S.J.V. Sambeeck, S. Martens, G. Vos, Maastricht,
Netherlands
0190
Area Setubal
Poster Corner
Chairs: Samuel Ajizian, Winston Salem, United States & TBA
10:10 - 12:00
L I V E S 2 012
J. Textoris, R. Ouedraogo, A. Daumas, E. Ghigo,
C. Capo, M. Leone, J.-L. Mège, Marseille Cedex,
France
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
IDENTIFICATION OF VARIOUS ACTIVATION STATES OF MACROPHAGES
BY MALDI-TOF MASS SPECTROMETRY
107
MONDAY 15 OCTOBER
Y. Yamaguchi, G. Inagawa, Y. Horimoto, T. Goto,
Yokohama, Japan
0191
EVALUATION OF CORTISOL LEVEL AS PROGNOSTIC FACTOR IN
Paeditatric PATIENTS WITH ACUTE SHOCK IN A SINGLE CENTRE
E.J. Ha, Y.A. Kim, W.K. Jang, S.J. Park, Seoul,
Republic of Korea
0192
STANDARD DEEP HYPOTHERMIC CIRCULATORY ARREST FOR PAEDIATRIC
CARDIAC SURGERY IS NOT A RISK FACTOR OF ACUTE KIDNEY INJURY
ASSESSED BY NEW BIOMARKERS
T. Mroczek, M. Miklaszewska, K. Zachwieja,
P. Korohoda, J. Skalski, J. Pietrzyk, Krakow,
Poland
0193
STEP - SPECIALISED PAEDIATRIC EMERGENCY TEAM FOR INTERHOSPITAL
TRANSPORT OF CRITICALLY ILL CHILDREN
A. Dinis, A. Dias, J.F. Farela Neves, L. Carvalho,
C. Pinto, T. Dionísio, Coimbra, Portugal
0194
FEASIBILITY OF TRANS-THORACIC ECHOCARDIOGRAPHIC ASSESSMENT
TO DETERMINE FLUID RESPONSIVENESS IN CHILDREN WITH SEPTIC
SHOCK
K. Sasidaran, J. Muralidharan, S.C. Singhi,
M.K. Rohit, Chandigarh, India
0195
AN EVALUATION OF CRITICAL CARE REFERRALS USING LEVELS OF
CRITICAL CARE AND A MODIFIED SBAR COMMUNICATION TOOL
M.M. Tanaka Gutiez, L.M. Holler Sotomayor,
D. Waldschutz, O. Rice, D. Harding, M. Jennings,
0196
CAN WE YET ASSESS THE QUALITY OF DNAR (DO NOT ATTEMPT
RESUSCITATION) ORDERS INSTITUTED BY AN ESTABLISHED MEDICAL
EMERGENCY TEAM AT A DISTRICT GENERAL HOSPITAL IN UNITED
KINGDOM? AN OBSERVATIONAL STUDY
L. Kocierz, I. Walker, J. Bhogal, L. Jones, A. Low,
R. Anslow, D. Pandit, Dudley, United Kingdom
0197
THE CHALLENGES OF OFF-SERVICE PATIENTS: EXPLORING PATTERNS OF
UTILISATION OF CRITICAL CARE RESPONSE TEAMS (CCRT)
I.A. Daley, L.A. Hawryluck, A. Doyle, D. Morris,
Toronto, Canada
0198
USE OF HIGH-FIDELITY SIMULATION TRAINING TO IMPROVE DELIVERY
OF HIGH QUALITY BLS BY FIRST RESPONDERS
N. Wong, K. Allan, T. Aves, P. Dorian, Toronto,
Canada
0199
A PROSPECTIVE AUDIT: CENTRAL VENOUS CANNULATION - TECHNIQUES
AND COMPLICATIONS AT SULTAN QABOOS UNIVERSITY HOSPITAL,
MUSCAT, OMAN
S.K. Birur Sadashivaiah, R. Kausalya,
D. Dyamanna, Muscat, Oman
0200
INTRODUCTION OF A SEPSIS SCREENING TOOL AND CARE BUNDLE
USING A MOULAGE-BASED TRAINING PROGRAM TO IMPROVE
RECOGNITION AND MANAGEMENT OF SEVERE SEPSIS
T. Stephens, H. Mills, S. Nourse, A. Lillis,
G. Mandersloot, J. Hadley, London, United
Kingdom
0201
USEFULNESS OF AUTOPSY STUDIES IN ICU
P. Fernandez Ugidos, R. Gomez Lopez,
M.J. Garcia Monge, M. Mourelo Fariña, P. Vidal
Cortes, R. Estevez Loureiro, R. Alvarez Rodriguez,
J. Priego Sanz, D. Freire Moar, Ourense, Spain
0202
IMPLEMENTING THE LIVERPOOL CARE PATHWAY FOR THE DYING
PATIENT ACROSS A REGIONAL CRITICAL CARE NETWORK
D. Parsons, M. Gambles, L. Chapman, Liverpool,
United Kingdom
0203
CHEST PAIN UNITS. ARE THEY USEFUL TODAY?
M.A. Ramirez-Marrero, I. Vegas-Vegas, M. CanoGarcia, D. Gaitan-Roman, B. Luque-Aguirre,
G. Ballesteros-Derbenti, M. de Mora-Martin,
Malaga, Spain
0204
BENEFICIAL EFFECTS OF THE PRESCRIPTION OF IVABRADINE IN PATIENTS
WITH CHEST PAIN AND ANGIOGRAPHICALLY NORMAL CORONARY
ARTERIES
M.A. Ramirez-Marrero, B. Perez-Villardon,
I. Vegas-Vegas, D. Gaitan-Roman, M. CanoGarcia, G. Ballesteros-Derbenti, M. de MoraMartin, Malaga, Spain
0205
PROFESSIONAL PROFILE OF FEMALE DOCTORS WORKING AT CHILEAN
INTENSIVE CARE UNITS
C.C. Herrera Contreras, A. Cortes, Santiago, Chile
0206
PRE-ICU UNDERSTANDING OF SODIUM AND WATER PHYSIOLOGY AND
MANAGEMENT OF DYSNATREMIA ARE SUBOPTIMAL
R. Nagappan, P. Gibson, Melbourne, Australia
0207
INFLUENCE OF LIBERALISATION OF ICU VISITING POLICES ON BURNOUT
OF DOCTORS AND NURSES
A. Giannini, G. Miccinesi, E. Prandi, M. Audisio,
A. Bencivinni, E. Biagioni, E. Castenetto,
I. Laganà, R. Oggioni, V. Porta, R. Salcuni,
A. Sarti, M.G. Visconti, C. Borreani, Milan, Italy
0208
ASSESSMENT OF NEED FOR TRAINING OF JUNIOR DOCTORS IN INTRA
HOSPITAL TRANSFER OF ACUTELY ILL PATIENTS
C.N. Prasad, R. Hayes, M. Ranganathan,
Nuneaton, United Kingdom
0209
Area Sintra
Poster Corner
IMPROVING ICU CARE & ORGANISATION
Chairs: Hans Flaatten, Bergen, Norway & Jacques-André Romand, Geneva, Switzerland
10:10 - 12:00
108
MANUAL CUFF PALPATION TEST IN CHILDREN
13-17 October 2012
L I V E S 2 012
PNEUMONIA REVISITED
Chairs: Garyfallia Poulakou, Athens, Greece & Geoffrey Bellingan, London, United Kingdom
10:10 - 12:00
PROGNOSTIC BIOMARKERS IN SEVERE COMMUNITY-ACQUIRED
PNEUMONIA (SCAP) PATIENTS ADMITTED TO THE ICU
O. Omelyanenko, A. Makarevich, P. Jagus,
J. Chorostowska-Wynimko, Minsk, Belarus
0210
REDUCTION OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THROUGH
REPOSITIONING IN CRITICALLY ILL PATIENTS
M. Colmenero, F. Manzano, M.-R. Mañas-Vera,
M.D.M. Jiménez-Quintana, A.M. Pérez-Pérez,
E. Fernández-Móndejar, Granada, Spain
0211
FIBEROPTIC BRONCHOSCOPY IN INTENSIVE CARE UNIT: ANALYSIS OF 276
PROCEDURES. A REPORT OF 8 YEARS OF EXPERIENCE
A. Estella, Jerez, Spain
0212
A STRATEGY BASED ON GALACTOMANN ANTIGEN DETECTION AND
PCR FOR INVASIVE ASPERGILLOSIS FOLLOWING INFLUENZA A (H1N1)
PNEUMONIA
C. Guervilly, A. Roch, S. Ranque, J.-M. Forel,
L. Papazian, Marseille, France
0213
VENTILATOR ASSOCIATED PNEUMONIA (VAP) EPIDEMIOLOGY IN ICU
BEFORE THE IMPLANTATION OF ZERO PNEUMONIA PROTOCOL
M. Colomo Gonzalez, M.M. Jimenez Quintana,
M.S. Monsalve Álvarez de Cienfuegos,
M.R. Mañas Vera, L.I. Rodriguez Peralta,
M. Barranco Ruiz, Granada, Spain
0214
INCREASED MORTALITY IN NON-AIDS PATIENTS WITH SEVERE
PNEUMOCYSTIS PNEUMONIA RECEIVING HIGH DOSE ADJUNCTIVE
STEROIDS
V. Lemiale, A. Debrumetz, C. Alberti, A. Delannoy,
N. Maziers, J.-R. Zahar, C. Declaux, G. Bollée,
E. Azoulay, Paris, France
0215
CONTINUOUS INFUSION OF PIPERACILLIN TAZOBACTAM IN
PSEUDOMONAS AERUGINOSA INFECTION: A PROPENSITY SCORE
MATCHED MULTICENTRE COHORT STUDY
B. Serra de Oliveira, J. Gonçalves-Pereira,
S. Janeiro, J. Estilita, C. França, Lisboa, Portugal
0216
COST EFFECTIVENESS ANALYSIS OF SDD AND SOD USE IN DUTCH ICUS
M. Bakker, A.M.G.A. De Smet, E.A.N. Oostdijk,
A. De Wit, M.J.M. Bonten, Utrecht, Netherlands
0217
PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA BY EARLY
TRACHEOSTOMY IN PATIENTS WITH TRAUMA: PROPENSITY SCORE
MATCHING ANALYSIS
N. Saito, T. Yagi, Y. Hara, H. Matsumoto,
K. Mashiko, Chiba, Japan
0218
PLASMA UBIQUINONE LEVELS ARE UNAFFECETED BY SIMVASTATIN IN
ACUTE LUNG INJURY
D. Brealey, I. Hargreaves, J. Land, M. Singer, D. Mc
Auley, London, United Kingdom
0219
VENTILATOR-ASSOCIATED PNEUMONIA IN CARDIAC INTENSIVE CARE
UNITS: A SURVEY OF UK PRACTICE
A. Wong, P. Diprose, Southampton, United
Kingdom
0220
RISK FACTORS FOR THE DEVELOPMENT OF VENTILATOR ASSOCIATED
PNEUMONIA AFTER CARDIAC SURGERY
M. Zambon, G. Bertarelli, G. Landoni, G. Borghi,
L. Fumagalli, G. Marino, A. Zangrillo, Milan, Italy
0221
IMPACT OF APPLYING VENTILATOR CARE BUNDLE ON VENTILATOR
ASSOCIATED PNEUMONIA INCIDENCE RATE. DOES IT WORK IN
DEVELOPING COUNTRIES?
M. Botros, M.M. Farrag, A.M. Lotfy, S. Farouk,
H.M. Mostafa, A.H. Sayed, A. Zaghloul,
A.M. Hasanin, H. Azizi, A.M. Mukhtar, Cairo,
Egypt
0222
EFFECT OF CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUS ON THE
PROGNOSIS OF MECHANICALLY VENTILATED PATIENTS SUSPECTED TO
HAVE VENTILATOR-ASSOCIATED PNEUMONIA
Y. Coisel, S. Bousbia, J.-M. Forel, B. Lascola,
D. Raoult, S. Jaber, L. Papazian, Montpellier,
France
0223
Poster Corner
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Life-Priority
L I V E S 2 012
109
ROOM Lisbon
HOW DO I PREVENT ARDS IN PATIENTS AT RISK?
Chair: Claude Guérin, Lyon, France
Presentation
11:10 - 12:00
Ognjen Gajic, Rochester, United States
ROOM Berlin Clinical Challenges Session HOW DO I EVALUATE AND MANAGE A COMATOSE PATIENT?
Chair: Nino Stocchetti, Milan, Italy
Presentation
11:10 - 12:00
Tarek Sharshar, Paris, France
ROOM Barcelona Clinical Challenges Session HOW DO I MANAGE CONTACT ISOLATION FOR
MULTIRESISTANT BACTERIAS?
Chair: Antonio Torres, Barcelona, Spain
Presentation
11:10 - 11:20
ROOM Geneva
Christian Brun-Buisson, Creteil, France
HOW DO I MANAGE THE BURN PATIENT?
Chair: Stijn Blot, Ghent, Belgium
Presentation
11:10 - 12:00
ROOM Rome
Philipp Metnitz, Vienna, Austria
Continuous Professional Education Session
ETHICS OF COST CONTAINMENT
Chairs: Peter Suter, Geneva, Switzerland & Bob Truog, Boston, United States
11:10 - 11:35
Cost containment and ICU activities
Jukka Takala, Bern, Switzerland
11:35 - 12:00
Impact of budget reduction on healthcare
Peter Suter, Geneva, Switzerland
ROOM Glasgow
Clinical Challenges Session HOW DO I TREAT HIV/AIDS IN THE ANTIRETROVIRAL THERAPY ERA?
MONDAY 15 OCTOBER
Chair: Jordi Rello, Barcelona, Spain
Presentation
11:10 - 12:00
ROOM Stockholm
Fernando Bozza, Rio de Janeiro, Brazil
Clinical Challenges Session HOW DO I MANAGE CANCER PATIENTS IN THE ICU?
Chair: Manu Malbrain, Antwerp, Belgium
Presentation
11:10 - 12:00
ROOM Paris
Frédéric Pène, Paris, France
HOW DO I TREAT MUSCLE WEAKNESS IN THE ICU?
Chair: Jan Wernerman, Stockholm, Sweden
11:10 - 12:00
Presentation
ROOM Vienna
Carole Ichai, Nice, France
HOW DO I IMPROVE PATIENT-VENTILATOR SYNCHRONY?
Chair: Michael Quintel, Gottingen, Germany
11:10 - 12:00
Presentation
ROOM Athens
Jordi Mancebo, Barcelona, Spain
Clinical Challenges Session HOW DO I REDUCE GUILT DURING family meetings?
Chair: Margaret Herridge, Toronto, Canada
11:10 - 12:00
110
Presentation
13-17 October 2012
Nurses
&
AHP
Bara Ricou, Geneva, Switzerland
L I V E S 2 012
12:30 - 12:35
Introduction
12:35 - 13:10
13:10 - 13:45
Renal Recovery After Acute Kidney Injury: Clinical and Health Economic
Considerations
Max Bell, Stockholm, Sweden
13:45 - 14:00
Discussion
ROOM Berlin
Industry Sponsored Session
THE FUTURE OF GLUCOSE MONITORING IN THE ICU
Chairs: Carole Ichai, Nice, France & Jean-Charles Preiser, Brussels, Belgium
12:30 - 13:00
13:00 - 13:30
Nigel Scawn, Liverpool, United Kingdom
13:30 - 14:00
Clinical experience with the GlucoClear Continuous Glucose Monitoring
System
Luc Foubert, Aalst, Belgium
ROOM BARCELONA
Industry Sponsored Session Individualised nutritional strategies in ICU
Chairs: Martin Dünser, Salzburg, Austria & Jukka Takala, Bern, Switzerland
12:30 - 12:35
Welcome and introduction
12:35 - 12:55
12:55 - 13:15
Jan Wernerman, Stockolm, Sweden
13:15 - 13:35
Stephan Jakob, Bern, Switzerland
13:35 - 13:55
13:55 - 14:00
ROOM Geneva
Industry Sponsored Session GOOD CLINICAL NUTRITION PRACTICE
Chairs: Pierre Dechelotte, Rouen, France & Mette Berger, Lausanne, Switzerland
12:30 - 12:35
Introduction
Pierre Dechelotte, Rouen, France
12:35 - 13:15
Is it worth adapting the energy and protein intake to the patient’s
13:15 - 13:55
John Stover, Zurich, Switzerland
13:55 - 14:00
Concluding remarks
ROOM Rome
Chair: Marco Maggiorini, Zurich, Switzerland & TBA
111
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
room Lisbon
Industry Sponsored Session New Clinical Perspectives on the Management of
Critically Ill Patients with Acute Kidney Injury
BRAIN MONITORING IN ICU: WHY AND HOW?
Chairs: Giuseppe Citerio, Monza, Italy & Can Ince, Rotterdam, Netherlands
12:30 - 12:40
Introduction
12:40 - 13:05
Importance of NIRS Monitoring in ICU after cardiac surgery
Rudolf Keunen, The Hague, Netherlands
13:05 - 13:30
Monitoring oxygen delivery in high risk surgery: Evidence and new
possibilities?
13:30 - 13:55
Sedation Management in ICU with processed EEG technology
Rafael Manez, Barcelona, Spain
13:55 - 14:00
Questions and Conclusion
L I V E S 2 012
111
ROOM GLASGOW
Chairs: Jean-François Timsit, Grenoble, France & Mervyn Singer, London, United Kingdom
12:30 - 12:40
Opening Remarks
Mervyn Singer, London, United Kingdom
12:40 - 13:00
The physiologic basis of haemodynamics treatment in sepsis and septic
shock
Walter Hasibeder, Ried Im Innkreis, Austria
13:00 - 13:20
Preclinical data suppporting betablockers rationale in sepsis
Alain Rudiger, Zurich, Switzerland
13:20 - 13:40
Betablocker use in septic patient: Experience of a single centre pilot
Andrea Morelli, Rome, Italy
13:40 - 13:50
Panel question session
13:50 - 14:00
Concluding comments
ROOM Stockholm Industry Sponsored Session
CHANCE OF SUCCESS IN NIV
OPTIMISING PATIENT-VENTILATOR INTERACTION AND
Chairs: Massimo Antonelli, Rome, Italy & Paolo Navalesi, Alessandria, Italy
12:30 - 13:00
An overview of NIV ventilation
Paolo Navalesi, Alessandria, Italy
13:00 - 13:30
Leo Heunks, Nijmegen, Netherlands
13:30 - 14:00
NIV NAVA in the post-operative setting
Mathieu Raux, Paris, France
ROOM Paris
NEW AKI BIOMARKERS: A REVOLUTION IN RISK ASSESSMENT
Chairs: Eric Hoste, Ghent, Belgium & Claudio Ronco, Vicenza, Italy
MONDAY 15 OCTOBER
12:30 - 12:40
Introduction
12:40 - 13:20
New biomarkers: A revolution in risk assessment
13:20 - 14:00
Expert panel on AKI and Risk Assessment
Michael Joannidis, Innsbruck, Austria
Lakhmir Chawla, Washington, United States
ROOM Vienna Industry Sponsored Session OPTIFLOW™ - EXTENDING THE BOUNDARIES OF OXYGEN THERAPY:
LATEST TRIAL RESULTS AND EVOLVING CLINICAL EXPERIENCE
Chairs: John Laffey, Galway, Ireland & Salvatore Maggiore, Rome, Italy
112
12:30 - 13:00
Recent advances in nasal high flow with Optiflow™
Jean-Damien Ricard, Paris, France
13:00 - 13:30
Latest trial results and clinical experience in the cardiothoracic
population
Rachael Parke, Auckland, New Zealand
13:30 - 13:45
population
Shay McGuinness, Auckland, New Zealand
13:45 - 14:00
Optiflow™ during bronchoscopy
João Wink, Porto, Portugal
13-17 October 2012
L I V E S 2 012
Philips
12:30 - 12:50
Bundles of joy - reducing harm on the ICU
12:50 - 13:00
Discussion
13:00 - 13:20
Breaking walls - saving lives! The impact of MET-systems
13:20 - 13:30
Discussion
13:30 - 13:50
Keep it simple, keep it safe: Early recognition of patient deterioration
and impact on ICU performance
13:50 - 14:00
Discussion
Area Beja
Poster Corner
Tamas Szakmany, Llantrisant, United Kingdom
Jens-Christian Schewe , Bonn, Germany
Chris Subbe , Wrexham, United Kingdom
TECHNOLOGY FOR VENTILATORY SUPPORT
Chairs: Franco Valenza, Milan, Italy & Michael Quintel, Gottingen, Germany
14:00 - 15:50
CHANGES IN SKELETAL MUSCLE NADH REDOX STATE, TISSUE
OXYGENATION AND MICROVASCULAR BLOOD FLOW DURING GRADED
HYPOXIA
N.J. Ekbal, A. Mayevsky, M. Singer, London,
United Kingdom
0224
INFLUENCE OF BODY DIMENSIONS IN THE ANALYSIS OF PULMONARY
PULSATILITY BY ELECTRICAL IMPEDANCE TOMOGRAPHY
F.J. da Silva Ramos, L.C.P. Azevedo,
G.P.P. Schettino, M.B.P. Amato, E.L.V. Costa, Sao
Paulo, Brazil
0225
COMPARISON OF TWO METHODS FOR ANALYSIS OF PULMONARY
PULSATILITY BY ELECTRICAL IMPEDANCE TOMOGRAPHY: APNEA AND
ELECTROCARDIOGRAPHY-GATING
F.J. da Silva Ramos, L.C.P. Azevedo,
G.P.P. Schettino, M.B.P. Amato, E.L.V. Costa, Sao
Paulo, Brazil
0226
A PRELIMINARY STUDY ASSESSING THE ACOUSTICAL ENVIRONMENT OF
AN INTENSIVE CARE UNIT
D. Dawson, G. Memoli, R. Barham, M. Hamilton,
M. Grounds, B. Phillips, London, United Kingdom
0227
MONITORING OF THE WEANING PROCESS IN PATIENTS WITH
SUCCESSFUL OUTCOME AFTER MECHANICAL VENTILATION
M. Matveev, V. Krasteva, I. Jekova, G. Georgiev,
L. Todorova, R. Prokopova, Sofia, Bulgaria
0228
TIDAL VOLUME DELIVERY FROM ICU VENTILATORS IN BTPS CONDITION.
A BENCH MODEL
P. Duchateau, C. Guérin, Lyon, France
0229
IMPLICATIONS OF HEART AND LUNG INTERACTIONS DURING THE FIRST
3 MINUTES OF APNEA TESTING IN CPAP
C. González-Fernández, I. Rubio-López,
M.A. Ballesteros-Sanz, F.J. Burón-Mediavilla,
J.C. Rodríguez-Borregán, M. López-Sánchez,
V. Suárez-lópez, A. Quesada-Suescun, Santander,
Spain
0230
PERFORMANCE OF AN ICU VENTILATOR AND TWO TURBIN-BASED
VENTILATORS DEDICATED TO NON INVASIVE VENTILATION (NIV) IN
SIMULATED HIGH INSPIRATORY EFFORT AND RATE: A NIV BENCH-STUDY
L. Piquilloud, P. Reichmuth, D. Thevoz, P. Jolliet,
J.-P. Revelly, Lausanne, Switzerland
0231
UTILISATION OF A CLOSED LOOP DEVICE TO TITRATE OXYGEN FLOW
(FREEO2) IN COPD EXACERBATION. A RANDOMISED CONTROLLED PILOT
STUDY
F. Lellouche, P.-A. Bouchard, M. Roberge,
G. Babin, E. L’Her, F. Maltais, Y. Lacasse, Québec,
Canada
0232
BENEFITS OF HIGH FLOW NASAL OXYGEN CANNULA THERAPY AFTER
ENDOTRACHEAL EXTUBATION
N. Rittayamai, J. Tschiekuna, P. Ruchiwit,
Bangkok, Thailand
0233
IN VITRO EVALUATION OF SIX DIFFERENT HEAT MOISTURE EXCHANGERS
FOR SPONTANEOUSLY BREATHING TRACHEOSTOMISED PATIENTS
C. Brusasco, F. Corradi, F. Simonassi, M. Bona,
F. Bruno, M. Marsili, M. Vargas, P. Pelosi, Genoa,
Italy
0234
EXTRACORPOREAL CARBON DIOXIDE REMOVAL: A NEW LOW FLOW
VENO-VENOUS DEVICE IN LUNG TRANSPLANTATION
B. Bergantino, F. Ruberto, F. Pugliese, C. D’Arena,
P. Congi, M. Frattini B, Roma, Italy
0235
CLOSE-LOOP OXYGEN TITRATION SYSTEM (FREEO2) DURING
NONINVASIVE VENTILATION AND CPAP IN HEALTHY SUBJECT WITH
INDUCED HYPOXEMIA
P.-A. Bouchard, M.-C. Ferland, G. Babin, E. L’Her,
F. Lellouche, Québec, Canada
0236
PLASMAPHERESIS: A REVIEW OF OUR PRACTICE WITH AN UNUSUAL
TECHNIQUE IN ICU
A. Farinha, I. Gonçalves, R. Ribeiro, Setúbal,
Portugal
0237
L I V E S 2 012
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Athens
Chairs: Tamas Szakmany, Llantrisant, United Kingdom & Hans Flaatten, Bergen, Norway
113
Poster Corner
Nurses
&
AHP
IMPROVING COMMUNICATION IN THE ICU
Chairs: Bara Ricou, Geneva, Switzerland & Andrej Michalsen, Tettnang, Germany
14:00 - 15:50
MONDAY 15 OCTOBER
Area Braga
A SURVEY OF INTENSIVE CARE UNIT DISCHARGE COMMUNICATION
PRACTICES IN THE UNITED KINGDOM
D.J.N. Wong, A.J. Wickham, Chertsey, United
Kingdom
0238
IMPROVING COMMUNICATION IN A NEURO-TRAUMA CRITICAL CARE
UNIT
A.A. Waters, D. Bhasker, H. Mcconnell, Newcastle
upon Tyne, United Kingdom
0239
FULL DISCLOSURE AFTER A LETHAL, PREVENTABLE MEDICATION ERROR
T. van Galen, S.F.M. Evelein-Brugman,
Amsterdam, Netherlands
0240
A QUALITATIVE STUDY OF THE HEALTHCARE WORKERS’ EXPERIENCE OF
THE ICU DIARIES
M. Garrouste-Orgeas, A. Périer, A. RevahLevy, C. Bruel, N. Cousin, S. Angeli, S. Brochon,
F. Philippart, B. Misset, Paris, France
0241
A SURVEY OF ICU MEDICAL STAFF ON INTERDISCIPLINARY
COMMUNICATION ABOUT END-OF-LIFE CARE AND BURNOUT
D. Schwarzkopf, H. Skupin, I. Westermann,
R. Pfeifer, M. Fritzenwanger, A. Guenther,
B. Kabisch, H.-R. Figulla, O.W. Witte, K. Reinhart,
C.S. Hartog, Jena, Germany
0242
SATISFACTION AND EMOTIONAL BURDEN OF RELATIVES ON THE ICU
D. Schwarzkopf, S. Behrend, I. Westermann,
H. Skupin, R. Pfeifer, M. Fritzenwanger,
A. Guenther, B. Kabisch, K. Reinhart, C.S. Hartog,
Jena, Germany
0243
PRACTICES OF RELATIONSHIP BETWEEN MEDICAL STAFF AND ICU
PATIENTS’ RELATIVES AND ETHICAL DECISIONS IN 66 SOUTHERN
FRENCH INTENSIVE CARE UNITS: A ONE-DAY SURVEY
C. Roger, M. Leone, S. Jaber, J.-M. Constantin,
B. Allaouchiche, J.-Y. Lefrant, Nimes, France
0244
COMMUNICATION WITH RELATIVES - IS IT TIME WE SET STANDARDS?
C. Ball, S. Moss, D. Bryden, Sheffield, United
Kingdom
0245
DIFFERENCES AMONG ICU DOCTORS AND NURSES FACING END-OF-LIFE
DECISIONS ON PORTUGUESE ICU (RESULTS FROM THE DEFIVUCI STUDY)
A. Carneiro, Porto, Portugal
0246
“REST IN PEACE”: FORMALISING THE PROCESS OF CONFIRMING DEATH
M.N. Kigozi, Y. Cheung, K. Grant, J. Ball,
A. Zoumprouli, London, United Kingdom
0247
SOCIO-POLITICAL BACKGROUND FOR ORGAN DONATION IN 4TH
MILITARY HOSPITAL IN WROCLAW
T. Zawada, Z. Sycz, W. Mielnicki, J. Bartczak,
P. Garba, Wroclaw, Poland
0248
ATTITUDES TOWARDS DOCUMENTATION OF TREATMENT LIMITATIONS
IN A UK INTENSIVE CARE UNIT
S.E. Liu, R.W. Hewson, London, United Kingdom
0249
UTILITY OF WEBCAM FACIAL FEATURE TRACKING AND KINECTTM
SENSOR ARM MOVEMENT TRACKING AS HANDS-FREE TEXT
COMMUNICATORS FOR PATIENTS IN CRITICAL CARE UNIT WHO CANNOT
OTHERWISE COMMUNICATE
M.B. Muthuswamy, D. Williams, J. Dingley,
Swansea, United Kingdom
0250
COMMUNICATION RELATED TO END OF LIFE CARE DURING SHIFT
HANDOVERS IN ICUS IN ISRAEL, THE UK AND AUSTRALIA
R. Endacott, F.D.K. Ganz, J. Benbenishty, M. Ben
Nunn, H. Ryan, W. Chamberlain, C. Boulanger,
K. Davies, A. Schoter, W. Chaboyer, Plymouth,
United Kingdom
0251
Area Cascais
Poster Corner NON-INVASIVE VENTILATION: INDICATIONS & LIMITS
Chairs: Marcelo Amato, Sao Paulo, Brazil & Jean-Jacques Rouby, Paris, France (TBC)
14:00 - 15:50
114
INCREASED USE OF NON-INVASIVE VENTILATION AND CHANGES IN
INDICATIONS AMONG FRENCH ICUS: THE 2011 OVNI STUDY
A. Demoule, A. Kouatchet, S. Jaber, J. Lambert,
F. Meziani, S. Perbet, L. Camous, R. JanssenLangenstein, M. Alves, B. Zuber, F. Collet,
J. Messika, X. Favre, O. Guisset, B. Misset,
A. Lafabrie, L. Brochard, E. Azoulay, Paris, France
0252
PREDICTIVE FACTORS FOR NONINVASIVE VENTILATION FAILURE IN
HYPERCAPNIC ACUTE RESPIRATORY FAILURE
D. Contou, C. Fragnoli, A. Cordoba Izquierdo,
F. Boissier, C. Brun-Buisson, A.W. Thille, Creteil,
France
0253
THE EFFECT OF HIGH FLOW CONDITIONED OXYGEN THERAPY ON
PREVENTION OF POST-EXTUBATION FAILURE IN A NON-SELECTED
POPULATION OF CRITICALLY ILL PATIENTS. A PRELIMINARY CASECONTROL STUDY
G. Hernandez, C. Vaquero, P. Gonzalez, S. Garcia,
E. de la Fuente, A. Villasclaras, C. Pardo, R. Cuena,
R. Fernandez, Madrid, Spain
0254
13-17 October 2012
L I V E S 2 012
0255
ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH
HAEMATOLOGIC MALIGNANCIES
M. Turkoglu, G.U. Erdem, E. Suyanı, M.E. Sancar,
M.M. Yalçın, G. Aygencel, Z. Akı, G. Sucak,
Ankara, Turkey
0256
EFFECTIVENESS OF NON-INVASIVE VENTILATION IN THE TREATMENT
OF SEVERE PNEUMONIA. DIFFERENCES BETWEEN THE COMMUNITYACQUIRED PNEUMONIA AND NOSOCOMIAL PNEUMONIA
A. Carrillo, G. Gonzalez, A. Lopez, J.C. Pardo,
N. Llamas, M.N. Alcazar, M.A. Fernandez,
J. Canovas, Murcia, Spain
0257
RISK FACTORS FOR FAILURE OF NON-INVASIVE VENTILATION IN THE
TREATMENT OF RESPIRATORY FAILURE EXACERBATIONS IN OBESITY
HIPOVENTILATION SYNDROME
G. Gonzalez, A. Carrillo, A. Lopez, N. Llamas,
J.C. Pardo, M.N. Alcazar, M.A. Fernandez,
A. Ramos, Murcia, Spain
0258
A DIAPHRAGM SONOGRAPHY STUDY OF ALTERATIONS IN BREATHING
PATTERN INDUCED BY SWITCH FROM NASAL TO ORAL BREATHING
E. Koco, G. Minas, P. Chatzaras, A. Kalakonas,
V. Makrakis, C. Chaintoutis, M. Tsagourias,
0259
AVOIDING INVASIVE MECHANICAL VENTILATION BY EXTRACORPOREAL
CARBON DIOXIDE REMOVAL IN PATIENTS FAILING NONINVASIVE
VENTILATION
S. Kluge, S. Braune, M. Engel, A. Nierhaus,
D. Frings, H. Ebelt, A. Uhrig, M. Metschke,
K. Wegscheider, N. Suttorp, S. Rousseau,
Hamburg, Germany
0260
MONITORING OF NONINVASIVE VENTILATION BY THE SOFTWARE
OF THE VENTILATORS IN THE ICU PATIENTS WITH HYPERCAPNIC
RESPIRATORY FAILURE
G. Gursel, M. Aydogdu, M. Turk, Y. Aldag, Ankara,
Turkey
0261
BRONCHOSCOPIC INTUBATION DURING NON-INVASIVE VENTILATION
FOR REFRACTORY HYPOXEMIC RESPIRATORY FAILURE
I.Z. Barjaktarevic, D. Berlin, New York, United
States
0262
EXTERNAL NASAL DILATOR STRIP IMPROVE OXYGENATION IN INTENSIVE
CARE PATIENTS
T. Kimura, S. Mimuro, M. Doi, S. Sato,
Hamamatsu, Japan
0263
EFFECTS OF UPPER AIRWAY OBSTRUCTION ON RESPIRATORY
MECHANICS IN A VARIABLE COMPLIANCE MODEL
S.-H. Yun, J.-C. Park, Jeju, Republic of Korea
0264
IMPACT OF POST-OPERATIVE HYPOXIA AND CPAP USE IN PATIENTS
AFTER MAJOR ABDOMINAL SURGERY IN THE CRITICAL CARE UNIT OF A
UK TEACHING HOSPITAL
V.C. Banks, A. Glossop, Sheffield, United
Kingdom
0265
Area Coimbra
Poster Corner
BEDSIDE ASSESSMENT OF HAEMODYNAMICS
Chairs: Michel Slama, Amiens, France & Xavier Monnet, Kremlin-Bicetre, France
14:00 - 15:50
DIASTOLIC LEFT VENTRICULAR FUNCTION BY ECHOCARDIOGRAPHY
IN PATIENTS WITH SHOCK: TIME COURSE AND IMPLICATIONS FOR
MORTALITY
L. Bergenzaun, H. Ohlin, P. Gudmundsson,
R. Willenheimer, M.S. Chew, Malmö, Sweden
0266
CAN I PREDICT CARDIAC INDEX USING CENTRAL VENOUS OXYGEN
SATURATION IN PATIENTS WITH SEPTIC SHOCK?
R. Neira, C. Luengo, Santiago, Chile
0267
ACCURACY OF RESPIRATORY VARIATIONS OF R-WAVE AMPLITUDE IN
LEAD II TO PREDICT FLUID RESPONSIVENESS IN CRITICALLY ILL PATIENTS
S. Petiot, Y. Mahjoub, E. Lorne, A.-A. Seydi,
M. Levrard, N. Ammenouche, N. Airapetian,
A. Friggeri, F. Tinturier, H. Dupont, Amiens,
France
0268
NON-INVASIVE DETERMINATION OF STROKE VOLUME CHANGES IN
RESPONSE TO PASSIVE LEG RAISING MANEUVER. ECHOCARDIOGRAPHY
VERSUS NICOM ®. PRELIMINARY RESULTS
C. Mora, X. Garcia, C. Sabatier, J. Mesquida,
J. Masip, F. Baigorri, A. Artigas, Sabadell, Spain
0269
PREVALENCE OF GLOBAL LEFT VENTRICULAR MECHANICAL
DYSSYNCHRONY AS MEASURED BY TOTAL-ISOVOLUMIC TIME IN
PATIENTS ON THE CARDIOTHORACIC INTENSIVE CARE
G. Tavazzi, E. Ridha, B. Waldron, S. Price, A. Vazir,
Pavia, Italy
0270
ASSESSMENT OF PLEURA- AND PERICARDIAL EFFUSION AFTER
OPEN HEART SURGERY USING FOCUS ASSESSED TRANSTHORACIC
ECHOCARDIOGRAPHY
L. Kamstrup Christiansen, C. Alcaraz Frederiksen,
J. Fridolf Hermansen, P. Juhl-Olsen, E. Sloth,
Aarhus N, Denmark
0271
INITIAL CLINICAL EXPERIENCE WITH A NOVEL, MINIATURISED
TRANSOESOPHAGEAL ECHOCARDIOGRAPHY PROBE
M. Geisen, F. Caliandro, M.E. Edsell, H. Meeran,
M. Cecconi, S.N. Fletcher, London, United
Kingdom
0272
L I V E S 2 012
J.A. De Araujo Neto, R.F. Bomfim, F.B. Lima,
A.C. Gouveia, G.F. Amaral, F.M.P. Garrido,
J.R. Silva, F.F. Amorim, M.O. Maia, Brasilia, Brazil
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
THE NONINVASIVE VENTILATION IN THE TREATMENT OF ARF IN
PATIENTS WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA
115
PREDICTION OF CARDIAC INDEX (CI) BY BODY SURFACE TEMPERATURES
MEASURED WITH TEMPERATURE PROBES AND NON-CONTACT
INFRARED THERMOMETER
W. Huber, A. Meidert, B. Saugel, V. Phillip,
C. Schultheiss, S. Mair, U. Mayr, R. Schmid,
Munich, Germany
0273
TEI INDEX AND ENDOMYOCARDIAL LONGITUDINAL STRAIN VALUE IN
ACUTE PATIENTS WITH MYOCARDIAL INFARCTION OR PERICARDIAL
DISEASE
M. Ruiz Bailen, A. Castillo Rivera, A. Gomez
Blizniak, D. Matallana Zapata, M.A. Martinez
Arco, E. Ranea Ortega, Jaen, Spain
0274
HAEMODYNAMIC ASSESSMENT IN THE ACUTE PHASE OF SEPTIC SHOCK
- DO THE RIVERS CRITERIA LAST LONGER THAN SIX HOURS?
M.W. Prull, B. Sasko, A. Bittlinsky, T. Butz,
G. Plehn, M. van Bracht, H.-J. Trappe, Herne,
Germany
0275
ASSESSMENT OF LEFT VENTRICULAR PERFORMANCE IN PATIENTS WITH
COPD
R.R. Omar, W.A. Radwan, M.M. Khalaf,
D.M. Ragab, S.F. Mikhail, Cairo, Egypt
0276
GOAL-DIRECTED HAEMODYNAMIC THERAPY IN CARDIAC SURGICAL
PATIENTS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED
CONTROLLED TRIALS
H.D. Aya, M. Geisen, C. Ebm, M. Hamilton,
A. Rhodes, M. Cecconi, London, United Kingdom
0277
ULTRASONOGRAPHIC INVESTIGATION OF THE EFFECT OF POSITIVE
END EXPIRATORY PRESSURE (PEEP) ON THE CROSS-SECTIONAL AREA
(CSA) OF THE FEMORAL VEIN IN ADULT PATIENTS WITH MECHANICAL
VENTILATION
J.-H. Ryu, S.-S. Han, S.-H. Do, Seongnam-si,
Republic of Korea
0278
Area Estoril
Poster Corner
Chairs: Mitchell Levy, Providence, United States & Susanne Toussaint, Berlin, Germany
MONDAY 15 OCTOBER
14:00 - 15:50
116
LIPOPROTEIN PATTERNS RELATED TO NEUTROPHIL CD64-EXPRESSION
AND METABOLIC INDICES IN SEVERE SEPSIS AND NON-INFECTIOUS SIRS
IN CHILDREN
M.D. Fitrolaki, H. Dimitriou, A.-M. Spanaki,
E. Tavladaki, S. Ilia, E. Geromarkaki, E. Vasilaki,
E. Blevrakis, G. Briassoulis, Heraklion, Greece
0279
ENDOCARDITIS AT ICU: COULD WE PREDICT MORTALITY?
P. Fernandez Ugidos, R. Gomez Lopez, P. Vidal
Cortes, V. Aller Fernandez, M.T. Bouza Vieiro,
L. Seoane Quiroga, G.B. Besteriro Grandio,
M. Mourelo Fariña, J.M. Lopez Perez, Ourense,
Spain
0280
INFECTIONS IN MECHANICALLY VENTILATED PATIENTS IN CANADIAN
INTENSIVE CARE UNITS
R. Matta, T. Sinuff, D. Heyland, D. Cook, P. Dodek,
X. Jiang, A. Day, J. Muscedere, Kingston, Canada
0281
IMMUNOPHENOTYPIC ANALYSIS AND FUNCTIONAL CHANGES IN SEPTIC
ICU PATIENTS:DIAGNOSTIC ACCURACY AND PROGNOSTIC VALUE
K. Arvaniti, A. Fleva, C. Chaintoutis, D. Lathyris,
A. Mpamzelis, A. Pitsioulis, A. Pavlitou-Tsiontsi,
0282
RELATIONSHIP BETWEEN POLYMORPHONUCLEAR LEUKOCYTE
(PMN) COUNT IN BRONCHOALVEOLAR LAVAGE FLUID (BALF) AND
FUNGUS CONTENT IN GRAM’S STAIN AND FUNGUS CONTENT IN FINAL
MICROBIOLOGICAL REPORT
G. Cavric, S. Naumovski Mihalic, M. Bogdanovic
Dvorzak, G. Erceg, M. Rehoric Krkusek, D. Ilic,
K. Njers, I. Budimir, I. Prkačin, Zagreb, Croatia
0283
ANTIBIOTIC DEESCALATION DURING THERAPY OF POSTOPERATIVE
PERITONITIS
P. Montravers, H. Houissa, P. Piednoir, N. Allou,
R. Bronchard, Paris, France
0284
CORRELATION BETWEEN CARBAPENEM USE DENSITY AND THE
INCIDENCE OF IMIPENEM AND MEROPENEM RESISTANT GRAM
NEGATIVE ORGANISMS IN A MEDICAL INTENSIVE CARE UNIT
A.K. Gupta, A. Gupta, V. Gupta, A. Arora,
A. Varma, New Delhi, India
0285
AN EPIDEMIOLOGICAL SURVEY OF HIV TESTING IN A LARGE UNIVERSITY
HOSPITAL INTENSIVE CARE DEPARTMENT
M. Dodd, A. Tridente, Sheffield, United Kingdom
0286
TIGECYCLINE USE IN CRITICALLY ILL PATIENTS. DO WE NEED HIGHER
DOSES?
G. De Pascale, L. Montini, V. Bernini, V. Raggi,
P. De Santis, A. Moccaldo, A. Occhionero, P. De
Santis, E. Piervincenzi, E. Tanzarella, S. Cutuli,
M.A. Pennisi, M. Antonelli, Rome, Italy
0287
ANALYSIS OF ALL BACTEREMIA EPISODES CAUSED BY CARBAPENEMASE
- PRODUCING KLEBSIELLA IN AN INTENSIVE CARE UNIT (ICU)
E.E. Paramythiotou, M. Rizos, A. Antonopoulou,
F. Frantzeskaki, T. Panagea, A. Antoniadou,
P. Kopteridis, G. Petrikkos, A. Armaganidis,
Athens, Greece
0288
13-17 October 2012
L I V E S 2 012
0289
TIME LAG ANALYSIS TO IDENTIFY A RELATIONSHIP BETWEEN COLISTIN
CONSUMPTION AND RESISTANCE IN GRAM NEGATIVE BACTERIA IN A
TERTIARY CARE HOSPITAL
A. Gupta, A.K. Gupta, V. Gupta, A. Arora,
A. Varma, New Delhi, India
0290
MORTALITY OF ACINETOBACTER BAUMANNII BACTEREMIA IN
AN INTENSIVE CARE UNIT. THE ROLE OF INADEQUATE EMPIRICAL
ANTIBIOTIC TREATMENT AND MUTIRESISTANCE
R. Zaragoza, J.J. Camarena, R. González,
S. Sancho, J.J. Tamarit, F. Puchades, A. Artero,
J.M. Nogueira, Valencia, Spain
0291
OUTCOMES FOR VERY ELDERLY PATIENTS ADMITTED TO INTENSIVE
CARE UNITS WITH COMMUNITY ACQUIRED PNEUMONIA: A SINGLE
CENTRE EXPERIENCE
J. Bramall, B. Hogan, B. Agarwal, A. Walecka,
0292
Poster Corner
INTENSIVE CARE IN SPECIFIC PATIENT POPULATIONS
Chairs: Hans Flaatten, Bergen, Norway & Kathryn Rowan, London, United Kingdom
14:00 - 15:50
MATERNAL ADMISSIONS TO CRITICAL CARE - A 3 YEAR REVIEW
N. Bandla, G. Simon, Wolverhampton, United
Kingdom
0293
EPIDEMIOLOGY OF HIV-INFECTED PATIENTS ADMITTED TO AN
INTENSIVE CARE UNIT: A 20-YEAR STUDY
A.S. Santos, A. Ferreira, C. Piñeiro, R. Serrão,
C. Alves, M.L. Santos, A. Sarmento, Porto,
Portugal
0294
CATHETER-RELATED BACTEREMIA IN A BURN CENTRE INTENSIVE CARE
UNIT
S. Wiramus, K. Bihi, S. Bordon, P. Ainaud,
V. Bernini, J. Albanèse, J. Textoris, Marseille,
France
0295
AN EPIDEMIOLOGIC STUDY OF BURN PATIENTS ADMITTED IN A BURN
INTENSIVE CARE UNIT
C. Guallar, M. Sánchez, L. Cachafeiro, E. Herrero,
M.J. Asensio, M. Hernandez, B. Galvan, A. Garciade-Lorenzo, Madrid, Spain
0296
TOO OLD FOR INTENSIVE CARE? DO PATIENTS AGED 80 YEARS OR MORE
HAVE A WORSE OUTCOME THAN THE GENERAL POPULATION DURING
OR FOLLOWING INTENSIVE CARE ADMISSION?
A. Myers, R. Conway, S. Jankowski, London,
United Kingdom
0297
THE IMPACT OF AGE ON OUTCOME AFTER MAJOR SURGICAL
PROCEDURES
Y. Sakr, C. Elia, C. Schoenfeld, O. Bayer, C. Ewald,
K. Reinhart, Jena, Germany
0298
SURVIVAL AND FUNCTIONAL AUTOMONY AT 6 MONTH OF PATIENTS
OLDER THAN 75 YEARS ADMITTED TO ICU
P. Villa, M.-C. Pintado, M. Trascasa, R. Molina,
J. Lujan, C. Arenillas, J.-A. Cambronero, Alcala de
Henares, Spain
0299
CHARACTERISTICS AND PROGNOSIS OF ELDERLY PATIENTS ADMITTED
TO THE INTENSIVE CARE UNIT
J. Moreno Quintana, A. Narvaez de Linares,
A. López Coronado, R. Rivera Fernández,
Málaga, Spain
0300
OCTAGENERIANS ON THE ICU: ARE WE DOING IT RIGHT?
H. Rajanna, T. Szakmany, Llantrisant, United
Kingdom
0301
ACUTE RESPIRATORY FAILURE IN NEUTROPENIC PATIENTS
D. Mokart, E. Azoulay, A. Bourmaud,
A. Kouatchet, F. Pene, V. Lemiale, J. Lambert,
F. Bruneel, F. Vincent, M. Legrand, A. Rabbat,
M. Darmon, Saint-Etienne, France
0302
SHORT AND LONG TERM OUTCOME OF HAEMATOPOIETIC STEM CELL
TRANSPLANTATION (HSCT) RECIPIENTS ADMITTED TO THE ICU
S. Ajani, M. Litzow, W. Hogan, S. Peters, B. Afessa,
Rochester, United States
0303
CHARACTERISTICS AND OUTCOMES OF LONG STAY (>16 DAYS) CANCER
PATIENTS IN THE INTENSIVE CARE UNIT
A. Achilleos, T. Wigmore, P. Gruber, London,
United Kingdom
0304
PATIENTS WITH HAEMATOLOGICAL MALIGNANCY REQUIRING INTENSIVE
CARE TREATMENT: A FIVE YEAR REVIEW
P. Edmondson, T. Astles, N. Bhuiyan, Liverpool,
United Kingdom
0305
EVALUATION OF ONCOLOGICY PATIENTS ADMITTED TO AN INTENSIVE
CARE UNIT
M. Mesquita Pinto, C. Carvalho, J. Silvestre,
J. Gonçalves Pereira, P. Póvoa, Lisboa, Portugal
0306
L I V E S 2 012
M. Yaroustovsky, M. Abramyan,
B. Mamazakirova, D. Popov, M. Plyushch,
K. Rogalskaya, H. Nazarova, O. Stupchenko,
Moscow, Russian Federation
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Evora
COMPLEX METHODS OF EXTRACORPOREAL THERAPY IN PATIENTS WITH
SEVERE SEPSIS AFTER CARDIAC SURGERY
117
14:00 - 15:50
MONDAY 15 OCTOBER
Area Faro
Poster Corner
EVALUATING SYSTEMIC & MICRO CIRCULATION
Chairs: Azriel Perel, Tel Aviv, Israel & Alain Combes, Paris, France
TITRATING MEAN ARTERIAL PRESSURE IN CONSIDERATION OF
INTERINDIVIDUAL EFFECT IMPROVES MICROCIRCULATION IN PATIENTS
WITH SEPTIC SHOCK
Y.J. Xu, Y. Yang, B.H. Qiu, Nanjing, China
0307
TRANSPULMONARY THERMODILUTION (TPTD) MEASUREMENTS
WITH FEMORAL INDICATOR INJECTION: IS THERE A DIFFERENCE TO
MEASUREMENTS WITH JUGULAR INJECTION? A STUDY IN 43 PATIENTS
EQUIPPED WITH A FEMORAL AND A JUGULAR CENTRAL VENOUS
CATHETER AT DIFFERENT TIME POINTS
W. Huber, S. Mair, S. Götz, J. Tschirdewahn,
J. Siegel, B. Saugel, V. Phillip, C. Schultheiss,
R.M. Schmid, München, Germany
0308
THE RELATIONSHIP BETWEEN ECHOCARDIOGRAPHIC INDICES AND
EXTRAVASCULAR LUNG WATER DURING SPONTANEOUS BREATHING
TRIALS
D. Bagka, J. Papanikolaou, M. Ziaka, D. Makris,
E. Zakynthinos, Larissa, Greece
0309
DIASTOLIC DYSFUNCTION IS AN INDEPENDENT FACTOR OF WEANING
FAILURE
I. Konomi, A. Tasoulis, I. Kaltsi, P. Politis,
S. Sourlas, E. Karatzanos, G. Danalis, S. Nanas,
C. Routsi, Athens, Greece
0310
HYPOXIA INDUCIBLE FACTOR (HIF1a) GENE EXPRESSION IN HUMAN
SHOCK STATES
J. Textoris, N. Beaufils, G. Quintana, S. Wiramus,
A. Ben Lassoud, L. Zieleskiewicz, N. Lesavre,
C. Martin, J. Gabert, M. Leone, Marseille Cedex,
France
0311
POSTOPERATIVE CENTRAL VENOUS OXYGEN SATURATION AND
LACTATE LEVELS IN CARDIAC SURGERY PATIENTS: A PROSPECTIVE
OBSERVATIONAL STUDY
D. Unic-Stojanovic, S. Babic, M. Lukic,
M. Milojevic, N. Kalezic, M. Jovic, Belgrade,
Serbia
0312
RISK AND PROTECTIVE FACTORS FOR DEVELOPMENT OF HYPOXIC
HEPATITIS AND JAUNDICE IN CRITICALLY ILL PATIENTS
A. Drolz, T. Horvatits, K. Staufer, K. Roedl,
R. Saxa, U. Holzinger, C. Zauner, P. Schenk,
P. Schellongowski, G. Heinz, C. Madl,
V. Fuhrmann, Vienna, Austria
0313
TRANSPULMONARY THERMODILUTION (TPTD) WITH ROOMTEMPERATURE INJECTATES: A COMPARISON TO ICED INJECTATE IN 402
TPTDS USING THE PICCO-DEVICE
W. Huber, T. Kraski, B. Saugel, V. Phillip,
C. Schultheiss, A. Herrmann, S. Mair,
R.M. Schmid, Munich, Germany
0314
HYPOTHERMIA AMELIORATES GASTRIC MUCOSAL MICROVASCULAR
OXYGENATION DURING HYPOXIA
C. Vollmer, I. Bauer, S. Weiss, I. Schwartges,
O. Picker, Duesseldorf, Germany
0315
USE OF BIOMARKERS IN ACUTE PERICARDITIS
M. Recuerda, S. Gamaza, J. Leon, V. Perez,
M. Gracia, E. Leal, Cádiz, Spain
0316
TERLIPRESSIN VERSUS NOREPINEPHRINE FOR TREATMENT OF
VASODILATORY HYPOTENSION: A META-ANALYSIS OF RANDOMISED
CONTROLLED STUDIES
G. Borghi, T. Greco, M. Zambon, L. Pasin,
L. Mattioli, D. Febres Escalante, G. Landoni,
A. Zangrillo, Milan, Italy
0317
CLINICAL AND ELECTROCARDIOGRAPHY MARKERS OF RIGHT VENTRICLE
STRAIN AND EARLY ADVERSE OUTCOME IN PATIENTS WITH PULMONARY
EMBOLISM: RESULTS OF SINGLE CENTRE PROSPECTIVE STUDY
N. Bulj, V. Degoricija, M. Sharma, S. Šefer,
B. Baršić, Zagreb, Croatia
0318
SERUM LACTATE AS A PREDICTOR FOR LIFE-THREATENING
PNEUMATOSIS INTESTINALIS: RETROSPECTIVE STUDY OF 60 PATIENTS
H. Okamoto, T. Fukuoka, Kurashiki Okayama,
Japan
0319
IMPACT OF AN AEROBIC REHABILITATION PROGRAMME ON FITNESS
AND QOL IN ICU SURVIVORS: AN EXPLORATORY TRIAL (PIX STUDY)
B.A. Goodman, S. Bonner, A.M. Batterham,
J. Wright, K. Hugill, P. Howard, S. Howell,
G. Danjoux, Middlesbrough, United Kingdom
0320
SAFETY AND EFFICACY OF WHOLE-BODY-VIBRATION IN CRITICALLY ILL
PATIENTS
T. Wollersheim, K. Haas, M. Krebs, J. Malleike,
R. Moergeli, S. Weber-Carstens, Berlin, Germany
0321
THE RELATIONSHIP BETWEEN MUSCLE WEAKNESS AND POSTOPERATIVE
CATABOLISM AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
Y. Iida, K. Iwatsu, T. Kawabe, H. Tsubouchi,
A. Usui, S. Yamada, Aichi, Japan
0322
THE INCIDENCE OF SHOULDER DYSFUNCTION IN ICU SURVIVORS
O. Gustafson, Oxford, United Kingdom
0323
Area Fatima
Poster Corner
PHYSIOTHERAPY IN THE ICU
Chairs: David McWilliams, Manchester, United Kingdom & Giulia Pelucchi, Monza, Italy
14:00 - 15:50
118
13-17 October 2012
L I V E S 2 012
0324
IS THE FUNCTIONAL INDEPENDENCE MEASURE (FIM) A USEFUL
OUTCOME MEASURE IN CRITICAL CARE REHABILITATION?
F. Shaw, C. Purkiss, S. Finney, M. Griffiths,
C. Brown, London, United Kingdom
0325
PHYSIOTHERAPY RESOURCE NEEDS OF SEVERE RESPIRATORY FAILURE
PATIENTS
G. Cork, G. Davies, G. Cox, L. Osman, N. Barrett,
0326
LONG-TERM PHYSICAL FUNCTIONING CAN BE PREDICTED 3 MONTHS
AFTER DISCHARGE FROM THE INTENSIVE CARE UNIT
M. Schaaf van der, D.S. Dettling, A. Beelen,
D.A. Dongelmans, F. Nollet, Amsterdam,
Netherlands
0327
THE FEASIBILITY OF THE SIX MINUTE WALK TEST AND BARTHELL INDEX
TO MEASURE THE EFFECT OF A PHYSIOTHERAPY SERVICE MODEL IN AN
INTENSIVE CARE UNIT
S. Hanekom, Q. Louw, A. Coetzee, Cape Town,
South Africa
0328
IS THE MANCHESTER MOBILITY SCORE A USEFUL TOOL FOR
COMPARISON OF CRITICAL CARE REHABILITATION BETWEEN TRUSTS
D.J. McWilliams, T. Lea, Birmingham, United
Kingdom
0329
EPIDEMIOLOGY AND EARLY DIAGNOSIS OF HETEROTOPIC OSSIFICATION
IN CRITICAL ILL PATIENTS. PRELIMINARY DATA
A. Christakou, M. Alimantiri, E. Patsaki,
A. Kouvarakos, M. Papadopoulos, K. Stefanidis,
D. Karakitsos, C.S. Vrettou, V. Markaki, S. Nanas,
Athens, Greece
0330
THE EVALUATION OF EARLY-ONSET ELECTRIC STIMULATION OF THE
QUADRICEPS MUSCLE AFTER CARDIAC SURGERY IS LIMITED BY A SHORT
LENGTH OF STAY AT THE INTENSIVE CARE UNIT
M. Spiegl, J.M. Hiesmayr, T. Paternostro-Sluga,
K. Altmann, A. Fischer, A. Salamon, A. Winkler,
A. Schiferer, Vienna, Austria
0331
IS REHABILITATION AFTER IMPLANTATION OF LEFT VENTRICULAR
DEVICES (LVAD) AFFECTED BY THE SEVERITY OF PREOPERATIVE HEART
FAILURE?
A. Gatehouse, S. Schueler, Newcastle Upon Tyne,
United Kingdom
0332
Area Funchal
Poster Corner
POSTOPERATIVE MANAGEMENT OF CARDIO-SURGICAL PATIENTS
Chairs: Michael Sander, Berlin, Germany & Herwig Gerlach, Berlin, Germany
14:00 - 15:50
HIGH TIDAL VOLUMES IN WOMEN AND OBESE PATIENTS AFTER CARDIAC
SURGERY. SIZE DOES MATTER!
M. Chassé, S. Dionne, A. Bojmehrani, S. Simard,
J. Bussières, F. Dagenais, F. Lellouche, Québec,
Canada
0333
MONTORING OF REVERSAL OF PROPHYLACTIC AND THERAPEUTIC
RIVAROXABAN ANTICOAGULATION WITH PCC AND RFVIIA
M.K. Keller, E. Langer, C. Gericke, C. von
Heymann, Berlin, Germany
0334
APROTININ VERSUS TRANEXAMIC ACID IN CARDIAC SURGERY
M.J. Chaparro Sanchez, R. Rivera, M.D. Arias
Verdu, M.D. Fernandez Zamora, J.A. Arboleda,
M.A. Prieto Palomino, Málaga, Spain
0335
PERIOPERATIVE COAGULATION PROFILE EVALUATED WITH TEG® IN
PATIENTS UNDERGOING CRANIOTOMY FOR PRIMARY BRAIN TUMOR
REMOVAL
F. Curto, M. Giacomini, M. Mininni, S. Sangion,
G. Chevallard, S. Carenini, M. Teruzzi, C. Betto,
Milan, Italy
0336
EVALUATION OF SILENT PULMONARY EMBOLISM IN INTENSIVE CARE
UNIT
S. Wiramus, E. Arnoult, J. Textoris, E. Hammad,
L. Zieleskievicz, C.-D. Martin, M. Leone, Marseille,
France
0337
THE IMPACT OF CRITICAL CARE NURSE TRAINING ON
THROMBOELASTOGRAPHY USAGE TO GUIDE PERIOPERATIVE BLOOD
COMPONENT TRANSFUSION IN A CARDIOTHORACIC CRITICAL CARE
UNIT
A. Shah, P. Chan, R. Broomhead, M. Curtis,
D. Farrar, London, United Kingdom
0338
THE OBESITY PARADOX OF MORTALITY IN CARDIAC SURGERY. REALLY,
DOES OBESITY INCREASES THE RISK? ANALYSIS ARIAM REGISTRY OF
CARDIAC SURGERY
V. Olea Jiménez, E. Curiel Balsera, J. Muñoz Bono,
R. Rivera Férnandez, M. Álvarez Bueno, T. García
Paredes, J.A. Arboleda Sáncez, Málaga, Spain
0339
THE INCREASED RISK OF CARDIAC SURGERY IN ELDERLY PATIENTS.
CAN BENEFIT THE OCTOGENARIANS? THE PERIOPERATORY MORTALITY
AND POSTOPERATIVE COMPLICATIONS. ANALYSIS ARIAM REGISTRY OF
CARDIAC SURGERY
V. Olea Jiménez, E. Curiel Balsera, J.M. Mora
Ordoñez, R. Rivera Férnandez, M.D. Fernández
Zamora, J.C. Escudero Valera, Málaga, Spain
0340
REASONS OF THE POSTOPERATIVE ENCEPHALOPATHY IN
CARDIOSURGERY
T.V. Klypa, A. Shepelyuk, Moscow, Russian
Federation
0341
L I V E S 2 012
C. Black, M. Grocott, M. Singer, London, United
Kingdom
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
THE FEASIBILITY OF MEASURING OXYGEN CONSUMPTION DURING
REHABILITATION OF MECHANICALLY VENTILATED PATIENTS
119
IMC IS AN INDEPENDENT PREDICTOR FACTOR OF COMPLICATIONS
AFTER CARDIOVASCULAR SURGERY
M.N. Parias Ángel, A.M.G.F. García Fernández,
F. Prieto Valderrey, P. Font Ugalde, R. Guerrero
Pabón, E. Moreno Millán, J. Villegas del Ojo,
M. Cid Cumplido, Ciudad Real, Spain
0342
COGNITIVE DYSFUNCTION AFTER CARDIAC ANAESTHESIA IS
ASSOCIATED WITH PROLONGED HOSPITAL STAY
L.A. Rasmussen, C.-J. Jakobsen, Aarhus N,
Denmark
0343
MECHANICAL VENTILATION IN CARDIAC SURGERY: BENEFIT OF
OPEN LUNG APPROACH AND CONTINUED VENTILATION DURING
CARDIOPULMONARY BYPASS
R. Badenes, L. Alcover, M.J. Montero, C. Ferrando,
A. Gómez, L. Henao, J. Belda, Valencia, Spain
0344
REDUCING THE LEVEL OF POSTOPERATIVE THROMBOTIC
COMPLICATIONS BY USING THE COMBINATION OF LOW MOLECULAR
WEIGHT HEPARIN AND EPIDURAL ANAESTHESIA AT THE PATIENTS AFTER
TOTAL HYSTERECTOMY
O. Tarabrin, V. Dubinina, A. Turenko,
S. Tarasenko, S. Shcherbakov, D. Gavrychenko,
G. Mazurenko, Odessa, Ukraine
0345
PROLONGED QT INTERVAL AS A PREDICTOR OF MORTALITY IN STELEVATION MYOCARDIAL INFARCTION
M.D. Arias-Verdu, J. Arboleda-Sánchez, V. OleaJiménez, R. Rivera-Fernández, T. García-Paredes,
M. Alvarez-Bueno, J. Muñoz-Bono, Málaga,
Spain
0346
MICROPARTICLES EXPRESSION IN THE EARLY PHASE OF SHOCK
S. Wiramus, M. Haddam, J. Textoris, C. Brun,
F. Dignat-George, C.-D. Martin, L. Camoin-Jau,
M. Leone, Marseille, France
0347
C-REACTIVE PROTEIN (CRP) IS AS USEFUL AS PROCALCITONIN (PCT)
TO REDUCE ANTIBIOTIC EXPOSURE IN CRITICALLY-ILL PATIENTS WITH
SEPSIS: A RANDOMISED CLINICAL TRIAL
C.F. Oliveira, C.A. Oliveira, F.A. Botoni, C.B. Silva,
H.A. Pereira, V. Nobre, Belo Horizonte, Brazil
0348
ENDOTOXIN ACTIVITY IN SEPSIS AND SEPTIC SHOCK
M.P. Hilty, B. Eberle, M. Maggiorini, Zurich,
Switzerland
0349
METABONOMIC STUDY ON PATIENTS DIAGNOSED WITH SEVERE SEPSIS
AND SEPTIC SHOCK IN THE INTENSIVE UNIT
M. García Simón, J.M. Morales Tatay, D. Monleón
Salvado, V. Modesto i Alapont, R. Vento Rehues,
A. Jorda Miñana, J. Blanquer Olivas, Valencia,
Spain
0350
MR-PROADRENOMEDULLIN AS PROGNOSTIC BIOMARKER IN SEVERE
SEPSIS AND SEPTIC SHOCK
A. Baró, G. Rognoni, C. Murcia, P. Tejerina,
A. Garcia, C. Lorencio, A. Taché, J.-M. Sirvent,
Girona, Spain
0351
DIAGNOSTIC AND PREDICTIVE VALUE OF PRESEPSIN (SCD14-ST) IN THE
TIME COURSE OF SEPSIS
M. Behnes, D. Lepiorz, S. Lang, T. Kälsch,
M. Brueckmann, M. Borggrefe, U. Hoffmann,
Mannheim, Germany
0352
PROGNOSTIC VALUE OF SUPAR IN SEVERE SEPSIS AND SEPTIC SHOCK
PATIENTS
B. Suberviola, A. Castellanos-Ortega, D. Iglesias,
V. Suarez, F. Ortiz-Melón, L.-H. Marcos,
Santander, Spain
0353
VASPIN SERUM LEVELS IN PATIENTS WITH SEPSIS
M.C. Motal, G.A. Roth, A. de Abreu Santos,
K. Schebesta, D.A. Klaus, C.G. Krenn, Vienna,
Austria
0354
DOES THROMBOSPONDIN-1 EXPRESSION IN CIRCULATING
MONONUCLEAR CELLS HAVE A PROGNOSTIC INTEREST DURING HUMAN
SEPTIC SHOCK?
A.-C. Lukaszewicz, S. Gaugain, H. Haloui,
M. Grienay, V. Faivre, D. Payen, Paris, France
0355
NEW DIAGNOSTIC STRATEGY OF SEPSIS INDUCED DISSEMINATED
INTRAVASCULAR COAGULATION
A. Murai, H. Ishikura, T. Nishida, Y. Nakamura,
Y. Irie, T. Umemura, T. Kamitani, Fukuoka, Japan
0356
C-REACTIVE PROTEIN PROVIDES AN ESTIMATE OF EXCRETION OF
URINARY UREA NITROGEN
S. Naruse, Y. Kawashima, H. Kato, C. Ishida,
K. Mizuno, S. Mimura, S. Mimuro, Y. Obata,
M. Doi, S. Sato, Hamamatsu, Japan
0357
THE LECTIN PATHWAY OF THE COMPLEMENT SYSTEM IN CRITICALLY ILL
CHILDREN
C.M. Ingels, S. Thiel, I. Derese, L. Jensen,
R.N. Steffensen, P.J. Wouters, I. Vanhorebeek,
G. Van den Berghe, Leuven, Belgium
0358
Area Guarda
Poster Corner
EVALUATION OF SEPSIS BIOMARKERS
Chairs: Jérôme Pugin, Geneva, Switzerland & Pierre-François Laterre, Leuven, Belgium
MONDAY 15 OCTOBER
14:00 - 15:50
120
13-17 October 2012
L I V E S 2 012
0359
EVALUATION OF SERUM CRP VALUES IN DIFFERENT STAGES OF SEPSIS
C. Ece, I. Cankayali, C. Bor, K. Demirağ, M. Uyar,
A.R. Moral, İzmir, Turkey
0360
CONNECTION BETWEEN MYOCARDIAL OEDEMA, INFLAMMATION AND
FUNCTION DURING SEPSIS: ROLE OF ALPHA1 AMP-ACTIVATED PROTEIN
KINASE
D. Castanares-Zapatero, C. Sommereyns,
B. Gerber, D. Communi, M. Horckmans, C. Oury,
C. Lecut, J.-L. Vanoverschelde, L. Bertrand,
P.-F. Laterre, S. Horman, C. Beauloye, Brussels,
Belgium
0361
PHOSPHODIESTERASE-4-INHIBITION TO ATTENUATE HEPATOCELLULAR
INJURY DURING SYSTEMIC INFLAMMATION IN RATS
J. Wollborn, C. Wunder, N. Roewer, N. Schlegel,
M.A. Schick, Würzburg, Germany
0362
ACCELERATED AEROBIC GLYCOLYSIS - THE HALLMARK OF SEPSIS
ASSOCIATED MYOCARDIAL DYSFUNCTION?
K. Shekar, B.A. Brand, C. Norin, J.F. Fraser,
A. Staib, M.S. Chew, Malmö, Sweden
0363
SEPSIS DECREASES STROKE VOLUME YET INCREASES EX-VIVO
CARDIOMYOCYTE OXYGEN CONSUMPTION
B. Bollen Pinto, S. Tully, M. Singer, London, United
Kingdom
0364
P2X7 RECEPTOR AND SEPSIS- INDUCED ACUTE TUBULAR INJURY
N. Arulkumaran, A. Dyson, C. Turner, R.J. Unwin,
F.W. Tam, M. Singer, London, United Kingdom
0365
N-ACETYLCYSTEINE EARLY TREATMENT DURING FECAL PERITONITIS
PREVENTS KIDNEY CORTICAL MITOCHONDRIAL DYSFUNCTION, BUT IS
NOT ASSOCIATED WITH LESS SEPSIS-INDUCED ACUTE KIDNEY INJURY
T. Regueira, S.M. Jakob, F. Lillo, M. Zapata,
A. Fuentealba, M. Andresen, F. Moraga,
A. Meneses, D. Soto, Santiago, Chile
0366
MODULATION OF EXPRESSION AND FUNCTION OF ION CHANNELS IN
ATRIAL MYOCYTE FROM SEPTIC GUINEA PIG
N. Hatakeyama, Y. Aoki, K. Sakakibara,
N. Matsuda, H. Kinoshita, Y. Fujiwara, Nagakute,
Aichi, Japan
0367
GENETIC PREDISPOSITION TO ACUTE KIDNEY INJURY INDUCED BY
SEVERE SEPSIS AND SEPTIC SHOCK
C. Santiago, F. Gómez, A. Martín-Pellicer,
F. Frutos-Vivar, O. Peñuelas, N. Nin, A. Esteban,
J.A. Lorente, Madrid, Spain
0368
QUINIDINE PROTECTS THE GUT FROM PLATELET ACTIVATING FACTORINDUCED MICROCIRCULATORY DYSFUNCTION AND ORGAN FAILURE
I. Lautenschläger, H. Dombrowsky, J. Sarau,
Y.L. Wong, P. Zabel, S. Uhlig, I. Frerichs, N. Weiler,
Kiel, Germany
0369
AMELIORATION OF ACUTE LIVER INJURY THROUGH THE SUPPRESSION
OF UPREGULATED LEVELS OF ENDOTHELIN-1 AND TNF-a IN A RAT
MODEL OF ENDOTOXEMIA WITH THE BLOCKADE OF PROTEASE
ACTIVATED RECEPTOR-2 (PAR2)
S. Jesmin, T. Wada, S. Zaedi, N. Shimojo,
S.N. Sultana, M. Moroi, T. Watanebe, S. Gando,
Sapporo, Japan
0370
DO SOLUBLE LEVELS OF ENDOTHELIAL ADHESION MOLECULES REFLECT
ENDOTHELIAL ACTIVATION?
A.G. Kjærgaard, A. Dige, E. Tønnesen,
L. Wogensen, J. Krog, Aarhus C., Denmark
0371
TREND ANALYSIS OF URINE BIOCHEMISTRY PATTERN IN PATIENTS WITH
SEVERE SEPSIS OR SEPTIC SHOCK
C. Dupuis, M. Legrand, C. Simon, J. Mateo,
D. Payen, Paris, France
0372
ZONULIN - A NOVEL MARKER OF GUT WALL INTEGRITY DURING SEPSIS
D.A. Klaus, G.A. Roth, M.C. Motal, E.M. Schmidt,
D. Lebherz-Eichinger, C.G. Krenn, Vienna, Austria
0373
EFFECTS OF TNFα ON MUSCLE MEMBRANE EXCITABILITY: A
MODELISATION OF IONS CURRENTS AND MUSCLE ACTION POTENTIAL
M. Guillouet, G. Gueret, F. Rannou, M.A. Giroux
Metges, V. Nguyen Ba, J.-P. Pennec, Brest, France
0374
Poster Corner ORGAN DYSFUNCTION IN SEPSIS
Chairs: Michael Bauer, Jena, Germany & Christian Brun-Buisson, Creteil, France
14:00 - 15:50
L. Bronze, M. Andrade, M. Relvas, I. Arroja,
G. Morais, M. Seabra, M. Mendes, A. Aleixo,
Lisbon, Portugal
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Porto
SYSTEMIC INFLAMMATORY MARKERS AND CARDIAC TROPONIN IN
ACUTE MYOCARDIAL INFARCTION
L I V E S 2 012
121
14:00 - 15:50
MONDAY 15 OCTOBER
Area Setubal
Poster Corner OUTCOME FROM INTENSIVE CARE
Chairs: Kathleen Puntillo, San Francisco, United States & Bertrand Guidet, Paris, France
A POPULATION-BASED STUDY OF ACUTE NEUROMUSCULAR
RESPIRATORY FAILURE IN NORTHERN IRELAND: AETIOLOGY AND
OUTCOME
A.S. Carr, A.I. Hoeritzuar, R. Kee, M. Kinney,
J. Campbell, S. Maguire, A. Hutchinson,
G.V. Mcdonnell, Belfast, United Kingdom
0375
HEALTH RELATED QUALITY OF LIFE 6 MONTHS AFTER DISCHARGE FROM
INTENSIVE CARE UNIT: A COHORT STUDY
M. Redondo, F. Manzano Manzano, M.R. Mañas
Vera, S. Martínez Ruiz, A.M. Pérez Pérez,
M. Colmenero Ruiz, Granada, Spain
0376
EPIDEMIOLOGY OF FUNGAL INFECTIONS IN A GASTROENTEROLOGY
AND LIVER TRANSPLANT INTENSIVE CARE UNIT (ICU): AN INDIAN
EXPERIENCE
S. Gupta, R. Bagga, D. Govil, S. Bhatnagar,
S. Srinivasan, S. Patel, K.N. Jagadeesh, P. Pandey,
M. Sodhi, P. Singh, U. Baveja, A. Rattan, Y. Mehta,
Gurgaon, India
0377
“CASE MIX” CHANGES IN A MEDICAL INTENSIVE CARE UNIT AFTER A
GEOGRAPHICAL TRANSFER OF A THIRD LEVEL, UNIVERSITY HOSPITAL
J. Cebrián Domènech, F. Monsalve Vila,
J. Bonastre Mora, K. Vacacela Córdova, Valencia,
Spain
0378
EPIDEMIOLOGY OF ACUTE RESPIRATORY INSUFFICIENCY IN CRITICAL
CARE (ERICC TRIAL): A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL
STUDY IN BRAZILIAN ICUS
L. Azevedo, M. Soares, J. Salluh, M. Park, A. ReaNeto, U. Silva, P. Varaschin, V. Dantas, M. Knibel,
G. Schettino, Sao Paulo, Brazil
0379
DIARRHOEA IS ASSOCIATED WITH ADVERSE OUTCOMES IN CRITICAL
CARE
N. Tirlapur, C. Matejowsky, P. Coen, P. Wilson,
R. Moonesinghe, H. Montgomery, London,
United Kingdom
0380
SATISFACTION LEVEL OF PATIENTS AFTER ICU DISCHARGE
M.C. Guía, C. de Haro, V. Guía, G. Gomá,
A. Artigas, F. Baigorri, Sabadell, Spain
0381
SURVIVING SEPSIS CAMPAIGN GUIDELINES AND MORTALITY
M.-V. De La Torre-Prados, A. Garcia-De La Torre,
C. Trujillano-Fernández, N. Zamboschi, M. NietoGonzalez, A. Garcia Alcantara, C. Reina-Artacho,
P. Martinez-Lopez, F. Hidalgo Gómez, F. CotaDelgado, Malaga, Spain
0382
IMPACT OF COMPUTERISED MEWS ON ADULT HOSPITALISED PATIENT
CARE
R. Oggioni, L. Tadini Buoninsegni, R. Carlà,
T. Fratti, Florence, Italy
0383
OUTCOME OF COMPLEX MULTI-SYSTEM DISORDER PATIENTS REQUIRING
MULTIPLE ORGAN SUPPORT WITH A PROLONGED ICU LENGTH OF STAY
S. Clayton, G. Xia, M. Loftus, A. Ercole,
K. Gunning, D. Menon, R. Mahroof, Cambridge,
United Kingdom
0384
AGE IMPACT IN MORTALITY AND QUALITY OF LIFE 6 MONTHS AFTER ICU
DISCHARGE
M.C. Guía, C. de Haro, V. Guía, G. Gili, F. Baigorri,
A. Artigas, Sabadell, Spain
0385
DIC (DISSEMINATED INTRAVASCULAR COAGULATION) STATUS ON
ADMISSION TO ICU RELATES WITH THE MORTALITY IN CRITICALLY ILL
PATIENTS
M. Saito, M. Kang, R. Nagai, M. Takeda,
T. Harada, R. Moroi, M. Namiki, A. Yaguchi,
Tokyo, Japan
0386
EPIDEMIOLOGY AND OUTCOME OF THE SEPTIC PATIENTS IN A GENERAL
INTENSIVE CARE UNIT
V.F. Moreira, V. Goulão, T. Santos, E. Lafuente,
M.J. Fernandes, J.G. Silva, F. Santos, F. Moura,
R. Lopes, Penafiel, Portugal
0387
Area Sintra
Poster Corner
HAEMORRHAGIC STROKE: INTERVENTIONS & MARKERS
Chairs: Elisa Zanier, Milan, Italy & Jan Claassen, New York, United States (TBC)
14:00 - 15:50
122
HIGH SENSITIVE TROPONIN-T (HS-TNT) AND BRAIN NATRIURETIC
PEPTIDE (BNP) IN PATIENTS WITH SUBARACHNOIDAL HAEMORRHAGE
(SAH)
J. Oras, C. Grivans, S.E. Ricksten, H. SeemanLodding, Gothenburg, Sweden
0388
ANALYSIS OF CYTOKINE PROFILE, HAEME METABOLISM AND OXIDATIVE
STRESS AFTER HAEMORRHAGIC STROKE
C. Righy, M.F. Oliveira, H.C.C. Faria Neto,
P.T. Bozza, F. Bozza, Rio de Janeiro, Brazil
0389
HYDROXYETHYLSTARCH 130/0.4/9:1 EFFECTS ON CEREBRAL BLOOD
FLOW AND METABOLISM IN PATIENTS WITH VASOSPASM DUE TO
ANEURISMAL SUBARACHNOID HAEMORRHAGE
J. Titova, S. Petrikov, A. Solodov, B. Golubev,
V. Krylov, Moscow, Russian Federation
0390
INTRA-ARTERIAL NIMODIPINE FOR THE TREATMENT OF CEREBRAL
VASOSPASM IN PATIENTS WITH NON TRAUMATIC SUBARACHNOID
HAEMORRHAGE: ANGIOGRAPHIC AND CLINICAL RESULTS
M. Martinez, J. Perendreu, S. Lopez, D. Cánovas,
A. Carvajal, J. Cabiol, J. Branera, Sabadell, Spain
0391
13-17 October 2012
L I V E S 2 012
0392
EFFECTS OF SYSTEMIC ADMINISTRATION OF TETANUS TOXIN ON CELL
PROLIFERATION AND NEUROBLAST DIFFERENTIATION IN THE MOUSE
HIPPOCAMPAL DENTATE GYRUS
J.H. Cho, M.H. Won, C.W. Park, M.C. Shin,
Chuncheon-si, Republic of Korea
0393
EVALUATION OF SURGICAL INTERVENTION IN PATIENTS WITH
INTRAVENTRICULAR EXTENSION OF SUPRATENTORIAL INTRACEREBRAL
HAEMORRHAGE
R. Rivera-Fernández, F. Guerrero-López,
E. Castillo-Lorente, V. Olea-Jiménez, J. MoraOrdóñez, F. Rodriguez-Villanova, G. QuesadaGarcía, M. Arias-Verdú, Málaga, Spain
0394
RISK FACTORS ASSOCIATED TO MORBID-MORTALITY IN ICU PATIENTS
WITH SUBARACHNOID HAEMORRHAGE
J. Cabrera-Arrocha, D. Linares-Buitrago,
J.L. Ramirez-Cardozo, J.M. Gómez-Lama, S. RuízSantana, P. Saavedra, Las Palmas de Gran
Canaria, Spain
0395
ACUTE NEUROPHYSIOLOGIC PREDICTORS OF EARLY AND LATE
NEUROLOGIC OUTCOMES IN BRAIN INJURED PATIENTS: ASSESSING THE
RELIABILITY OF ELECTROENCEPHALOGRAPHY AND EVENT-RELATED
POTENTIALS
L. Prisco, F. Monti, P. Accardo, M. Cusenza,
M. Semencic, G. Romano, M. Ganau, London,
United Kingdom
0396
PROPHYLACTIC MAGNESIUM FOR IMPROVING NEUROLOGICAL
OUTCOME AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGE:
SYSTEMATIC REVIEW AND META-ANALYSIS
E. Golan, D. Vasquez, N.D. Ferguson,
N.K. Adhikari, D.C. Scales, Toronto, Canada
0397
ASSOCIATION OF FLUID BALANCE AND DELAYED CEREBRAL ISCHAEMIA
AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGE
L. Vergouw, D.W. Dippel, J. Bakker, M. van der
Jagt, Rotterdam, Netherlands
0398
MULTIMODAL NEUROMONITORING PROGNOSTIC SIGNIFICANCE IN THE
PATIENTS WITH INTRACRANIAL HAEMORRHAGE
V. Krylov, S. Petrikov, A. Solodov, B. Golubev,
Y. Titova, E. Karapetyan, Moscow, Russian
Federation
0399
IMPACT ON FUNCTIONAL OUTCOME AND QUALITY OF LIFE AT 6 AND 12
MONTHS AFTER SPONTANEOUS SUBARACHNOID HAEMORRHAGE
M. Argüeso, A. Mesejo, R. Vento, H. Martinez,
L. Palacios, J.I. Gil, M.N. Carbonell, Valencia,
Spain
0400
BRAIN INJURY BIOMARKERS AND INFLAMMATORY MARKERS IN
SPONTANEOUS SUBARACHNOID HAEMORRHAGE´S MORTALITY
A. Serrano, M. Juan, A. Mesejo, R. Ortiz, S. Borrás,
M.C. Corcobado, A. Bueno, M. Argüeso,
M. Sánchez-Casado, M. Quintana, Ciudad Real,
Spain
0401
Life-Priority
Poster Corner
OUTCOME PREDICTION AFTER CARDIAC ARREST
Chairs: Jerry Nolan, Bath, United Kingdom & Kjetil Sunde, Oslo, Norway
14:00 - 15:50
DIAGNOSIS PERFORMANCE OF HIGH SENSITIVITY TROPONIN ASSAY
IN OUT-OF-HOSPITAL CARDIAC ARREST PATIENTS WITH SUSPECTED
RECENT CORONARY OCCLUSION
G. Geri, N. Mongardin, C. Chenevier-Gobeaux,
F. Dumas, F. Pène, J. Charpentier, J.-D. Chiche,
J.-P. Mira, A. Cariou, Paris, France
0402
COPEPTIN LEVEL AT ADMISSION PREDICTS OUTCOMES IN OUT-OFHOSPITAL CARDIAC ARREST SURVIVORS
P. Ostadal, M. Prucha, A. Kruger, D. Vondrakova,
M. Janotka, Prague, Czech Republic
0403
HEPARIN BINDING PROTEIN AS AN INDICATOR OF CRITICAL ILLNESS
AND PREDICTOR OF OUTCOME IN CARDIAC ARREST
J. Dankiewicz, M. Annborn, M. Rundgren,
H. Friberg, Lund, Sweden
0404
WHICH IS A BETTER PREDICTOR OF SURVIVAL FOLLOWING CARDIAC
ARREST - AGE OF THE PATIENT OR FIRST DOCUMENTED RHYTHM?
A.K. Gupta, M. Talegaonkar, S. Dewan, A. Varma,
New Delhi, India
0405
PROCALCITONIN IN CARDIAC ARREST - AN INDICATOR OF SEVERITY OF
ILLNESS AND A PREDICTOR OF OUTCOME
M.L. Annborn, J. Dankiewicz, S. Hertel,
M. Rundgren, G. Smith, J. Struck, H. Friberg,
Lund, Sweden
0406
COMPARING OPEN-CHEST CARDIAC MASSAGE WITH CLOSED-CHEST
ONE IN TERMS OF TIME INTERVAL TO DETERMINING TERMINATION OF
RESUSCITATION BY IDENTIFYING UNRESUSCITATIVE STATE IN CASES OF
TRAUMATIC CARDIAC ARREST
N. Kaneko, Tokyo, Japan
0407
+
L I V E S 2 012
S. Pawar, V. Grover, H. Bhagat, Sydney, Australia
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
EFFICACY OF STELLATE GANGLION BLOCK IN TREATING POSTOPERATIVE
CEREBRAL VASOSPASM FOLLOWING ANEURYSMAL CLIPPING
Visit us at the
ESICM Booth
Exhibition Area A
123
HYPEROXIA POST CARDIAC ARREST: TOO MUCH OXYGEN FOR TOO
LONG?
M.N. Crews, T. Hargreaves, H. Kingston, M. Mogk,
I. Welters, Liverpool, United Kingdom
0408
EVOLUTION OF PATIENTS SURVIVING A HOSPITAL CARDIORRESPIRATORY
ARREST DURING A 10 YEARS PERIOD
M. Colomo Gonzalez, R. de la Chica Ruiz-Ruano,
A. Sanchez Gonzalez, L.I. Rodriguez Peralta,
B. Quirantes Sierra, M. Colmenero Ruiz, Granada,
Spain
0409
USEFULNESS OF EARLY PLASMA S-100B PROTEIN AND NSE
MEASUREMENTS TO IDENTIFY NEUROVASCULAR ETIOLOGIES OF
CARDIAC ARREST
N. Mongardon, M. Arnaout, C. GobeauxChenevier, G. Geri, N. Deye, I. Malissin,
J. Charpentier, F. Pène, J.-D. Chiche, J.-P. Mira,
F. Baud, A. Cariou, Paris, France
0410
INVESTIGATION OF THE CLINICAL BACKGROUND AND OUTCOME IN
SURVIVORS WHO WERE IMPLANTED CARDIOVERTER DEFIBRILLATORS
AFTER OUT-OF-HOSPITAL CARDIAC ARREST OF CARDIAC ORIGIN
S. Uegaki, M. Hayakawa, Y. Yanagida, S. Gando,
Sapporo, Japan
0411
THERAPEUTIC HYPOTHERMIA POST CARDIORESPIRATORY ARREST
N.J. Truman, J. Wood, Bolton, United Kingdom
0412
OUTCOME OF PATIENTS ADMITTED TO INTENSIVE CARE UNIT AFTER
OUT OF HOSPITAL CARDIAC ARREST
V.K. Venkatesh, V.K. Sekar, K. Antrolikar,
R. Hathotuwa, M. Kyi, Birmingham, United
Kingdom
0413
HYPOTHERMIA AFTER IN-HOSPITAL CARDIAC ARREST -HOSPITAL
M´BOIMIRIM - SAO PAULO
A.H.V. Andrade, A.C. Baruzzi, E.E. Taira,
C.M. Junior, S.A.E. Santos, R. Tomiosso,
G. Sampaio, A.L. Manoel, B. Taino, T.F. Pinto,
S. Abramovici, Sao Paulo, Brazil
0414
DIFFERENCES BETWEEN POST PREHOSPITAL AND INTRAHOSPITAL
CARDIAC ARREST ICU PATIENTS
A. Vakalos, M. Petkopoulou, D. Jannussis, Xanthi,
Greece
0415
ROOM Lisbon
Joint Session
CSCCM/ESICM - AKI FROM DIAGNOSIS TO TREATMENT
MONDAY 15 OCTOBER
Chairs: Bin Du, Beijing, China & Jean-Daniel Chiche, Paris, France
14:15 - 14:35
Diagnosis and classification of AKI
Xiu Ming Xi, Beijing, China
14:35 - 14:55
Risk assessment and prevention of AKI
14:55 - 15:15
Optimising renal perfusion - the best strategies
Bin Du, Beijing, China
15:15 - 15:35
Defining early start of RRT
15:35 - 15:50
Choosing the right modality of RRT
Penglin Ma, Beijing, China
ROOm Berlin
State of the Art Session PULMONARY EMBOLISM
Chairs: Davide Chiumello, Milan, Italy & Jordi Mancebo, Barcelona, Spain
14:15 - 14:35
Diagnostic strategies
14:35 - 14:55
Management of RV dysfunction
14:55 - 15:10
Thrombolysis: Where do we stand?
Bernd Böttiger, Heidelberg, Germany
15:10 - 15:30
Alternatives to heparin
15:30 - 15:50
Catheter and surgical embolectomy
Frédéric Baumann, Bern, Switzerland
Try the
e-posters
experience in the
exhibition
area
124
13-17 October 2012
L I V E S 2 012
14:15 - 14:30
HIGH REGIMEN OF CONTINUOUS INFUSION OF VANCOMYCIN DURING
CONTINOUS RENAL REPLACEMENT THERAPY
M. Beumier, H. Kabtouri, F. Cotton, M. Hites,
J.-L. Vincent, F. Jacobs, F.S. Taccone, Bruxelles,
Belgium
0416
14:30 - 14:45
A RANDOMISED CLINICAL TRIAL OF PERIODIC ASPIRATION OF
SUBGLOTTIC SECRETIONS IN PATIENTS RECEIVING MECHANICAL
VENTILATION
H. Fujimoto, O. Yamaguchi, H. Hayami,
M. Shimosaka, S. Tsuboi, M. Sato, S. Morita,
M. Saito, Yokohama, Japan
0417
14:45 - 15:00
EFFECTIVENESS OF NEBULISED AMPHOTERICIN B TO ERADICATE
CANDIDA COLONISATION FROM THE LOWER RESPIRATORY TRACTS OF
ICU PATIENTS
D.S.Y. Ong, P.M.C. Klein Klouwenberg,
M.J.M. Bonten, O.L. Cremer, Utrecht, Netherlands
0418
15:00 - 15:15
BIOMARKERS KINETICS TO EARLY PREDICT RESPONSE IN SEVERE
COMMUNITY-ACQUIRED PNEUMONIA
J.M. Pereira, A. Teixeira-Pinto, C. Basílio,
C. Sousa-Dias, P. Mergulhão, J.A. Paiva, Porto,
Portugal
0419
15:15 - 15:30
SEVERE COMMUNITY-ACQUIRED PNEUMONIA: THREE YEARS RESULTS IN
A POLYVALENT ICU
M. Nieto Gonzalez, N. Zamboschi, C. Trujillano
Fernandez, J. Perez Vacas, A. Puerto Morlan,
M.V. de la Torre Prados, A. Garcia de la Torre,
Malaga, Spain
0420
15:30 - 15:50
Discussion
ROOM Geneva Oral Presentations
INTENSIVE CARE 2
ASSESSING THE IMPACT OF INTERVENTIONS AND ORGANISATIONS IN
Chairs: Philipp Metnitz, Vienna, Austria & Bernhard Walder, Geneva, Switzerland
14:15 - 14:30
INTENSIVE AND INTERMEDIATE CARE UNITS IN EUROPEAN HOSPITALS
M. Capuzzo, T. Tassinati, R.P. Moreno,
A. Valentin, B. Guidet, G. Iapichino, C.D. Martin,
P. Merlani, A. Rhodes, Ferrara, Italy
0421
14:30 - 14:45
EFFECT OF DISCHARGE TO A STEP-DOWN UNIT AFTER CRITICAL ILLNESS
ON MORTALITY AND HOSPITAL LENGTH OF STAY: A PROPENSITY
MATCHED ANALYSIS
O.T. Ranzani, F.G. Zampieri, D.N. Forte,
L.U. Taniguchi, M. Park, L.C. Azevedo, São Paulo,
Brazil
0422
14:45 - 15:00
AFTER CRITICAL CARE, THEN WHAT? PATIENT SUPPORT AFTER CRITICAL
CARE: A MIXED METHOD LONGITUDINAL STUDY USING A NOVEL
RESEARCH TECHNIQUE
N.A. Pattison, G. O’Gara, J. Rattray, London,
United Kingdom
0423
15:00 - 15:15
FUNCTIONAL STATUS AS A PREDICTOR OF ADMISSION TO CRITICAL
CARE IN ACUTELY UNWELL PATIENTS
A. Tridente, A. Chick, S. Keep, S. Furmanova,
S. Webber, D. Bryden, Sheffield, United Kingdom
0424
15:15 - 15:30
IMPROVED QUALITY PATIENT OUTCOMES WITH THE INTRODUCTION OF
A CRITICAL CARE TRACHEOSTOMY MULTIDISCIPLINARY TEAM
S. O’Brien, R. Elebert, E. Carton, A. Dunne,
B. Marsh, D. Phelan, Dublin, Ireland
0425
15:30 - 15:50
Discussion
ROOM Rome
PATIENT SAFETY - «FIRST DO NO HARM»
Chairs: Julian Bion, Birmingham, United Kingdom & Patrick Ferdinande, Leuven, Belgium
14:15 - 14:35
Is the ICU a safe place?
Andreas Valentin, Vienna, Austria
14:35 - 14:55
Impact of implementing electronic systems
Ognjen Gajic, Rochester, United States
14:55 - 15:10
ICU staffing and patient safety
15:10 - 15:30
Delivering best care - the impact of standards and guidelines
Rui Paulo Moreno, Lisbon, Portugal
15:30 - 15:50
Quality indicators - a tool to improve patient safety
Andrew Rhodes, London, United Kingdom
L I V E S 2 012
Nurses
&
AHP
Oral Presentations METHODS TO OPTIMISE INFECTION OUTCOMEs IN THE ICU
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Barcelona
Chairs: Jan De Waele, Ghent, Belgium & Antonio Torres, Barcelona, Spain
125
ROOM Glasgow
Oral Presentations
OUTCOMES FOR THE HIGH-RISK SURGICAL PATIENT
Chairs: Robert Sanders, United Kingdom & Michelle Chew, Malmö, Sweden
14:15 - 14:30
META-ANALYSIS OF GOAL DIRECTED THERAPY IN HIGH-RISK PATIENTS
UNDERGOING MAJOR NON-CARDIAC SURGERY
G. Abuella, C. Corredor, N. Arulkumaran,
M. Hamilton, A. Rhodes, M. Cecconi, London,
United Kingdom
0426
14:30 - 14:45
USE OF SURGICAL SAFETY CHECKLIST REDUCED REOPERATIONS FOR
SURGICAL SITE INFECTION IN HIGH RISK PATIENTS
N. Wickboldt, A. Lübbeke, F. Hovaguimian,
C. Barea, F. Clergue, P. Hoffmeyer, B. Walder,
Geneva, Switzerland
0427
14:45 - 15:00
EARLY POSTOPERATIVE PROCALCITONIN AND ITS ASSOCIATION
WITH MORTALITY IN INTENSIVE CARE UNIT PATIENTS AFTER ELECTIVE
SURGERY
M. Kott, D. Schädler, G. Elke, G. Zick, I. Frerichs,
N. Weiler, Kiel, Germany
0428
15:00 - 15:15
TIME TRENDS, 30-DAY MORTALITY AND QUALITY OF CARE IN 3,438
PATIENTS WITH PEPTIC ULCER PERFORATION. A NATIONWIDE COHORT
STUDY FROM THE DANISH NATIONAL INDICATOR PROJECT
M.H. Møller, H.L. Larsson, S.P. Johnsen,
A.H. Madsen, J. Bendix, S. Rosenstock,
H. Jørgensen, S. Adamsen, R.W. Thomsen,
Copenhagen, Denmark
0429
15:15 - 15:30
ASSESSING MULTIPLE BIOMARKERS FOR DIAGNOSIS OF ACUTE KIDNEY
INJURY AFTER CARDIOPULMONARY BYPASS
J.R. Prowle, R. Bellomo, London, United Kingdom
0430
15:30 - 15:50
Discussion
ROOM Stockholm
Oral Presentations
NUTRITION AND GLYCAEMIC CONTROL IN ICU
MONDAY 15 OCTOBER
Chairs: Jean-Charles Preiser, Brussels, Belgium & Carole Ichai, Nice, France
14:15 - 14:30
CUMULATIVE TIME IN BAND (CTIB): GLYCAEMIC LEVEL, VARIABILITY AND
PATIENT OUTCOME ALL IN 1
S. Penning, M. Signal, J.-C. Preiser, G.M. Shaw,
A.J. Le Compte, C.G. Pretty, T. Desaive, J.G. Chase,
Liege, Belgium
0431
14:30 - 14:45
COMPARISON OF THREE ENTERAL FORMULAS TO GLYCAEMIC AND
INFECTIOUS CONTROL IN CRITICALLY ILL PATIENTS UNDER MECHANICAL
VENTILATION: HIGH-PROTEIN, HIGH-PROTEIN DISEASE-SPECIFIC AND
DISEASE-SPECIFIC DIET SUPPLEMENTED WITH GLUTAMINE
M. Juan, A. Mesejo, A. Serrano, C. Corcobado,
A. Bueno, L. Yuste, R. Ortiz, C. Espinosa,
A. Ambrós, Ciudad Real, Spain
0432
14:45 - 15:00
CAN THE GASTRIC HORMONE GHRELIN ATTENUATE CATABOLISM AND
ENHANCE RECOVERY AND REHABILITATION IN A RODENT MODEL OF
ZYMOSAN PERITONITIS?
N.E. Hill, K.G. Murphy, S. Brett, D.R. Wilson,
G. Frost, W. Dhillo, S.R. Bloom, M. Singer, London,
United Kingdom
0433
15:00 - 15:15
IS EARLY ENTERAL NUTRITION MORE EFFECTIVE THAN LATE IN
REDUCING ORGAN FAILURE RATES IN ICU?
V. Moro, M. Pongracz, B. Volgyes, J. Gal,
A. Csomos, Budapest, Hungary
0434
15:15 - 15:30
BEING OVERWEIGHT OR OBESE IS ASSOCIATED WITH DECREASED
MORTALITY IN CRITICALLY ILL PATIENTS: A POST HOC ANALYSIS OF A
LARGE REGIONAL ITALIAN MULTICENTRE COHORT
Y. Sakr, C. Elia, L. Mascia, B. Barberis,
S. Cardellino, S. Livigni, G. Fiore, C. Filippini,
V.M. Ranieri, Jena, Germany
0435
15:30 - 15:50
Discussion
ROOM Paris
Oral Presentations
THE BEST IN NEUROINTENSIVE CARE: ACUTE BRAIN INJURY
Chairs: Mauro Oddo, Lausanne, Switzerland & David Menon, Cambridge, United Kingdom
126
14:15 - 14:30
ASSESSING THE CLINICAL AND COST-EFFECTIVENESS OF ALTERNATIVE
CARE PATHWAYS FOR CRITICALLY ILL PATIENTS WITH ACUTE TRAUMATIC
BRAIN INJURY
R. Grieve, M.Z. Sadique, M. Gomes, D.K. Menon,
K.M. Rowan, D.A. Harrison, London, United
Kingdom
0436
14:30 - 14:45
METABOLIC DISTURBANCES ARE MORE FREQUENT AND SEVERE IN
PERILESIONAL THAN IN NORMAL APPEARING BRAIN TISSUE AFTER
TRAUMATIC BRAIN INJURY
S. Magnoni, M. Macri’, R. Di Rosso, F. Stretti,
S. Aresi, P. Scarone, N. Stocchetti, Milan, Italy
0437
14:45 - 15:00
EARLY GASTROSTOMY AND TRACHEOSTOMY PREVENT VENTILATOR
ASSOCIATED PNEUMONIA IN TRAUMATIC BRAIN INJURED PATIENTS
A.M. Fayed, T.H. Elbadawy, M.A. Gamal,
T.N. Habib, Alexandria, Egypt
0438
15:00 - 15:15
EVALUATION OF THE EFFECTS OF INCREASED INTRA-ABDOMINAL
PRESSURE (IAP) ON INTRACRANIAL PRESSURE (ICP), BRAIN TISSUE
PRESSURE OXYGEN (PBTO2) AND SATURATED JUGULAR BULB (SJO2) IN A
PORCINE NORMOVOLEMIC MODEL
J.J. Martinez, M. Poblano, J. Leco, F. Tendillo,
J. Lomeli, E. Deloya, L. Torres, F. Jimenez,
J. Carmona, Mexico, Mexico
0439
13-17 October 2012
L I V E S 2 012
15:30 - 15:50
Discussion
ROOM Vienna
Oral Presentations
M.L. Leoni, S. Magnoni, A. Colombo, M. Gotti,
V. Conte, G. Bertani, N. Stocchetti, Milan, Italy
0440
SEPSIS THERAPY: NEW HINTS FROM THE LAB
Chairs: Alexandre Mebazaa, Paris, France & John Kellum, Pittsburgh, United States
14:15 - 14:30
EFFECTS OF STATINS ON MITOCHONDRIAL RESPIRATION AND OUTCOME
DURING EXPERIMENTAL SEPSIS
J. Morel, I. Hargreaves, B. Bollen Pinto, D. Brealey,
J. Backman, A. Dyson, M. Singer, Saint-Etienne,
France
0441
14:30 - 14:45
STATINS PROTECTS COGNITIVE IMPAIRMENT IN ANIMAL MODEL OF
SEPSIS
F.A. Bozza, P. Reis, P.C. Alexandre, M.M. Pitombo,
H.C. Castro-Faria-Neto, Rio de Janeiro, Brazil
0442
14:45 - 15:00
TARGETING DEXAMETHASONE TO THE RECEPTOR CD163 ON PORCINE
MACROPHAGES. IN VIVO ATTENUATION OF THE INFLAMMATORY
RESPONSE TO ENDOTOXIN WITHOUT ENDOGENOUS CORTISOL
SUPPRESSION
A. Granfeldt, C.L. Hvas, J.H. Graversen,
P.A. Christensen, M.D. Petersen, G. Anton,
P. Svendsen, C. Sølling, E. Tønnesen,
S.K. Moestrup, H.J. Møller, Aarhus, Denmark
0443
15:00 - 15:15
ERYTHROPOIETIN IMPROVES RATS SURVIVAL AND ACTIVATES AKT
PATHWAY IN ACUTE SEPSIS
A. Blet, M. Sadoune, J. Lemarié, N. Bihry,
R. Merval, E. Polidano, J.-L. Samuel, B. Lévy,
A. Mebazaa, Nancy, France
0444
15:15 - 15:30
DOSE-RESPONSE ANALYSIS OF LONG TERM ANGIOTENSIN II INFUSIONS
AS A VASOPRESSOR AGENT IN EXPERIMENTAL SEPSIS
A. Pereira, T.D. Correa, S. Djafarzadeh, J. Takala,
S. Jakob, Bern, Switzerland
0445
15:30 - 15:50
Discussion
ROOM Athens
Oral Presentations
PERIPHERAL PERFUSION
Chairs: Bernard Cholley, Paris, France & Gorazd Voga, Celje, Slovenia
14:15 - 14:30
SUPERIORITY OF MILD HYPOTHERMIA OVER CONTROLLED
NORMOTHERMIA IN BLOOD PRESSURE AND CEREBRAL OXYGENATION
MAINTENANCE, RESUSCITABILITY, AND PREVENTION OF ORGAN
DAMAGE AFTER CARDIAC ARREST IN PORCINE MODEL
P. Ostadal, M. Mlcek, A. Kruger, S. Horakova,
F. Holy, M. Janotka, T. Svoboda, J. Belohlavek,
O. Kittnar, P. Neuzil, Prague, Czech Republic
0446
14:30 - 14:45
THE HAEMODYNAMIC AND MICROCIRCULATORY EFFECTS OF GRADED
HYPOVOLEMIA IN SPONTANEOUSLY BREATHING SUBJECTS
E. Zollei, V. Bertalan, A. Nemeth, P. Csabi,
I. Laszlo, J. Kaszaki, L. Rudas, Szeged, Hungary
0447
14:45 - 15:00
PERIPHERAL PERFUSION ALTERATIONS AFTER MAJOR ABDOMINAL
SURGERY ARE ASSOCIATED WITH POSTOPERATIVE COMPLICATIONS
M.E. van Genderen, J. Paauwe, A. Lima, J. Bakker,
J. van Bommel, Rotterdam, Netherlands
0448
15:00 - 15:15
NITROGLYCERIN DOSE-DEPENDENT IMPROVES PERIPHERAL PERFUSION
IN PATIENTS WITH CIRCULATORY SHOCK: RESULTS OF A PROSPECTIVE,
CROSS-OVER STUDY
A. Lima, M. Van Genderen, J. Van Bommel,
J. Bakker, Rotterdam, Netherlands
0449
15:15 - 15:30
SUBLINGUAL MICROCIRCULATION IN INTENSIVE CARE PATIENTS WITH
INTRA-ABDOMINAL HYPERTENSION
L. Maddison, J. Karjagin, M. Buldakov, M. Mäll,
R. Kruusat, K. Lillemäe, J. Starkopf, Tartu, Estonia
0450
15:30 - 15:50
Discussion
ROOM Lisbon Joint Session
GLUCOSE TRANSPORT KINETICS IS PRESERVED IN TRAUMATIC BRAIN
INJURY PATIENTS BUT THE MAXIMAL TRANSPORT RATE MIGHT BE
REDUCED
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
15:15 - 15:30
SCCM/ESICM - ACTIVATED PROTEIN C: REVEALING THE DEFICITS IN OUR
Chairs: Andrew Rhodes, London, United Kingdom & Clifford Deutschman, Philadelphia, United States
16:00 - 16:20
The rise and fall of a new drug
16:20 - 16:40
Was there sufficient pre-clinical data for the initial Xigris hopes?
16:40 - 17:00
Was there sufficient clinical evidence for the initial Xigris hype?
17:00 - 17:20
Better sepsis therapy: Did the ends justify the means?
17:20 - 17:40
Relationship between industry, academia and clinicians: Can we get it
right?
Clifford Deutschman, Philadelphia, United States
17:40 - 18:00
Designing research on ICU syndromes: Lessons learned?
Jean-Paul Mira, Paris, France
L I V E S 2 012
127
ROOM Berlin
Thematic Session
THERAPEUTIC TARGETS SELECTION IN ACUTE RESPIRATORY FAILURE
Chairs: Laurent Brochard, Geneva, Switzerland & Antonio Pesenti, Monza, Italy
16:00 - 16:20
Targeting normal values in critical illness. What is the rationale?
Brian Kavanagh, Toronto, Canada
16:20 - 16:40
Oxygenation in ARDS. Time to lower the target?
16:40 - 17:00
Hypercapnia. Friend or foe?
John Laffey, Galway, Ireland
17:00 - 17:20
Tidal volume or lung strain?
17:20 - 17:40
Plateau pressure or driving pressure?
Marcelo Amato, Sao Paulo, Brazil
17:40 - 18:00
Extracorporeal technologies: Do they change the “rules”?
Antonio Pesenti, Monza, Italy
ROOM Barcelona
Thematic Session
Nurses
&
AHP
AN UPDATE ON VAP
Chairs: Claude Martin, Marseille, France & Antonio Torres, Barcelona, Spain
16:00 - 16:20
Non-pharmacologic prevention approaches
Stijn Blot, Ghent, Belgium
16:20 - 16:40
The prevention bundle approach: Does it work?
Jordi Rello, Barcelona, Spain
16:40 - 17:00
SDD: Value and pitfalls
Marc Bonten, Utrecht, Netherlands
17:00 - 17:20
New data for old antibiotics: Is there a magic bullet?
Jean-François Timsit, Grenoble, France
17:20 - 17:40
Aerosolised antibiotics for VAP due to Gram-negative bacteria: Ready
for use?
Jean Chastre, Paris, France
17:40 - 18:00
Do we need new treatment guidelines?
Antonio Torres, Barcelona, Spain
ROOM Geneva
Joint Session
MONDAY 15 OCTOBER
Chairs: Jacques Duranteau, Kremlin-Bicetre, France & Bernd Böttiger, Heidelberg, Germany
16:00 - 16:20
Recent important changes in resuscitation
Kjetil Sunde, Oslo, Norway
16:20 - 16:40
PCI strategy after cardiac arrest
16:40 - 17:00
Pharmacological approach in post-CA brain protection
17:00 - 17:20
Benefits and limits of therapeutic hypothermia
Michael Holzer, Vienna, Austria
17:20 - 17:40
Post-cardiac arrest shock
17:40 - 18:00
Post-resuscitation bundle
Jerry Nolan, Bath, United Kingdom
ROOM Rome
Continuous Professional Education Session SHOCK REVISITED
Chairs: Michael Pinsky, Pittsburgh, United States & Marco Maggiorini, Zurich, Switzerland
16:00 - 16:20
From normal physiology to shock
16:20 - 16:40
Identify shock etiology
16:40 - 17:00
Pulmonary hypertension
Warren Zapol, Boston, United States
17:00 - 17:20
Haemodynamic monitoring to guide treatment
17:20 - 17:40
From best fluids to best catecholamines
17:40 - 18:00
Assessing perfusion and response to treatment
+
128
13-17 October 2012
Visit us at the
Level 1
L I V E S 2 012
ETHICAL DILEMMAS IN INTENSIVE CARE
16:00 - 16:20
Patient autonomy vs. the autonomy of the care taker
Bob Truog, Boston, United States
16:20 - 16:40
Claims of patients and families
Elie Azoulay, Paris, France
16:40 - 17:00
Centralisation of care - is it better?
J. Randall Curtis, Seattle, United States
17:00 - 17:20
Donation of organs
Beatriz Dominguez-Gil, Madrid, Spain
17:20 - 17:40
Dealing with staff burnout
Andrej Michalsen, Tettnang, Germany
17:40 - 18:00
Triage in the elderly
ROOM Stockholm
Thematic Session
REGIONAL CITRATE ANTICOAGULATION FOR DUMMIES
Chairs: Heleen Oudemans-van Straaten, Amsterdam, Netherlands & Eric Hoste, Ghent, Belgium
16:00 - 16:20
Anti-inflammatory properties of citrate
Bruce Molitoris, Indiana, United States
16:20 - 16:40
Metabolic aspects of citrate anticoagulation
16:40 - 17:00
How to apply citrate in patients with liver impairment?
Thorsten Slowinsky, Berlin, Germany
17:00 - 17:20
Lactate and citrate - competitors or companions?
Heleen Oudemans-van Straaten, Amsterdam,
Netherlands
17:20 - 17:40
The problems of citrate in high dose CRRT
17:40 - 18:00
CRRT modality influence citrate application
Ravindra Mehta, San Diego, United States
ROOM Paris
Thematic Session
INTENSIVE CARE IN RESOURCE-POOR SETTINGS
Chairs: Martin Dünser, Salzburg, Austria & Andreas Valentin, Vienna, Austria
16:00 - 16:20
Establishing an ICU service in a resource-poor setting
Guillaume Thiery, Paris, France
16:20 - 16:40
Establishing a comprehensive intensive care training course in a
resource-poor setting
Marcus Schultz, Amsterdam, Netherlands
16:40 - 17:00
Recommendations for sepsis management in resource-poor settings
Rashan Haniffa, Colombo, Sri Lanka
17:00 - 17:20
The problem of antimicrobial resistance in resource-poor settings
Otgon Baatar, Ulaanbaatar, Mongolia
17:20 - 17:40
Challenges of providing critical care medicine in Africa
Arthur Kwizera, Kampala, Uganda
17:40 - 18:00
Critical care aspects during a poliomyelitis epidemic in the 21st century
ROOM Vienna
Thematic Session RAPID RESPONSE SYSTEMS REVISITED
Chairs: Hans Flaatten, Bergen, Norway & Maurizia Capuzzo, Ferrara, Italy
16:00 - 16:20
The rationale for Rapid Response Systems
Francesca Rubulotta, London, United Kingdom
16:20 - 16:40
Exploring the evidence for Rapid Response Systems
16:40 - 17:00
Intensive Care - defined by illness and not by location
17:00 - 17:20
Implementation of a standardised RRS worldwide
17:20 - 17:40
The role of a standardised RRS in Holland
Peter van der Voort, Amsterdam, Netherlands
17:40 - 18:00
Rapid Response Systems and end-of-life care
L I V E S 2 012
Thematic Session
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
room Glasgow
Chairs: J. Randall Curtis, Seattle, United States & Andrej Michalsen, Tettnang, Germany
129
ROOM Athens
Controversies Session SDD IN MY ICU
Chair: George Dimopoulos, Athens, Greece
16:00 - 16:10
Yes
16:10 - 16:20
No
Anders Perner, Copenhagen, Denmark
16:20 - 16:30
Discussion
ROOM Athens
State of the Art Session RECOVERY FROM TRAUMATIC BRAIN INJURY
Chairs: Javier Provencio, Cleveland, United States & Mauro Oddo, Lausanne, Switzerland
16:40 - 17:00
Neurorestoration after TBI
Elisa Zanier, Milan, Italy
17:00 - 17:20
Biomarkers of brain repair and recovery
Peter Leroux, Philadelphia, United States
17:20 - 17:40
Neural plasticity after TBI: Evidence from functional neuroimaging
David Menon, Cambridge, United Kingdom
17:40 - 18:00
Genetic polymorphism: Does it matter?
Javier Provencio, Cleveland, United States
ROOM Geneva Industry Sponsored Session MANAGEMENT OF INTRA-ABDOMINAL HYPERTENSION: DON’T
LET THE PRESSURE TAKE CONTROL - CONVATEC
Chairs: Claudia Spies, Berlin, Germany & Ricardo Matos, Lisbon, Portugal
18:15 - 18:35
Definitions and epidemiology on abdominal hypertension and
abdominal compartment syndrome: Past, present and future
18:35 - 18:55
Clinical experience on management of intra-abdominal hypertension
18:55 - 19:15
Medical management of abdominal hypertension: What is new?
ROOM Stockholm
Industry Sponsored Session EFFECTIVE GLYCAEMIA CONTROL
Chairs: Michael Hiesmayr, Vienna, Austria & Jean-Charles Preiser, Brussels, Belgium
MONDAY 15 OCTOBER
18:15 - 18:35
Glycaemia in ICU: State of the art
Björn Ellger, Munster, Germany
18:35 - 18:55
Patient-specific glycaemic control software in the ICU setting
Alexandre Guerrini, Saint Avertin, France
18:55 - 19:15
Computer-assisted glucose regulation in critically ill patients: A proof of
concept study
Pierre Kalfon, Chartres, France
ROOM Vienna Industry Sponsored Session
Thermo Fisher
GUIDING ANTIBIOTIC THERAPY TO TACKLE RESISTANCE FORMATION
Chairs: Jean Chastre, Paris, France & Tobias Welte, Hanover, Germany
18:15 - 18:20
Introduction - Status of antibiotic resistance in ICUs
Tobias Welte, Hanover, Germany
18:20 - 18:45
Antibiotic resistance: From underlying mechanisms to the patients in
the ICU
Rafael Cantón, Madrid, Spain
18:45 - 19:10
Antibiotic guidance in the ICU
Jérôme Pugin, Geneva, Switzerland
19:10 - 19:15
Summary of symposium
130
13-17 October 2012
L I V E S 2 012
“The reduction of ventilation
times is bringing down length
of stay on the ICU.”
Jim, 46, chief doctor
e us
and se
e
m
o
C
,
M 2012
at ESIC . 18.
no
boot h
At your side in intensive care: Dräger.
The intensive care area is one of the most complex and cost-intensive areas in any hospital. Spiralling
costs, rising morbidity and a trend towards individualised therapies are increasing the demand for
higher levels of efficiency. At Dräger, we have a long history of developing solutions that address not
only therapeutic, but also work flow improvement. Our innovative technology can turn an intensive
care unit into a healing environment, where your patients feel more comfortable and your staff are
naturally motivated.
2830
LEARN MORE ABOUT OUR SOLUTIONS: WWW.DRAEGER.COM/ICU
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
tuesday 16 october
132
13-17 October 2012
L I V E S 2 012
10:10 - 12:00
Area Beja
Area Braga
Area Cascais
Area Coimbra
Area Estoril
Area Evora
Technology
assessment in
acute respiratory
failure
Nutrition &
glucose control
Cardiovascular
failure in the icu
Fluid &
haemodynamics
in the surgical
patient
Risk factors,
prophylaxis &
outcome of icu
infections
Management of
cardiovascular
patients
Area Faro
Area Fatima
Area Funchal
Area Guarda
Area Porto
Area Setubal
Ventilatory
support in the
brain-injured
patient
Ards: new trends
in treatment 1
Abdominal
complications in
the icu
Area Sintra
Life-Priority
Paediatrics 2:
not small adults!
Epidemiology
of icu-related
infections
Emergency
medicine
End of life care ethics of research
Nurses
&
AHP
POSTER overview
POSTER OVERVIEW - TUESDAY 16 OCTOBER
Organisation of
intensive care
14:00 - 15:50
Poster corners afternoon
Area Braga
Area Cascais
Area Coimbra
Area Estoril
Airway care &
instrumentation
Area Evora
Clinical outcome
predictors in
sepsis
Electrolytes &
trace elements
Ventilatory
support 1
Fluid
responsiveness
& goal directed
therapy
Area Faro
Area Fatima
Area Funchal
Area Guarda
Area Porto
Area Setubal
Optimising tissue
oxygenation
Pneumonia in the
icu: prevention &
treatment
Neuroemergencies
& trauma
Evaluation of
care in trauma
& emergency
medicine
Indicators of cost,
quality & outcome
Septic shock:
metabolic
markers, organ
dysfunction &
therapy
Area Sintra
Life-Priority
Nursing
interventions
Audit &
assessment
of critical care
practice
Nurses
&
AHP
Sedation practices
& delirium
TUESDAY 16 OCTOBER
Area Beja
L I V E S 2 012
133
programme overview
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
TUeSDAY 16 October
Room
Lisbon
Berlin
Barcelona
08:30
Elderly in intensive
care
Organ failure in
sepsis
Crrt in specific
situations
Abstract award
winning session
Prevention of
infections in the icu
setting
09:30
Geneva
Manipulating the
microcirculation
Rome
Liver emergencies
in the icu
09:30-09:40
09:40
Metabolism in icu
The best in
neurointensive care:
encephalopathy and
polyneuropathy
Transfusion in the
icu
How do i diagnose
interstitial
pneumonia?
How do i read head
ct and a mri scan?
Blood sugar
monitoring
EDWARDS
PULSION
FRESENIUS KABI
ORION PHARMA
Haemodymanic
monitoring
Picco for
haemodynamic
monitoring:
indications,
strategies & benefit
Volume
management in
trauma, surgery and
icu
Emerging
therapeutic options
for the icu patient
Do medical journals
modify our practice?
Adequate and
appropriate
treatment of icu
infections
Difficult infections in
the icu
11:00
Nurses
&
AHP
11:00-11:10
Respiratory
monitoring for
dummies
11:10
12:00
Cardiovascular
monitoring for
dummies
12:00-12:30
12:30
14:00
14:00-14:15
14:15
15:45
Ards: defining,
monitoring
& outcome
Cardiovascular
monitoring update
15:45-16:00
16:00
18:00
Icm: year in review
Caring for the
lungs of the
haemodynamically
challenged patient
Early goal-directed
therapy
Assessment of
lung aeration and
collapse in ards
Fighting multi-drug
resistant pathogens
18:00-18:15
18:15-19:30
Session references
134
Clinical challenges session
Oral presentations
Poster corners
from bench to bedside
Industry sponsored session
25th Annual
25th Annual
Congress
Congress
13-1713-17
October
October
20122012
ccl -ccl
lisbon
- lisbon
- PORTUGAL
- PORTUGAL
L I V E S 2 012
Sepsis, epidemiology
& outcome
How do i counsel in
and beyond the icu?
Nurses
&
AHP
Nurses
&
AHP
Secondary insults in
trauma patients
Paris
Vienna
Athens
Etco/esicm optimising the icu
management of the
organ donor
From the icu to nobel
prize and back
Hyponatremia
guidelines
Cardiovascular
ultrasounds
Future perspectives in
ards treatment
Esc/esicm - update
on cardiogenic shock
How do i manage a
How do i find the focus How do i manage chest patient with suspected
in my sepsis patient?
trauma?
acute pulmonary
embolism?
Pfizer
COVIDIEN
MAQUET
MRSA nosocomial
pneumonia today:
How can we ensure
optimal outcomes
On the way to perfect
synchrony
Co2 reduction,
something we should
care about!
Sepsis, trauma
and kidney injury:
epidemiology and
outcome
End of life care - ethics
of research 2
Abc of paediatric
intensive care for the
adult intensivist
Achieving a culture of
safety
Nurses
&
AHP
Nurses
&
AHP
Acute kidney injury
Long-term outcome
and sequelae from
sepsis
Therapeutic
hypothermia
Overfeeding in icu A real problem?
General Assembly
L I V E S 2 012
How do i interpret
metabolic acidosis?
Molecular mechanisms
in sepsis
Surveillance of vap
is an useful quality
indicator
End of life decisions
programme overview
Preventing
postoperative
infection
Stockholm
Preparing the icu
nursing workforce for
2020
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Glasgow
135
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Lisbon
Thematic Session
ELDERLY IN INTENSIVE CARE
Chairs: Charles Sprung, Jerusalem, Israel & Margaret Herridge, Toronto, Canada
08:30 - 08:50
Physiologic changes in the elderly
Brian Marsh, Dublin, Ireland
08:50 - 09:10
Intensive care benefit for the elderly
09:10 - 09:30
Benefit comes with specific care
Ana Rosa, Lisbon, Portugal
ROOM Berlin
Thematic Session ORGAN FAILURE IN SEPSIS
Chairs: Clifford Deutschman, Philadelphia, United States & Tarek Sharshar, Paris, France
08:30 - 08:50
Sclerosing cholangitis
08:50 - 09:10
Molecular basis of organ failure
09:10 - 09:30
Septic encephalopathy
Clifford Deutschman, Philadelphia, United
States
ROOM Barcelona
Thematic Session
CRRT IN SPECIFIC SITUATIONS
Chairs: Claudio Ronco, Vicenza, Italy & Eric Hoste, Ghent, Belgium
08:30 - 08:50
RRT in cardiorenal syndrome
Wilfred Druml, Vienna, Austria
08:50 - 09:10
RRT in patients with liver failure
Marlies Ostermann, London, United Kingdom
09:10 - 09:30
RRT in sepsis and septic shock
ROOM Geneva
From Bench to Bedside Session
MANIPULATING THE MICROCIRCULATION
Chairs: Can Ince, Rotterdam, Netherlands & Daniel De Backer, Brussels, Belgium
08:30 - 08:50
Defining the best perfusion
08:50 - 09:10
Microcirculatory dysfunction after brain injury
09:10 - 09:30
Microcirculation during surgery and trauma
Shaman Jhanji, London, United Kingdom
ROOM Rome
LIVER EMERGENCIES IN THE ICU
Chairs: Julia Wendon, London, United Kingdom & Pierre-François Laterre, Leuven, Belgium
08:30 - 08:50
Acute viral hepatitis
Julia Wendon, London, United Kingdom
08:50 - 09:10
Alcohol-induced hepatitis and decompensated cirrhosis
09:10 - 09:30
Liver emergencies during pregnancy
ROOM Glasgow
Thematic Session
PREVENTING POST-OPERATIVE INFECTION
Chairs: Jordi Rello, Barcelona, Spain & Claudia Spies, Berlin, Germany
08:30 - 08:50
New insights in epidemiology and costs of post-operative infection
08:50 - 09:10
Strategies for reducing postoperative infections
09:10 - 09:30
Quality improvement to prevent infection
Try the
e-posters
experience in the
exhibition
area
136
13-17 October 2012
L I V E S 2 012
PREPARING THE ICU NURSING WORKFORCE FOR 2020
Chairs: Christina Jones, Liverpool, United Kingdom & Barbara McLean, Atlanta, United States
08:30 - 08:50
Preparing generation Y for ICU nursing
Terry O’Reilly, London, United Kingdom
08:50 - 09:10
Keep the experienced nurse working
09:10 - 09:30
E-learning for continuing education
Sonia Labeau, Ghent, Belgium
ROOM Paris
Joint Session
Nurses
&
AHP
ETCO/ESICM - OPTIMISING THE ICU MANAGEMENT OF THE ORGAN DONOR
Chairs: Giuseppe Citerio, Monza, Italy & Beatriz Dominguez-Gil, Madrid, Spain
08:30 - 08:45
Changing the treatment targets: From the acute phase to donation of
organs
Francesco Procaccio, Rome, Italy
08:45 - 09:00
Cardiac output monitoring guided haemodynamic therapy in brain
dead organ donors
09:00 - 09:15
How to improve transplanted organ performance? The process starts in
the ICU
Alexander Manara, Bristol, United Kingdom
09:15 - 09:30
The impact of ICU treatment on transplanted organs
Franco Valenza, Milan, Italy
ROOM Vienna
FROM THE ICU TO NOBEL PRIZE AND BACK
Chairs: Fernando Bozza, Rio de Janeiro, Brazil & Jérôme Pugin, Geneva, Switzerland
08:30 - 08:50
Toll-like receptors
08:50 - 09:10
Dendritic cells
09:10 - 09:30
How does this help to understand pneumonia?
Jean-Paul Mira, Paris, France
ROOM Athens
Thematic Session
HYPONATREMIA GUIDELINES
Chairs: Michael Joannidis, Innsbruck, Austria & Jan Wernerman, Stockholm, Sweden
08:30 - 08:50
Why guidelines for hyponatremia are needed? How are they generated?
08:50 - 09:10
My current diagnostic approach for hyponatremia in the ICU
Carole Ichai, Nice, France
09:10 - 09:30
My current therapeutic approach for hyponatremia in the ICU
ROOM Lisbon
Oral Presentations
ABSTRACT AWARD WINNING SESSION
Chairs: Giuseppe Citerio, Monza, Italy & Richard Beale, London, United Kingdom
09:40 - 09:55
COMPARISON OF NEW CLINICAL DEFINITION OF ARDS WITH AUTOPSY
FINDINGS
A.W. Thille, P. Fernández-Segoviano,
J.M. Rodriguez, J.A. Aramburu, P. Cardinal,
O. Penuelas, J.A. Lorente, F. Frutos-Vivar,
A. Esteban, Getafe, Madrid, Spain
0451
09:55 - 10:10
DISTRIBUTION OF LUNG INFLAMMATION AFTER VENTILATION
ACCORDING TO ARDSNET IN EXPERIMENTAL LUNG INJURY
J.B. Borges, E. Costa, C. Widström, E. Maripuu,
M. Bergquist, L. Lucchetta, F. Suarez-Sipmann,
A. Larsson, M. Amato, G. Hedenstierna, Uppsala,
Sweden
0452
10:10 - 10:25
LECTIN PATHWAY OF COMPLEMENT ACTIVATION AFTER SUBARACHNOID
HAEMORRHAGE
T. Zoerle, R. Zangari, F. Orsini, S. Parrella,
V. Conte, N. Stocchetti, E.R. Zanier, M.-G. De
Simoni, Milan, Italy
0453
10:25 - 10:40
DELIRIUM, SUB-SYNDROMAL DELIRIUM, ANTIPSYCHOTIC USE, AND
ASSOCIATED CLINICAL OUTCOMES IN CRITICALLY ILL MECHANICALLY
VENTILATED PATIENTS ENROLLED IN THE SLEAP MULTICENTRE
RANDOMISED TRIAL
S. Mehta, J. Devlin, Y. Skrobik, M. Meade,
D. Cook, D. Fergusson, M. Steinberg, J. Granton,
N. Ferguson, M. Tanios, P. Dodek, R. Fowler,
K. Burns, M. Jacka, K. Olafson, S. Keenan,
S. Reynolds, J. Kutsogiannis, R. Mallick, L. Burry,
Toronto, Canada
0454
10:40 - 10:55
Discussion
L I V E S 2 012
Thematic Session
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Stockholm
137
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
138
ROOM Berlin
Oral Presentations
Nurses
&
AHP
PREVENTION OF INFECTIONS IN THE ICU SETTING
Chairs: George Dimopoulos, Athens, Greece & Jean-François Timsit, Grenoble, France
09:40 - 09:55
WHY THE RATES OF MECHANICAL VENTILATION-RELATED PNEUMONIA
HAVE DECREASED IN SPAIN?
F. Alvarez-Lerma, M. Palomar, P. Olaechea,
M.J. López Pueyo, J. Insausti, M.P. Gracia,
R. Gimeno, I. Seijas, Barcelona, Spain
0455
09:55 - 10:10
PROTECTIVE EFFECTS OF FCGR2A POLYMORPHISM IN INVASIVE
PNEUMOCOCCAL DISEASES
A. Bouglé, A. Max, N. Mongardon, D. Grimaldi,
F. Pène, C. Rousseau, J.D. Chiche, J.P. Bedos,
E. Vicaut, J.P. Mira, Paris, France
0456
10:10 - 10:25
CAN WE PREDICT PNEUMOCOCCAL BACTERAEMIA IN PATIENTS WITH
SEVERE COMMUNITY-ACQUIRED PNEUMONIA?
J.M. Pereira, A. Teixeira-Pinto, C. Basílio,
C. Sousa-Dias, P. Mergulhão, J.A. Paiva, Porto,
Portugal
0457
10:25 - 10:40
SURVEILLANCE OF VENTILATOR ASSOCIATED PNEUMONIA IN
A DUTCH INTENSIVE CARE AND THE INFLUENCE OF SELECTIVE
DECONTAMINATION OF THE DIGESTIVE TRACT
E. de Jong, A.M. Kaiser, A. Beishuizen,
S.F.M. Evelein-Brugman, M.C. de Waard,
J.M. Peppink, C.M.J.E. Vandenbroucke-Grauls,
A.R.J. Girbes, Amsterdam, Netherlands
0458
10:40 - 10:55
COST-EFFECTIVENESS OF RISK-BASED STRATEGIES FOR ANTIFUNGAL
PROPHYLAXIS AMONG NON-NEUTROPENIC, CRITICALLY ILL ADULT
PATIENTS: THE FIRE STUDY
D.A. Harrison, R. Grieve, M.Z. Sadique, E. Allen,
K.M. Rowan, London, United Kingdom
0459
ROOM Barcelona
Oral Presentations METABOLISM IN ICU
Chairs: Olav Rooyackers, Stockholm, Sweden & Karin Amrein, Graz, Austria
09:40 - 09:55
DYNAMICS OF SKELETAL MUSCLE ATROPHY AND ATROPHY GENE
EXPRESSION IN CRITICALLY ILL PATIENTS DURING ICU STAY
T. Wollersheim, S. Weber-Carstens, C. Egbers,
A. Luther, M. Krebs, J. Hamati, D. Lodka,
C. Kleber, C. Spies, S. Spuler, J. Fielitz, Berlin,
Germany
0460
09:55 - 10:10
WHOLE BODY PROTEIN TURNOVER IN MECHANICALLY VENTILATED ICU
PATIENTS
O. Rooyackers, R. Kouchek-Zadeh, I. Tjäder,
Å. Norberg, M. Klaude, J. Wernerman, Huddinge,
Sweden
0461
10:10 - 10:25
DOES BODY MASS INDEX INFLUENCE MUSCLE WASTING FOLLOWING
CRITICAL ILLNESS?
E. Segaran, M. Stotz, L. Wandrag, M. Hickson,
0462
10:25 - 10:40
DETERMINATION OF A SIMPLIFIED METHOD FOR ESTIMATING RESTING
ENERGY EXPENDITURE IN CRITICALLY ILL PATIENTS
J.-C. Preiser, M.H. Simonsen, Brussels, Belgium
0463
10:40 - 10:55
CHANGE OF SERUM ALBUMIN AND RISK OF ALL-CAUSE MORTALITY IN
CRITICAL ILLNESS: A COHORT STUDY
K.B. Christopher, G.W. Reed, M. Nurok,
T. Moromizato, F.K. Gibbons, G.P. Topulos,
Boston, United States
0464
ROOM Geneva Oral Presentations
POLYNEUROPATHY
THE BEST IN NEUROINTENSIVE CARE: ENCEPHALOPATHY &
Chairs: Tarek Sharshar, Paris, France & Francesco Procaccio, Rome, Italy
09:40 - 09:55
BRAIN BIOENERGETICS IMBALANCE AND OXIDATIVE STRESS IN
SYSTEMIC INFLAMMATION AND SEPSIS
F. Bozza, J.C. d’Avila, R. Carnevale, L. GarciaSouza, P.A. Reis, R.G. Novaes, H.C. Castro-FariaNeto, M.F. Oliveira, Rio de Janeiro, Brazil
0465
09:55 - 10:10
EARLY TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN
PATIENTS WITH CRITICAL ILLNESS POLYNEUROPATHY ─ A RANDOMISED
CONTROLLED, DOUBLE BLINDED STUDY
R. Brunner, W. Rinner, R. Kitzberger, T. Sycha,
J. Warszawska, U. Holzinger, C. Madl, Vienna,
Austria
0466
10:10 - 10:25
EFFECT OF ELECTRICAL MUSCLE STIMULATION IN PREVENTION OF ICU
ACQUIRED MUSCLE WEAKNESS AND FACILITATING WEANING FROM
MECHANICAL VENTILATOIN
H. Abokhabar, A. Abouelela, I. Abdelkarim,
Alexandria, Egypt
0467
10:25 - 10:40
RESPIRATORY PARAMETERS IMPROVES DURING DIAPHRAGMATIC
PACING IN HIGH SPINAL CORD LESIONS PATIENTS
M. Giacomini, F. Curto, C. Betto, T. Redaelli,
D. Facchetti, D. Falchetti, E. Mantovani, I. Chiusa,
Milan, Italy
0468
13-17 October 2012
L I V E S 2 012
TRANSFUSION IN THE ICU
09:40 - 10:00
New experimental insights about transfusions
10:00– 10:20
Transfusion in the perioperative phase
10:20 - 10:40
Transfusion in acute brain damage
10:40 - 11:00
Alternatives to transfusion
ROOM Glasgow
Oral Presentations
SEPSIS, EPIDEMIOLOGY & OUTCOME
Chairs: Derek Angus, Pittsburgh, United States & Martin Dünser, Salzburg, Austria
09:40 - 09:55
HAS MORTALITY DECREASED IN MECHANICALLY VENTILATED PATIENTS
WITH SEPSIS IN THE LAST DECADE?
N. Nin, O. Peñuelas, N. Ferguson, M. Gonzalez,
J. Hurtado, B. Du, A. Ali Zeggwagh, A. Anzueto,
F. Frutos-Vivar, A. Esteban, J.Á. Lorente, Madrid,
Spain
0470
09:55 - 10:10
INCIDENCE, ORGAN DYSFUNCTION AND MORTALITY IN SEVERE SEPSIS.
A SPANISH MULTICENTRE STUDY AND COMPARISON WITH A 2002
COHORT
M.M. García García, R. Herrán Monge, A. Muriel
Bombín, P.A. Merino García, M.P. Pérez,
F. Gandía Martínez, A.M. Domínguez Berrot,
S. Moradillo González, B. Álvarez Martínez,
S. Macías, C. Tarancón, M.J. López Pueyo,
D. Moreno Torres, J. Blanco Varela, Valladolid,
Spain
0471
10:10 - 10:25
DEGREE OF COMPLIANCE WITH RECOMMENDATIONS FOR TREATMENT
OF SEVERE SEPSIS AFTER 5 YEARS OF CONDUCTING EDUCATIONAL
CAMPAIGN. RESULTS OF A SPANISH MULTICENTER STUDY
R. Herrán Monge, A. Muriel Bombín, M.M. García
García, P.A. Merino García, D. Carriedo Ule,
M. Martínez Barrios, S. Moradillo González,
N. Albalá, R. Cítores González, D. Moreno Torres,
B. Álvarez Martínez, R. Pajares, C. Tarancón,
J. Blanco Varela, Valladolid, Spain
0472
10:25 - 10:40
THE SEVERITY OF ORGAN DYSFUNCTION IS ASSOCIATED WITH EARLY
DEATH IN SEVERE SEPSIS AND SEPTIC SHOCK PATIENTS
F.R. Machado, E.M. Ferreira, P. Schippers,
I.C. Paula, J.L.G. Amaral, N.S. Mansur,
R. Salomao, Sao Paulo, Brazil
0473
10:40 - 10:55
COHORT OF CRITICALLY ILL PATIENTS WITH MULTI-ORGAN
DYSFUNCTION: POST-HOSPITALISATION MORTALITY AND RELATED
PROGNOSTIC FACTORS
V. Hortigüela Martín, M. Sánchez Casado,
S. Rodríguez Villar, C. Marco Shulcke,
M. Quintana Díaz, M. Arrese Cosculluela, Toledo,
Spain
0474
ROOM Stockholm
Oral Presentations
SECONDARY INSULTS IN TRAUMA PATIENTS
Chairs: Jacques Duranteau, Kremlin-Bicetre, France (TBC) & Kjetil Sunde, Oslo, Norway
09:40 - 09:55
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL
STEM CELLS IN TRAUMATISED MICE BRAIN IS NOT AFFECTED BY
IMMUNOSUPPRESSIVE TREATMENT
E.R. Zanier, F. Pischiuta, D. Giovanna, A. Biondi,
E. Biagi, G. Citerio, M.-G. De Simoni, Milan, Italy
0475
09:55 - 10:10
IS SPECIFIC MONITORING OF FIBRINOGEN UPON ADMISSION OF
TRAUMA PATIENTS REALLY JUSTIFIED? COHORT OF 663 SEVERE TRAUMA
PATIENTS
P. Deras, J. Charbit, C. Maury, P. Chardon,
J.P. Roustan, X. Capdevila, Montpellier, France
0476
10:10 - 10:25
THE TWIN ATTACKS IN NORWAY ON JULY 22, 2011 - THE TRAUMA
CENTRE INTENSIVE CARE UNIT CHALLENGES AND SOLUTIONS
T.M. Gundem, N. Meidell, F. Heyerdal,
S. Beitland, K. Gaustad, P. Kvandal, A. Bøen,
K.M. Kolstadbraaten, C. Gaarder, P.A. Næss,
K. Sunde, Oslo, Norway
0477
+
L I V E S 2 012
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
room Rome
Chairs: Jean-Daniel Chiche, Paris, France & Rupert Pearse, London, United Kingdom
Visit us at the
Level 1
139
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
10:25 - 10:40
EARLY TRANSFUSION OF BLOOD PRODUCTS IN PATIENTS WITH SEVERE
BLEEDING IN PENETRATING ABDOMINAL TRAUMA
C.A. Ordoñez, M. Badiel, M. Cepeda,
M. Granados, J.H. Loaiza, C. Macia, L. Pino,
W. Botache, D. Scavo, J.C. Puyana, G. Ospina,
Cali, Colombia
0478
10:40 - 10:55
THE USE OF PRE-HOSPITAL END-TIDAL CO2 MONITORING IN MAJOR
TRAUMA: IN PATIENTS WITH SEVERE HEAD INJURY AND MAJOR
TRAUMA, DOES CAPNOGRAPHY REPRESENT AN ACCURATE AND
EFFECTIVE GUIDE TO PRE-HOSPITAL VENTILATION?
M. Patterson, M. Conway, London, United
Kingdom
0479
ROOM Paris
Oral Presentations
CARDIOVASCULAR ULTRASOUNDS
Chairs: Jan Poelaert, Brussels, Belgium & Antoine Vieillard-Baron, Boulogne, France
09:40 - 09:55
DOPPLER BASED RENAL RESISTIVE INDEX PREDICTS REVERSIBILITY OF
ACUTE KIDNEY INJURY AFTER CARDIAC SURGERY
P.-G. Guinot, E. Bernard, L. Badoux, O. Abou
Arab, H. Dupont, Amiens, France
0480
09:55 - 10:10
QUALITATIVE EVALUATION OF RESPIRATORY CHANGES IN INFERIOR
VENA CAVA DIAMETER IN INTENSIVE CARE UNIT: A RELIABLE AND FAST
TECHNIQUE
A. Duwat, E. Zogheib, P.G. Guinot, F. Trojette,
F. Levy, M. Slama, H. Dupont, Amiens, France
0481
10:10 - 10:25
USEFULNESS OF THE TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION
AND OF THE DOPPLER TISSUE IMAGING OF TRICUSPID ANNULAR
MOTION TO DETECT RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS
WITH ACUTE PULMONARY EMBOLISM
O. Hamzaoui, K. Belkhouja, K. Ben Romdhane,
J. Ben Khelil, M. Besbes, Clamart, France
0482
10:25 - 10:40
THE DIAGNOSTIC AND THE PROGNOSTIC VALUE OF THE PEAK SYSTOLIC
TRICUSPID ANNULAR VELOCITY IN CRITICALLY ILL PATIENTS
O. Hamzaoui, K. Ben Romdthane, K. Belkhouja,
J. Ben Khelil, M. Besbes, Clamart, France
0483
10:40 - 10:55
SEMI AUTOMATED ESTIMATION OF EJECTION FRACTION WITH AUTOEF
AT THE BEDSIDE SHOWS GOOD CORRELATION WITH GOLD STANDARD
METHOD
C.A. Frederiksen, P. Juhl-Olsen, J.F. Hermansen,
E. Sloth, Aarhus, Denmark
0484
ROOM Vienna
Oral Presentations
FUTURE PERSPECTIVES IN ARDS TREATMENT
Chairs: Marco Ranieri, Turin, Italy & Jordi Mancebo, Barcelona, Spain
09:40 - 09:55
RANDOMISED CONTROLLED TRIAL OF TWO METHODS OF NASAL
CONTINUOUS POSITIVE AIRWAY PRESSURE (NCPAP) IN PRETERM
INFANTS WITH RESPIRATORY DISTRESS SYNDROME: UNDERWATER
BUBBLY CPAP VS. MEDIJET SYSTEM DEVICE
M.B. Hosseini, M. Heidarzadeh, M. Balila, Tabriz,
Iran, Republic of Islamic
0485
09:55 - 10:10
THE VOLATILE ANAESTHETIC SEVOFLURANE ATTENUATES VENTILATORINDUCED LUNG INJURY THROUGH INHIBITION OF ERK1/2 AND AKT
SIGNAL TRANSDUCTION
C.-Y. Jeong, S.-H. Kwak, S. Chung, Gwangju,
Republic of Korea
0486
10:10 - 10:25
LONG-TERM LUNG STABILITY DURING MECHANICAL VENTILATION
AFTER ELECTRICAL IMPEDANCE TOMOGRAPHY (EIT) GUIDED PEEPTITRATION IN A PORCINE ACID ASPIRATION MODEL OF ACUTE
A. Reske, S. Wolf, T. Muders, H. Starke, A. Rau,
D. Buchloh, A. Beilicke, S. Hammermüller,
0487
10:25 - 10:40
ASSESSMENT OF REGIONAL LUNG MECHANICS IN SEVERE ARDS USING
ELECTRICAL IMPEDANCE TOMOGRAPHY: IMPLICATIONS FOR THE
CHOICE OF VENTILATOR STRATEGY
L. Camporota, J. Smith, V. Della Torre,
V. Specchio, A. Sgobio, S. Reinero, E. Chinelli,
D. Arces, N. Barrett, R. Beale, London, United
Kingdom
0488
10:40 - 10:55
THE EFFECT OF BLOOD ACIDIFICATION ON EXTRACORPOREAL CARBON
DIOXIDE REMOVAL: LONG TERM ANIMAL STUDY
P. Mangili, S. Redaelli, V. Scaravilli, M. Giani,
S. Abd El Aziz El Sayed Deab, D. Ferlicca,
A. Zanella, A. Pesenti, N. Patroniti, Monza, Italy
0489
+
140
13-17 October 2012
Visit us at the
ESICM Booth
Exhibition Area A
L I V E S 2 012
Unknowns
in the ICU?
Join Edwards Lifesciences to find Clarity in Every Moment.
Attend our Lunch symposium:
Hemodynamic Monitoring
Tuesday, October 16 – 12.30-14.00, Room Berlin
Chairs: Jean-Louis Vincent, Belgium & Maurizio Cecconi, UK
Hemodynamic optimization: Is it cost-effective?
Maurizio Cecconi, UK
Integration of hemodynamic data at the bedside
Jean-Louis Vincent, Belgium
Application of a new transpulmonary thermodilution technique
Chris Hofer, Switzerland
Edwards, Edwards Lifesciences, the stylized E logo and Clarity in Every Moment are trademarks of
Edwards Lifesciences Corporation.
© 2012 Edwards Lifesciences Corporation. All rights reserved. E3139/08-12/CC
Edwards Lifesciences
Irvine, USA I Nyon, Switzerland
edwards.com
I Tokyo, Japan I Singapore, Singapore I São Paulo, Brazil
Invitation to Innovation
PULSION Symposium
ESICM 2012 -
The European Society of Intensive Care Medicine
Centro de Congressos de Lisboa (CCL), Lisbon, Portugal
13th - 17th October 2012, Booth number 15 on Block 9
PiCCO for haemodynamic monitoring:
Indications, strategies & benefit
Tuesday, 16th October 2012
12:30 – 14:00 hrs
Room Barcelona, First Floor
Panel members:
ro
p
e
h
c
un
L
lb
l
i
w
Javier Belda (Valencia, Spain)
Jean-Loius Teboul (Paris, France)
•
Benefit of early optimized critical care patient management with PiCCO
Daniel Reuter (Hamburg, Germany)
•
Consequences of haemodynamic monitoring strategies in septic shock patients
Jean-Loius Teboul (Paris, France)
•
Solving therapeutic conflicts in ARDS – Clinical case studies
Azriel Perel (Tel-Aviv, Israel)
PULSION Medical Systems SE • Hans-Riedl-Str. 21 • D-85622 Feldkirchen, Germany
Tel. +49-(0)89-45 99 14-0 • Fax +49-(0)89-45 99 14-18
info.DE@pulsion.com • www.PULSION.com
d!
e
vid
ESC/ESICM - UPDATE ON CARDIOGENIC SHOCK
09:40 - 10:00
Medical management: An update
Johan Lassus, Helsinki, Finland
10:00 - 10:20
When and how to revascularise?
Eduardo Oliveira, Lisbon, Portugal
10:20 - 10:40
How to monitor?
10:40 - 11:00
Assist Devices: What, how and when?
Area Beja
Poster Corner
TECHNOLOGY ASSESMENT IN ACUTE RESPIRATORY FAILURE
Chairs: Armand Girbes, Amsterdam, Netherlands & Salvatore Maggiore, Rome, Italy
10:10 - 12:00
EXTRA-VASCULAR LUNG WATER IS AN INDEPENDENT PROGNOSTIC
FACTOR IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
M. Jozwiak, S. Silva, R. Persichini, N. Anguel,
D. Osman, C. Richard, J.L. Teboul, X. Monnet, Le
Kremlin Bicetre, France
0490
NON INVASIVE MEASUREMENT OF BOHR´S DEAD SPACE USING
VOLUMETRIC CAPNOGRAPHY
A. Santos, G. Tusman, S. Bohm, M. Muñoz,
J.B. Borges, A. Larsson, G. Hedenstierna,
F. Suarez-Sipmann, Madrid, Spain
0491
THE EFFECT OF VENTILATION WITH DIFFERENT FRACTIONS OF INSPIRED
OXYGEN ON INTRAPULMONARY SHUNT IS ALTERED BY LUNG INJURY
A. Reske, S. Hammermüller, S. Wolf, A. Rau,
D. Buchloh, H. Starke, S. Huckauf, T. Muders,
0492
USE OF A FULLY CLOSE LOOP VENTILATION MODE IN LONG TERM
VENTILATED ICU PATIENT: A PROSPECTIVE FEASABILITY STUDY
A. Garnero, J.-M. Arnal, M. Wysocki, D. Demory,
L. Ducros, G. Corno, A. Berric, S.-Y. Donati,
J. Durand-Gasselin, Toulon, France
0493
EFFECTS OF ANAESTHESIA, MUSCLE PARALYSIS AND CONTROLLED
MECHANICAL VENTILATION ON LUNG DIFFUSION FOR CARBON
MONOXIDE (DLCO): PRELIMINARY RESULTS
D. Bonacina, F. Di Marco, E. Vassena, E. Pitino,
A. Bronco, M. Laratta, F. Verga, F. Pozzi,
R. Fumagalli, Monza, Italy
0494
RESPONSE CHARACTERISTICS OF PORTABLE VENTILATION SYSTEM:
“BOUSSIGNAC VYLIFE”
J.M. Serrano Simon, A. Rodriguez Perea, R. Leon
Lopez, A. Mula Gomez, M.D. Bautista Rodriguez,
A. Pontes Moreno, Cordoba, Spain
0495
MONITORING INTRINSIC PEEP BY DIAPHRAGMATIC ELECTRICAL
ACTIVITY DURING ASSISTED SPONTANEOUS BREATHING
A. Coppadoro, G. Bellani, M. Turella, T. Mauri,
S. Arrigoni Marocco, N. Patroniti, A. Pesenti,
Monza, Italy
0496
IMPACT OF NAP4: AN AUDIT INTO AIRWAY MANAGEMENT ON A
GENERAL ICU
H. Lewis, A. Martin, J. Patel, Birmingham, United
Kingdom
0497
HIGH OXYGENATION INDEX: BAD LUNGS OR BAD DOCTORS?
R. Gosavi, T. Szakmany, Llantrisant, United
Kingdom
0498
IMPACT OF LACTIC ACID AND GLUCOSE SOLUTION INFUSIONS ON CO(2)
PRODUCTION: PRELIMINARY DATA FROM AN EXPERIMENTAL STUDY IN
PIGS
M. Giani, A. Zanella, S. Redaelli, P. Mangili,
V. Scaravilli, D. Ferlicca, E. Rezoagli, V. Ormas,
S. Sosio, N. Patroniti, A. Pesenti, Monza, Italy
0499
EXTRACORPOREAL MEMBRANE OXIGENATION IN LUNG
TRASPLANTATION ON OUR FIRST TWELVE CASES
M. López-Sanchez, I. Rubio-López,
J.C. Rodríguez-Borregán, C. GonzálezFernández, F.J. Burón-Mediavilla, F. Ortiz-Melón,
A. Quesada-Suescun, Santander, Spain
0500
IMPACT OF AIRWAY PRESSURE RELEASE VENTILATION (APRV) AND
BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE (BIPAP) MODES
ON THE LUNG PROTECTION IN A SPONTANEOUSLY BREATHING LUNG
MODEL
E. Akoumianaki, J.C. Lefebvre, A. Lyazidi,
F. Sferazza Papa, K. Saihi, L. Brochard,
J.C.M. Richard, Geneva, Switzerland
0501
AUTOMATED CLOSED-LOOP OXYGEN ADMINISTRATION (FREEO2)
DURING THE EMERGENCY CARE OF ACUTE RESPIRATORY FAILURE. A
MULTICENTRIC RANDOMISED CONTROLLED STUDY [PRELIMINARY
RESULTS]
E. L’Her, P.-A. Bouchard, F. Lellouche, Brest Cedex,
France
0502
NATIONAL SURVEY OF USE OF OSCILLATOR IN UNITED KINGDOM
J. Rees, R. Mccartney, T. Lawy, R. Mosaheb,
S. Saha, Romford, United Kingdom
0503
L I V E S 2 012
Joint Session
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Athens
Chairs: Alexandre Mebazaa, Paris, France & Eduardo Oliveira, Lisbon, Portugal
143
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Braga
Poster Corner
NUTRITION & GLUCOSE CONTROL
Chairs: Marcus Schultz, Amsterdam, Netherlands & Michaël Casear, Leuven, Belgium
10:10 - 12:00
EARLY ENTERAL FEEDING IN CRITICALLY ILL SURGICAL PATIENTS
UNDERWENT EMERGENCY GASTROINTESTINAL SURGERY
J.Y. Kim, H.J. Shim, J.Y. Jang, J.G. Lee, Seoul,
Republic of Korea
0504
IMPLEMENTATION OF A PROACTIVE NUTRITION CLINICAL PRACTICE
INCREASES THE PROPORTION OF MECHANICALLY VENTILATED PATIENTS
ACHIEVING ENTERAL NUTRITION TARGETS IN THE ADULT NEUROINTENSIVE CARE UNIT (NICU)
C.T. Chong, B. Lim, J. Tan, H.L. Tan, Singapore,
Singapore
0505
CLINICAL AUDIT OF NUTRITIONAL SUPPORT IN GENERAL INTENSIVE
CARE UNIT
G. Maryem, E. Balakumar, A. Gratrix, Hull, United
Kingdom
0506
TIME OF ONSET OF ENTERAL NUTRITION IN THE CARDIAC PATIENT,
IMPROVED AFTER THE COUNSEL OF THE NUTRITIONAL TEAM?
M.J. Garcia-Monje, A. Ayucar Ruiz de Galarreta,
I. Astola, B. Besteiro, A. Vázquez, F. Pita, G. Lugo,
A Coruña, Spain
0507
EARLY ENTERAL NUTRITION IN POSTOPERATIVE CARDIAC SURGERY IN
PATIENTS WITH HAEMODYNAMIC FAILURE. FINAL RESULTS
J.L. Flordelís Lasierra, J.L. Pérez Vela, E. Torres
Sánchez, L.D. Umezawa Makikado, L. Colino
Gómez, B. Maroto Rodríguez, P. Arribas López,
E. Renes Carreño, J. Gutierrez Rodríguez,
M.A. Corres Peiretti, N. Perales Rodríguez de
Viguri, J.C. Montejo González, Madrid, Spain
0508
NUTRITIONAL SUPPORT IN SURGICAL TREATMENT OF PATIENTS WITH
HEAD AND NECK TUMORS
M. Pankratova, V. Khoronenko, J. Donskova,
Moscow, Russian Federation
0509
DEVELOPMENT OF AN INTENSIVE CARE UNIT “CATCH UP” FEEDING
STRATEGY: AN AUDIT OF NUTRITIONAL ADEQUACY
A.-C. Glynn, I. De Brito-Ashurst, A. Sharma,
J. Wootton, J. Mulae, A. Wypych-Zych, London,
United Kingdom
0510
DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL (GI)-MOTILITY
DISORDERS - RESULTS OF A SURVEY AMONG AUSTRIAN AND ESTONIAN
INTENSIVE CARE PHYSICIANS (ICP) NUTRITIONAL MANAGEMENT - A
COMPARISON OF AUSTRIAN AND ESTONIAN INTENSIVE CARE UNITS
(ICU)
M. Schörghuber, A. Reintam Blaser, J. Starkopf,
E. Tatzl, S. Fruhwald, Graz, Austria
0511
DURATION OF TIME TILL NORMOGLYCAEMIA WITH STRICT GLYCAEMIC
CONTROL IS INDEPENDENTLY ASSOCIATED WITH LENGTH OF STAY IN
ICU
R.T.M. van Hooijdonk, R.E. Harmsen, S.J. Gesink,
F. van Braam Houckgeest, J.P. van der
Sluijs, P.E. Spronk, M.J. Schultz, Amsterdam,
Netherlands
0512
IMPACT OF HYPOGLYCAEMIA AND MEAN BLOOD GLUCOSE ON
MORTALITY IN CRITICALLY ILL PATIENTS - A RETROSPECTIVE COHORT
STUDY
G. Adelsmayr, R. Brunner, U. Holzinger, Vienna,
Austria
0513
EVALUATION OF GLYCAEMIC CONTROL WITH DIFFERENT INTENSIVE
INSULINE PROTOCOLS IN CRITICALLY ILL PATIENTS
C. Yuruk, B. Bilgili, H.B. Cift, N. Akgun, Istanbul,
Turkey
0514
GLUCOSE CONTROL IN CRITICAL CARE: PRELIMINARY EXPERIENCE OF
THE B BRAUN SPACE GLUCOSE CONTROL™ SYSTEM
R.J. Goss, R.M. Goss, J.J. Paddle, Truro, United
Kingdom
0515
GLYCAEMIA MONITORISATION AND MORTALITY IN SEREVE SEPSIS AND
SEPTIC SHOCK
M.V. De la Torre-Prados, A. Garcia-De la Torre,
N. Zamboschi, J. Perez-Vacas, C. TrujillanoFernández, M. Nieto-Gonzalez, A. Garcia
Alcantara, A. Vallejo-Baez, C. HernándezSánchez, Malaga, Spain
0516
A SPOONFUL OF SUGAR - GLYCAEMIC CONTROL USING A MODIFIED
BATH PROTOCOL IN AN ADULT INTENSIVE CARE UNIT
Z. Whitman, N. Flint, S. Das, Leicester, United
Kingdom
0517
+
144
13-17 October 2012
Visit us at the
Level 1
L I V E S 2 012
CARDIOVASCULAR FAILURE IN THE ICU
10:10 - 12:00
EXTRACORPOREAL TREATMENTS AS A RISK FACTORS FOR DEEP VENOUS
THROMBOSIS IN CRITICALLY ILL PATIENTS
A. Cecchi, G. Zagli, M. Bonizzoli, L. Perretta,
R. Cammelli, S. Damiani, L. Tutino, F. Barbani,
M. Boddi, A. Peris, Florence, Italy
0518
SAFETY OF PREOPERATIVE USE OF ANGIOTENSIN-CONVERTING ENZYME
INHIBITORS/ANGIOTENSIN IN CARDIAC SURGERY
A.J. Frenette, Y. Lamarche, É. David,
D. Brindamour, J. Bouchard, D.R. Williamson,
Montreal, Canada
0519
HAEMODYNAMICS, INFLAMMATION AND MORTALITY IN MEDICAL
PATIENTS WITH FIRST DIAGNOSIS ATRIAL FIBRILLATION WITHIN A
GENERAL INTENSIVE CARE UNIT
K. Tober, T. Quasim, J. Kinsella, Glasgow, United
Kingdom
0520
EPIDEMIOLOGY, CAUSES AND OUTCOME OF CARDIAC ARREST IN HIV
INFECTED PATIENTS: RESULTS OF THE MULTICENTRIC CARAIDS STUDY
G. Geri, N. Mongardon, N. Deye, R. Sonneville,
F. Boissier, S. Perbet, L. Camous, V. Lemiale,
M. Thirion, A. Mathonnet, L. Bodson, S. Gaudry,
A. Kimmoun, S. Legriel, N. Lerolle, D. Luis, C.E. Luyt, J. Mayaux, B. Guidet, J.-P. Mira, A. Cariou,
Paris, France
0521
RIGHT VENTRICULAR DYSFUNCTION MAY WORSEN RENAL FUNCTION
AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
O. Abou Arab, P.-G. Guinot, L. Badoux,
E. Bernard, H. Dupont, Amiens, France
0522
EFFICACY OF LEVOSIMENDAN IN INTENSIVE CARE UNIT PATIENTS WITH
IMPAIRED CARDIAC FUNCTION MANIFESTING FAILURE TO WEAN FROM
MECHANICAL VENTILATION
K. Tsikritsaki, G. Koukoulitsios, I. Dimitroulis,
K. Dimakou, I. Andrianakis, K. Mendrinou,
I. Tsiouboutariou, P. Dourou, N. Pentilas,
M. Paidonomos, Athens, Greece
0523
DIABETES AND INSULIN: CORONARY ANATOMY AND SURVIVAL IN
DIABETIC PATIENTS WITH CARDIOGENIC SHOCK
R. Manzanedo, F. Jiménez, J. Blanco, A. Uriarte,
J. Medina, E. Gross, V. Nieto, M. SánchezPalacios, Las Palmas de Gran Canaria, Spain
0524
A SURVEY ON THE IMPLEMENTATION OF THE EARLY GOAL-DIRECTED
THERAPY FOR THE PATIENTS SUFFERING WITH POST-CARDIAC ARREST
SYNDROME IN SUZHOU AREA
J. Zhu, L. Liu, Suzhou, China
0525
RESULTS VARIANTS OF INTENSIVE THERAPY OF PULMONARY
HYPERTENSION IN PATIENTS WITH CONGENITAL HEART DISEASE AFTER
SURGICAL CORRECTION
R.A. Ibadov, K.K. Abralov, A.S. Arifjanov,
N.Y. Alimdjanova, N.A. Strijkov, Tashkent,
Uzbekistan
0526
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) VS.
CONVENTIONAL SURGERY (AVR)
E. Trujillo-Garcia, E. Curiel-Balsera, C. JoyaMontosa, V. Olea-Jiménez, R. GutierrezRodríguez, A. Narváez-de Linares, J.M. MoraOrdoñez, Málaga, Spain
0527
CLINICAL VALUE REGULATED SUBCLAVIAN-PULMONARY ANASTOMOSIS
IN THE EARLY POSTOPERATIVE PERIOD IN PATIENTS WITH FALLOT´S
TETRALOGY
R.A. Ibadov, H.K. Abrolov, D.I. Zhulamanova,
A.S. Arifjanov, N.A. Strijkov, Tashkent, Uzbekistan
0528
SCREENING OF ASYMPTOMATIC PATIENTS PRIOR TO TRASPLANTATION
OF SOLID ORGANS: PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY
VALUE
D. Gaitan Roman, B. Perez Villardon,
M.A. Ramirez Marrero, M. Cano Garcia,
M.A. Roldan Jimenez, R. Vivancos Delgado,
M. De Mora Martin, Malaga, Spain
0529
T-PIECE IMPROVES ARTERIAL AND CENTRAL VENOUS OXYGENATION IN
TRACHEOSTOMISED PATIENTS AS COMPARED TO PRESSURE SUPPORT
(PS) VENTILATION
A. Lovas, R. Kószó, Z. Molnár, Szeged, Hungary
0530
Area Coimbra
Poster Corner
FLUID & HAEMODYNAMICS IN THE SURGICAL PATIENT
Chairs: Patrick Honoré, Brussels, Belgium & Shaman Jhanji, London, United Kingdom
10:10 - 12:00
RESPIRATORY VARIATION OF STROKE VOLUME MEASURED BY
OESOPHAGEAL DOPPLER PREDICT FLUID RESPONSIVENESS DURING
LAPAROSCOPY
B. De Broca, O. Abou Arab, E. Bernard, L. Badoux,
P.-G. Guinot, H. Dupont, Amiens, France
0531
TIDAL VOLUME INSTEAD OF ALVEOLAR PRESSURE VARIATION IS THE
MAJOR DETERMINANT FOR PULSE PRESSURE VARIATION
C.-H. Lee, H. Chang, J.-Y. Wang, C.-S. Lim, M.C. Lee, C.-C. Lan, K.-M. Chao, Taipei, Taiwan,
Republic of China
0532
L I V E S 2 012
Poster Corner
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Cascais
Chairs: Daniel De Backer, Brussels, Belgium & Matthieu Legrand, Paris, France
145
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
146
NEITHER DYNAMIC, STATIC NOR VOLUMETRIC VARIABLES CAN
ACCURATELY PREDICT FLUID RESPONSIVENESS EARLY AFTER
ABDOMINOTHORACIC OESOPHAGECTOMY FOR OESOPHAGEAL CANCER
H. Ishihara, E. Hashiba, J. Saito, H. Okawa,
T. Kasai, T. Tsubo, K. Hirota, Hirosaki-Shi, Japan
0533
EFFECTS OF CRYSTALLOIDS VERSUS COLLOIDS FOR GOAL DIRECTED
FLUID THERAPY ON POSTOPERATIVE PROCALCITONIN LEVELS AFTER
MAJOR ABDOMINAL SURGERY
M.J. Fas, J.M. Alonso-Iñigo, C. Arbona, S. Tormo,
A. Almela, Alzira, Spain
0534
CHANGES IN FLUID VOLUME PARAMETERS IN PATIENTS WITH SUBTOTAL
OESOPHAGECTOMY DURING THE FIRST THREE DAYS AFTER THE
SURGERY
E. Hashiba, H. Ishihara, H. Okawa, T. Tsubo,
K. Hirota, Hirosaki, Japan
0535
INFLUENCE OF FLUID MANAGEMENT IN THE PROGNOSIS OF
MECHANICALLY VENTILATED PATIENTS
M. Recuerda, A. Estella, V. Perez Madueño,
M. Gracia, E. Leal, J. Sanchez, M. Jaen, Jerez,
Spain
0536
VALUE OF ELEVATED EXTRAVASCULAR LUNG WATER INDEX AND
NON-INVASIVE MECHANICAL VENTILATION IN THE POSTOPERATIVE
RESPIRATORY FAILURE
F.J. Redondo Calvo, R. Villazala, A.S. Yuste,
A. Mendiola, N. Bejarano, Ciudad Real, Spain
0537
BALANCED CRYSTALLOID VERSUS BALANCED COLLOID SOLUTION
WITHIN A GOAL-DIRECTED ALGORITHM
A. Feldheiser, V. Pavlova, T. Bonomo, A. Jones,
C. Fotopoulou, J. Sehouli, K.-D. Wernecke,
C. Spies, Berlin, Germany
0538
DIFFERENT COMBINATIONS OF COLLOIDS AND CRYSTALLOIDS IN
MAJOR ABDOMINAL SURGERY: HAEMODYNAMICS EFFECTS
D. Levit, A. Levit, Ekaterinburg, Russian
Federation
0539
COLLOID VERSUS CRYSTALLOID TO PRELOAD BEFORE SPINAL
ANAESTHESIA AT TRANSURETHRAL RESECTION OF THE PROSTATE: A
RANDOMISED TRIAL
A.M. Ovezov, D.V. Gorbachev, J.V. Ovcharova,
E.D. Nad’kina, A.G. Markov, Moscow, Russian
Federation
0540
VOLUMEN ASSESSMET IN PATIENTS DURING MAYOR LIVER RESECTIONS.
IS THE BEST THE CENTRAL VENOUS PRESSURE?
F.J. Redondo Calvo, R. Villazala, D. Padilla,
P. Arenas, A.S. Yuste, P. Villarejo, V. Baladron,
Ciudad Real, Spain
0541
COMPARISON OF CENTRAL VENOUS PRESSURE MEASUREMENTS
MADE WITH A WATER COLUMN AND A PRESSURE TRANSDUCER IN ICU
PATIENTS
G. Choutas, V. Ntzani, D. Karapanos,
N. Maliahovas, K. Mpakalouli, G. Anthopoulos,
Athens, Greece
0542
CONTROVERSY OF THE USE OF ALBUMIN IN CRITICAL PATIENTS
S. Giestas, A.R. Ramalho, J.P. Baptista, N. Devesa,
P. Martins, A. Simões, A.P. Casanova, J. Pimentel,
Coimbra, Portugal
0543
EFFECT OF DIFFERENT THERAPY OPTIONS ON IMMUNOGLOBULIN
LEVELS IN PATIENTS SUFFERING FROM LIVER FAILURE
D. Lebherz-Eichinger, R. Schwarzer,
E.M. Schmidt, M.C. Motal, D.A. Klaus,
A. Mangold, H.J. Ankersmit, C.G. Krenn,
G.A. Roth, Vienna, Austria
0544
Area Estoril
Poster Corner
RISK FACTORS, PROPHYLAXIS & OUTCOME OF ICU INFECTIONS
Chairs: Jérôme Pugin, Geneva, Switzerland & Claudia Spies, Berlin, Germany
10:10 - 12:00
CURB-65 AND PNEUMONIA SEVERITY INDEX FOR INFLUENZA A H1N1V
PNEUMONIA
A. Estella, L. Pérez Fontaiña, V. Perez Madueño,
M. Recuerda, E. Leal, M. Gracia, J. Sanchez,
M. Jaen, Jerez, Spain
0545
DEXAMETHASONE AND SURVIVAL IN PATIENTS WITH SEVERE
COMMUNITY-ACQUIRED PNEUMONIA
C. Gutu-Bahov, S. Matcovschi, T. Dumitras,
L. Sidorenco, C. Zubarev, Chisinau, Moldova
0546
THE IMPACT OF SURFACE CLEANING BY BIOSHIELD®75 ON INFECTION
RATES IN INTENSİVE CARE UNIT
G. Ersöz, A.A. Altunkan, M. Uğuz, S. Karaçorlu,
Z. Kaya, A. Kaya, Mersin, Turkey
0547
CAN ROUTINE CLINICAL CHEMISTRY RESULTS BE RELATED TO THE
VOLUME OF DISTRIBUTION OF AMPHOTERICIN B LIPID COMPLEX IN
CRITICALLY ILL PATIENTS?
M.E. Malone, C. Gowing, M. Barry, E. Deasy,
P. Kavanagh, O.I. Corrigan, D.M. D’Arcy,
M. Donnelly, Dublin, Ireland
0548
REDUCING CENTRAL VENOUS CATHETER INFECTION - DOES THE STAY
SUTURE FOR CVC FIXATION IMPROVE INSERTION SITE COVERAGE?
T.E. Williams, S. Jhawar, E. O’ Callaghan, O. Al
Rawi, Liverpool, United Kingdom
0549
NURSE-LED QUALITY IMPROVEMENT PROGRAMME TO REDUCE
HEALTHCARE RELATED INFECTIONS: 4 YEARS EXPERIENCE
A. Hermon, T. Pain, H. Jerrett, P. Beckett,
T. Szakmany, Llantrisant, United Kingdom
0550
13-17 October 2012
L I V E S 2 012
0551
USE OF CDC CRITERIA TO CLASSIFY INFECTIONS IN CRITICALLY ILL
PATIENTS: RESULTS FROM AN INTEROBSERVER AGREEMENT STUDY
P.M.C. Klein Klouwenberg, D.S.Y. Ong, L.D. Bos,
F.M. de Beer, M.A. Huson, M. Straat, L.A. van
Vught, L. Wieske, J. Horn, M.J. Schultz, T. van
der Poll, M.J.M. Bonten, O.L. Cremer, Utrecht,
Netherlands
0552
DURATION OF HYPOTENSION DURING SEPSIS DETERMINES THE
EVOLUTION OF ACUTE KIDNEY INJURY
K. Janssen van Doorn, W. Verbrugghe, V. De Wit,
K. Wouters, P. Jorens, Edegem, Belgium
0553
THE CHRONIC HEPATITIS E INFECTION IS ASSOCIATED WITH A SPECIFIC
INTERFERON-RELATED TRANSCRIPTIONAL PROGRAM
J. Textoris, V. Moal, A. Ben Amara, V. Mehraj,
Y. Berland, P. Colson, C. Capo, J.-L. Mège,
Marseille Cedex, France
0554
CLINICAL, LABORATORY AND RADIOLOGICAL DIFFERENCES IN
CRITICALLY ILL AND NON-CRITICALLY ILL H1N1 POSITIVE PATIENTS
M.E. Kelly, B. Moreton, D. Marriot, G. Masterson,
A.S. Brown, M. Mogk, I.D. Welters, Liverpool,
United Kingdom
0555
QUALITY OF ANTIBIOTIC USE IN INTENSIVE CARE UNITS: EVALUATION OF
PARENTERAL VANCOMYCIN USE IN A DUTCH ICU
J. Schouten, I. Verlinden, M. Nabuurs, A. Voss,
H. Huntjens-Fleuren, T. Sprong, Nijmegen,
Netherlands
0556
CLINICAL OUTCOME AND MICROBIOLOGICAL ASPECTS IN SECONDARY
PERITONITIS: THE ROLE OF RECENT ANTIBIOTIC EXPOSURE
R. Jiménez, A. Ortín, S. Rebollo, L. Herrera,
A. Fernández, M. Galindo, S. Moreno, L. Tárraga,
G. Escudero, S. Martínez, A. Ojados, J.M. Castillo,
M.M. Ortiz, J.M. Allegue, Cartagena, Spain
0557
ABDOMINAL INFECTIONS IN THE ICU - DATA FROM THE EPIC II STUDY
J. De Waele, R. Moreno, J. Lipman, C. Martin,
J. Rello, A. Anzueto, Y. Sakr, J. Vincent, Ghent,
Belgium
0558
Poster Corner
MANAGEMENT OF CARDIOVASCULAR PATIENTS
Chairs: Michael Hiesmayr, Vienna, Austria & Barbara McLean, Atlanta, United States
10:10 - 12:00
COMPARATIVE EFFECTS OF DEXMEDETOMIDINE AND CLONIDINE,
ALPHA 2 AGONIST, ON CARDIAC FUNCTION, CORONARY VASOACTIVITY
AND VENTRICULAR ELECTROPHYSIOLOGY IN GUINEA-PIG
S. Shibata, S. Fujisawa, K. Ono, Akita, Japan
0559
CAN CARDIOPULMONARY EXERCISE TESTING HELP TO FAST-TRACK
PATIENTS FOR OPEN AAA REPAIR?
D. Timbrell, J. Gudgeon, S. Tote, Frimley, Surrey,
United Kingdom
0560
COMPARISON OF CUSTODIOL HTK AND REPEATED OXYGENATED
WARM BLOOD CARDIOPLEGIA FOR ARTERIAL SWITCH OPERATION IN
NEONATES
H. Peperstraete, M. Bojan, M. Lilot, L. Tourneur,
P. Vouhé, P. Pouard, Paris, France
0561
THE RELATIONSHIP BETWEEN MELATONIN AND SYSTEMIC
INFLAMMATORY RESPONSE SYNDROME IN PATIENTS UNDERGOING
CARDIOPULMONARY BYPASS
H. Yenice, Z. Özer, G. Eskandari, G. Orekici,
K. Karaca, D. Yapıcı, Mersin, Turkey
0562
INFLAMMATORY MARKERS IN THE LUNG DURING OPEN AORTIC
SURGERY MEASURED BY BRONCHIAL MICRODIALYSIS
S.S. Tyvold, S. Gunnes, O. Lyng, S. Dragsund,
T. Dahl, E. Solligård, P. Aadahl, Trondheim,
Norway
0563
PROPHYLACTIC EFFECT OF DEXMEDETOMIDINE FOR
SUPRAVENTRICULAR ARRHYTHMIA IN CARDIAC POSTOPERATIVE
PATIENTS
T. Niwa, R. Hasegawa, M. Kawase, Y. Nakashima,
T. Ichihara, Seto, Japan
0564
HIGH-SENSITIVE TROPONIN T ASSAY IN THE POSTOPERATIVE CARDIAC
SURGERY
B. Maroto, J.L. Perez, J. Gutierrez, E. Renes,
P. Arribas, M.A. Pierreti, N. Perales, Madrid, Spain
0565
ATRIAL FIBRILLATION; HAEMODYNAMICS AND MORTALITY IN POSTOPERATIVE PATIENTS ON A GENERAL INTENSIVE CARE UNIT
K. Tober, T. Quasim, J. Kinsella, Glasgow, United
Kingdom
0566
PERIOPETARIVE COMPLICATIONS IN ACUTE TYPE A AORTIC SYNDROME
R. Gómez-López, P. Fernández-Ugidos, P. VidalCortés, M.T. Bouza Vieiro, A.V. Aller Fernandez,
L. Seoane Quiroga, J. Priego Sanz, A. Ceniceros
Barros, B. Besteiro Grandio, F.R. Pampin Huerta,
S. Fojon Polanco, J.M. Lopez Perez, E. Rodriguez
Garcia, Ourense, Spain
0567
L I V E S 2 012
M. Zambon, G. Bertarelli, G. Landoni,
L. Fumagalli, G. Borghi, G. Marino, A. Zangrillo,
Milan, Italy
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Evora
INCREASED INCIDENCE BUT DECREASED MORTALITY OF METICILLIN
RESISTANT STAPHYLOCOCCUS SPECIES (MRS) INFECTIONS IN A CARDIAC
SURGICAL INTENSIVE CARE UNIT
147
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
148
Area Faro
HIGH-SENSITIVE TROPONIN T ASSAY IN THE DIAGNOSIS OF
PERIOPERATIVE MYOCARDIAL INFARCTION AFTER HEART SURGERY
B. Maroto Rodríguez, J. Gutierrez Rodríguez,
J.L. Pérez Vela, P. Arribas López, M.A. Corres
Pieretti, N. Pereales Rodríguez de Viguri, Madrid,
Spain
0568
EVALUATION OF DEXMEDETOMIDINE HYDROCHLORIDE AS A BASAL
AGENT IN CONSERVATIVE THERAPY FOR ACUTE AORTIC DISSECTION
S. Naruse, Y. Kawashima, H. Kato, C. Ishida,
K. Mizuno, S. Mimura, S. Mimuro, Y. Obata,
M. Doi, S. Sato, Hamamatsu, Japan
0569
CLINICAL CHARACTERISTICS AND INITIAL MANAGEMENT OF ACUTE
TYPE A AORTIC SYNDROME
R. Gómez-López, P. Fernández-Ugidos, P. VidalCortés, M.T. Bouza-Vieiro, A.V. Aller-Fernández,
L. Seoane-Quiroga, J. Priego-Sanz, A.I. Suarez
Freire, V. Rodriguez Lopez, I. Astola Hidalgo,
S. Fojon-Polanco, J.M. López-Pérez, E. Rodriguez
García, Ourense, Spain
0570
HAEMODYNAMIC AND OXYGEN TRANSPORT DURING
AORTOCORONARY SHUNTING ON THE WORKING HEART
R.A. Ibadov, A.A. Mansurov, A.S. Arifjanov,
Z.N. Mansurov, N.A. Strijkov, Tashkent,
Uzbekistan
0571
HAEMODYNAMIC CHANGES AFTER AORTIC CLAMPING AND
UNCLAMPING IN ELECTIVE ABDOMINAL AORTIC SURGERY - AORTIC
ANEURYSM DISEASE VERSUS AORTIC OCCLUSIVE DISEASE
J. Bisgaard, H.K. Joergensen, T. Gilsaa, Kolding,
Denmark
0572
Poster Corner
VENTILATORY SUPPORT IN THE BRAIN-INJURED PATIENT
Chairs: Bernard Vigué, Kremlin-Bicetre, France & Arjen Slooter, Utrecht, Netherlands
10:10 - 12:00
IS PACO2 MANAGEMENT OPTIMAL UNDER CONTROLLED MECHANICAL
VENTILATION (CMV) DURING NEURO-RESUSCITATION?
L. Piquilloud, P. Reichmuth, M. Oddo, P. Jolliet,
J.-P. Revelly, Lausanne, Switzerland
0573
HIGH FREQUENCY OSCILLATORY VENTILATION (HFO) COMBINED
WITH TRACHEAL GAS INSUFFLATION (TGI) AS A RESCUE VENTILATION
STRATEGY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
(ARDS) AND TRAUMATIC BRAIN INJURY (TBI)
C.S. Vrettou, S. Malachias, S.G. Zakynthinos,
S.D. Mentzelopoulos, Athens, Greece
0574
HIGH-FREQUENCY OSCILLATORY VENTILATION IN PATIENTS WITH
CEREBRAL ANEURISMS RUPTURE
A. Solodov, S. Petrikov, E. Komardina,
E. Karapetyan, Y. Titova, V. Krylov, Moscow,
Russian Federation
0575
HAEMODYNAMIC AND OXIMETRIC STABILITY DURING APNEA TESTING
IN CPAP
C. González-Fernández, I. Rubio-López,
M.A. Ballesteros-Sanz, M. López-Sánchez,
J.C. Rodríguez-Borregán, F.J. Burón-Mediavilla,
E. Miñambres- García, A. Quesada-Suescun,
Santander, Spain
0576
SEVOFLURANE SEDATION USING THE ANAESTHETIC CONSERVING
DEVICE AFTER NEUROSURGERY
R. Badenes, L. Alcover, M. De Fez, M.J. Montero,
L. Henao, A. Gómez, V. Quilis, J. Belda, Valencia,
Spain
0577
USE OF A HEATED HUMIDIFIER ALLOWS TO SAFELY REDUCE TIDAL
VOLUME IN PATIENTS WITH ACUTE BRAIN AND LUNG INJURY
F.A. Idone, S. Pitoni, A. Moccaldo,
M.T. Santantonio, M.M. Bitondo, A. Caricato,
M. Antonelli, S.M. Maggiore, Roma, Italy
0578
TRACHEOSTOMY INSERTION ON THE NEUROCRITICAL CARE UNIT
(NCCU): A 3 YEAR RETROSPECTIVE REVIEW
D.J. Stubbs, A. Longworth, R. Burnstein,
Cambridge, United Kingdom
0579
PREDICTING FACTORS OF PROLONGED MECHANICAL VENTILATION AND
NEED OF TRACHEOTOMY IN PATIENTS WITH SEVERE HAEMORRHAGIC
STROKE
F. Hernandez-Hazañas, M.L. Gascon Castillo,
J.J. Egea Guerrero, C. Garcia Alfaro, P.I. Jimenez
Fernandez, J.M. Dominguez Roldan, Sevilla,
Spain
0580
BENEFITS OF PERFORMING EARLY TRACHEOSTOMY IN THE INTENSIVE
CARE UNIT OF A SECONDARY LEVEL HOSPITAL OF NORTH INDIA, OUR
TWO YEARS EXPERIENCES
D. Dhanda, N.C. Dhanda, Patiala, India
0581
EARLY VERSUS LATE TRACHEOSTOMY IN PATIENTS WITH ACUTE BRAIN
INJURY
K. Tsikritsaki, G. Koukoulitsios, K. Mendrinou,
I. Tsiouboutariou, I. Andrianakis, P. Dourou,
M. Mavromati, N. Panagiotopoulou, K. Tsironas,
P. Spyrou, M. Paidonomos, Athens, Greece
0582
13-17 October 2012
L I V E S 2 012
Visit us
at boot
h
17
Lunch Symposium
Volume Therapy
in Surgery and ICU
Tuesday, 16th October 2012
12:30 – 14:00h, Room Geneva
Prof. Hugo Van Aken, Germany
Moderator
Lunch Symposium
Good Clinical
Nutrition Practice
12:30 – 14:00h
Room Geneva
The use of colloids in patients
with head injury
Prof. Hugo Van Aken, Germany
Safety of modern HES in surgery
Prof. Richard Weiskopf, USA
Efficacy and safety of HES 130/0.4 in trauma
Satellite Symposium
Effective Glycaemia Control
18:15 – 19:15h
Room Stockholm
Associate Prof. William Lance Michell, South Africa
Role of HES in the ICU
Prof. Martin Westphal, Germany
[dexmedetomidine hcl] injection
Rapid and sustained benefits
for the failing heart
Cooperative comfortable
sedation
You are most welcome to join us for the Lunch Satellite Symposium
EMERGING THERAPEUTIC OPTIONS
FOR THE ICU PATIENT
Tuesday 16 October at 12:30 – 14:00
Room Rome, Lisboa Congress Centre
CHAIRS
Mervyn Singer, London, UK
Miguel Tavares, Oporto, Portugal
TOPICS AND SPEAKERS
DEXMEDETOMIDINE AND LEVOSIMENDAN – NEW STUDIES, NOVEL INSIGHTS
Mervyn Singer, London, UK
SEDATION, IMMUNOMODULATION AND DELIRIUM
Robert Sanders, London, UK
PHARMACOLOGICAL STRATEGIES TO IMPROVE WEANING FROM MECHANICAL VENTILATION
Leo Heunks, Nijmegen, The Netherlands
Welcome!
0583
PHYSIOLOGICAL VARIABLES DERANGEMENTS ARE POWERFUL
PREDICTORS OF OUTCOME AFTER TRAUMATIC BRAIN INJURY
C. Capisani, C. Guerzoni, C. Bagna,
I. Mastromauro, F. Civiletti, C. Filippini,
T. Howells, I. Piper, C. Micelli, F. Mafrica, V. Fanelli,
L. Mascia, Torino, Italy
0584
ANALYSIS OF ARTIFICIAL RESPIRATION, CONTROLLED VOLUME AND
PRESSURE, IN PATIENTS WITH HAEMORRHAGIC STROKE
A. Gritsan, A. Gazenkampf, N. Dovbish,
Krasnoyarsk, Russian Federation
0585
TREATMENT OF COMBINED BURN AND SMOKE INHALATION INJURY
WITH COMBINED ANTICOAGULANTS VS. SOLE ANTITHROMBIN:
POTENTIAL BENEFITS AND PITFALLS
S. Rehberg, Y. Yamamoto, L. Sousse, D.L. Traber,
P. Enkhbaatar, Galveston, United States
0586
IS ABSOLUTE OESOPHAGEAL PRESSURE RELATED TO SEVERITY OF
ILLNESS IN ALI/ARDS PATIENTS?
D. Chiumello, M. Cressoni, A. Marino, M. Brioni,
I. Cigada, F. Menga, M. Amini, L. Gattinoni,
Milan, Italy
0587
CHANGES IN THE INCIDENCE, TREATMENT AND MORTALITY OF ARDS IN
A WHOLE NATION OVER 23 YEARS OF FOLLOW-UP
M.I. Sigurdsson, A.D. Möller, T.S. Gunnarsson,
K. Sigvaldason, G.H. Sigurdsson, Reykjavik,
Iceland
0588
RECRUTEMENT MANOEUVERS IN ACUTE LUNG INJURY/ACUTE
RESPIRATORY DISTRESS SYNDROME. A SYSTEMATIC REVIEW
C. Guérin, L. Ayzac, Lyon, France
0589
EXTRACORPOREAL MEMBRANE OXYGENATION IN PATIENTS WITH
HAEMATOLOGIC MALIGNANCIES AND SEVERE ACUTE RESPIRATORY
DISTRESS SYNDROME
P. Schellongowski, R. Ullrich, O. Robak,
A. Bojic, A. Hermann, W.R. Sperr, W. Rabitsch,
P. Knoebl, V. Fuhrmann, K. Laczika, G.J. Locker,
T. Staudinger, Vienna, Austria
0590
PROGNOSIS OF PATIENTS UNDER MECHANICAL VENTILATION WHO
NEED EARLY REINTUBATION
A. Corrales Cruz, E. Gonzalez, A. Murillo Martin,
M.A. Garijo Catalina, J.M. Añón Elizalde,
M. Quintana, A. Garcia de Lorenzo, V. Córcoles,
C. Martin Delgado, A. García Fernandez, R. Diaz
Alersi, J. Montejo, J. López Martinez, Cuenca,
Spain
0591
INTUBATION-RELATED TRACHEAL ISCHAEMIC LESIONS: INCIDENCE, RISK
FACTORS AND OUTCOME
S. Nseir, L. Touat, C. Fourrier, P. Ramon,
A. Durocher, Lille, France
0592
A SYSTEMATIC REVIEW OF PHARMACOTHERAPIES FOR ACUTE
RESPIRATORY DISTRESS SYNDROME (ARDS)
A. Duggal, A. Ganapathy, M. Ratnapalan,
J. Tsang, T. Sinuff, K.E. Burns, M.O. Meade,
N. Adhikari, Toronto, Canada
0593
HAEMODYNAMIC EFFECTS OF PRONE POSITIONING IN PATIENTS WITH
ACUTE RESPIRATORY DISTRESS SYNDROME
M. Jozwiak, R. Persichini, J.L. Teboul, S. Silva,
D. Chemla, N. Anguel, C. Richard, X. Monnet, Le
Kremlin Bicetre, France
0594
EVALUATION OF UTILISATION OF INHALED NITRIC OXIDE IN ARDS
PATIENTS IN A UNIVERISITY HOSPITAL: ARE THERE SUBGROUPS WHO
RESPOND BETTER?
R. Sarkar, S. Kudsk-Iversen, J. Walker, L. Poole,
0595
NON-PHARMACOLOGICAL TREATMENTS FOR ALI/ARDS. AN ESICM
SYSTEMATIC REVIEW
C. Guérin, L. Ayzac, Lyon, France
0596
TIMING OF ARDS RESOLUTION UNVEILED - RELIABILITY OF T.A.R.U.
STUDY
K. Rahul, M. Vela, M. Biehl, G. Li, A. Ahmed,
O. Gajic, E. Bloomfield, Rochester, United States
0597
IMPACT OF THE IMPLEMENTATION OF A PROTOCOL-DIRECTED
MANAGEMENT ON THE SURVIVAL OF PATIENTS WITH ACUTE
P. Beuret, N. Pelletier, B. Philippon, X. Fabre,
M. Kaaki, S. Quenet, Roanne, France
0598
UTILITY ARDSNET MODEL OF MORTALITY IN PATIENTS WITH ACUTE
M.A. Pomposo, E. Monares, R. Chaires,
M. Poblano, J. Aguirre, J. Franco, Mexico, Mexico
0599
Area Fatima
Poster Corner
Chairs: Anders Larsson, Uppsala, Sweden & Marcelo Amato, Sao Paulo, Brazil
10:10 - 12:00
L I V E S 2 012
F. Hernandez Hazañas, M.L. Gascon Castillo,
P.I. Jimenez Fernandez, C. Garcia Alfaro,
J.M. Dominguez Roldan, F. Murillo Cabezas,
Sevilla, Spain
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
DIFFUSE AXONAL INJURY AS A PREDICTOR OF NEED OF PROLONGED
MECHANICAL VENTILATION IN HEAD INJURED PATIENTS
151
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Funchal
Poster Corner
ABDOMINAL COMPLICATIONS IN THE ICU
Chairs: Manu Malbrain, Antwerp, Belgium & Bernhard Walder, Geneva, Switzerland
10:10 - 12:00
EFFECT OF THORACIC EPIDURAL ANALGAESIA ON THE INCIDENCE OF
COMPLICATIONS IN PATIENTS UNDERGOING COLONIC AND RECTAL
CANCER SURGERY: A RETROSPECTIVE ANALYSIS OF DATA FROM 610
PATIENTS
D. Levit, A. Podgorbunskikh, A. Levit,
Ekaterinburg, Russian Federation
0600
LONG-TERM MORTALITY IN PEPTIC ULCER PERFORATION - A FOLLOWUP STUDY
M.H. Møller, M. Vester-Andersen, R.W. Thomsen,
Copenhagen, Denmark
0601
DEMOGRAPHICS AND OUTCOME OF PATIENTS SUBMITTED TO MAJOR
ABDOMINAL SURGERY
R. Rosa, J.A. Lopes, C. Teixeira, N. Rodrigues,
R. Branco, I. Mendes, L. Peixoto, S. Dias, A. Gomes
da Costa, H. Bicha Castelo, Lisbon, Portugal
0602
POSTOPERATIVE HIGH FREQUENCY CHEST WALL OSCILLATION THERAPY
IN CRITICALLY ILL ABDOMINAL SURGERY PATIENTS: RANDOMISED
CONTROLLED STUDY
S. Kaya, R. Coskun, K. Gundogan, M. Guven,
M. Sungur, Kayseri, Turkey
0603
EXTENDED MEASUREMENTS OF INTRA-ABDOMINAL PRESSURE DO NOT
INCREASE THE DETECTION RATE OF INTRA-ABDOMINAL HYPERTENSION
A. Reintam Blaser, S. Sarapuu, K. Tamme,
J. Starkopf, Tartu, Estonia
0604
INTENSIVE CARE UNIT ADMISSION AFTER CYTOREDUCTIVE SURGERY
AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY. AN
INEVITABLE MEASURE?
V.M. Piot, M.P. Buise, I.H. deHingh, Eindhoven,
Netherlands
0605
HYPERLACTATEMIA PREDICTS POSTOPERATIVE FISTULA AFTER
PANCREATIC SURGERY
N. De Schryver, X. Wittebole, C. Hubert, J.F. Gigot, P.-F. Laterre, D. Castanares-Zapatero,
Brussels, Belgium
0606
THE DEVELOPMENT CHARACTERISTIC OF RESPIRATORY COMPLICATIONS
IN THE EARLY POSTOPERATIVE PERIOD AFTER SURGERIES PERFORMED
ON OESOPHAGUS
A.S. Arifjanov, L.A. Nazirova, R.A. Ibadov,
N.A. Strijkov, Tashkent, Uzbekistan
0607
VALUE OF C REACTIVE PROTEIN AND PROCALCITONINE IN THE
EVALUATION OF GRAPH FUNCTION AFTER LIVER TRANSPLANT
G. Seller-Perez, M. Herrera Gutierrez, R. LozanoSaez, C. Aragon-Gonzalez, E. Aguiar-Flores,
G. Quesada-Garcia, Malaga, Spain
0608
DOES INDOCYANINE GREEN (IG) CLEARANCE (IGC R15) PREDICT
MORBIDITY AND MORTALITY AFTER HEPATIC RESECTION FOR
HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS?
E. Mazza, D. Kroeller, M. Prosperi, M.C. Grugni,
O. Amici, E. Roselli, L. De Carlis, M. Nichelatti,
A. De Gasperi, Milan, Italy
0609
PREOPERATIVE CARDIAC RISK EVALUATION (PCRE) IN LIVER
TRANSPLANT (LTX) CANDIDATES: REVISITING THE PROCESS TO TARGET
THE APPROACH OF THE ASYMPTOMATIC CANDIDATE
A. De Gasperi, M. Cova, E. Mazza, G. Pesce,
F. Tardini, M. Prosperi, A. Corti, Milan, Italy
0610
EMERGENCY LAPAROTOMIES; OUTCOME ON SURGICAL MORTALITY;
THE EFFECT OF A ROUTINE ADMISSION POLICY FOR POSTOPERATIVE
PATIENTS TO CRITICAL CARE (ITU AND HDU) FOLLOWING EMERGENCY
SURGERY
S. Jankowski, L. Mulleague, K. Hornby, M. Lister,
J. Denman, Surrey, United Kingdom
0611
AUDIT OF LEVEL OF CARE AND EMERGENCY LAPAROTOMIES
B.S. Grewal, A. Ramoutar, P. Patel, M. Dawson,
Derby, United Kingdom
0612
EMERGENCY LAPAROTOMY- USE OF CRITICAL CARE RESOURCES AND
MORTALITY IN A UK TEACHING HOSPITAL
A. Trimmings, M. Paul, S. Tilston, A. Canavan,
D. Helm, P. Tinga, Brighton, United Kingdom
0613
152
13-17 October 2012
L I V E S 2 012
EMERGENCY MEDICINE
10:10 - 12:00
CLINICAL SIGNIFICANCE OF PROCALCITONIN (PCT) LEVELS IN PATIENTS
WITH SUSPECTED INFECTION ADMITTED TO THE EMERGENCY
DEPARTMENT
T. Mauri, B. Cambiaghi, M. Corciulo, V. Riva,
R. Stracka, M. Sandini, A. Pradella, S. Magni,
L. Carati, A. Pesenti, C. Giannattasio, Monza,
Italy
0614
HAEMOPERITONEUM SEMI-QUANTITATIVE ANALYSIS ON HOSPITAL
ADMISSION IMPROVES THE PREDICTION OF MASSIVE TRANSFUSION: A
STUDY OF 381 SEVERELY INJURED PATIENTS WITH BLUNT ABDOMINAL
TRAUMA
J. Charbit, M. Mahul, O. Martinez, I. Millet,
P. Taourel, X. Capdevila, Montpellier, France
0615
DETERMINATION OF GAS FLOW VIA AIRWAY EXCHANGE CATHETERS
USED FOR AIRWAY EMERGENCIES
C. Gore, K. Schebesta, G. Ihra, London, United
Kingdom
0616
ARE WE STUCK IN PROFESSIONAL SILOS? A NEEDS ANALYSIS FOR INTERHOSPITAL PATIENT TRANSFER TRAINING
A. Muchembled, C. Coyle, H. Snelgrove,
G. Mcanulty, M. Teig, E. Ogilvie, A. Toner,
0617
EVALUATION OF CONTINUOUS NON-INVASIVE BLOOD
PRESSURE MEASUREMENT USING CNAP DURING INTERHOSPITAL
TRANSPORTATION OF INTENSIVE CARE PATIENTS
F. Reifferscheid, C. Ilies, L. Moikow, R. Hanss, Kiel,
Germany
0618
CHARACTERISTICS OF PATIENTS ADMITTED TO THE INTENSIVE CARE
UNIT FOLLOWING SELF-POISONING IN AN IRISH HOSPITAL
A. Mc Mahon, E. Dunne, G. Fitzpatrick, Dublin,
Ireland
0619
THE EFFECTS OF CHANGES TO RESUSCITATION GUIDELINES ON THE
INCIDENCE OF SEVERE CHEST WALL INJURY IN COMATOSE SURVIVORS
OF OUT OF HOSPITAL CARDIAC ARREST
K.S. Ang, N. Young, Edinburgh, United Kingdom
0620
HIGH SENSITIVITY CARDIAC TROPONIN AS A SCREENING TOOL IN A
GENERAL EMERGENCY DEPARTMENT
L. Bronze, M. Monteiro, A. Dias, L. Almeida,
P. Marques, C. Simões, C. Catalão, A. Aleixo,
Lisbon, Portugal
0621
A PROSPECTIVE INTERVENTION STUDY TO COMPARE EFFICIENCY
OF DIFFERENT COOLING TECHNOLOGIES FOR MILD THERAPEUTIC
HYPOTHERMIA
P. Sonder, G.N. Janssens, C.L. Henry, C. Dezfulian,
J. Rittenberger, C. Callaway, A.R. Girbes,
A. Beishuizen, K.H. Polderman, Pittsburgh,
United States
0622
INTEGRATION OF A CARDIAC OUTPUT MONITORING SYSTEM INTO A
SEPSIS MANAGEMENT BUNDLE IN THE EMERGENCY DEPARTMENT
R. Allin-Khan, M. Abu-Habsa, P. Holmes,
M. Patterson, T. Harris, London, United Kingdom
0623
THE STRONG ION GAP IN THE EMERGENCY DEPARTMENT
J. Grundlingh, V. Jessop, T. Harris, London,
United Kingdom
0624
NON-INVASIVE VENTILATION (NPPV/CPAP) IN PATIENTS WITH CHEST
TRAUMA: A SYSTEMATIC REVIEW
A. Duggal, P. Perez d’Empaire, L. Tremblay,
T. Sinuff, Toronto, Canada
0625
HEAD INJURY (TBI) LIGHT: IS IT BE WORSE ANTIPLATELET OR
ANTICOAGULATION?
M. Quintana, R.E. Rodiles, M. Martí, S. Fabra,
A.M. Borobia, M.A. Rivera, A.M. Martinez Virto,
Madrid, Spain
0626
USE OF TOLVAPTAN IN INTENSIVE CARE PATIENTS
S. Mimuro, T. Kimura, S. Naruse, M. Doi, S. Sato,
Hamamatsu, Japan
0627
Area Porto Poster Corner
Nurses
&
AHP
END OF LIFE CARE - ETHICS OF RESEARCH
Chairs: Julie Benbenishty, Jerusalem, Israel & Paulo Maia, Porto, Portugal
10:10 - 12:00
WHO SHOULD CARE FOR ADVANCE DIRECTIVES?
F. Gigon, P. Merlani, B. Ricou, Geneva,
Switzerland
0628
END-OF-LIFE DECISION-MAKING IN PATIENTS WITH SEVERE SEPSIS
D. Schwarzkopf, I. Westermann, H. Skupin,
R. Pfeifer, M. Fritzenwanger, A. Guenther,
B. Kabisch, I. Peschel, C. Engel, U. Settmacher,
T. Doenst, K. Reinhart, C.S. Hartog, Jena,
Germany
0629
PRACTICES AND PERCEPTIONS OF CAREGIVERS IN THE DECISIONMAKING PROCESS (DMP) FOR WITHDRAWING LIFE-SUPPORTING
TREATMENTS (LST): A FRENCH SURVEY
S. Valera, I. Vinatier, M.-L. Baillot, I. BourgeonGhittori, C. Clec’h, K. Couchoux, V. Franja,
S. Jeune, V. Lombardo, S. Lusso, Y. Maetens,
C. Mossadegh, E. Rosset, B. Souweine, M. Lloung,
Paris, France
0630
L I V E S 2 012
Poster Corner
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Guarda
Chairs: Hans Friberg, Lund, Sweden & Bernd Böttiger, Heidelberg, Germany (TBC)
153
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
154
PARENTAL EXPERIENCE OF END-OF LIFE CARE IN THE PAEDIATRIC ICU: A
QUALITATIVE STUDY IN THE ITALIAN CONTEXT
A. Giannini, G. Lamiani, I. Fossati, E. Prandi,
E. Vegni, Milan, Italy
0631
PRELIMINARY EXPERIENCE WITH THE INTRODUCTION OF THE
LIMITATION OF LIFE-SUSTAINING THERAPIES IN THE ELECTRONIC
MEDICAL RECORD
R. Poyo-Guerrero, M. Aranda Perez,
A. Mendiguren, L. Socias, M. Borges Sa, G. Rialp,
Palma de Mallorca, Spain
0632
COMBINING QUANTITATIVE AND QUALITATIVE METHODOLOGIES:
DISCREPANCIES OR SYNERGIES?
J.M. Weld, D. Phelan, M. Curran, C. Breen,
M. Fitzgibbon, M. Hanlon, M. McGovern,
M. Slater, Dublin, Ireland
0633
PROGNOSIS OF PATIENTS WITH NON RESECTABLE LUNG CANCER
ADMITTED IN ICU: A 6-YEAR SINGLE-CENTRE SURVEY
C. Guervilly, S. Ollier, M. Adda, A. Loundou,
A. Roch, J.-M. Forel, L. Papazian, Marseille,
France
0634
AGE AND END-OF-LIFE DECISIONS IN PORTUGUESE ICU (RESULTS FROM
THE DEFIVUCI STUDY)
A. Carneiro, A. Dias, A. Amaro, C. Tapadinhas,
F. Esteves, L. Santos, J. Vaz, P. Fernandes,
P. Marçal, Z. Costa E Silva, C. Dias, A.T. Pinto,
Porto, Portugal
0635
DIFFERENT POINT OF VIEW IN THERAPY RESTRICTION. COMPARISON
OF THE OPINIONS OF HUNGARIAN INTENSIVE CARE NURSES AND
PHYSICIANS
L. Zubek, G. Élő, L. Szabó, O. Szűcs, C. Varga,
J. Gál, Budapest, Hungary
0636
TREATMENT OF TERMINAL PATIENTS IN AN INTENSIVE CARE UNIT (ICU/
HU)
R.D. Moritz, F.O. Machado, Florianopolis, Brazil
0637
END OF LIFE ISSUES IN EUROPEAN ICU´S
L.M. De Giudici, M. Melis, Cagliari, Italy
0638
ETHICS OF HOSPITAL RESUSCITATION - OPINIONS OF DOCTORS
J. Bartczak, T. Zawada, W. Mielnicki, Z. Sycz,
0639
RESULTS OF ORGAN DONATION PROGRAMME IN OUR HOSPITAL FROM
2004 TO 2011
Z. Gavranovic, A. Horvat, A. Gopcevic, M. Vucic,
B. Rode, Zagreb, Croatia
0640
VERY ELDERLY PATIENTS IN INTENSIVE CARE UNIT. ANALYSIS AND
OUTCOME OF A GROWING POPULATION
A. Alvarez Saiz, E. Pino Moya, P. Ortega Zarza,
I. Romero Barroso, O. Barakat, H. González
Pinero, Minas de Riotinto, Spain
0641
PROJECT ICU WITHOUT WALLS: EFFECT ON MORBIDITY AND MORTALITY
OF THE PATIENTS OF INTENSIVE CARE UNIT (ICU)
A. Abella, C. Hermosa, V. Enciso, I. Torrejón,
I. Salinas, J.J. Sicilia, T. Mozo, E. Calvo, F. Gordo,
Coslada, Spain
0642
INCREASED MORTALITY ASSOCIATED WITH BEFORE NOON ADMISSION
TO INTENSIVE CARE: A RETROSPECTIVE ANALYSIS
J. Moreno Cuesta, T. Prabhahar, H. Runyaro
Murwisi, A.-F. Chan, M. Sivarajaratnam,
F. Kovari, R. Kumarakulasingam, G. Park,
0643
EFFICACY OF AN OUTREACH TEAM IN COMPARING OUR TWO HOSPITAL
SITES REGARDING TIME FROM DECISION TO ADMISSION TO INTENSIVE
CARE UNIT
R. Dhotarkar, J. Ricketts, A. Csomos, High
Wycombe, United Kingdom
0644
ESTIMATED TOTAL AND ADVANCED RESPIRATORY SUPPORT BED DAYS
FOR PATIENTS WITH TRACHEOSTOMIES IN CRITICAL CARE UNITS IN
ENGLAND
B. McGrath, R. Templeton, Manchester, United
Kingdom
0645
IMPACT OF ICU OCCUPANCY ON SURVIVAL OF SEPSIS PATIENTS
ADMITTED VIA THE EMERGENCY DEPARTMENT
D. Yergens, P. Faris, R. Jolley, H. Quan, W.A. Ghali,
C.J. Doig, Calgary, Canada
0646
RELATIONSHIP BETWEEN DISTANCE TRAVELLED TO AN INTENSIVE CARE
UNIT AND HOSPITAL OUTCOMES IN PATIENTS WITH SEPSIS AND SEVERE
SEPSIS
R. Jolley, A. Patel, D. Yergens, C.J. Doig, Calgary,
Canada
0647
INTENSIVE CARE UNIT IN THE EMERGENCY DEPARTMENT: A POSITIVE
EXPERIENCE FROM A TAIWAN TERTIARY MEDICAL CENTRE
Y.-L. Chan, C.-H. Li, S.-S. Chang, K.-F. Chen,
J.-C. Tseng, F.-L. Wang, T.-F. Chiu, J.-C. Chen,
Taoyuan, Taiwan, Republic of China
0648
OFF-HOURS ICU ADMISSION AND ITS IMPACT ON MORTALITY: A SINGLE
CENTRE EXPERIENCE
M. Tay, W.J. Ngerng, T. Kiong, K.C. See,
H.J. Khalizah, H.S. Yip, M.Y. Chew, A. Tan,
H.F. Lim, R. Capistrano, Y.H. Ting, R. Narendran,
W.L. Tan, C.H. Tan, J. Phua, Singapore, Singapore
0649
Area Setubal
Poster Corner
ORGANISATION OF INTENSIVE CARE
Chairs: Arie Bastiaan Johan Groeneveld, Amsterdam, Netherlands & Brian Marsh, Dublin, Ireland
10:10 - 12:00
13-17 October 2012
L I V E S 2 012
25th European Society of Intensive Care Medicine (ESICM) Annual Congress: Lives 2012
Lisbon, Portugal, 13-17 October 2012
Pfizer International Operations-sponsored satellite symposium
MRSA nosocomial pneumonia today:
how can we ensure optimal outcomes?
Tuesday 16 October 2012, 12:30-14:00
Glasgow Room, Centro de Congressos de Lisboa
Programme
Co-chairs: Tobias Welte (Hannover, Germany) and Jean-François Timsit
(Grenoble, France)
12:30-12:35
Tobias Welte
12:35-13:00
How do I ensure appropriate
therapy for my patients with
MRSA nosocomial pneumonia?
Alexander Soriano
(Barcelona, Spain)
13:00-13:25
How can I avoid the pitfalls of
MRSA VAP diagnosis and treatment?
Jean Chastre
(Paris, France)
13:25-13:50
What do the MRSA nosocomial
pneumonia guidelines mean for me?
Tobias Welte
13:50-14:00
Q&A
All
For Portuguese prescribing information, please consult Zyvoxid SmPC (available upon request)
SpecialtyCare
Care
Speciality
EU.ZYVOX.2012.033
SYMPOSIUM 2
CO 2 REDUCTION, SOMETHING WE
SHOULD CARE ABOUT!
Welcome to the MAQUET sponsored symposium.
Program:
Introducing a new therapy for CO2 removal with pump
How much CO 2 is too much CO 2?
assisted lung protection (PALP®). Come visit our booth for
Wolfram Windisch, MD, PhD, Cologne State Hospital,
product information, one to one talks and more.
Cologne, Germany
CO 2 reduction, something we should care about!
Time: Tuesday October 16, 12:00–14:30
Place: Room Paris
Chairpersons:
Antonio Pesenti, MD, PhD, University of Milan-Bicocca,
Milan, Italy and Alain Combes, MD, PhD, Groupe Hospitalier
Pitié-Salpêtrière, Paris, France
Maquet Cardiopulmonary AG | maquet.com CO 2 Removal in early ARDS, a paradigm change?
Alain Combes, MD, PhD, Groupe Hospitalier PitiéSalpêtrière, Paris, France
CO 2 Removal, the fast line in the emergency room?
Roberto Roncon de Albuquerque, MD, PhD, Hospital
de Sao Joao, Porto, Portugal
0650
FIRST DATA OF ANALYSIS OF HANDOVER FROM INTENSIVE CARE UNIT
TO MEDICAL HIGH DEPENDENCY UNIT
G. Zagli, G. Toccafondi, M. Bonizzoli, F. Pieralli,
R. Tartaglia, C. Nozzoli, A. Peris, Florence, Italy
0651
OBSERVATIONAL PROSPECTIVE STUDY OF WHICH PATIENTS WOULD
BENEFIT FROM A FOLLOW UP PROGRAM ON THE WARD AFTER BEING
DISCHARGED FROM ICU
P. Martinez-Lopez, N. Zamboschi, C. ReinaArtacho, M.V. De la Torre-Prados, Malaga, Spain
0652
INTERHOSPITAL TRANSFERS IN A NON-TERTIARY HOSPITAL - DOES THE
PRACTICE MEET THE GUIDELINES?
M. Rooms, F. Kovari, London, United Kingdom
0653
ICU MORTALITY RATES IN ADMISSIONS DURING WEEKENDS, NIGHTS
AND OUT-OF-HOURS
M.S.F. Chong, H. Martin, C. Mearns, P. Morgan,
0654
REORGANISATION OF ADMISSION DEPARTMENT AND CREATION
THE EMERGENCY DEPARTMENT IN KIPSHIDZE CENTRAL UNIVERSITY
HOSPITAL (TBILISI, GEORGIA)
V. Kaloiani, Tbilisi, Georgia
0655
MORTALITY EVOLUTION IN THE LAST DECADE IN PAEDIATRIC INTENSIVE
CARE - A MULTIDISCIPLINARY UNIT EXPERIENCE
C. Carvalho, M. Margatho, F. Neiva, A. Dinis,
A. Dias, T. Dionísio, L. Carvalho, J.F. Farela Neves,
Coimbra, Portugal
0656
“EARLY LACTATE AREA” AS AN OUTCOME PREDICTOR IN PAEDIATRIC
SEPTIC SHOCK
Y.A. Kim, E.-J. Ha, W.K. Jhang, S.J. Park, Seoul,
Republic of Korea
0657
NOSOCOMIAL INFECTIONS IN THE PAEDIATRIC INTENSIVE CARE UNIT:
ANALYSIS OF RISK FACTORS
E. Esteban, R. Ferrer, M. Urrea, L. Rozas,
M. Balaguer, F.J. Cambra, I. Jordan, Esplugues de
Llobregat, Spain
0658
COMPLICATIONS OF EMERGENT ENDOTRACHEAL INTUBATION IN
CHILDREN AND ADOLESCENTS IN THE INTENSIVE CARE UNIT AND
EMERGENCY ROOM
S. Kajihara, F. Shinichi, T. Tanaka, M. Kusumoto,
Y. Yamaguchi, Y. Saji, H. Takeda, Y. Uetani, Kobe
City, Japan
0659
MENINGOCOCCAL DISEASE ADMISSIONS IN A PAEDIATRIC INTENSIVE
CARE UNIT
C. Pinto, G. Januario, S. Ferreira, A. Dinis,
L. Carvalho, F. Neves, Coimbra, Portugal
0660
EALY GOAL-DIRECTED THERAPY IN PAEDIATRIC PATIENTS WITH SEVERE
BURN INJURY
A. Lekmanov, D. Azovskiy, S. Pilyutik,
M. Astamirov, Moscow, Russian Federation
0661
PAEDIATRIC HYPOTENSION: QUANTIFICATION OF THE DIFFERENCES
BETWEEN THE TWO CURRENT DEFINITIONS
H.H. Shieh, A.E. Gilio, E.R. Barreira, E.J. Troster,
A.M. Cordeiro Ventura, P.F. Goes, D.C. Souza,
J.M. Sinimbu Filho, A. Bousso, Sao Paulo, Brazil
0662
INTRA-ABDOMINAL TUMORS IN A PICU
E. Blevrakis, T. Tavladaki, A.M. Spanaki,
E. Vasilaki, S. Ilia, E. Geromarkaki, M.D. Fitrolaki,
G. Briassoulis, Heraklion, Greece
0663
INFLUENZA A (H1N1) VIRUS IN A PICU
E. Blevrakis, T. Tavladaki, A.M. Spanaki,
M.D. Fitrolaki, S. Ilia, E. Vasilaki, E. Geromarkaki,
0664
ARTERIAL THROMBOPHILIA IN PAEDIATRIC INTENSIVE CARE UNIT
T. Tavladaki, E. Blevrakis, A.M. Spanaki, S. Ilia,
M.D. Fitrolaki, E. Geromarkaki, E. Vasilaki,
0665
IMMUNE CONDITION IN CHILDREN WITH NEPHROTIC SYNDROME
A.M. Sharipov, K.A. Khamzayev, Tashkent,
Uzbekistan
0666
ACUTE FLACCID PARALYSIS IN PAEDIATRIC CARE UNIT (PICU)
T. Tavladaki, E. Blevrakis, A.M. Spanaki,
E. Vasilaki, E. Geromarkaki, D. Fitrolaki, S. Ilia,
0667
PREDICTIVE FACTORS FOR NIV SUCCESS IN ACUTE RESPIRATORY FAILURE
AT CHILDREN
I. Klironomi, E. Celaj, E. Kola, R. Lluka, A. Vula,
D. Sala, G. Sallabanda, S. Sallabanda, Tirana,
Albania
0668
ONCOLOGIC CASES NEEDED HOSPITALISATION IN PICU AT UNIVERSITY
HOSPITAL DURING 2005 TO 2011 PERIOD
T. Tavladaki, E. Blevrakis, M. Marinaki,
A.M. Spanaki, S. Ilia, G. Briassoulis, Heraklion,
Greece
0669
Area Sintra
Poster Corner
Chairs: Samuel Ajizian, Winston Salem, United States & Maria Karantza, Athens, Greece
10:10 - 12:00
L I V E S 2 012
R. Lowsby, E. Harvey, C. Downes, K. Sim,
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
OUT OF HOURS ADMISSION TO INTENSIVE CARE: DOES IT MAKE A
DIFFERENCE?
157
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Life-Priority
Poster Corner
EPIDEMIOLOGY OF ICU-RELATED INFECTIONS
Chairs: Christian Brun-Buisson, Creteil, France & Jean-Louis Teboul, Kremlin-Bicetre, France
10:10 - 12:00
ANALYSIS OF RISK FACTORS FOR CRBSI IN A HOSPITAL-WIDE TPN
POPULATION - AN ASSOCIATION WITH LIPID ADMINISTRATION
E. Fitzgerald, K. Boner, J. Bourke, M. Lynch,
M. McGovern, C.M. Walshe, D. Phelan, Dublin,
Ireland
0670
COMPLICATIONS OF PERIPHERALLY INSERTED CENTRAL CATHETERS
(PICC)
R. Varghese, K. Krishnareddy, U. Edke, V. Redona,
S. Sara, Abu Dhabi, United Arab Emirates
0671
NO DIFFERENCE IN THE CATHETER RELATED INFECTION (CRI) RATES
BETWEEN TOTAL PARENTERAL NUTRITION (TPN) AND STANDARD
INTENSIVE CARE UNIT / HIGH DEPENDENCY UNIT (ICU / HDU) CENTRAL
VENOUS CATHETERS (CVCS)
E. Fitzgerald, C. Walshe, J. Bourke, L. Maureen,
M. Foley, C. O’Loughlin, D. Phelan, Dublin,
Ireland
0672
RISK FACTORS FOR IN-HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS
WITH BACTEREMIA
J.M. Pereira, J. Cortez, J.A. Paiva, Oporto,
Portugal
0673
VENTILATOR ACQUIRED PNEUMONIA IN A NEUROSURGICAL ICU: A
PROSPECTIVE STUDY
B. Lund, P.H. Conroy, J. O’Rourke, Dublin, Ireland
0674
USE OF TIGECYCLINE IN INTENSIVE CARE: A FRENCH PROSPECTIVE
OBSERVATIONAL STUDY
P. Montravers, H. Dupont, J.-P. Bedos, Paris,
France
0675
COLONISATION OF INLINE SUCTION CATHETER AT 72 HOURS
U. Borg, Boulder, United States
0676
STREAMLINING OF ANTIBIOTIC THERAPY AND OUTCOME OF ICU
PATIENTS
A. Ancion, N. Layios, N. Monique, V. Christel,
P. Damas, Liège, Belgium
0677
MODIFICATION OF LOCAL ECOLOGY AND GUIDELINES DEVIATION
EXPLAIN FAILURE OF EMPIRIC ANTIMICROBIAL THERAPY IN
INTRAABDOMINAL INFECTIONS
J. Textoris, S. Wiramus, C. Contargyris,
B. Ragonnet, F. Antonini, C. Martin, M. Leone,
Marseille Cedex, France
0678
MANAGING CONTINUOUS VANCOMYCIN INFUSION
M. Fernandes, R. Pinho, P. Reis, P. Campos,
A. Dagge, P. Marçal, P. Amaro, Santa Maria da
Feira, Portugal
0679
PREVALENCE OF ANTIBIOTIC USE AGAINST MULTI-DRUG RESISTANT
GRAM-POSITIVES (MDR-GP) IN ICUS IN THE REGION OF MADRID
M. Nieto, M. Sanchez, Madrid, Spain
0680
CHARACTERISTICS OF EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL)
PRODUCERS ISOLATED IN A JAPANESE UNIVERSITY HOSPITAL
S. Uegaki, M. Hayakawa, Y. Yanagida, S. Gando,
Sapporo, Japan
0681
IMMUNITY IN SEPTIC PATIENTS WITH PNEUMONIA
F. Valenzuela-Sánchez, J.F. Rodríguez-Gutierrez,
B. Valenzuela-Sánchez, R. Bohollo-Austria,
V. Pérez-Madueño, M. Recuerda-Núñez, Jerez de
la Frontera, Spain
0682
COST-EFFECTIVENESS ANALYSIS OF IMMUNONUTRITION FOR UPPER
GASTROINTESTINAL CANCER PATIENTS UNDERGOING SURGERY IN
BRITISH HOSPITALS
H. Chevrou-Séverac, L. Weijers, I. Eijgelshoven,
Vevey, Switzerland
0683
ROOM Lisbon
Clinical Challenges Session RESPIRATORY MONITORING FOR DUMMIES
11:10 - 12:00
Presentation
ROOM Berlin
Clinical Challenges Session CARDIOVASCULAR MONITORING FOR DUMMIES
Chair: Elias Knobel, Sao Paulo, Brazil
11:10 - 12:00
Presentation
ROOM Barcelona
Azriel Perel, Tel Aviv, Israel
HOW DO I DIAGNOSE INTERSTITIAL PNEUMONIA?
Chair: Antonio Pesenti, Monza, Italy
11:10 - 12:00
158
Presentation
13-17 October 2012
L I V E S 2 012
HOW DO I READ HEAD CT AND A MRI SCAN?
11:10 - 12:00
Presentation
ROOM Rome
Peter Horn, Berlin, Germany
BLOOD SUGAR MONITORING
Chairs: Annika Reintam Blaser, Tallin, Estonia & Pierre-François Laterre, Leuven, Belgium
11:10 - 11:35
Clinical relevance of glucose control
Jean-Charles Preiser, Brussels, Belgium
11:35 - 12:00
Glucose measurements and monitoring
Olav Rooyackers, Stockholm, Sweden
ROOM Glasgow
HOW DO I COUNSEL IN AND BEYOND THE ICU?
Chair: Maurizia Capuzzo, Ferrara, Italy
11:10 - 12:00
Presentation
ROOM Stockholm
Christina Jones, Liverpool, United Kingdom
HOW DO I FIND THE FOCUS IN MY SEPSIS PATIENT?
Chair: José Artur Paiva, Porto, Portugal
11:10 - 12:00
Presentation
ROOM Paris
Susanne Toussaint, Berlin, Germany
HOW DO I MANAGE CHEST TRAUMA?
Chair: Paolo Pelosi, Genova, Italy
11:10 - 12:00
Presentation
ROOM Vienna Clinical Challenges Session
PULMONARY EMBOLISM?
HOW DO I MANAGE A PATIENT WITH SUSPECTED ACUTE
Chair: Fabio Silvio Taccone, Brussels, Belgium
11:10 - 12:00
Presentation
ROOM Athens
HOW DO I INTERPRET METABOLIC ACIDOSIS?
Chair: Thorsten Slowinsky, Berlin, Germany
11:10 - 12:00
Presentation
+
L I V E S 2 012
Visit us at the
ESICM Booth
Exhibition Area A
Nurses
&
AHP
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Geneva
Chair: Peter Leroux, Philadelphia, United States
159
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
160
ROOM Berlin
Industry Sponsored Session HAEMODYMANIC MONITORING
Chairs: Maurizio Cecconi, London, United Kingdom & Jean-Louis Vincent, Brussels, Belgium
12:30 - 13:00
Haemodynamic optimisation: Is it cost-effective?
13:00 - 13:30
Integration of haemodynamic data at the bedside
13:30 - 14:00
ROOM Barcelona Industry Sponsored Session
STRATEGIES & BENEFIT
PICCO FOR HAEMODYNAMIC MONITORING: INDICATIONS,
Chairs: Jean-Louis Teboul, Kremlin-Bicetre, France & Javier Belda, Valencia, Spain
12:30 - 13:00
Benefit of early optimised critical care patient management with PiCCO
Daniel Reuter, Hamburg, Germany
13:00 - 13:30
Consequences of haemodynamic monitoring strategies in septic shock
patients
13:30 - 14:00
Solving therapeutic conflicts in ARDS - clinical case studies
ROOM Geneva
VOLUME MANAGEMENT IN TRAUMA, SURGERY, AND ICU
Chairs: Charles Sprung, Jerusalem, Israel & Hugo Van Aken, Munster, Germany
12:30 - 13:00
Volume management in trauma
William Lancelot Michell, Cape Town, South
Africa
13:00 - 13:30
Volume management in acute resuscitation
Richard Weiskopf, Tiburon, United States
13:30 - 14:00
Volume management in ICU
Martin Westphal, Munster, Germany
ROOM Rome
EMERGING THERAPEUTIC OPTIONS FOR THE ICU PATIENT
Chairs: Miguel Tavares, Leça da Palmeira, Portugal & Mervyn Singer, London, United Kingdom
12:30 - 13:00
Dexmedetomidine and levosimendan - new studies, novel insights
13:00 - 13:30
Sedation, immunomodulation and delirium
Robert Sanders, United Kingdom
13:30 - 14:00
Pharmacological strategies to improve weaning from mechanical
ventilation
ROOM GLASGOW Industry Sponsored Session
we ensure optimal outcomes?
MRSA nosocomial pneumonia today: how can
Chairs: Jean-François Timsit, Grenoble, France & Tobias Welte , Hanover, Germany
12:30 - 12:35
12:35 - 13:00
How do I ensure appropriate therapy for my patients with MRSA
nosocomial pneumonia?
Alexander Soriano, Barcelona, Spain
13:00 - 13:25
How can I avoid the pitfalls of MRSA VAP diagnosis and treatment?
13:25 - 13:50
What do the MSRA nosocomial pneumonia guidelines mean for me?
13:50 - 14:00
Q&A
13-17 October 2012
L I V E S 2 012
ON THE WAY TO PERFECT SYNCHRONY
12:30 - 13:00
Diaphragm dysfunction at ICU (VIDD) - clinical implications
Samir Jaber, Montpellier, France
13:00 - 13:30
PAV+ - what European experts think about it
Jean-Christophe Richard, Geneva, Switzerland
13:30 - 14:00
Patient ventilator synchrony - intensivists daily nightmare? Case
presentation and interactive discussion
ROOM Paris
CO2 REDUCTION, SOMETHING WE SHOULD CARE ABOUT!
Chairs: Antonio Pesenti, Monza, Italy & Alain Combes, Paris, France
12:30 - 13:00
How much CO2 is too much CO2?
Wolfram Windisch, Cologne, Germany
13:00 - 13:30
CO2 Removal in early ARDS, a paradigm change?
13:30 - 14:00
CO2 Removal, the fast line in the emergency room?
Roberto Roncon de Albuquerque, Porto,
Portugal
Area Beja
Poster Corner
CLINICAL OUTCOME PREDICTORS IN SEPSIS
Chairs: Jan Bakker, Rotterdam, Netherlands (TBC) & Akos Csomos, Budapest, Hungary
14:00 - 15:50
TIMING OF DECOMPRESSION IN SEVERE ACUTE PANCREATITIS
COMBINED WITH ABDOMINAL COMPARTMENT SYNDROME: A MATTER
OF LIFE OR DEATH
L. Ke, H.-B. Ni, W. Li, Nanjing, China
0684
LACTATE CLEARANCE WITHIN THE FIRST 24 HOURS OF SEPSIS
C. de Haro, E. Torrents, R. Ferrer, A. Navas,
M.L. Martinez, A. Artigas, Sabadell, Spain
0685
IMPROVED OUTCOME OF SEVERE ACUTE PANCREATITIS IN THE
INTENSIVE CARE UNIT
P. Pavlidis, S. Crichton, J. Lemmich Smith,
D. Morrison, C. McKenzie, S. Atkinson,
D. Wyncoll, M. Ostermann, London, United
Kingdom
0686
RECTUS ABDOMINIS MUSCLE TISSUE METABOLISM IN PATIENTS WITH
INTRA-ABDOMINAL HYPERTENSION
L. Maddison, J. Karjagin, J. Tenhunen, J. Starkopf,
Tartu, Estonia
0687
HIGH SENSITIVITY TROPONIN-T AS PROGNOSTIC BIOMARKER AND
RELATION WITH MYOCARDIAL DISFUNCTION IN SEVERE SEPSIS AND
SEPTIC SHOCK
C. Murcia, G. Rognoni, A. Baró, A. Ochagavía,
C. Ferri, C. Pedrós, A. Álvarez, J.-M. Sirvent,
Girona, Spain
0688
THE PIRO CONCEPT: RESPONSE-ASSOCIATED CONDITIONS FOR
COMMUNITY-ACQUIRED SEVERE SEPSIS AND SEPTIC SHOCK RELATEDMORTALITY (RESULTS FROM THE SACIUCI STUDY)
C. Granja, P. Póvoa, A. Carneiro, C. Lobo,
A. Teixeira-Pinto, A. Costa-Pereira, Porto,
Portugal
0689
OUTCOMES FOLLOWING SEVERE ACUTE PANCREATITIS IN A HPB
REFFERAL HOSPITAL ICU
A. Krige, S. Ghabina, K. Girgirah, Blackburn,
United Kingdom
0690
SEARCH FOR THE HOLY GRAIL: TISSUE MARKERS FOR SEPSIS
N. Jain, Indore, India
0691
THE PROGNOSTIC VALUE OF CENTRAL VENOUS TO ARTERIAL PCO2-GAP
IN PATIENTS ADMITTED TO ICU WITH SEVERE SEPSIS OR SEPTIC SHOCK:
TIME DOES MATTER
M.C. Lont, P.A. van Beest, N.D. Holman,
B. Loef, M.A. Kuiper, E.C. Boerma, Leeuwarden,
Netherlands
0692
PROGNOSTIC VALUE OF INFECTION MARKERS IN SEPTIC PATIENTS
ADMITTED TO ICU
N.J. Ferreira, A. Raimundo, A. Marques, S. Beirão,
P. Coutinho, Coimbra, Portugal
0693
OXYGEN EXTRACTION FRACTION IS ASSOCIATED WITH PROGNOSIS OF
PATIENTS WITH SEPTIC SHOCK
K.M. You, W.Y. Kwon, G.J. Suh, K.S. Kim, H.J. Lee,
Y.S. Jung, Seoul, Republic of Korea
0694
THE PIRO CONCEPT: ORGAN DYSFUNCTION-ASSOCIATED CONDITIONS
FOR COMMUNITY-ACQUIRED SEVERE SEPSIS AND SEPTIC SHOCK
RELATED-MORTALITY (RESULTS FROM THE SACIUCI STUDY)
C. Granja, P. Póvoa, A. Carneiro, C. Lobo,
A. Teixeira-Pinto, A. Costa-Pereira, Porto,
Portugal
0695
L I V E S 2 012
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Stockholm
Chairs: Massimo Antonelli, Rome, Italy & Laurent Brochard, Geneva, Switzerland
161
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Braga
IMPACT OF FLUID BALANCE IN THE OUTCOME OF SEPTIC CRITICALLY ILL
PATIENTS
A.S. Raimundo, N. Ferreira, A. Marques, S. Beirão,
P. Coutinho, Coimbra, Portugal
0696
MITOCHONDRIAL FUNCTION EVALUATION IN PERIPHERAL BLOOD
LYMPHOCYTES AND THEIR RELATION WITH MULTIPLE ORGAN
DYSFUNCTION AND OUTCOME IN SEPTIC PATIENTS IN CRITICAL CARE
UNITS, MEDELLÍN COLOMBIA
J. Bejarano Botero, L.M. Martinez Sanchez,
D.P. Cuesta Castro, L.E. Botero Palacio, A.E. Marin
Castro, J.A. Castañeda Alvarez, M. Rojas Lopez,
I.C. Ortiz Trujillo, Medellin, Colombia
0697
THE ASSOCIATION BETWEEN HYPERPHOSPHATEMIA AND MORTALITY IN
CRITICALLY ILL PATIENTS
J.S. Hundert, A.B. Braun, M. Mendu, F.K. Gibbons,
K.B. Christopher, Boston, United States
0698
THE ASSOCIATION OF MALNUTRITION AND MORTALITY FOLLOWING
CRITICAL ILLNESS: A REGISTRY BASED COHORT STUDY
K.M. Mogensen, T. Moromizato, F.K. Gibbons,
K.B. Christopher, Boston, United States
0699
ACUTE VARIATION OF URINARY PH AND AMMONIUM DURING
CONTROLLED HYPO- AND HYPER-VENTILATION: A PRELIMINARY
REPORT
P. Caironi, L. Zazzeron, C. Rovati, E. Scotti,
M. Ferrari, D. Ottolina, M. Chiodi, C. Marenghi,
L. Gattinoni, Milan, Italy
0700
IS VITAMIN D DEFICIENCY ASSOCIATED WITH DEVELOPMENT OF
ACINETOBACTER BAUMANNII INFECTION IN CRITICALLY ILL PATIENTS?
M. Turkoglu, G. Aygencel, M. Dizbay, A.F. Tuncel,
B. Aslan Candır, Y. Deligoz Bildeci, H. Paşaoğlu,
Ankara, Turkey
0701
RELATIONSHIP BETWEEN ZINC, MAGNESIUM AND SUPEROXIDE
DISMUTASE AS ANTIOXIDANT BIOMARKERS IN CRITICALLY ILL PATIENT
J.I. Martín López, J. Molina, D. Florea, L. Sáez,
E. Millán, M. Navarro, A. Pérez De la Cruz,
E. Planells, Motril, Spain
0702
CHANGES ON SELENIUM BIOMARKERS IN CRITICAL CARE PATIENTS
DURING ICU STAY
J.I. Martín López, R. García del Moral, E. Millán,
J. Molina, D. Florea, L. Sáez, M. Rodriguez Elvira,
E. Planells, Motril, Spain
0703
PROGNOSTIC CONSEQUENCES OF BORDERLINE DYSNATREMIA: PAY
ATTENTION TO MINIMAL SERUM SODIUM CHANGE
M. Darmon, E. Diconne, B. Souweine, S. Ruckly,
C. Adrie, E. Azoulay, C. Clec’h, M. GarrousteOrgeas, C. Schwebel, D. Goldgran-Toledano,
H. Khallel, A.-S. Dumenil, S. Jamali, C. Cheval,
B. Allaouchiche, F. Zeni, J.-F. Timsit, SaintEtienne, France
0704
ASSOCIATION OF VITAMIN D DEFICIENCY AND THE DEVELOPMENT OF
SEPSIS: A REGISTRY BASED COHORT STUDY
K.B. Christopher, T. Moromizato, A.A. Litonjua,
A.B. Braun, F.K. Gibbons, E. Giovannucci, Boston,
United States
0705
INCIDENCE AND CLINICAL CONSEQUENCES OF ACUTE TUMOR LYSIS
SYNDROME IN HIGH RISKS HAEMATOLOGICAL MALIGNANCY AT THE
ERA OF URATE OXIDASE: RESULTS OF A MULTICENTRE COHORT STUDY
M. Darmon, F. Vincent, L. Camous,
C. Thieblemont, C. Bonmati, T. Braun, D. Caillot,
J. Cornillon, S. Dimicoli, L. Galicier, A. Garnier,
S. Girault, D. Rousseau, J.-P. Marolleau,
P. Moreau, E. Raffoux, C. Recher, A. Thiebaud,
E. Azoulay, Saint-Etienne, France
0706
THE EFFECT OF HIGH DOSE OF ZINC AND SELENIUM ON SERUM LEVELS
OF INTERLEUKIN-2 AND T-LYMPHOCYTE IN SURGICAL CANCER PATIENTS
W.T. Salem, R.M. Aboelmagd, M.K. Helaly, Cairo,
Egypt
0707
ELECTROLYTE SUPPLEMENTATION IN CRITICALLY ILL ADULTS: ARE WE
KEEPING UP?
M. Crews, A. Carins, S. Arshad, M. Mogk,
I. Welters, Liverpool, United Kingdom
0708
HYPOPHOSPHATAEMIA: AN UNDERESTIMATED COMPLICATION IN
TREATMENT OF SEVERE DIABETIC KETOACIDOSIS
P. Tesinsky, J. Gojda, A. Jirka, J. Svanda, Prague,
Czech Republic
0709
ABNORMAL POTASSIUM LEVELS IN ICU PATIENTS: RELATION WITH
OUTCOME
E.J. Mijzen, M. Hoekstra, M.W. Nijsten,
Groningen, Netherlands
0710
THE INFLUENCE OF TWO POTASSIUM TARGET LEVELS ON THE FLUID
BALANCE IN CRITICALLY ILL PATIENTS
L. Hessels, M. Hoekstra, L. Yeh, M.W. Nijsten,
Groningen, Netherlands
0711
Poster Corner
ELECTROLYTES & TRACE ELEMENTS
Chairs: Karin Amrein, Graz, Austria & Patrick Ferdinande, Leuven, Belgium
14:00 - 15:50
+
162
13-17 October 2012
Visit us at the
Level 1
L I V E S 2 012
14:00 - 15:50
INTRA-THORACIC PRESSURE DISTRIBUTION DURING MECHANICAL
VENTILATION: INFLUENCE OF TIDAL VOLUME AND THORACIC
COMPLIANCE
B. Lansdorp, C. Hofhuizen, M. van Lavieren,
J. Lemson, H. van Swieten, J. van der Hoeven,
P. Pickkers, Nijmegen, Netherlands
0712
OUTCOMES OF PATIENTS RECEIVING INVASIVE MECHANICAL
VENTILATION REFERRED TO A NATIONAL WEANING UNIT IN THE UK
M.A. Pittman, S.K. Banerjee, R. Chadwick,
N. Oscroft, M.G. Davies, T.G. Quinnell, I.E. Smith,
0713
TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) IS ASSOCIATED
WITH DISEASE SEVERITY AND MORTALITY IN ACUTE RESPIRATORY
FAILURE
J. Hästbacka, T. Tervahartiala, R. Linko, T. Sorsa,
T. Varpula, V. Pettilä, Helsinki, Finland
0714
PREDICTIVE FACTORS FOR EXTUBATION FAILURE IN MEDICAL ICU
PATIENTS
F. Boissier, H. Ben Ghezala, K. Razazi, C. BrunBuisson, A.W. Thille, Creteil, France
0715
STATIC AIRWAY, LUNG AND CHEST WALL PRESSURE-VOLUME CURVES
IN HEALTHY AND LAVAGE INJURED LUNGS AND AT INCREASED
INTRAABDOMINAL PRESSURE IN PIGS
S. Lundin, O. Stenqvist, A. Larsson, Gothenburg,
Sweden
0716
THE PULMONARY VASCULAR PERMEABILITY INDEX PVPI IS DEPENDENT
ON AGE AND BODY HEIGHT OF A PATIENT
S. Wolf, P. Friederich, J. Landscheidt, C. Lumenta,
L. Schuerer, A. Riess, Berlin, Germany
0717
FIRST REPORT OF REVERSE TRIGGERING (RESPIRATORY ENTRAINMENT)
IN CRITICALLY ILL ADULTS: AN OBSERVATIONAL STUDY
E. Akoumianaki, N. Rey, A. Lyazidi, N. PerezMartinez, L. Brochard, J.C.M. Richard, Geneva,
Switzerland
0718
LUNG HYPERINFLATION MAY DEPRESS RIGHT VENTRICULAR FUNCTION
AND LEFT VENTRICULAR DIASTOLIC FUNCTION IN POST CARDIAC
SURGERY PATIENTS
F. Turani, M. Falco, R. Barchetta, F. Candidi, C. Di
Corato, F. Leonardis, Roma, Italy
0719
PULMONARY ADMINISTRATION OF ACTIVATED RECOMBINANT
FACTOR VII IN DIFFUSE ALVEOLAR HAEMORRHAGE IN PULMONARY
LYMPHANGIOLEIOMYOMATOSIS: A CASE REPORT
I. Zýková, L. Žihlová, L. Picmaus, P. Sedlák,
P. Švancar, D. Morman, Liberec, Czech Republic
0720
INTRABDOMINAL PRESSURE IN DIFFERENT LEVELS OF BED POSITION
AND PEEP IN ICU PATIENTS
E. Papacrivou, D. Makris, E. Manoulakas,
D. Bagka, K. Matzarlis, E. Zakinthinos, Larissa,
Greece
0721
THE ROLE OF RESIDUAL PULMONARY FUNCTION DURING VV-ECMO
SUPPORT IN AN EXPERIMENTAL MODEL OF MULTIORGAN FAILURE
ASSOCIATED WITH SEVERE RESPIRATORY FAILURE
M. Park, L. Azevedo, E. Costa, M. Amato,
C. Carvalho, G. Schettino, Sao Paulo, Brazil
0722
HIGH MOPRTALITY IN SEVERE ARDS- IS THE ASSOCIATED CIRCULATORY
FAILURE THE CULPRIT?
S. Jog, R. Prasad, A. Prasad, P. Balasaheb,
B. Bhagyashri, P. Divyesh, P. Monika, S. Safal,
Pune, India
0723
COMPARISON OF TWO METHODS OF WEANING OF MECHANICAL
VENTILATION (T TUBE AND PSV ZEEP) DURING A FIRST TEST OF
WEANING
S. Perbet, A. Soummer, B. Pereira, S. CayotConstantin, M. Jabaudon, Q. Lu, J.-E. Bazin,
J.-J. Rouby, J.-M. Constantin, Clermont-Ferrand,
France
0724
ADVERSE RESPIRATORY EVENTS IN THE POST-ANAESTHETIC CARE UNIT
D. Xará, H. Pereira, J. Mendonça, A. Santos,
F. Abelha, Porto, Portugal
0725
Area Coimbra
Poster Corner
FLUID RESPONSIVENESS & GOAL DIRECTED THERAPY
Chairs: Michael Pinsky, Pittsburgh, United States & Michel Slama, Amiens, France
14:00 - 15:50
THE EFFECT OF SEMIRECUMBENT POSITION ON HAEMODYNAMIC
STABILITY IN VENTILATED CRITICALLY ILL PATIENTS - PROSPECTIVE
MULTIVARIATE ANALYSIS
I. Goecze, F. Strenge, F. Zeman, M. Creutzenberg,
B.M. Graf, H.J. Schlitt, T. Bein, Regensburg,
Germany
0726
FLUID RESPONSIVENESS INCREASED AFTER PROPOFOL INFUSION IN
T. Yu, Y.Z. Huang, F.M. Guo, Y. Yang, J.-L. Teboul,
D. Burkhoff, H.B. Qiu, Nanjing, China
0727
TISSUE PERFUSION INDICATORS PREDICT AND DEPEND ON SYSTEMIC
FLUID RESPONSIVENESS IN CRITICALLY ILL SEPTIC PATIENTS WITH
PRESUMED HYPOVOLEMIA
E. Klijn, M.H.N. van Velzen, A.B.J. Groeneveld,
A.P. Lima, J. Bakker, J. van Bommel, Rotterdam,
Netherlands
0728
L I V E S 2 012
Poster Corner
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Cascais
Chairs: Salvatore Maggiore, Rome, Italy & Michael Quintel, Gottingen, Germany
163
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
164
GOAL-DIRECTED THERAPY FOLLOWING CARDIAC SURGERY IMPROVES
RENAL FUNCTION AND REDUCES DURATION OF STAY IN INTENSIVE
CARE
R.E. Thomson, H. Meeran, M. Cecconi, N. AlSubaie, London, United Kingdom
0729
DRAINAGE OF PLEURAL EFFUSIONS MAY INCREASE PRELOAD AND BE
PART OF HAEMODYNAMIC OPTIMISATION
J.F. Hermansen, P. Juhl-Olsen, C.A. Frederiksen,
L.K. Christiansen, E. Sloth, Aarhus N, Denmark
0730
NON-INVASIVE ASSESSMENT OF HAEMODYNAMIC RESPONSE TO
A FLUID CHALLENGE USING FEMORAL DOPPLER IN CRITICALLY ILL
VENTILATED PATIENTS
A. Luzi, P. Marty, A. Mari, J.-M. Conil, T. Geeraerts,
B. Lepage, O. Fourcade, S. Silva, V. Minville,
Toulouse, France
0731
CHANGES IN ARTERIAL BLOOD PRESSURE INDUCED BY PASSIVE LEG
RAISING PREDICT HYPOTENSION DURING INDUCTION OF SEDATION
T. Yu, Y.Z. Huang, F.M. Guo, Y. Yang, H.B. Qiu,
Nanjing, China
0732
VALIDITY OF CORRECTED FLOW TIME (FTC) AS A PREDICTOR OF FLUID
RESPONSIVENESS IN PATIENTS WITH SEPSIS-INDUCED HYPOTENSION
S.-M. Jung, S. Ryu, Y.-C. Cho, S.-H. Lee, J.-S. Lim,
S.-Y. Yun, I.-S. Yoo, Daejeon, Republic of Korea
0733
THE DIAMETER AND COLLAPSIBILITY OF THE INFERIOR VENA CAVA DO
NOT CORRELATE WITH CHANGES IN CARDIAC OUTPUT DURING EARLY
HAEMORRHAGE: A CONTROLLED STUDY IN HEALTHY BLOOD DONORS
P. Juhl-Olsen, C.A. Frederiksen, S.T. Vistisen,
L.K. Christiansen, E. Sloth, Aarhus N, Denmark
0734
COMPARING HAEMODYNAMIC EFFECTS DURING TWO METHODS OF
EXTERNAL LEG COMPRESSION VERSUS PASSIVE LEG RAISING AFTER
CARDIAC SURGERY
M. Helmi, R. de Wilde, J. Jansen, B. Geerts,
P. van den Berg, M. Versteegh, D. Gommers,
A. Groeneveld, Rotterdam, Netherlands
0735
MODIFICATION OF STROKE VOLUME VARIATION WITH INCREASED
INTRA-ABDOMINAL PRESSURE IN NORMOVOLEMIC PORCINE MODEL
E. Deloya Tomas, J.M. Lomelí Teran, J.J. Martinez
Mazariegos, T. Mondragon Labelle, M. Quintero
Amaya, J.S. Leco Romero, D. Hernandez,
F. Tendillo, M. Poblano, Mexico City, Mexico
0736
COMPARISON OF CENTRAL VENOUS CATHETER AND PULMONARY
ARTERY CATHETER GOAL DIRECTED THERAPY IN PATIENTS WITH SEVERE
SEPSIS AND SEPTIC SHOCK
R. Coskun, K. Gundogan, G. Altinyurt, M. Guven,
M. Sungur, Kayseri, Turkey
0737
PULSE PRESSURE AND STROKE VOLUME VARIATION ARE GOOD
PREDICTORS OF FLUID RESPONSIVENESS IN SEVERE SEPSIS PATIENTS
Z. Drvar, R. Baronica, B. Tomasevic, M. Pavlek,
M. Miric, M. Peric, Zagreb, Croatia
0738
PROTOCOLISED GOAL-DIRECTED HAEMODYNAMIC MANAGEMENT
INCREASES AVAILABLE HEART DONORS
I. Rubio-López, C. González-Fernádez,
M.A. Ballesteros-Sanz, J.C. Rodríguez-Borregán,
M. López-Sánchez, D. Iglesias-Posadilla,
F.J. Burón-Mediavilla, E. Miñambres- García,
A. Quesada-Suescun, Santander, Spain
0739
Area Estoril
Poster Corner
Nurses
&
AHP
AIRWAY CARE & INSTRUMENTATION
Chairs: Barbara McLean, Atlanta, United States & Giulia Pelucchi, Monza, Italy
14:00 - 15:50
CLINICAL PROFILE OF PATIENTS REFERRED TO CHEST PAIN UNIT FROM
EMERGENCY HOSPITAL DEPARTMENT
M.A. Ramirez-Marrero, I. Vegas-Vegas, M. CanoGarcia, D. Gaitan-Roman, B. Luque-Aguirre,
Malaga, Spain
0740
CAN FIXED NO. 7.5 ET TUBE SAVE LIVES BETTER IN EMERGENCY?
V. Joshi, Indore, India
0741
THE EFFECTS AND SAFETY OF CLOSED TRACHEAL SUCTION SYSTEM
VERSUS OPEN TRACHEAL SUCTION SYSTEM FOR MECHANICALLY
VENTILATED PATIENTS: A META-ANALYSIS
L. Dong, T. Yu, Y. Yang, H. Qiu, Nanjing, China
0742
MULTICENTRE OBSERVATIONAL STUDY ON PRACTICE OF TRACHEAL
SUCTIONING IN PATIENTS UNDER MECHANICAL VENTILATION
P. Beuret, C. Roux, A. Constan, Roanne, France
0743
PERCUTANEOUS TRACHEOSTOMY: AN AUDIT OF A GREEK MILITARY
FORCES ICU
G. Choutas, V. Ntzani, D. Karapanos,
A. Kostantinou, H. Skotra, G. Anthopoulos,
Athens, Greece
0744
FEASIBILITY AND SAFETY OF BRONCHOSCOPE-AIDED PERCUTANEOUS
DILATATION TRACHEOSTOMY IN OBESE CRITICALLY ILL PATIENTS
K. Tsikritsaki, G. Koukoulitsios, K. Mendrinou,
I. Tsiouboutariou, N. Pentilas, P. Dourou,
I. Andrianakis, P. Spyrou, K. Tsironas,
M. Paidonomos, Athens, Greece
0745
PERCUTANEOUS TRACHEOSTOMY PERFORMED WITHOUT
BRONCHOSCOPIC GUIDANCE: EXPERIENCE IN 310 PATIENTS
R. Avila, N. Carrizo, A. Gamboa, I. Ponzo, Santa
Fe, Argentina
0746
13-17 October 2012
L I V E S 2 012
0747
DEVELOPMENT OF POST EXTUBATION PNEUMONIA: ROLE OF 24 HOURS
OF ENDOTRACHEAL INTUBATION AND MECHANICAL VENTILATION. AN
EXPERIMENTAL STUDY
A. Zanella, E. Rezoagli, M. Cressoni, D. Ferlicca,
L. Berra, T. Kolobow, Monza, Italy
0748
THE IMPACT OF CRITICAL CARE ON ORAL HEALTH. AN OBSERVATIONAL
STUDY
I. Needleman, J. Ryu, S. Boluda, G. Bercades,
J. Nagle, D. Brealey, M. Sachdev, D. MoskalFitzpatrick, K. Lewis, E. Agudo, J. Suvan,
N. Donos, A. Petrie, M. Singer, London, United
Kingdom
0749
ORAL CARE AND COLONISATION IN A MULTIDISCIPLINARY ICU
S. Chatzispyrou, M. Parisi, E. Kampisiouli,
E. Mpaloiti, D. Panopoulou, A. Argyropoulou,
S. Nanas, Athens, Greece
0750
A RESEARCH ON PREDICTIVE FACTORS OF TRACHEOSTOMY FOR
PATIENT WITH ACUTE ORGANOPHOSPHATE INSECTICIDE POISONING
PATIENTS
N.S. Cho, S.P. Kim, S.J. Kim, S.H. Cho, Y.J. Park,
Gwang Ju, Republic of Korea
0751
AUDIT REGARDING THE REQUIREMENT OF CHEST X–RAYS FOLLOWING
PERCUTANEOUS DILATATIONAL TRACHEOSTOMY
K. Girgirah, J. Garbaino, J.C. Watts, Manchester,
United Kingdom
0752
INCIDENCE, SEVERITY AND TREATMENT OF DELIRIUM IN CARDIAC
SURGERY PATIENTS: AN OBSERVATIONAL STUDY
S.S. Pedersen, V.L. Jørgensen, Copenhagen,
Denmark
0754
THE USE OF HOPANTENIC ACID FOR THE CORRECTION OF
POSTOPERATIVE COGNITIVE DYSFUNCTION IN SCHOOL-AGE CHILDREN:
A RANDOMISED TRIAL
A.M. Ovezov, M.A. Lobov, A.V. Lugovoy,
M.V. Panteleeva, M.N. Borisova, I.E. Gus’kov,
P.S. Myatchin, E.D. Nad’kina, Moscow, Russian
Federation
0755
DELIRIUM INCIDENCE AND OUTCOMES OF OCTOGENARIANS ADMITTED
TO A UK TEACHING HOSPITAL CRITICAL CARE UNIT AFTER EMERGENCY
SURGERY OVER A 3 YEAR PERIOD
V.C. Banks, Sheffield, United Kingdom
0756
INCIDENCE OF INADEQUATE EMERGENCE AFTER ANAESTHESIA:
EMERGENCE DELIRIUM AND HYPOACTIVE EMERGENCE IN THE POSTANAESTHESIA CARE UNIT
D. Xará, A. Silva, J. Mendonça, F. Abelha, Porto,
Portugal
0757
IS DELIRIUM IN OLDER INTENSIVE CARE PATIENTS AN INDEPENDENT
PREDICTOR OF HOSPITAL LENGTH OF STAY?
V. Gherghina, G. Nicolae, Constanta, Romania
0758
BIOMARKERS AND ASSOCIATED FACTORS FOR ICU DELIRIUM
R. Tsuruta, K. Kaneda, Y. Oda, Y. Kawamura,
M. Fujita, M. Todani, R. Tanaka, T. Nakahara,
Y. Koga, C. Oshima, Y. Ogino, S. Fukuda,
S. Kasaoka, Ube, Japan
0759
THE WHITE STUFF: USAGE AND MONITORING FOR COMPLICATIONS AT
THE ROYAL LONDON HOSPITAL ICU
F. Yau, A. Lam, M. Healy, London, United
Kingdom
0760
LONG-TERM OUTCOME OF DELIRIUM IN CRITICALLY ILL PATIENTS
A.E. Wolters, D. van Dijk, O.L. Cremer, D.W. de
Lange, A.J.C. Slooter, Utrecht, Netherlands
0761
HEART RATE VARIABILITY IN INTENSIVE CARE UNIT PATIENTS WITH
DELIRIUM
I.J. Zaal, A.W. van der Kooij, L.J. van Schelven,
P.L. Oey, A.J.C. Slooter, Utrecht, Netherlands
0762
IT MUST SEDATE PATIENTS ON EXTRA CORPOREAL LIFE SUPPORT (ECLS)
A. Bataillard, A. Hebrard, M. Casez-Brasseur,
D. Michel, P. Albaldejo, J.F. Payen, Grenoble,
France
0763
RESPIRATORY TOXICITY OF BUPRENORPHINE RESULTS FROM
THE BLOCKAGE OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF
NORBUPRENORPHINE AT THE BLOOD-BRAIN BARRIER IN MICE
B. Mégarbane, H. Alhaddad, S. Cisternino,
P. Risède, F.J. Baud, Paris, France
0764
Poster Corner
SEDATION PRACTICES & DELIRIUM
Chairs: Margaret Herridge, Toronto, Canada & Torsten Schröder, Berlin, Germany (TBC)
14:00 - 15:50
+
L I V E S 2 012
L. Ruff, Liverpool, United Kingdom
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Evora
LOW PRESSURE HIGH VOLUME CUFFED ENDOTRACHEAL TUBES IN
EMERGENCY SURGERY
Visit us at the
ESICM Booth
Exhibition Area A
165
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
166
Area Faro
Poster Corner OPTIMISING TISSUE OXYGENATION
Chairs: Can Ince, Rotterdam, Netherlands & Didier Payen de La Garanderie, Paris, France
14:00 - 15:50
VARIABILITY OF DIFFERENTIAL INVASIVE BLOOD PRESSURE
MEASUREMENTS AT RADIAL AND FEMORAL SITES IN HIGH DOSE
NOREPINEPHRINE-REQUIRING SEPTIC SHOCK
S. Clayton, R.A. Parker, R. Parkhill, A. Ercole,
D. Menon, R. Mahroof, Cambridge, United
Kingdom
0765
INCREASED HEPATIC ARTERIAL BLOOD FLOW COMPENSATION FOR
PORTAL FLOW REDUCTION (HEPATIC ARTERIAL BUFFER RESPONSE)
WITH ANGIOTENSIN II DESPITE DECREASED HEPATIC ARTERIAL
CONDUCTANCE
A. Pereira, S. Djafarzadeh, J. Takala, S. Jakob,
Bern, Switzerland
0766
MYCOPHENOLATE MOFETIL REDUCED RENAL INFLAMMATION AND
PROTECTED RENAL CORTICAL OXYGENATION AFTER ISCHAEMIA/
REPERFUSION INJURY
R. Bezemer, B. Ergin, A. Kandil, E. Almac,
C. Demirci, C. Ince, Amsterdam, Netherlands
0767
HYPOTHERMIA IMPROVES MICROVASCULAR OXYGENATION DURING
HAEMORRHAGIC CONDITIONS
O. Picker, I. Bauer, I. Schwartges, M. Swertz,
C. Vollmer, Duesseldorf, Germany
0768
HYPEROXIA ALTERS MUSCLE MICROVASCULATURE AND METABOLISM IN
HEALTHY INDIVIDUALS
F. Puflea, D. Orbegozo Cortes, K. Donadello,
F.S. Taccone, D. De Backer, L. Gottin, J.-L. Vincent,
J. Creteur, Brussels, Belgium
0769
METHYLENE BLUE IN HYPOTENSIVE CRITICALLY ILL PATIENTS. A METAANALYSIS OF RANDOMISED CONTROLLED STUDIES
M. Zambon, L. Pasin, T. Greco, M. Crivellari,
G. Borghi, G. Landoni, A. Zangrillo, Milan, Italy
0770
THE CARDIOVASCULAR EFFECTS OF SODIUM HYDROGEN SULFIDE
(NAHS) IN ANAESTHETISED MECHANICALLY VENTILATED PIGS
D.M.J. Milstein, M.C. Dirkes, C. Ince, T.M. van
Gulik, Amsterdam, Netherlands
0771
NO AGREEMENT OF MIXED VENOUS AND CENTRAL VENOUS PCO2-GAP
IN SEPSIS
Netherlands
0772
HYPERCAPNIA IMPROVES MICROCIRCULATORY OXYGENATION IN SEPTIC
RATS BY RESTORING FLOW-OXYGENATION RELATIONSHIP
C. Beck, F. Barthel, C. Stuebs, C. Vollmer,
O. Picker, Duesseldorf, Germany
0773
THE RULE OF LTB4/BLT1 SIGNALING IN THE ISCHAEMIA REPERFUSION
INJURY OF LIVER
H. Saito, Y. Kosaka, M. Majima, Y. Nara,
T. Takehiko, Y. Nagahara, T. Otsuka, M. Toda,
H. Okamoto, Sagamihara, Japan
0774
SIGNIFICANCE OF AN ABNORMALLY LOW OR HIGH RESTING STO2
VALUES IN PREDICTING HIGH RISK OF MORTALITY IN CRITICALLY ILL
PATIENTS
A. Lima, M. van Genderen, T. Boerstra, J. van
Bommel, J. Bakker, Rotterdam, Netherlands
0775
WHAT PART OF CARDIAC FUNCTION IS REPRESENTED BY CENTRAL
VENOUS OXYGEN SATURATION?
M.W. Prull, A. Bittlinsky, B. Sasko, G. Plehn,
T. Butz, M. van Bracht, H.-J. Trappe, Herne,
Germany
0776
VENOUS TO ARTERIAL PCO2 DIFFERENCE (PCO2-GAP) CANNOT BE USED
AS PREDICTOR OF CARDIAC INDEX IN SEPTIC PATIENTS
Netherlands
0777
Area Fatima
Poster Corner
PNEUMONIA IN THE ICU: PREVENTION & TREATMENT
Chairs: Garyfallia Poulakou, Athens, Greece & Marc Bonten, Utrecht, Netherlands
14:00 - 15:50
COMMUNITY ACQUIERED PNEUMONIA IN THE ICU: SOMETHING TO
FEAR?
A.M. Lubombo, P. Carcelén, Z.E. Aray,
S.M. Cortés, A. Marcos, F.C. Tarancón,
T.L. Álvarez, A.C. Caballero, Zamora, Spain
0778
PROCALCITONIN AND D-DIMER IN PREDICTING CLINICAL OUTCOMES
AND PROGNOSIS IN SEVERE COMMUNITY-ACQUIRED PNEUMONIA
(SCAP) PATIENTS
0779
THE DIAGNOSIS OF HOSPITAL ACQUIRED PNEUMONIA (HAP) IN A
CARDIOTHORACIC HIGH DEPENDENCY UNIT (HDU)
B.E. Garfield, S. Weiss, C. Morgan, P. Marino,
0780
EFFICACY OF IMPLEMENTING A CARE BUNDLE TO PREVENT
VENTILATOR-ASSOCIATED PNEUMONIA (VAP)
A. Socias Mir, L. Gutiérrez Madroñal, J. Barceló
Planas, G. Rialp Cervera, P. Ibáñez Lucia, Palma
de Mallorca, Spain
0781
13-17 October 2012
L I V E S 2 012
0782
HYPERBARIC OXYGEN THERAPY: A FORGOTTEN TOOL IN THE
TREATMENT OF SEVERE SOFT TISSUE INFECTIONS?
R. Fernandes, S. Jordão, E. Molinos, T. Fernandes,
E. Gomes, O. Camacho, R. Araújo, Matosinhos,
Portugal
0783
THE ROLE OF C-REACTIVE PROTEIN AND THE SOFA SCORE AS
PARAMETER FOR CLINICAL DECISION MAKING IN SURGICAL PATIENTS
DURING THE INTENSIVE CARE UNIT COURSE
Z.C. Meyer, J.M.J. Schreinemakers, P.G.H. Mulder,
R.A.L. de Waal, A.A.M. Ermens, L. van der Laan,
Breda, Netherlands
0784
CLINICAL AND MICROBIOLOGICAL FEATURES OF INFECTIONS DURING
POST-OPERATIVE PERIOD AFTER HEART TRANSPLANTATION
P. Fernandez Ugidos, R. Gomez Lopez, R. Marzoa
Rivas, E. Barge Caballero, M.J. Paniagua Martin,
J. Muñiz, Z. Grille Cancela, M.A. Solla Buceta,
P. Vidal Cortes, M.J. García Monge, A.V. Aller
Fernandez, A. Castro Beiras, M.G. Crespo Leiro,
Ourense, Spain
0785
AUTONOMIC DYSFUNCTION IN INFANTS WITH RSV INFECTION
C. Liebrand, M. Bouwman, I. Ahout, M. Kox,
C. Neeleman, Nijmegen, Netherlands
0786
HEALTHCARE-ASSOCIATED BACTEREMIA IN A UNIVERSITY HOSPITAL IS
DIFFERENT FROM COMMUNITY-ACQUIRED BACTEREMIA
L. De Bus, P. Depuydt, G. Coessens, J. Boelens,
G. Claeys, J. Decruyenaere, Ghent, Belgium
0787
UTILITY OF MONITORING PROCALCITONIN, INTERLEUKIN-6 AND
COMPLEMENT-5A IN THE PREDICTION OF ANASTOMOTIC LEAKAGE
AFTER ABDOMINAL SURGERY
U. Zielińska-Borkowska, N. Dib, T. Skirecki,
Warsaw, Poland
0788
APPLICATION OF CHARLSON COMORBIDITY INDEX IN ICU PATIENTS
WITH BACTERAEMIA AND MORTALITY PREDICTION
M. Couto, R. Pimentel, A. Leitão, P. Mergulhão,
J.A. Paiva, Porto, Portugal
0789
“IF YOU CANNOT MEASURE IT, YOU CANNOT IMPROVE IT”: A SURVEY
OF DATA COLLECTION SYSTEMS TO MONITOR AND GUIDE INFECTION
PREVENTION EFFORTS ICUS
M.-L. Lambert, M. Palomar, A. Ingenbleek,
M. Hiesmayr, U. Frank, Barcelona, Spain
0790
CATHETER-RELATED BLOODSTREAM INFECTION (CRBSI) ERADICATION:
A FAILED TRY
C. Vannucci, P. Burtin, P. Mion, P. André,
A. Granier, M. Parneix, Montpellier, France
0791
THE CRITICAL ILLNESS POLYNEUROPATHY IN SEPTIC PATIENTS WITH
PROLONGED WEANING FROM MECHANICAL VENTILATION. IS THE
DIAPHRAGM ALSO AFFECTED? A PILOT STUDY
R.P. Oliveira, P. Santos, C. Teixeira, A. Savi,
F. Neres, A.S. Machado, J.G. Maccari, M. Ribeiro,
F. Rotta, Porto Alegre, Brazil
0792
NEUROLOGICAL DISEASE IN HIV-INFECTED PATIENTS - A 20-YEAR
RETROSPECTIVE STUDY IN AN ICU
A. Santos, S. Xerinda, P. Figueiredo, C. Abreu,
R. Poinhos, M.L. Santos, S. António, Porto,
Portugal
0793
USE XANTHINE OXIDASE ACTIVITY IN OPTIMIZATION OF TREATMENT
PATIENTS WITH ACUTE CEREBRAL STROKE
E. Oreshnikov, S. Oreshnikova, Cheboksary,
Russian Federation
0794
SEVERE CEREBRAL VENOUS THROMBOSIS IN ICU: 32 PATIENTS IN A
RETROSPECTIVE COHORT STUDY
B. Soyer, M. Rusca, A.-C. Lukaszewicz, I. Crassard,
D. Bresson, J.-P. Guichard, J. Mateo, D. Payen,
Paris, France
0795
INCIDENCE AND OUTCOME OF PATIENTS DIAGNOSED OF ICU-ACQUIRED
WEAKNESS
O. Peñuelas, F. Frutos-Vivar, A.W. Thille,
N.D. Ferguson, F. Rios, S.M. Maggoire,
A. Villagomez, M. Gonzalez, A. Anzueto,
A. Esteban, Getafe, Spain
0796
LONG TERM PROGNOSIS OF PATIENTS WITH ACUTE STROKE TREATED
WITH SYSTEMIC THROMBOLYSIS. A REPORT OF 6 YEARS OF EXPERIENCE
IN A COMMUNITY HOSPITAL
V. Pérez Madueño, Á. Estella García, M. Recuerda
Núñez, M. Gracia Romero, E. Leal Roca,
J. Sánchez Ruiz, M. Jaén Franco, F. Delgado,
A. Jareño Chaumel, Jerez de la Frontera, Spain
0797
CLINICAL CHARACTERISTICS, RISK FACTORS ASSOCIATED WITH
MORTALITY AND OUTCOMES IN A COHORT OF ADULT ICU PATIENTS
WITH REFRACTORY STATUS EPILEPTICUS
R. Soley, D. Gutiérrez, L. Sanchez, M. Koborzan,
L. Conde, L. Corral, J.I. Herrero, M. Falip, J. Miró,
M. Veciana, R. Mañez, Hospitalet de Llobregat,
Spain
0798
Area Funchal
Poster Corner
NEURO-EMERGENCIES & TRAUMA
Chairs: Tarek Sharshar, Paris, France & Pedro Navarrete Navarro, Granada, Spain
14:00 - 15:50
L I V E S 2 012
C.M. Ramírez Martín, M.D. Milán Rodríguez,
M.A. De La Torre Acosta, E. Hernández Mendoza,
B. Yanez Quintana, Las Palmas de Gran Canaria,
Spain
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
APPLICATION OF A SELECTIVE DECONTAMINATION OF THE DIGESTIVE
TRACT PROTOCOL IN A MIXED UNIVERSITY HOSPITAL ICU DURING 6
MONTHS: PRELIMINARY RESULTS
167
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
168
BRAIN ABSCESSES IN ICU. EPIDEMIOLOGICAL STUDY AND ANALYSIS OF
MORTALITY DETERMINANTS
A.V. Aller-Fernández, M. Mourelo-Fariña,
I. Astola-Hidalgo, P. Vidal Cortés, M.T. BouzaVieiro, L. Seoane-Quiroga, M.J. García Monje, La
Coruña, Spain
0799
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AFTER
LIVER TRANSPLANTATION: A STUDY OF SEVEN CASES
A. Sawamura, Y. Yanagida, Y. Honma,
H. Yamamoto, T. Honma, N. Kubota, S. Uegaki,
M. Hayakawa, S. Gando, Sapporo City, Japan
0800
RISK FACTORS FOR DEATH IN STROKE PATIENTS WITHOUT
SUPRANORMAL LEVEL OF URIC ACID IN BLOOD AND / OR
CEREBROSPINAL FLUID
E. Oreshnikov, S. Oreshnikova, Cheboksary,
Russian Federation
0801
INFRATENTORIAL STROKES: AN ALTERNATIVE APPROACH
T.G. Loza, D. Batista, I. Maia, E. Monteiro, S. Silva,
A. Cerejo, C. Dias, J.A. Paiva, Porto, Portugal
0802
FUNCTIONAL OUTCOME AFTER DECOMPRESSIVE CRANIECTOMY IN
MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION
D. Arias-Verdú, R. Rivera-Fernández,
M.J. Chaparro-Sánchez, A. Muñoz-López,
D. Fernandez-Zamora, G. Quesada-García,
Málaga, Spain
0803
MUCORMYCOSIS AFTER SEVERE TRAUMA
I. Saez de la Fuente, M. Fernández Chico,
A. Robles Alonso, Z. Molina Collado, C. García
Fuentes, E. Alted López, Madrid, Spain
0804
PELVIC BONE FRACTURES ASSOCIATED WITH INTRA-ABDOMINAL SOLID
ORGAN INJURY
S.H. Kim, Ulsan, Republic of Korea
0805
Area Guarda
Poster Corner
EVALUATION OF CARE IN TRAUMA & EMERGENCY MEDICINE
Chairs: Geoffrey Bellingan, London, United Kingdom & Claude Martin, Marseille, France
14:00 - 15:50
RECOMBINANT FACTOR VIIA (RFVIIA) IN A PIG MODEL OF
COAGULOPATHY WITH BLUNT LIVER INJURY UNDER SEVERE
HYPOTHERMIA
S. Loubele, T. Braunschweig, R. Rossaint, H. ten
Cate, H. Spronk, B. Lauritzen, O. Grottke,
Maastricht, Netherlands
0806
NOT ONLY ADMISSION HYPERGLYCAEMIA BUT BLOOD GLUCOSE
VARIABILITY ARE RELIABLE OUTCOME PREDICTORS IN SEVERE
TRAUMATIC PATIENTS
T. Kamitani, H. Ishikura, R. Yuge, R. Ichiki,
M. Mizunuma, K. Hoshino, A. Murai, Fukuoka,
Japan
0807
EVALUATION OF CENTRAL VENOUS AND ARTERIAL CATHETERISATION
FOR SEVERE TRAUMA PATIENTS IN THE TRAUMA BAY
S. Hamada, M. Fromentin, M. Ronot, T. Gauss,
A. Harrois, J. Duranteau, J. Mantz, C. PaugamBurtz, Clichy, France
0808
IS THE RENAL ANGIOEMBOLISATION AN AGGRAVATING FACTOR OF
RENAL FUNCTION FOR TRAUMA PATIENTS WITH HIGH-GRADE RENAL
TRAUMAS?
M. Saour, J. Charbit, J. Manzanera, L. Barral,
I. Millet, P. Taourel, X. Capdevila, Montpellier,
France
0809
TETRATHIOMOLYBDATE, A SLOW RELEASE SULPHIDE DONOR, IMPROVES
SURVIVAL IN A RAT MODEL OF HAEMORRHAGE/REPERFUSION INJURY
A. Dyson, L. Andreeva, J. Martin, M. Singer,
0810
CID SCORE IN TRAUMATIC AND NON-SCHEDULED SURGICAL PATIENTS
ON ADMISSION OF A GENERAL INTENSIVE CARE UNIT HAS PROGNOSTIC
VALUE
T. Santos, V. Moreira, V. Goulão, E. Lafuente,
M.J. Fernandes, J.G. Silva, F. Santos, F. Moura,
R. Lopes, Penafiel, Portugal
0811
USING THE INTRA-OSSEOUS ACCESS IN ADULT PATIENTS IN 2012: WHAT
ABOUT TWO YEARS AFTER THE RECOMMENDATIONS OF ILCOR 2010?
S. Perbet, B. Abbal, S. Colomb, S. Ehrmann,
J. Schmidt, J.-E. Bazin, J.-M. Constantin,
Clermont-Ferrand, France
0812
USE OF INTRACRANIAL PRESSURE MONITORING IN FRANCE: PHRC FIRST
DESCRIPTIVE DATA
S. Mirek, J.-M. Yeguiayan, N. Opprecht,
C. Bonithon-Kopp, M. Freysz, Dijon, France
0813
INSULIN RESISTANCE IN SEVERE TRAUMA WITHOUT HEAD INJURY AS
EARLY PREDICTOR OF ICU LENGTH OF STAY: A PROSPECTIVE, PILOT
STUDY
M. Bonizzoli, C. Lazzeri, S. Degl’Innocenti,
G. Zagli, J. Parodo, P. Dammiano, M. Solaro,
G. Gensini, A. Peris, Florence, Italy
0814
SEDATION, VENTILATION AND CARDIOVASCULAR SUPPORT IN BURNS
INTENSIVE CARE UNIT PATIENTS
S. Palazzo, C. Wall, E. James, P. McCabe,
M. Hayes, M. Takata, M. Vizcaychipi, London,
United Kingdom
0815
MORTALITY IN EXTRADURAL HAEMATOMAS - IS TIME TO THEATRE A
FACTOR?
L. Ruff, F. Lecky, Liverpool, United Kingdom
0816
13-17 October 2012
L I V E S 2 012
0817
EVALUATION OF CARE IN TRAUMATIC SEVERE ILLNESS BY TRAUMA
SCORE (TS) - INJURY SEVERITY SCORE (ISS) (TRISS). EXPERIENCE IN ONE
TRAUMA CENTRE IN SPAIN DURING 9 YEARS
M. Chico Fernandez, C. García Fuentes, D. Toral
Vazquez, F. Maimir Jane, S. Bermejo Aznarez,
E. Alted López, Madrid, Spain
0818
IN-HOSPITAL PAEDIATRIC TRAUMA DEATHS: EPIDEMIOLOGY, TRAUMA
MECHANISM, SEVERITY, LOCATION, TYPE OF INJURY, SURVIVAL
PROBABILITY, PRE-HOSPITAL CARE AND EMERGENT MANAGEMENT
R. Kvederiene, V. Zilinskaite, A. Radziunas,
Vilnius, Lithuania
0819
Poster Corner
INDICATORS OF COST, QUALITY & OUTCOME
Chairs: Maurizia Capuzzo, Ferrara, Italy & Christina Jones, Liverpool, United Kingdom
14:00 - 15:50
THE PHYSIOTHERAPY SERVICE MODEL USED IN A SURGICAL INTENSIVE
CARE UNIT AFFECTS NURSING WORKLOAD: A PRELIMINARY STUDY
S. Hanekom, Q. Louw, A. Coetzee, Cape Town,
South Africa
0820
MOBILITY STATUS AT ICU DISCHARGE PREDICTS HOSPITAL DISCHARGE
DESTINATION IN LONG-TERM INTENSIVE CARE UNIT (ICU) PATIENTS
M. Green, I.A. Leditschke, N. Williams, M. Murray,
M. Walker, I.A. Mitchell, B. Bissett, Canberra,
Australia
0821
IN-HOSPITAL CARTOGRAPHY OF CARDIAC ARREST
C. Vannucci, P. Burtin, P. Courant, J.Y. Bigeon,
D. Bessou, E. Hatterer, Montpellier, France
0822
THE ECONOMIC IMPACT OF CRITICAL CARE FELLOWSHIP TRAINING
J.E. Carter, D.L. Johnson, R.E. Stafford, P.B. Rich,
Chapel Hill, United States
0823
CRITICAL CARE OUTREACH TEAMS: A REVIEW OF CRITICAL CARE
OUTREACH SERVICE PROVISION IN THE NHS
R.L. McCartney, S. Saha, J. Rees, R. Mosaheb,
T. Lawy, Romford, United Kingdom
0824
DOES THE CANCER DIAGNOSIS MATTER ON EMOTIONAL DISTRESS IN AN
ICU POPULATION?
R.R. Fumis, P. Martins, G. Schettino, Sao Paulo,
Brazil
0825
VARIABLE, INDIVIDUALISED COST OF A GREEK ICU
D. Karabatsou, E. Boutzouka, E. Tsigou,
M. Tsironi, G. Baltopoulos, Athens, Greece
0826
CORRELATION OF QUALITY OF LIFE INSTRUMENTS AND FUNCTIONAL
STATUS INSTRUMENTS IN CRITICALLY ILL PATIENT
C. de Haro, M.C. Guia, V. Guia, F. Baigorri,
A. Artigas, Sabadell, Spain
0827
EVALUATION OF STRESS LEVELS IN INTENSIVE CARE DOCTORS IN INDIA
R. Amte, P.B. Gopal, K. Munta, S.P. Haranath,
Hyderabad, India
0828
QUALITY OF CARE AND OUTCOME IN PATIENTS ADMITTED TO ICU WITH
ACUTE KIDNEY INJURY
S. Lane, J.W. Zwaal, A. Blyth, Kingston Upon
Thames, United Kingdom
0829
EVIDENCE AS A BASIS FOR CLINICAL PRACTICE GUIDELINES ON
MECHANICAL VENTILATION IN INTENSIVE CARE IN SWEDEN
G. Vogel, A.C. Eldh, Stockholm, Sweden
0830
COMPARATIVE ANALYSIS BETWEEN PATIENTS WITH LONG ICU STAY
DEPENDING ON A YEAR SURVIVAL
L. Santana-Cabrera, R. Lorenzo-Torrent,
M. Sánchez-Palacios, J.D. Martin-Santana,
C. Rodríguez-Escot, B. del Amo Nolasco, G. PérezAcosta, Las Palmas de Gran Canaria, Spain
0831
GLOBAL AND HIDDEN MORTALITY OF PATIENTS ADMITTED AFTER
CARDIAC ARREST UNDER THERAPEUTIC HYPOTHERMIA
M.J. Garcia-Monje, I. Astola, A. Ceniceros,
A. Lopez, V. Rodriguez, V. Aller, J.M. Lopez Perez,
J.M. Gulias, D. Freire, A Coruña, Spain
0832
INDICATORS OF REINSTITUTION OF VENTILATORY SUPPORT AFTER
EXTUBATION FAILURE
N. Umei, K. Atagi, H. Okuno, Y. Seino, Y. Otsuka,
A. Ujiro, H. Shimaoka, Osaka, Japan
0833
L. Thakuria, M. Nel, A. Radhakrishan, C. Gomez,
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
Area Porto
A RETROSPECTIVE REVIEW OF SURGICAL AIRWAY MANAGEMENT IN
MAJOR TRAUMA PATIENTS ON THE INTENSIVE CARE UNIT (ICU)
Try the
e-posters
experience in the
exhibition
area
L I V E S 2 012
169
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
170
area Setubal
Poster Corner
SEPTIC SHOCK: METABOLIC MARKERS, ORGAN DYSFUNCTION & THERAPY
Chairs: Frédérique Schortgen, Creteil, France & Anders Perner, Copenhagen, Denmark
14:00 - 15:50
ENDOTHELIAL-SPECIFIC ARGININOSUCCINATE-SYNTHETASE KNOCK-OUT
MICE HAVE IMPAIRED ARGININE DE NOVO SYNTHESIS, NO PRODUCTION
AND MICROCIRCULATION DURING ENDOTOXEMIA
K.A.P. Wijnands, N.M.S. van den Akker,
M. Ghosh, D.M. Meesters, J.J. Briedé, E.S. Köhler,
M.A.M.J. van Zandvoort, W.H. Lamers,
D.G.M. Molin, M. Poeze, Maastricht, Netherlands
0834
NOREPINEPHRINE VERSUS ANGIOTENSIN-II AS VASOPRESSORS IN SEPTIC
SHOCK: EFFECTS ON INFLAMMATORY RESPONSE, TISSUE PERFUSION
AND ORGAN FUNCTION IN A PORCINE MODEL OF FECAL PERITONITIS
T.D. Correa, V. Jeger, M. Vuda, S. Djafarzadeh,
J. Takala, S.M. Jakob, Bern, Switzerland
0835
CHANGES IN HEPATIC AND RENAL PERFUSION DURING SEPSIS IN ICU
PATIENTS
K. Staufer, E. Kometer, D. Reichhold, A. Drolz,
C. Zauner, M. Trauner, V. Fuhrmann, Vienna,
Austria
0836
INFLAMMATION-INDUCED INCREASE IN WHOLE BLOOD VISCOSITY
DURING HUMAN ENDOTOXEMIA
A.S.E. John, J. Zwaag, M.J. Dorresteijn, L.T. van
Eijk, G. Pop, J.G. van der Hoeven, P. Pickkers,
Nijmegen, Netherlands
0837
RED BLOOD CELL TRANSFUSION AND MORTALITY IN PATIENTS WITH
SEVERE SEPSIS AND SEPTIC SHOCK
I. Jaffer Sathick, R. Kashyap, J. Valerio-Rojas,
R. Cartin-Ceba, Rochester, United States
0838
CLINICAL ASSESSMENT OF THE ENDOTHELIAL GLYCOCALYX TO
MONITOR VASCULAR DYSFUNCTION IN SEPTIC SHOCK PATIENTS
H. Vink, S. Hubble, K.A. Wijnands, C. Thorn,
D. Mawson, S. Roos, M. Poeze, A. Shore,
Maastricht, Netherlands
0839
HISTOLOGIC INDICATORS OF CATECHOLAMINE-INDUCED
CARDIOTOXICITY IN SEPTIC SHOCK
C.A. Schmittinger, M.W. Dünser, C. Torgersen,
C.M. Steger, Lucerne, Switzerland
0840
ESMOLOL EFFECTS ON HEART RATE VARIABILITY IN SEPTIC SHOCK
J. Aboab, R. De Olivera, V. Sebille, A. Mansart,
J. Mangalaboyi, M. Jourdain, D. Annane,
Garches, France
0841
LEUCO-DEPLETED BLOOD TRANSFUSION DOES NOT PRODUCE AN
INFLAMMATORY RESPONSE IN CRITICALLY ILL ADULTS: RESULTS FROM A
RANDOMISED CONTROLLED TRIAL
Z. Jiwaji, K.P. Nunn, A. Conway Morris,
A.J. Simpson, A. Rossi, T.S. Walsh, Edinburgh,
United Kingdom
0842
VASOPRESSIN IMPACT IN MICROCIRCULATORY FLOW IN SEPTIC SHOCK
PATIENTS
A.P.M. Nascente, F.G.R. Freitas, A.T. Bafi,
F.R. Machado, Sao Paulo, Brazil
0843
TRANSFUSION REQUIREMENTS IN SEPTIC SHOCK (TRISS) TRIAL
- PROTOCOL OF AN ONGOING SCANDINAVIAN MULTICENTRE,
RANDOMISED CLINICAL TRIAL OF THE EFFICACY AND SAFETY OF RED
BLOOD CELL TRANSFUSION IN PATIENTS WITH SEPTIC SHOCK
L.B. Holst, J. Wetterslev, P. Johansson,
J. Wernerman, A. Åneman, A.B. Guttormsen,
S. Karlsson, G. Klemenzson, N. Haase, A. Perner,
Copenhagen, Denmark
0844
SHOCK INDEX (SI) IS THE BEST PREDICTOR OF MORTALITY IN SEPTIC
SHOCK
P. Barriga, E. Monares, R. Chaires, I. Galvan,
M. Poblano, J. Aguirre, G. Camarena, J. Franco,
Mexico, Mexico
0845
EFFECTS OF HYDROXYETHYLSTARCHES WITH DIFFERENT
CONCENTRATIONS AND MOLECULAR WEIGHTS ON HAEMODYNAMICS
AND RENAL FUNCTION IN A PORCINE TWO HIT MODEL OF SHOCK
C. Thiele, T.-P. Simon, F. Stadermann,
T. Schürholz, K.U. Amann, G. Marx, Aachen,
Germany
0846
IS LACTATE THE CULPRIT IN SEPSIS ASSOCIATED METABOLIC ACIDOSIS?
R. Tuffin, S. Fletcher, Bradford, United Kingdom
0847
Area Sintra
Poster Corner
Nurses
&
AHP
NURSING INTERVENTIONS
Chairs: Paul Mayo, New York, United States & Bernard Vigué, France
14:00 - 15:50
PICC: PASSPORT TO DISCHARGE?: NURSE LED PERIPHERALLY INSERTED
CENTRAL CATHETERS CAN PROVIDE EFFECTIVE VASCULAR ACCESS
ASSESSMENT AND PLACEMENT, WITH THE CAPACITY TO SUPPORT
PATIENTS´ ACCESS NEEDS TO DISCHARGE
H. Baker, C. Boulanger, V. Shawyer, C. Courtice,
J. Nixon, S. Hill, Exeter, Devon, United Kingdom
0848
THE QUALITY OF NURSING PRACTICE IN THE DETECTION AND INITIAL
MANAGEMENT OF THE DETERIORATING WARD PATIENT
M. Odell, Reading, United Kingdom
0849
USE OF PHYSICAL RESTRAINT IN DUTCH INTENSIVE CARE UNITS:
PREVALENCE AND MOTIVES
R.J. Raijmakers, R.L. Vroegop, M. van den
Boogaard, A.W. van der Kooi, A.J. Slooter,
0850
13-17 October 2012
L I V E S 2 012
0851
VISUAL Q-CPR® FEEDBACK DURING CPR BY EXPERIENCED ICU NURSES
INCREASES CONSISTENCY OF RATE OF CHEST COMPRESSIONS
E.A. Icke, H.P.M.M. Gelissen, Amsterdam,
Netherlands
0852
EVALUATION TO STUDY THE EFFECT OF A SPECIAL MATTRESS ON THE
INCIDENCE OF SACRAL PRESSURE ULCER
W. Groetelaers, M. van den Boogaard, Nijmegen,
Netherlands
0853
THE IMPLEMENTATION OF A NURSE DRIVEN GLUCOSE REGULATION
INTENSIVE CARE PATIENTS (GRIP) AS A FULLY-AUTOMATED FEATURE OF
METAVISION
A.M. Morreale-Tulleken, J. Boer, A.J. Wignand,
A. Beishuizen, M.C. de Waard, R. Driessen,
0854
CRITICAL CARE OUTREACH: CHANGING THE GAME
J. Burke, S. Wood, L. Smith, A. Hermon,
T. Szakmany, Llantrisant, United Kingdom
0855
INTERMITTENT ASPIRATION OF SUBGLOTTIC SECRETIONS AND
TRACHEAL MUCOSA DAMAGE
E. Suys, K. Nieboer, W. Stiers, L. Huyghens, J. De
Regt, H. Spapen, Brussels, Belgium
0856
ENHANCING EARLY CRITICAL ILLNESS RECOVERY THROUGH THE USE OF
A ‘USER CENTRED CRITICAL CARE DISCHARGE INFORMATION PACK’
S. Bench, P. Griffiths, P. Hopkins, T. Day,
P. Milligan, L. Yardley, K. Heelas, C. White,
0857
LOWERING OF SINUSITIS INCIDENCE BY INTRODUCTION OF A SINUSITIS
PROPHYLAXIS
M. Hout van der, L. Duijn, A.-M. Kaiser,
J. Peppink, C. Vandenbroucke-Grauls, A. Girbes,
0858
Life-Priority
Poster Corner
AUDIT & ASSESSMENT OF CRITICAL CARE PRACTICE
Chairs: Julian Bion, Birmingham, United Kingdom & Peter van der Voort, Amsterdam, Netherlands
14:00 - 15:50
OVERESTIMATION OF MORTALITY AFTER APPLYING THE EUROSCORE TO
ELDERLY PATIENTS. ANALYSIS OF THE DATABASE ARIAM OF CARDIAC
SURGERY
G. Jimenez-Perez, J. Muñoz-Bono, E. CurielBalsera, R. Rivera-Fernandez, M.D. Arias-Verdu,
E. Marquez-Alvarez, F.J. Gomez-Carrero,
Malaga, Spain
0859
ASSESSING OUTCOME AFTER CRITICAL ILLNESS BY USE OF A NATIONAL
INTENSIVE CARE REGISTRY (SIR)
L. Orvelius, S. Walther, H. Gren, C. Mårdh,
G. Karlström, F. Sjöberg, Linköping, Sweden
0860
MODIFIED EARLY WARNING SCORE (MEWS) IS A POOR DISCRIMINATOR
IN ONCOLOGY PATIENTS OF THE NEED FOR CRITICAL CARE ADMISSION
AND 30 DAY MORTALITY
T. Cooksley, E. Kitlowski, P. Haji-Michael,
Manchester, United Kingdom
0861
EARLY ADMISSION IMPROVES LONG TERM OUTCOME IN PATIENTS
DIAGNOSED WITH ACUTE PANCREATITIS ADMITTED TO ICU
P. Vidal-Cortés, P. Lameiro-Flores, M. MoureloFariña, A.V. Aller-Fernández, P. FernándezUgidos, R. Gómez-López, M.T. Alves-Pérez,
E. Rodríguez-García, Ourense, Spain
0862
AN AUDIT ON VENOUS THROMBOEMBOLISM PROPHYLAXIS
PRESCRIPTION IN HIGH RISK PATIENTS
D. Turner, L. Ma, S. McAuliffe, C. Peters, London,
United Kingdom
0863
CHANGING PATTERNS OF CRITICAL INCIDENTS IN A UK HOSPITAL
CRITICAL CARE UNIT: 2010 - 2012
N. Jain, S. Singh, E. Christie, Chester, United
Kingdom
0864
CHEST X RAY INDICATIONS AND DOCUMENTATION IN INTENSIVE CARE:
REAUDIT AND PROGRESS
H. Aladin, R. Puttaswamy, S. McCormick,
J. Bleasdale, M. Patel, Birmingham, United
Kingdom
0865
TRANSFUSION PRACTICE IN THE INTENSIVE CARE UNIT
L.D. Umezawa Makikado, M. Chico Fernandez,
C. García Fuentes, C. Grande García, Z. Molina
Collado, C. Mudarra Reche, J.L. Flordelís Lasierra,
J.A. Sánchez-Izquierdo Riera, J.C. Montejo
González, Madrid, Spain
0866
EFFECTIVE EYE CARE PREVENTS CORNEAL COMPLICATION IN
VENTILATED PATIENTS IN MEDICAL INTENSIVE CARE UNIT
M.F. Azfar, Riyadh, Saudi Arabia
0867
SEQUENTIAL AUDIT OF VENTILATOR CARE BUNDLE COMPLIANCE IN A
UK GENERAL ICU
H. Morton, M. Carpenter, Newcastle Upon Tyne,
United Kingdom
0868
L I V E S 2 012
M. Colmenero, F. Manzano, A.M. Pérez-Pérez,
D. Roldan, M.-A. Del Moral, M.-A. Sanchez-Moya,
M.-R. Mañas-Vera, E. Fernández-Móndejar,
Granada, Spain
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
EFFECTIVENESS OF A REGIMEN OF REPOSITIONING EVERY 2 HOURS
VERSUS EVERY 4 HOURS USING ALTERNATING PRESSURE MATTRESSES
IN PREVENTING PRESSURE ULCERS IN PATIENTS ON MECHANICAL
VENTILATION. THE PUPPAS RANDOMISED CONTROLLED TRIAL
171
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
CAN A CERTIFIED INTENSIVIST AND ICU RENOVATION IMPROVE PATIENT
OUTCOMES AFTER CARDIAC SURGERY?
Y. Onodera, R. Akimoto, T. Kobayashi,
M. Iwabuchi, S. Oda, M. Nakane, K. Kawamae,
Yamagata City, Japan
0869
CRITICAL CARE FACTORS AFFECTING POST OPERATIVE MORTALITY IN
ABDOMINAL AORTIC ANEURYSMS(AAA) - A FIVE YEAR RETROSPECTIVE
ANALYSIS
S.D. Chaudhry, S. Anipindi, Stafford, United
Kingdom
0870
H1N1 - ONE YEAR FOLLOW UP STUDY
A. Biswas, F. Alam, K. Hattery, A. O Brien,
S. Mahdy, J. O Driscall, C. Motherway, Limerick,
Ireland
0871
A SERVICE ANALYSIS OF ROUTINE PATHOLOGY INVESTIGATIONS ON A
CRITICAL CARE UNIT
K. Bailey, R. Davidson, S. Beards, Manchester,
United Kingdom
0872
room Lisbon
Oral Presentations
ARDS: DEFINING, MONITORING AND OUTCOME
Chairs: Antonio Pesenti, Monza, Italy & Laurent Brochard, Geneva, Switzerland
14:15 - 14:30
IMPACT OF INFLAMMATION BIOMARKERS ON THE ARDS DEFINITION
S. Mrozek, M. Jabaudon, L. Roszyk, S. Jaber,
Q. Lu, C. Paugham, K. Asehnoune, J.-Y. Lefrant,
J.M. Constantin, Clermont-Ferrand, France
0873
14:30 - 14:45
MINIMALLY INVASIVE SHUNT ESTIMATION USING VOLUMETRIC
CAPNOGRAPHY
A. Santos, F. Suarez-Sipmann, S. Bohm,
J.B. Borges, M. Muñoz, A. Larsson,
G. Hedenstierna, G. Tusman, Madrid, Spain
0874
14:45 - 15:00
VENTILATORY RATIO A BEDSIDE TOOL TO MONITOR VENTILATORY
EFFICIENCY- PHYSIOLOGICAL ANALYSIS AND CLINICAL USE IN ARDSNET
DATABASE
P. Sinha, M.K. Vukoja, O. Gajic, N. Fauvel,
P. Singh, N. Soni, London, United Kingdom
0875
15:00 - 15:15
QUANTIFICATION OF DEAD SPACE AS A PREDICTOR OF MORTALITY IN
PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME IN EARLY
STAGE
M.E. Plazolles Delgado, M.V. Nievas, H. Aguirre
Bermeo, L. Zapata Fenor, J. Mancebo Cortes,
I. Moran Chorro, Barcelona, Spain
0876
15:15 - 15:30
INCREASED MORTALITY IN PATIENTS OVER 75 YEARS WITH MECHANICAL
VENTILATION FOR MORE THAN 7 DAYS
M. Redondo Orts, F. Manzano Manzano,
M.D.M. Jimenez, M. Monsalve-Alvarez
Cienfuegos, J. Castaño, Granada, Spain
0877
15:30 - 15:50
Discussion
room BERLIN
Thematic Session
DO MEDICAL JOURNALS MODIFY OUR PRACTICE?
Chairs: Howard Bauchner, Chicago, United States & Marco Ranieri, Turin, Italy
14:15 - 14:35
The editor’s mandate: From impact factor to clinical impact
Howard Bauchner, Chicago, United States
14:35 - 14:50
The editor’s headache: Duplicate publications, salami publication &
fraud
14:50 - 15:05
The clinician’s mandate: Implementing evidence into clinical practice
15:05 - 15:20
The clinician’s headache: Selecting and reading the best literature
Elie Azoulay, Paris, France (TBC)
15.20 - 15:35
The researcher’s challenge: Publishing negative, industry-funded trials
15.35 - 15.50
Discussion
172
13-17 October 2012
L I V E S 2 012
ADEQUATE AND APPROPRIATE TREATMENT OF ICU INFECTIONS
14:15 - 14:30
EVIDENCE-BASED RECOMMENDATIONS TO INCREASE THE APPROPRIATE
USAGE OF ANTIBIOTICS IN ICU PATIENTS: A 5-DAY BUNDLE
J. Schouten, G. de Angelis, T. Sprong, M. Nabuurs,
M. Antonelli, H. van Groningen, A. Voss,
M. Hulscher, E. Taconelli, Nijmegen, Netherlands
0878
14:30 - 14:45
THE ANTI-INFLAMMATORY EFFECT OF PENTOXIFYLLINE IN LPS-INDUCED
ACUTE LUNG INJURY IS A2A-DEPENDENT
F.M. Konrad, G. Neudeck, I. Vollmer, K.C. Ngamsri, M. Thiel, J. Reutershan, Tübingen,
Germany
0879
14:45 - 15:00
CURRENT TREATMENT FOR SEVERE COMMUNITY-ACQUIRED
PNEUMONIA: LESSONS FROM THE N1H1 PADEMIC
C. Lluch Candal, B. Sánchez González,
C. Cabeza, E. Piacentini, S. Quintana, R. Ferrer
Roca, Terrassa, Spain
0880
15:00 - 15:15
LUNG ULTRASONOGRAPHY FAILS DETECTION OF NON-SUBPLEURAL
COMMUNITY ACQUIRED PNEUMONIA
F. Corradi, L. Ball, C. Brusasco, M. Vargas,
A. Garlaschi, F. Altomonte, P. Moscatelli, P. Pelosi,
Genoa, Italy
0881
15:15 - 15:30
EFFICIENCY OF A PNEUMATIC DEVICE IN CONTROLLING CUFF PRESSURE
OF POLYURETHANE-CUFFED TRACHEAL TUBES: A RANDOMISED
CONTROLLED STUDY
S. Nseir, E. Jaillette, F. Zerimech, J. De Jonckheere,
M. Balduyck, A. Durocher, Lille, France
0882
15:30 - 15:50
Discussion
room Geneva
Oral Presentations
DIFFICULT INFECTIONS IN THE ICU
Chairs: Jordi Rello, Barcelona, Spain & Frédéric Pène, Paris, France
14:15 - 14:30
IMPAIRED VIRULENCE OF A CLINICAL STRAIN OF ACINETOBACTER
BAUMANNII RESISTANT TO COLIMYCINE IN A RAT MODEL OF ACUTE
PNEUMONIA
S. Hraiech, A. Roch, T. Atieh, L. Papazian, J.M. Rolain, D. Raoult, F. Brégeon, Marseille,
France
0883
14:30 - 14:45
IMPROVING HAND HYGIENE IN INTENSIVE CARE UNITS: A MULTI-CENTRE
INTERVENTION STUDY
L. Derde, R. Stellato, C. Brun Buisson, M. Bonten,
0884
14:45 - 15:00
RANDOMISED CONTROLLED TRIAL OF CHLORHEXIDINE DRESSING AND
HIGHLY ADHESIVE DRESSING FOR PREVENTING CATHETER-RELATED
INFECTIONS IN THE ICU
J.-F. Timsit, O. Mimoz, B. Mourvillier, S. Ruckly,
J.-C. Lucet, Grenoble, France
0885
15:00 - 15:15
TDM BASED DOSE OPTIMISATION OF PIPERACILLIN AND MEROPENEM: A
RANDOMISED CONTROLLED TRIAL
J. De Waele, S. Carrette, M. Carlier, V. Stove,
E. Hoste, P. Depuydt, J. Decruyenaere,
A. Verstraete, Ghent, Belgium
0886
15:15 - 15:30
CLINICAL FEATURES AND OUTCOMES OF CRITICALLY ILL PATIENTS WITH
SHIGATOXIN-INDUCED HAEMOLYTIC UREMIC SYNDROME
S. Braune, D. Wichmann, M. von Heinz,
A. Nierhaus, H. Becker, G. Meyer, M. MüllerSchulz, J. Fricke, A. de Weerth, W. Hoepker,
J. Fiehler, T. Magnus, C. Gerloff, U. Panzer,
R. Stahl, S. Kluge, Hamburg, Germany
0887
15:30 - 15:50
Discussion
room Berlin
CARDIOVASCULAR MONITORING UPDATE
Chairs: Daniel De Backer, Brussels, Belgium & Xavier Monnet, Kremlin-Bicetre, France
14:15 - 14:35
Absolute values vs. changes at the bedside
14:35 - 14:55
From arterial pressure to cardiac output
14:55 - 15:10
Doppler techniques
15:10 - 15:30
Completely non invasive technologies
15:30 - 15:50
Volumetric monitoring
L I V E S 2 012
Oral Presentations
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
room Barcelona
Chairs: Jeff Lipman, Brisbane, Australia & Christian Brun-Buisson, Creteil, France
173
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
174
room Glasgow
Oral Presentations
SEPSIS, TRAUMA AND KIDNEY INJURY: EPIDEMIOLOGY AND OUTCOME
Chairs: Wilfred Druml, Vienna, Austria & Penglin Ma, Beijing, China
14:15 - 14:30
PROSPECTIVE EXTERNAL VALIDATION OF RISK PREDICTION MODELS
FOR ACUTE TRAUMATIC BRAIN INJURY IN UK CRITICAL CARE UNITS: THE
RAIN STUDY
D.A. Harrison, K.A. Griggs, M. Gomes,
D.K. Menon, K.M. Rowan, London, United
Kingdom
0888
14:30 - 14:45
NATIONAL TRENDS IN SEVERE SEPSIS HOSPITAL INCIDENCE IN SPAIN: A
POPULATION BASED STUDY, 1999-2009
C. Bouza, T. Lopez-Cuadrado, J.M. Amate,
Madrid, Spain
0889
14:45 - 15:00
SEPTIC ACUTE KIDNEY INJURY IN THE CRITICALLY ILL
M. Poukkanen, S. Karlsson, K.-M. Kaukonen,
A.-M. Korhonen, S.T. Vaara, S. Hovilehto,
O. Inkinen, R. Laru-Sompa, T. Kaminski, V. Pettilä,
Rovaniemi, Finland
0890
15:00 - 15:15
EARLY TRACHEOSTOMY INCREASES HOSPITAL MORTALITY AFTER
R. Schmutz, H. Hochrieser, P. Bauer, W. Mauritz,
P.G.H. Metnitz, Vienna, Austria
0891
15:15 - 15:30
INCIDENCE, RISK FACTORS, AND MORTALITY OF ACUTE KIDNEY INJURY
IN FINNISH INTENSIVE CARE UNITS: THE FINNAKI STUDY
S. Nisula, K.-M. Kaukonen, S.T. Vaara, A.M. Korhonen, M. Poukkanen, S. Karlsson,
M. Haapio, O. Inkinen, I. Parviainen,
R. Suojaranta-Ylinen, J.J. Laurila, J. Tenhunen,
M. Reinikainen, T. Ala-Kokko, E. Ruokonen,
A. Kuitunen, V. Pettilä, Helsinki, Finland
0892
15:30 - 15:50
Discussion
room Stockholm
Oral Presentations
Nurses
&
AHP
END OF LIFE CARE - ETHICS OF RESEARCH 2
Chairs: Charles Sprung, Jerusalem, Israel & J. Randall Curtis, Seattle, United States
14:15 - 14:30
PREDICTION OF DEATH IN LESS THAN 60 MINUTES FOLLOWING
WITHDRAWAL OF CARDIO-RESPIRATORY SUPPORT IN INTENSIVE CARE
UNITS: THE PREDICT STUDY
J. Brieva, N. Coleman, J. Lacey, P. Harrigan,
T. Lewin, G. Carter, New Lambton, Australia
0893
14:30 - 14:45
PRACTICES IN LIFE-SUSTAINING TREATMENT AND PERCEPTIONS OF
CAREGIVERS: A FRENCH SURVEY
I. Vinatier, S. Valéra, M.-L. Baillot, I. BourgeonGhittori, C. Clec’h, K. Couchoux, V. Franja,
S. Jeune, M. Lloung, V. Lombardo, S. Lusso,
Y. Maetens, C. Mossadegh, E. Rosset,
B. Souweine, Paris, France
0894
14:45 - 15:00
END OF LIFE CARE IN THE ICU: CAN A GUIDELINE FOR WITHHOLDING
AND WITHDRAWING THERAPY IMPROVE INTERDISCIPLINARY
COLLABORATION AND PATIENT CARE?
H.I. Jensen, J. Ammentorp, H. Ørding, Vejle,
Denmark
0895
15:00 - 15:15
CHANGES IN END-OF-LIFE DECISION MAKING IN A CENTRAL LONDON
ADULT INTENSIVE CARE UNIT FOLLOWING THE INTRODUCTION OF
THREE END-OF-LIFE INTERVENTION TOOLS. ENRICH INVESTIGATORS
P. Hopkins, C. Bell, A. Feehan, K. Peters,
C. Rumble, C. Shipman, S. Heenan, J. Noble,
O. Dampier, W. Prentice, S. Leonard, R. Burman,
J. Koffman, I. Higginson, London, United
Kingdom
0896
15:15 - 15:30
OPIOIDS AND SEDATIVES DO NOT SEEM TO CONTRIBUTE TO TIME TILL
DEATH AFTER WITHDRAWAL OF LIFE SUSTAINING THERAPY IN DUTCH
CRITICALLY ILL ICU PATIENTS
J.L. Epker, E.J.O. Kompanje, Rotterdam,
Netherlands
0897
15:30 - 15:50
Discussion
room Paris
Oral Presentations
ACUTE KIDNEY INJURY
Chairs: Lui Forni, Worthing, United Kingdom & Claude Guérin, Lyon, France
14:15 - 14:30
COMBINATION OF RENAL BIOMARKERS PREDICTS ACUTE KIDNEY
INJURY IN CRITICALLY ILL ADULTS
S. Kokkoris, M. Parisi, S. Ioannidou, E. Douka,
C. Pipili, M. Mitsogianni, T. Kyprianou,
A. Kotanidou, S. Nanas, Athens, Greece
0898
14:30 - 14:45
PREDICTIVE VALUE OF NEUTROPHIL GELATINASE-ASSOCIATED
LIPOCALIN (NGAL) FOR ACUTE KIDNEY INJURY IN INTENSIVE CARE
PATIENTS - A SYSTEMATIC REVIEW
P.B. Hjortrup, N. Haase, M. Wetterslev, A. Perner,
København Ø, Denmark
0899
13-17 October 2012
L I V E S 2 012
M. Raimundo, S. Crichton, M. Ostermann,
Lisbon, Portugal
0900
15:00 - 15:15
HUMAN ALBUMIN VERSUS ISOTONIC SODIUM BICARBONATE IN
PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN CRITICALLY ILL
PATIENTS
A.M. Fayed, Alexandria, Egypt
0901
15:15 - 15:30
PREVALENCE OF KIDNEY DYSFUNCTION IN THE ICU. RESULTS OF THE
COFRADE MULTICENTRE STUDY
M. Herrera Gutierrez, G. Seller-Perez,
J.A. Sanchez-Izquierdo-Riera, J. Maynar-Moliner,
R. Lozano-Saez, A. Roglan-Piqueras, C. BenitoPuncel, E. Casanoves-Laparra, R. SierraCamerino, F. Guerrero-Lopez, Malaga, Spain
0902
15:30 - 15:50
Discussion
room Vienna
Oral Presentations
THERAPEUTIC HYPOTHERMIA
Chairs: Bernd Böttiger, Heidelberg, Germany (TBC) & Alain Cariou, Paris, France
14:15 - 14:30
BRAIN DAMAGE IN NON-SURVIVORS AFTER CARDIAC ARREST AND
THERAPEUTIC HYPOTHERMIA
B. Erik, E. Englund, Lund, Sweden
0903
14:30 - 14:45
USE OF THERAPEUTIC HYPOTHERMIA IN THE ICU PREDICTS SURVIVAL
IN UNCONSCIOUS OUT-OF-HOSPITAL CARDIAC ARREST PATIENTS
INDEPENDENT OF AGE, ORIGIN AND INITIAL RHYTHM
E. Søreide, T.W. Lindner, J. Langørgen, K. Sunde,
J.T. Kvaløy, Stavanger, Norway
0904
14:45 - 15:00
CHANGES OF INFLAMMATORY MEDIATORS DURING REWARMING
PERIOD AFTER MILD THERAPEUTIC HYPOTHERMIA
H.J. Lee, G.J. Suh, W.Y. Kwon, K.S. Kim, Y.S. Jung,
Y.H. Kwak, Seoul, Republic of Korea
0905
15:00 - 15:15
MONITORING OF BACTERAEMIA IN POST-CARDIAC ARREST PATIENTS
TREATED WITH MILD THERAPEUTIC HYPOTHERMIA
M.C. de Waard, E. de Jong, A.M. Kaiser,
A.R. Girbes, Amsterdam, Netherlands
0906
15:15 - 15:30
COMPARISON OF TWO DIFFERENT COOLING TECHNIQUES TO ACHIEVE
MILD THERAPEUTIC HYPOTHERMIA IN POST-CARDIAC ARREST PATIENTS
P. Banwarie, M.C. de Waard, A.R. Girbes,
A.B. Groeneveld, Amsterdam, Netherlands
0907
15:30 - 15:50
Discussion
room Athens
Oral Presentations
MOLECULAR MECHANISMS IN SEPSIS
Chairs: Brian Kavanagh, Toronto, Canada & Jérôme Pugin, Geneva, Switzerland
14:15 - 14:30
ASSESSMENT OF THE SAFETY AND FEASIBILITY OF ADMINISTERING
ANTI-PYRETIC THERAPY IN CRITICALLY ILL ADULTS: A RANDOMISED
CLINICAL TRIAL
D.J. Niven, H.T. Stelfox, P. Kubes, K.B. Laupland,
Calgary, Canada
0908
14:30 - 14:45
TIMING OF INTUBATION IN SEPTIC SHOCK PATIENTS: THE BREATHE
SURVEY
J. Aboab, E. de Montmollin, R. Ferrer, E. Azoulay,
D. Annane, Garches, France
0909
14:45 - 15:00
THE EFFECTS OF ANTI-PYRETIC THERAPY ON THE IMMUNOLOGY OF
FEVER IN CRITICALLY ILL ADULTS: SECONDARY ANALYSIS FROM A
RANDOMISED CLINICAL TRIAL
D.J. Niven, C. Jenne, P. Kubes, H.T. Stelfox,
K.B. Laupland, Calgary, Canada
0910
15:00 - 15:15
A POSITIVE FLUID BALANCE AND USED LOOP DIURETICS AMOUNT ARE
ASSOCIATED INCREASED MORTALITY IN INTENSIVE CARE UNIT
C.W. Kim, S.J. Lee, M.K. Lee, J.H. Lee, S.J. Yong,
K.C. Shin, W.Y. Lee, Wonju, Republic of Korea
0911
15:15 - 15:30
OXYGEN DELIVERY AND DEMAND DURING FEVER AND NORMOTHERMIC
CONDITIONS IN SEPTIC PATIENTS
G. Choutas, V. Ntzani, D. Karapanos, A. Katsika,
M. Pra, G. Anthopoulos, Athens, Greece
0912
15:30 - 15:50
Discussion
+
L I V E S 2 012
LOWER MEAN ARTERIAL BLOOD PRESSURE AND SYSTEMIC OXYGEN
DELIVERY ON DAY OF EARLY AKI ARE ASSOCIATED WITH INCREASED
RISK OF PROGRESSIVE AKI AND MORTALITY
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
14:45 - 15:00
Visit us at the
ESICM Booth
Exhibition Area A
175
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
176
room Lisbon
Thematic Session
ICM: YEAR IN REVIEW
Chairs: Massimo Antonelli, Rome, Italy & Andrew Rhodes, London, United Kingdom
16:00 - 16:20
Intensive care medicine in 2012
16:20 - 16:40
The best in mechanical ventilation
Salvatore Maggiore, Rome, Italy
16:40 - 17:00
The best in infections
17:00 - 17:20
The best in neuro intensive care
Giuseppe Citerio, Monza, Italy
17:20 - 17:40
The best in nephrology and epidemiology
17:40 - 18:00
The best in cardiovascular intensive care
room Berlin Thematic Session
CARING FOR THE LUNGS OF THE HAEMODYNAMICALLY CHALLENGED PATIENT
Chairs: Didier Payen de La Garanderie, Paris, France & Michael Pinsky, Pittsburgh, United States
16:00 - 16:20
Heart-lung interactions for dummies
16:20 - 16:40
Optimising ventilation strategies in right-heart failure
Didier Payen de La Garanderie, Paris, France
16:40 - 17:00
Open lung strategies during shock: Balancing competing priorities
17:00 - 17:20
Fluid management in septic ARDS patient
17:20 - 17:40
When heart failure compromises ventilation weaning
17:40 - 18:00
Can novel imaging modalities help optimise the heart-lung interaction?
rooM Barcelona
Thematic Session
EARLY GOAL-DIRECTED THERAPY
Chairs: Daniel De Backer, Brussels, Belgium & Jean-Louis Vincent, Brussels, Belgium
16:00 - 16:20
What is the evidence for early goal-directed therapy?
Kathryn Rowan, London, United Kingdom
16:20 - 16:40
EGDT in sepsis
16:40 - 17:00
EGDT in high risk surgical patients
17:00 - 17:20
How early is not too late?
17:20 - 17:40
Less invasive devices for EGDT
17:40 - 18:00
First do not harm: When to stop?
room Geneva Continuous Professional Education Session
COLLAPSE IN ARDS
ASSESSMENT OF LUNG AERATION AND
Chairs: Luciano Gattinoni, Milan, Italy & Michael Quintel, Gottingen, Germany
16:00 - 16:20
Assessing lung function - don’t forget the basics!
16:20 - 16:40
Should we use œsophageal pressure monitoring?
16:40 - 17:00
How useful are lung volume measurements?
17:00 - 17:20
What can we learn from exhaled breath analysis?
17:20 - 17:40
Lung ultrasound - does it have a role?
17:40 - 18:00
Electrical Impedance Tomography
Michael Quintel, Gottingen, Germany
13-17 October 2012
L I V E S 2 012
FIGHTING MULTI-DRUG RESISTANT PATHOGENS
16:00 - 16:20
KPC-producers: What’s new in epidemiology and treatment
Garyfallia Poulakou, Athens, Greece
16:20 - 16:40
How to manage untreatable infections with Gram-negative pathogens?
Jean-François Timsit, Grenoble, France
16:40 - 17:00
Extensive drug and pandrug resistance organisms: What does the
pipeline hold?
Garyfallia Poulakou, Athens, Greece
17:00 - 17:20
Antimicrobial combinations with colistin: What to expect?
Jeff Lipman, Brisbane, Australia
17:20 - 17:40
Inhaled colistin: An update of indications and effectiveness
Claude Martin, Marseille, France
17:40 - 18:00
Colistin resistance in the clinical setting: A nightmare without dawn
room Glasgow
Thematic Session
ABC’s OF PAEDIATRIC INTENSIVE CARE FOR THE ADULT INTENSIVIST
Chairs: Samuel Ajizian, Winston Salem, United States & Mark Peters, London, United Kingdom
16:00 - 16:20
Comparative adult and paediatric physiology
Mark Peters, London, United Kingdom
16:20 - 16:40
Stabilisation and transport
Samuel Ajizian, Winston Salem, United States
16:40 - 17:00
Diabetic Ketoacidosis (DKA)
Maria Karantza, Athens, Greece
17:00 - 17:20
Paediatric trauma
Thomas Geeraerts, Toulouse, France
17:20 - 17:40
Paediatric respiratory insufficency
17:40 - 18:00
PICU monitoring: The differences
TBA
room Stockholm
Thematic Session
ACHIEVING A CULTURE OF SAFETY
Chairs: Sonia Labeau, Ghent, Belgium & Julie Benbenishty, Jerusalem, Israel
Nurses
&
AHP
16:00 - 16:20
Essential conditions to achieve a culture of patient safety
Barbara McLean, Atlanta, United States
16:20 - 16:40
Defining safety indicators
Rui Paulo Moreno, Lisbon, Portugal
16:40 - 17:00
Increasing safety through care bundles implementation
17:00 - 17:20
Avoiding readmissions
17:20 - 17:40
Prevention of pressure sores
Terry O’Reilly, London, United Kingdom
17:40 - 18:00
Avoiding accidental extubation
David McWilliams, Manchester, United Kingdom
room Paris
Thematic Session
LONG-TERM OUTCOME AND SEQUELAE FROM SEPSIS
Chairs: Margaret Herridge, Toronto, Canada & Fernando Bozza, Rio de Janeiro, Brazil
16:00 - 16:20
What does long-term survival mean after sepsis?
16:20 - 16:40
Protracted critical illness: The chronic ICU patient after sepsis
Susanne Toussaint, Berlin, Germany
16:40 - 17:00
Physical disability of sepsis survivors
17:00 - 17:20
Mental disability after sepsis
Fernando Bozza, Rio de Janeiro, Brazil
17:20 - 17:40
Rehabilitation after Severe Critical Illness
Margaret Herridge, Toronto, Canada
17:40 - 18:00
Help to self-help: the German sepsis AID
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
rooM Rome
Chairs: José Artur Paiva, Porto, Portugal & Laurent Papazian, Marseille, France
Try the
e-posters
experience in the
exhibition
area
L I V E S 2 012
177
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
178
rooM Vienna
Thematic Session
OVERFEEDING IN ICU - A REAL PROBLEM?
Chairs: Jan Wernerman, Stockholm, Sweden & Mette Berger, Lausanne, Switzerland
16:00 - 16:20
Caloric mismatch in the early phase
Michaël Casear, Leuven, Belgium
16:20 - 16:40
Does type of calories matter?
Jean-Charles Preiser, Brussels, Belgium
16:40 - 17:00
Is it possible to overfeed enterally?
Annika Reintam Blaser, Tallin, Estonia
17:00 - 17:20
How dangerous is caloric deficit?
17:20 - 17:40
Is fat-free nutrition the option?
17:40 - 18:00
The protein requirement in the early phase
Jan Wernerman, Stockholm, Sweden
rooM Athens
Controversies Session
SURVEILLANCE OF VAP IS AN USEFUL QUALITY INDICATOR
Chair: Francesca Rubulotta, London, United Kingdom
16:00 - 16:10
Yes
16:10 - 16:20
No
Akos Csomos, Budapest, Hungary
16:20 - 16:30
Discussion
room Athens
END OF LIFE DECISIONS
Chairs: Jozef Kesecioglu, Utrecht, Netherlands & Charles Sprung, Jerusalem, Israel
16:40 - 17:00
End of life decisions are not an ethical issue
17:00 - 17:20
Withdrawal of care is not euthanasia
17:20 - 17:40
Implementing shared decision making
J. Randall Curtis, Seattle, United States
17:40 - 18:00
Financial resources will play a role in EoL decisions in the near future
Bob Truog, Boston, United States
13-17 October 2012
L I V E S 2 012
Live the Dimar™* ZIP helmet experience
Booth #28, Exhibition Area A
NONINVASIVE VENTILATION... COMFORTABLY
Dimar™* Helmet Range
for CPAP and noninvasive mechanical ventilation
The Dimar ZIP helmet range features a unique patented 240 degrees
zip system offering:
 Patient safety, compliance and comfort during installation
 Patient access without the need to remove the helmet
Newport HT70 Plus™ Ventilator
Puritan Bennett™ 840 Ventilator
The Dimar ZIP helmet range is available in CPAP, NIMV, neonatal
and pediatric versions and in six sizes with unique advantages for
the patient and caregiver.
The Dimar ZIP helmet range is specially suited for use with the
Puritan Bennett™ 840 ventilator, the Newport™ e360 and HT70
Plus™ ventilators from Covidien, and the Dimar™* Easyflow CPAP
generator.
Dimar™* Easyflow CPAP Generator
Newport™ e360 Ventilator
Covidien is the exclusive distributor of Dimar products in the EMEA. Dimar Srl. is the manufacturer of record for the Dimar
product line and is responsible for maintaining all governmental and regulatory authorizations for the DimAir product line.
Dimar and DimAir are trademarks of Dimar Srl.
IIMPORTANT : Please refer to the package insert for complete instructions, contraindications, warnings and precautions
COVIDIEN, COVIDIEN with logo, Covidien logo and “positive results for life” are U.S. and internationally registered trademarks of Covidien AG.
Other brands are trademarks of a Covidien company. ™* are trademarks of their respective owners. ©2012 Covidien. - 12 TSE 0003 ESICM12 GB - 08/2012
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
WEDNESDAY 17 october
180
13-17 October 2012
L I V E S 2 012
Area Beja
Area Braga
Area Cascais
Ards: New trends
in treatment 2
Renal replacement
therapy in the icu
Ventilatory
support 2
Area Faro
Area Fatima
Quality & safety in
the icu
Technology in the
icu
Area Funchal
Icu infections:
biomarkers
& antimicrobial
treatment 2
Area Sintra
Life-Priority
Nursing
assessment &
training
Training icu teams
Area Coimbra
Technology for the
failing heart
& kidney
Area Guarda
Area Estoril
Area Evora
Bundles for icu
infections
Neuro-intensive
care
Area Porto
Area Setubal
Acute kidney
injury:
pathophysiology
Re-evaluation of
sepsis therapies
Scoring &
prognosis in icu
patients
L I V E S 2 012
POSTER OVERVIEW
10:10 - 12:00
WEDNESDAY 17 OCTOBER
POSTER OVERVIEW - WEDNESDAY 17 OCTOBER
181
programme OVERVIEW
WEDNESDAY 17 October
Room
08:30
10:00
Lisbon
Berlin
Barcelona
Geneva
Rome
Challenging the
updated ards
definition
Assessing
intravascular volume
and tissue perfusion
Difficulties in
antibiotic dosing:
data from dali
Understanding
sepsis
Neurological
emergencies for
dummies: when
do we need
neurosurgery?
Inflammatory
pathways in ards
Multi-drug resistant
bacteria in the
icu: lessons from
mosar
Dali and mosar
studies
Specific lung
infections: diagnosis
and treatment
Dealing with high
icp: everything you
need to know
President’s session:
shaping the next
30 years
Mechanical
ventilation:
hot topics 2012
Optimal tissue
perfusion
Fluid therapy in
septic shock
The burn patient
10:00 - 10:10
10:10
11:30
11:30-12:00
12:00
14:00
14:00-14:15
14:15
16:30
Hot topics Session
Session references
Oral presentations
From bench to bedside
Poster corners
182
13-17 October 2012
L I V E S 2 012
Stockholm
Difficult decisons in
icu
Esa/esicm perioperative care in
europe
The changing face of
aki
Regenerative medicine
The future for ards?
Therapeutic cooling
and outcome after
cardiac arrest
Understanding icu
delirium
Future therapies of
systemic inflammation
Predictors of outcome
in critical illness
Oxygen and the brain:
new insights
Post-cardiac arrest
management:
answering the
important questions
Vienna
Thinking globally to
improve patient care
Athens
Nursing care for my
patient with…
Nurses
&
AHP
Exploring
hypoperfusion
Emerging therapeutic
options for aki
The icu physician is an
endangered spieces
Sedation, analgaesia
and delirium in critical
care
Paris
programme OVERVIEW
Glasgow
L I V E S 2 012
183
ROOM Lisbon
Thematic Session
CHALLENGING THE UPDATED ARDS DEFINITION
Chairs: Marco Ranieri, Turin, Italy & Antonio Pesenti, Monza, Italy
08:30 - 08:50
The rationale for a new ARDS definition
08:50 - 09:10
ARDS new definition: The consensus process
09:10 - 09:30
Validy of the new ARDS Criteria: Insights from prior datasets
Luciano Gattinoni, Milan, Italy
09:30 - 09:50
How the criteria will shape future research and clinical Care?
09:50 - 10:00
Discussion
ROOM Berlin
Thematic Session
ASSESSING INTRAVASCULAR VOLUME AND TISSUE PERFUSION
Chairs: Jean-Louis Teboul, Kremlin-Bicetre, France & Daniel De Backer, Brussels, Belgium
08:30 - 08:50
Do we need cardiac output monitoring?
08:50 - 09:10
What is fluid responsiveness?
09:10 - 09:30
Cardiac output monitoring: Where are we?
09:30 - 09:50
Do we need tissue perfusion monitoring?
09:50 - 10:00
Discussion
ROOM Barcelona
Thematic Session
DIFFICULTIES IN ANTIBIOTIC DOSING: DATA FROM DALI
Chairs: George Dimopoulos, Athens, Greece & Jordi Rello, Barcelona, Spain
08:30 - 08:50
How PK/PD can help dosing?
08:50 - 09:10
PK/PD of antifungal drugs
09:10 - 09:30
Dosing in CRRT
Claude Martin, Marseille, France
09:30 - 09:50
Dosing in MODS
Jan De Waele, Ghent, Belgium
09:50 - 10:00
Discussion
ROOM Geneva
UNDERSTANDING SEPSIS
Chairs: Herwig Gerlach, Berlin, Germany & Richard Beale, London, United Kingdom
08:30 - 08:50
Current epidemiologic patterns
08:50 - 09:10
Pathophysiology of the host response
Herwig Gerlach, Berlin, Germany
09:10 - 09:30
Lifesaver 1: Early diagnosis
09:30 - 09:50
Lifesaver 2: Early aggressive therapy. Focus control, antibiotics and fluids
09:50 - 10:00
Discussion
ROOM Rome Continuous Professional Education Session
WHEN DO WE NEED NEUROSURGERY?
NEUROLOGICAL EMERGENCIES FOR DUMMIES:
Chairs: Peter Horn, Berlin, Germany & Elisa Zanier, Milan, Italy
184
08:30 - 08:50
Intra-parenchymal haemorrhage
08:50 - 09:10
Intraventricular haemorrhage: Drainage vs. clot lysis?
09:10 - 09:30
Acute ischaemic stroke
09:30 - 09:50
Nino Stocchetti, Milan, Italy
09:50 - 10:00
Discussion
13-17 October 2012
L I V E S 2 012
Thematic Session
ROOM Glasgow
DIFFICULT DECISIONS IN ICU
Chairs: Jozef Kesecioglu, Utrecht, Netherlands & Charles Sprung, Jerusalem, Israel
08:30 - 08:50
Family members make decisions
08:50 - 09:10
Medical staff makes decisions
09:10 - 09:30
How to apply measures impossible to benefit
Andrej Michalsen, Tettnang, Germany
09:30 - 09:50
Informing the family members
Bara Ricou, Geneva, Switzerland
09:50 - 10:00
Discussion
ROOM Stockholm
Joint Session
ESA/ESICM - PERIOPERATIVE CARE IN EUROPE
Chair: Andrew Rhodes, London, United Kingdom
08:30 - 08:50
Standards of perioperative care in Europe
Bernhard Walder, Geneva, Switzerland
08:50 - 09:10
Determinants of ICU admission after surgery
09:10 - 09:30
European Surgical Outcomes Study (EuSOS)
09:30 - 09:50
Looking forward: Optimisation of ICU resources
09:50 - 10:00
Discussion
ROOM Paris
Thematic Session
THE CHANGING FACE OF AKI
Chairs: Ravindra Mehta, San Diego, United States & Marlies Ostermann, London, United Kingdom
08:30 - 08:50
Fluid overload: The key factor of AKI?
Bin Du, Beijing, China
08:50 - 09:10
Fluid responsiveness of AKI: Does it exist?
Netherlands
09:10 - 09:30
It is all inflammation
Bruce Molitoris, Indiana, United States
09:30 - 09:50
Is loss of renal function in AKI really reversible?
Marlies Ostermann, London, United Kingdom
09:50 - 10:00
Discussion
ROOM Vienna
REGENERATIVE MEDICINE - THE FUTURE FOR ARDS?
Chairs: John Laffey, Galway, Ireland & Paolo Pelosi, Genova, Italy
Stem cells for ALI/ARDS
John Laffey, Galway, Ireland
08:50 - 09:10
Stem cells for other lung diseases
Patricia Rocco, Rio de Janeiro, Brazil
09:10 - 09:30
Tissue engineering towards organ replacement
Paolo Macchiarini, Florence, Italy
09:30 - 09:50
Translating to the clinical setting: Potential and Pitfalls
Paolo Pelosi, Genova, Italy
09:50 - 10:00
Discussion
ROOM Athens
Thematic Session
NURSING CARE FOR MY PATIENT WITH…
Chairs: Stijn Blot, Ghent, Belgium & Ana Rosa, Lisbon, Portugal
Nurses
&
AHP
08:30 - 08:50
Deep venous thrombosis
08:50 - 09:10
Uncontrolable diarrhoea
Barbara McLean, Atlanta, United States
09:10 - 09:30
Non-invasive ventilation
David McWilliams, Manchester, United Kingdom
09:30 - 09:50
Extracorporeal support
Giulia Pelucchi, Monza, Italy
09:50 - 10:00
Discussion
L I V E S 2 012
08:30 - 08:50
185
ROOM Lisbon
Oral Presentations
INFLAMMATORY PATHWAYS IN ARDS
Chairs: Brian Kavanagh, Toronto, Canada & Franco Valenza, Milan, Italy
10:10 - 10:25
ANGIOGENIC FACTORS AND THEIR SOLUBLE RECEPTORS IN ACUTE
LUNG INJURY (ALI)/ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN
T. Wada, S. Jesmin, S. Gando, A. Mizugaki,
Y. Yanagida, H. Yokota, Sapporo, Japan
0913
10:25 - 10:40
USEFULNESS OF PROCOLLAGEN III IN THE DIAGNOSIS OF BIOPSYPROVEN LUNG FIBROSIS COMPLICATING ARDS
J.-M. Forel, F. Voillet, A. Roch, S. Hraiech,
F. Xéridat, C. Guervilly, C. Farnarier, A.-M. Tasei,
L. Papazian, Marseille, France
0914
10:40 - 10:55
CISATRACURIUM DECREASES IN VITRO PRODUCTION OF
PROINFLAMMATORY MEDIATORS
J.-M. Forel, C. Farnarier, S. Hraiech, C. Guervilly,
V. Marin, F. Xeridat, M. Adda, L. Papazian,
Marseille, France
0915
10:55 - 11:10
THE ROLE OF PROCALCITONIN IN DISCRIMINATING BETWEEN SEPTIC
AND NON-SEPTIC CAUSES OF ARDS AND ASSESSING CLINICAL
PROGNOSIS
I. Tsangaris, A. Tsantes, P. Kopterides,
F. Drakopanagiotakis, A. Antonopoulou,
P. Papadopoulos, K. Kaziani, S. Karabi, N. Nikitas,
S. Assoti, E. Vrigkou, G. Tsaknis, A. Pappas,
A. Zerva, A. Armaganidis, Athens, Greece
0916
11:10 - 11:25
LUNG INJURY INDUCED EX VIVO BY HIGH TIDAL VOLUME VENTILATION.
EFFECTS OF THE PRESENCE OF BLOOD ELEMENTS
L. Martínez-Caro, L. Smit, C. Sánchez-Rodríguez,
P. Fernández-Segoviano, A. Ferruelo, N. Nin,
A. Esteban, J.A. Lorente, Getafe, Spain
0917
ROOM Berlin
MOSAR
MULTI-DRUG RESISTANT BACTERIA IN THE ICU: LESSONS FROM
Chairs: Jeff Lipman, Brisbane, Australia & Garyfallia Poulakou, Athens, Greece
10:10 - 10:30
Preventing transmission: Can we improve adherence to standard
precautions?
Christian Brun-Buisson, Creteil, France
10:30 - 10:50
Screening for MRSA in high-risk surgery patients
Stephan Harbarth, Geneva, Switzerland
10:50 - 11:10
Screening and isolation for MDRB in ICUs: How, when and for whom?
11:10 - 11:30
Cost-effectiveness of alternative approaches to control MDRB in ICUs
ROOM Barcelona
Oral Presentations
DALI AND MOSAR STUDIES
Chairs: Jean Chastre, Paris, France & Jean-Paul Mira, Paris, France
186
10:10 - 10:25
DALI: DEFINING ANTIBIOTIC LEVELS IN INTENSIVE CARE UNIT PATIENTS:
PIPERACILLIN MULTI-CENTRE POINT PREVALENCE PHARMACOKINETIC
STUDY
J.A. Roberts, M. Bassetti, J.J. DeWaele,
G. Dimopoulos, D. Koulenti, C. Martin,
P. Montravers, J. Rello, A. Rhodes, T. Starr,
S.C. Wallis, J. Lipman, Brisbane, Australia
0918
10:25 - 10:40
MEROPENEM MULTI-CENTRE POINT PREVALENCE PHARMACOKINETIC
STUDY
J.A. Roberts, J.J. De Waele, M. Bassetti,
G. Dimopoulos, D. Koulenti, C. Martin,
S.C. Wallis, J. Lipman, Ghent, Belgium
0919
10:40 - 10:55
CEFEPIME MULTI-CENTRE POINT PREVALENCE PHARMACOKINETIC
STUDY
J.A. Roberts, F. Rubulotta, M. Bassetti,
J.J. DeWaele, G. Dimopoulos, D. Koulenti,
C. Martin, P. Montravers, J. Rello, A. Rhodes,
T. Starr, S.C. Wallis, J. Lipman, London, United
Kingdom
0920
10:55 - 11:10
VANCOMYCIN MULTI-CENTRE POINT PREVALENCE PHARMACOKINETIC
STUDY
J.A. Roberts, D. Koulenti, M. Bassetti,
J.J. DeWaele, G. Dimopoulos, C. Martin,
S.C. Wallis, J. Lipman, Athens, Greece
0921
11:10 - 11:25
MASTERING HOSPITAL ANTIBIOTIC RESISTANCE (MOSAR): A EUROPEAN
CLUSTER-RANDOMIZED TRIAL ON REDUCING ACQUISITION OF
RESISTANT BACTERIA IN INTENSIVE CARE UNITS
L. Derde, B. Cooper, C. Brun Buisson, M. Bonten,
0922
13-17 October 2012
L I V E S 2 012
ROOM Geneva
TREATMENT
SPECIFIC LUNG INFECTIONS: DIAGNOSIS &
Chairs: Jordi Rello, Barcelona, Spain & George Dimopoulos, Athens, Greece
10:10 - 10:30
Lung infection in the immunocompromised
10:30 - 10:50
Other fungal infections
10:50 - 11:10
Pneumocystis jirovecii
11:10 - 11:30
Mycobacterial infections in the ICU
Stephan Harbarth, Geneva, Switzerland
ROOM Rome
NEED TO KNOW
DEALING WITH HIGH ICP: EVERYTHING YOU
Chairs: Peter Horn, Berlin, Germany & Pedro Navarrete Navarro, Granada, Spain
10:10 - 10:30
Brain compliance
10:30 - 10:50
ICP monitoring: Indications and techniques
10:50 - 11:10
ICP therapy: First-tier therapies
11:10 - 11:30
ICP therapy: Second-tier therapies
ROOM Glasgow
Oral Presentations
THERAPEUTIC COOLING AND OUTCOME AFTER CARDIAC ARREST
Chairs: Hans Friberg, Lund, Sweden & Fabio Silvio Taccone, Brussels, Belgium
10:10 - 10:25
TARGET TEMPERATURE MANAGEMENT AFTER OUT-OF-HOSPITAL
CARDIAC ARREST, AN INTERNATIONAL, MULTI-CENTRE, RANDOMISED,
PARALLEL GROUPS, ASSESSOR BLINDED CLINICAL TRIAL: NCT01020916
N. Nielsen, Helsingborg, Sweden
0923
10:25 - 10:40
EFFECTS OF HYPOTHERMIA ON CEREBRAL MICROCIRCULATION
K. Donadello, F. Su, F. Pulea, S. Scolletta, X. He,
O. De Witte, L. Gottin, J. Creteur, D. De Backer,
F.S. Taccone, Bruxelles, Belgium
0924
10:40 - 10:55
PROCALCITONIN AS A PREDICTOR OF POSTRESUSCITATION DISEASE
AND OUTCOME AFTER CARDIAC ARREST
K. Portmann*, H. Engel*, F. Feihl, P. Eggimann,
A. Rossetti, M. Oddo, Lausanne, Switzerland
0925
10:55 - 11:10
A PROSPECTIVE INTERVENTION STUDY TO COMPARE EFFICACY AND
RELIABILITY OF DIFFERENT COOLING TECHNOLOGIES FOR FEVER
CONTROL
G.N. Janssens, P. Sonder, A. Beishuizen,
C.L. Henry, J. Rittenberger, C. Callaway,
A.R. Girbes, K.H. Polderman, Pittsburgh, United
States
0926
11:10 - 11:25
PREDICTORS OF POOR NEUROLOGICAL OUTCOME IN PATIENTS AFTER
CARDIAC ARREST TREATED WITH THERAPEUTIC HYPOTHERMIA:
SYSTEMATIC REVIEW AND EVIDENCE BASED GUIDELINES
E. Golan, D.C. Scales, Toronto, Canada
0927
ROOM Stockholm Oral Presentations
UNDERSTANDING ICU DELIRIUM
10:10 - 10:25
SEDATION AND Analgaesia IN PATIENTS WITH NON-INVASIVE
VENTILATION. OBSERVATIONAL, MULTICENTRE AND INTERNATIONAL
STUDY
O. Peñuelas, F. Frutos-Vivar, A.C. Arroliga,
F. Rios, F. Gordo, S.M. Maggoire, A.W. Thille,
N.D. Ferguson, A. Anzueto, A. Esteban, Getafe,
Spain
0928
10:25 - 10:40
ICU PAIN RECALL AND COGNITIVE DYSFUNCTION IN ICU SURVIVORS:
THE MEMORY STUDY
A. Max, K. Puntillo, M. Chaize, A. Lafabrie,
I. Villard, E. Azoulay, Paris, France
0929
10:40 - 10:55
ACTIVE NOISE REDUCTION ON INTENSIVE CARE UNITS
S. Kirfel, A. Follmann, J. Kaliciak, R. Rossaint,
M. Vorländer, M. Czaplik, Aachen, Germany
0930
10:55 - 11:10
SLEEPMONITORING BY POLYSOMNOGRAPHY AND DELIRIUM
ASSESSMENT WITH THE CONFUSION ASSESMENT METHOD FOR THE
INTENSIVE CARE UNIT (CAM-ICU) IN UN-SEDATED, MECHANICALLY
VENTILATED PATIENTS: DELIRIOUS PATIENTS DO NOT SHOW
ELECTROPHYSIOLOGIC SLEEP-CHARACTERISTICS
H.C. Boesen, J.H. Andersen, H.L. Leonthin,
A. Bendtsen, P. Jennum, Glostrup, Denmark
0931
11:10 - 11:25
COSTS OF ICU-DELIRIUM
U. Guenther, F. Koegl, J. Oyen, C. Putensen, Bonn,
Germany
0932
L I V E S 2 012
Chairs: Claudia Spies, Berlin, Germany & Christina Jones, Liverpool, United Kingdom
187
ROOM Paris
Oral Presentations
FUTURE THERAPIES OF SYSTEMIC INFLAMMATION
Chairs: Didier Payen de La Garanderie, Paris, France & Susanne Toussaint, Berlin, Germany
10:10 - 10:25
EFFECTIVE TREATMENT OF OEDEMA AND ENDOTHELIAL BARRIER
DYSFUNCTION WITH IMATINIB
J. Aman, J. van Bezu, S.M. Vogel, S. Huveneers,
A. Vonk Noordegraaf, A.B.J. Groeneveld,
V.W.M. van Hinsbergh, G.P. van Nieuw
Amerongen, Amsterdam, Netherlands
0933
10:25 - 10:40
REVERSAL OF IMMUNOPARALYSIS IN HUMANS IN VIVO, A DOUBLEBLIND PLACEBO-CONTROLLED RANDOMISED PILOT-STUDY
J. Leentjens, M. Kox, R.M. Koch, L.A.B. Joosten,
F. Preijers, J.G. van der Hoeven, M.G. Netea,
P. Pickkers, Nijmegen, Netherlands
0934
10:40 - 10:55
EFFECTS OF A BRADYKININ-B2 RECEPTOR ANTAGONIST ON PLASMA
VOLUME, INFLAMMATORY RESPONSE AND PULMONARY OEDEMA IN A
SEPTIC ANIMAL MODEL
T.-P. Simon, T. Schürholz, S. Kern, C. Forberger,
G. Marx, Aachen, Germany
0935
10:55 - 11:10
INTERLEUKIN-7 RESTORES LYMPHOCYTE FUNCTIONS IN SEPTIC SHOCK
PATIENTS: A PRECLINICAL REPORT
F. Venet, A.-P. Foray, A. Villars-Mechin, C. Malcus,
F. Poitevin-Later, A. Lepape, G. Monneret, Lyon,
France
0936
11:10 - 11:25
INFLAMMATORY RESPONSE AND IMMUNOMODULATION DURING
COUPLED PLASMA FILTRATION ADSORPTION IN SEPTIC SHOCK
PATIENTS: CHARACTERISATION OF CYTOKINE ADSORPTION
F. Ferrari, M. Maio, D. Silengo, L. Sereni,
M.L. Wratten, M. Pozzato, S. Livigni, Torino, Italy
0937
ROOM Vienna
Oral Presentations
PREDICTORS OF OUTCOME IN CRITICAL ILLNESS
Chairs: Rui Paulo Moreno, Lisbon, Portugal & Bertrand Guidet, Paris, France
10:10 - 10:25
THE ASSOCIATION OF RED CELL DISTRIBUTION WIDTH AT HOSPITAL
DISCHARGE AND MORTALITY FOLLOWING CRITICAL ILLNESS: A COHORT
STUDY
S.W. Purtle, T. Moromizato, C.K. McKane,
F.K. Gibbons, K.B. Christopher, Boston, United
States
0938
10:25 - 10:40
INCIDENCE, CHARACTERISTICS AND OUTCOMES OF PREGNANCYRELATED CRITICAL ILLNESS OVER TIME IN CANADA
K. Aoyama, R.A. Fowler, S.E. Lapinsky,
D.C. Scales, R. Pinto, Toronto, Canada
0939
10:40 - 10:55
CHRONIC CRITICAL ILLNESS: SHORT TERM OUTCOME IN A LARGE
COHORT OF PATIENTS
Y.A. Cavayas, H.T. Wang, M.J. Dubois, Montreal,
Canada
0940
10:55 - 11:10
GASTROINTESTINAL (GI) SYMPTOMS DURING THE FIRST WEEK OF
INTENSIVE CARE ARE ASSOCIATED WITH POOR OUTCOME
A. Reintam Blaser, M.L.N.G. Malbrain, M. Björck,
M. Poeze, J. Starkopf, Tartu, Estonia
0941
11:10 - 11:25
WHAT IS THE BEST DEFINITION OF CHRONIC CRITICAL ILLNESS? A
MULTICENTRIC STUDY IN SOUTH OF BRAZIL
R.P. Oliveira, S.H. Loss, C. Marchese, M. Boniatti,
P.C. Balzano, A. Savi, E.S. Oliveira, C. Teixeira,
J.G. Maccari, A. Torelly, J. Höher, Porto Alegre,
Brazil
0942
ROOM Athens
Oral Presentations
EXPLORING HYPOPERFUSION
Chairs: Jean-Louis Teboul, Kremlin-Bicetre, France & Christoph Hofer, Zurich, Switzerland
188
10:10 - 10:25
ADMINISTRATION OF INSULIN LIMITS NO REFLOW PHE¬NOMENON
AND IMPROVES CORONARY BLOOD FLOW IN A PORCINE ISCHAEMIAREPERFUSION MODEL
I. Karellas, K. Chalkias, I. Terrovitis, E. Tsagalou,
E. Tsolakis, M. Bonios, I. Nanas, Athens, Greece
0943
10:25 - 10:40
NORMOBARIC HYPEROXIA ALTERS THE MICROCIRCULATION IN HEALTHY
SUBJECTS
D. Orbegozo Cortes, F. Puflea, K. Donadello,
F.S. Taccone, J. Creteur, J.-L. Vincent, D. De
Backer, Brussels, Belgium
0944
10:40 - 10:55
ASCORBIC ACID PROTECTS RENAL OXYGENATION AND OXIDATIVE
STRESS AFTER ISCHAEMIA/REPERFUSION INJURY
B. Ergin, R. Bezemer, A. Kandil, E. Almac,
C. Demirci, C. Ince, Amsterdam, Netherlands
0945
10:55 - 11:10
COMPARISON OF THE HAEMODYNAMIC EFFECT OF TWO “ENDOTHELINLIKE” PEPTIDES DERIVED FROM VENOM OF SNAKES OF THE GENUS
ATRACTASPIS
S. Malaquin, Y. Mahjoub, E. Lorne, A. Salomon,
G. Mourier, F. Ducancel, Z. Massy, H. Dupont,
Amiens, France
0946
11:10 - 11:25
PROPOFOL MAY REDUCE FLUID LOADING AND FLUID EXTRAVASATION
DURING TEPID CPB, COMPARED TO ISOFLURANE- AN EXPERIMENTAL
STUDY IN PIGS
H.K. Brekke, S. Lundemoen, V. Kvalheim,
P. Husby, Bergen, Norway
0947
13-17 October 2012
L I V E S 2 012
Poster Corner
10:10 - 12:00
METABOLOMIC ANALYSIS AS A DIAGNOSTIC TOOL FOR ACUTE
RESPIRATORY DISTRESS SYNDROME CAUSED BY VIRAL OR BACTERIAL
PNEUMONIA IN HUMANS
N. Nin, J.L. Izquierdo, P. Cardinal, I. SanchezMuñoz, S. López-Cuenca, J. Ruiz-Cabello,
A. Esteban, J.Á. Lorente, Madrid, Spain
0948
NEUTROPHIL PHOSPHOLIPID PROFILING IN PATIENTS WITH ARDS
A. Dushianthan, R. Cusack, V. Goss, M. Grocott,
A. Postle, Southampton, United Kingdom
0949
PHENOTYPIC CHARACTERISATION OF PATIENTS WITH ACUTE
RESPIRATORY DISTRESS SYNDROME (ARDS) ACCORDING TO
SURFACTANT SYNTHETIC FUNCTION
A. Dushianthan, R. Cusack, V. Goss,
J. Pappachan, A. Postle, M. Grocott,
Southampton, United Kingdom
0950
ADHERENCE TO A PROTECTIVE VENTILATION STRATEGY FOR PATIENTS
AT RISK OF ACUTE LUNG INJURY
E. Joynes, S. Dalay, J. Patel, S. Fayek,
0951
RESCUE ECMO THERAPY IN THE TREATMENT OF REFRACTORY ARDS: 35
PATIENTS IN A FRENCH HOSPITAL
E. Zogheib, C. Buchalet, P. Guinot, A. Benamar,
M. Detave, M. Moubarak, V. Hubert, T. Caus,
H. Dupont, Amiens, France
0952
PROGNOSTIC FACTORS DURING EXTRACORPOREAL MEMBRANE
OXYGENATION FOR ARDS: INTEREST OF THE SEQUENTIAL ORGAN
FAILURE (SOFA) SCORE
A. Roch, S. Ollier, C. Guervilly, J.-M. Forel,
M. Adda, S. Hraiech, F. Xeridat, L. Papazian,
Marseille, France
0953
CAN INITIAL INFLAMMATORY AND COAGULATION PARAMETERS
PREDICT DURATION AND OUTCOME OF VV-ECMO THERAPY IN ADULTS?
J. Rulíšek, P. Leden, M. Zakharchenko,
H. Bartakova, J. Belohlavek, J. Kunstyr, M. Balik,
Prague, Czech Republic
0954
RECRUITED VOLUME INDUCED BY POSITIVE END-EXPIRATORY
PRESSURE IN SUPINE AND PRONE POSITION IN PATIENTS WITH ACUTE
H. Aguirre-Bermeo, S. Italiano, M. Bitondo,
J. Grandjean, M. Turella, I. Morán, F. RocheCampo, J. Mancebo, Barcelona, Spain
0955
VARIATION IN FUNCTIONAL RESIDUAL CAPACITY AND END-EXPIRATORY
LUNG VOLUME WITH THE CHANGE OF SUPINE TO PRONE POSITION IN
PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
H. Aguirre-Bermeo, J. Grandjean, M. Bitondo,
S. Italiano, M. Turella, I. Morán, F. Roche-Campo,
J. Mancebo, Barcelona, Spain
0956
ACUTE RESPIRATORY DISTRESS SYNDROME, AND PRONE POSITION:
INCREASED PACO2 AS EARLY PREDICTOR OF MORTALITY
X. Sanchez, E. Monares, R. Chaires,
M.A. Pomposo, M. Poblano, J. Aguirre, J. Franco,
Mexico, Mexico
0957
PROGNOSTIC FACTORS OF MORTALITY IN PATIENTS WITH ACUTE
RESPIRATORY DISTRES SYNDROME
P. García Olivares, C. Caciano Reategui,
C. Ramírez, C. Bocanegra, D.O. Stanescu,
L. Tang, J.I. Montero, M. Zurita, M.A. Estévez,
A. Hernangómez, M. Díaz, I. De Sousa, J. Sagra,
B. Orville, Madrid, Spain
0958
CLINICAL AND ECONOMIC OUTCOME OF MECHANICALLY VENTILATED
PATIENTS UNDER DRG 475: ANALYSIS OF A NATIONAL DATABASE
C. Bouza, T. Lopez-Cuadrado, J. Amate, Madrid,
Spain
0959
HIGH FREQUENCY OSCILLATORY VENTILATION AND MINIMALLY
INVASIVE EXTRACORPOREAL CO2 REMOVAL IN SEVERE ARDS PATIENTS
V. Fanelli, F. Forfori, M. Pennisi, L. Del Sorbo,
U. Simonetti, R. Urbino, L. Mascia, F. Giunta,
M. Antonelli, V.M. Ranieri, Torino, Italy
0960
USE OF VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION
(V.-V. ECMO) TO ENSURE THE LUNG PROTECTIVE VENTILATION IN
TRAUMA PATIENTS
J. Swol, D. Buchwald, T.A. Schildhauer, Bochum,
Germany
0961
Area Braga
Poster Corner
Area Beja
Chairs: Warren Zapol, Boston, United States & Paolo Pelosi, Genova, Italy
RENAL REPLACEMENT THERAPY IN THE ICU
10:10 - 12:00
EDUCATION OF NURSES ON PRACTICAL ASPECTS OF CONTINUOUS
RENAL REPLACEMENT TREATMENT CAN LEAD TO AN INCREASED
CIRCUIT LIFE SPAN
M.D. van Dam-Noort, P.J. Thoral, T. van Galen,
0962
PHARMACOKINETICS OF GANCICLOVIR DURING CONTINUOUS
VENOVENOUS HAEMODIAFILTRATION
T. Horvatits, R. Kitzberger, A. Drolz, K. Staufer,
W. Jäger, M. Miksits, V. Fuhrmann, P. Schenk,
Vienna, Austria
0963
L I V E S 2 012
Chairs: Catherine Bouman, Amsterdam, Netherlands & Miet Schetz, Leuven, Belgium
189
PLASMA CONCENTRATIONS AND SIEVING COEFFICIENT OF
PROCALCITONIN DURING CONTINUOUS VENO-VENOUS
HAEMODIALYSIS WITH HIGH CUT OFF MEMBRANES IN SEPTIC PATIENTS:
A PRELIMINARY REPORT
C. Chelazzi, C. Giannoni, G. Villa, D. Giugni,
A.L. Caldini, A.R. De Gaudio, Firenze, Italy
0964
ACUTE KIDNEY INJURY AND RENAL REPLACEMENT THERAPY IN
CRITICALLY ILL PATIENTS WITH HYPOXIC HEPATITIS
A. Drolz, K. Staufer, K. Roedl, H. Herkner,
T. Horvatits, R. Saxa, C. Zauner, G. Heinz,
P. Schellongowski, M. Trauner, V. Fuhrmann,
Vienna, Austria
0965
RENAL REPLACEMENT CATHETER PLACEMENT ON A GENERAL INTENSIVE
CARE UNIT
M.W. Lyons, T. Miller, Liverpool, United Kingdom
0966
PREDICTION OF ICU-MORTALITY AND REQUIREMENT OF RENAL
REPLACEMENT THERAPY BY RIFLE, AKIN AND SERUM CREATININE ON
ADMISSION IN MEDICAL ICU PATIENTS
W. Huber, J. Schneider, B. Saugel, C. Schultheiss,
V. Phillip, A. Herrmann, S. Mair, R. Schmid,
Munich, Germany
0967
THE SAFETY OF FEMORAL VEIN INSERTION OF CRRT DIALYSIS
CATHETERS
M. Lipcsey, H.R. Chua, A.G. Schneider, R. Bellomo,
Uppsala, Sweden
0968
NOVEL LACTATE BUFFERED DIALYSIS AND SUBSTITUTION FLUID FOR
CITRATE ANTICOAGULATED CONTINUOUS RENAL REPLACEMENT
THERAPY
M. Balik, M. Zakharchenko, P. Leden, J. Rulíšek,
P. Herda, M. Otahal, H. Brodska, Prague 2, Czech
Republic
0969
HIGH VOLUME HAEMOFILTRATION AND VERY HIGH VOLUMEN
IMPROVES HAEMODYNAMICS AND RESPIRATORY VARIABLES AND
PROBABLY INCREASE SURVIVING IN SEPTIC SHOCK PATIENTS
F. Cota Delgado, C. Salazar Ramirez, M.V. De La
Torre Prados, Malaga, Spain
0970
INDICATIONS AND OUTCOMES FOR PATIENTS RECEIVING
HAEMOFILTRATION ON THE INTENSIVE CARE UNIT AT GOOD HOPE
HOSPITAL
A. Sykes, M. Kyi, Sutton Coldfield, United
Kingdom
0971
INTERMITTENT HAEMODIALYSIS VERSUS CONTINUOUS VENO-VENOUS
HAEMOFILTRATION: POTENTIAL COST SAVINGS FOR THE INTENSIVE
CARE UNIT
B. O’Farrell, B. Agarwal, A. Davenport, C. Laing,
S. Shaw, M. Thacker, London, United Kingdom
0972
EARLY TIMING IN SEPTIC SHOCK PATIENTS
X. Pérez, J. Sabater, M. Huguet, E. Santafosta,
J.C. López, V. Alonso, P. Sastre, L´Hospitalet de
Llobregat, Spain
0973
PROADRENOMEDULLIN LEVELS CHANGES AND CONTINUOUS
VENOVENOUS HAEMOFILTRATION IN CRITICALLY ILL PATIENT WITH
SEPTIC SHOCK AND ACUTE RENAL FAILURE OR MULTIPLE ORGAN
FAILURE THAT INVOLVES THE RENAL SYSTEM
G. Choutas, V. Ntzani, D. Karapanos, V. Petkidi,
V. Agelidou, G. Anthopoulos, Athens, Greece
0974
IL-6 IL10 AND CRP LEVELS ON PATIENTS WITH SEPTIC SHOCK AND RENAL
FAILURE UNDERGOING CONTINUOUS VENOVENOUS HAEMOFILTRATION
G. Choutas, V. Ntzani, D. Karapanos, K. Pavlias,
G. Pavlopoulou, G. Anthopoulos, Athens, Greece
0975
TO EXTUBATE OR NOT TO EXTUBATE: A PROSPECTIVE OBSERVATIONAL
STUDY OF FAILURE TO EXTUBATE DESPITE SUCCESSFULLY PASSING
SPONTANEOUS BREATHING TRIALS (SBT)
A. Kee, D. Huang, J. Phua, L. Azul, S.J. Magada,
T.K. Lim, A. Mukhopadhyay, Singapore,
Singapore
0976
EVALUATION OF A NEW TOOL TO MEASURE PATIENT’S HEIGHT DURING
MECHANICAL VENTILATION: IMPACT ON PROTECTIVE VENTILATION
IMPLEMENTATION
A. Bojmehrani, P.-A. Bouchard, E. L’Her,
F. Lellouche, Québec, Canada
0977
THE COMPARISON OF SPONTANEOUS BREATHING AND MUSCLE
PARALYSIS IN TWO DIFFERENT SEVERITIES OF EXPERIMENTAL LUNG
INJURY
T. Yoshida, A. Uchiyama, N. Matsuura, Y. Fujino,
São Paulo, Brazil
0978
PREVALENCE OF PATIENT-VENTILATOR ASYNCHRONY IN CRITICALLY ILL
PATIENTS
A. Villagra, B. Sales, J. Montanya, R. Fernandez,
E. Chacon, A. Estruga, U. Lucangello, O. GarciaEsquirol, G. M Albaiceta, A. Hernandez-Abadia,
E. Fernandez Mondejar, M.J. Burgueño,
J.C. Oliva, J. Villar, R.B. Kacmareck, G. Murias,
L. Blanch, Sabadell, Spain
0979
Area Cascais
Poster Corner
Chairs: Massimo Antonelli, Rome, Italy & Patricia Rocco, Rio de Janeiro, Brazil
10:10 - 12:00
190
13-17 October 2012
L I V E S 2 012
M.M. Bitondo, H.M. Aguirre, A. Moccaldo,
D. Grieco, F. Roche-Campo, M. Antonelli,
J. Mancebo Cortes, S.M. Maggiore, Roma, Italy
0980
COMPARISON OF SETTINGS AUTOMATICALLY DETERMINED BY A FULLY
CLOSE LOOP VENTILATION MODE WITH CLINICIAN MANUAL SETTINGS
IN ICU PATIENTS
J.-M. Arnal, A. Garnero, M. Wysocki, D. Demory,
L. Ducros, G. Corno, A. Berric, Y.S. Donati,
J. Durand-Gasselin, Toulon, France
0981
CAN WE EARLY IDENTIFY PATIENTS WITH A HIGH RISK OF PROLONGED
MECHANICAL VENTILATION IN INTENSIVE CARE UNIT?
S. Malaquin, N. Ammenouche, Y. Mahjoub,
M. Levrard, N. Airapetian, A. Seydi, F. Tinturier,
H. Dupont, Amiens, France
0982
CURRENT OXYGENATION PRACTICE IN MECHANICALLY VENTILATED
PATIENTS IN AN AUSTRALIAN TEACHING HOSPITAL
R. Panwar, N. Schmutz, D. Baguley, D. Pilcher,
A. Davies, M. Bailey, R. Bellomo, J. Cooper,
G. Capellier, Besançon, France
0983
ACCEPTABLE VENTILATOR SETTING AND MONITORING PARAMETER
RANGES FOR INITIATION OF CONTROLLED MECHANICAL VENTILATION A CLINICIAN SURVEY
L. Rose, L. Kenny, G. Tait, S. Mehta, Toronto,
Canada
0984
DELIVERY OF TIDAL VOLUME FROM FOUR ANAESTHESIA VENTILATORS
DURING VOLUME-CONTROLLED VENTILATION: A BENCH STUDY
G. Wallon, A. Bonnet, C. Guérin, Lyon, France
0985
CAN LUNG ULTRASONOGRAPHY HELP IN WEANING FROM MECHANICAL
VENTILATION?
R.P. Oliveira, A.C.P. Antonio, P.S. Castro,
L.F. Schulz, J.G. Maccari, C. Teixeira, E.S. Oliveira,
Porto Alegre, Brazil
0986
REDUCTION IN THE DURATION OF MECHANICAL VENTILATION
THROUGH BIESPECTRAL INDEX MONITOR. PRELIMINARY STUDY
S. Altaba Tena, L. Mateu Campos, A. Belenguer
Muncharaz, M.D. Ferrándiz Sellés, G. Cebrián
Graullera, L. Albert Rodrigo, I. Catalán Monzón,
J. De León Belmar, Castellon, Spain
0987
ICU CLINICIAN UNDERSTANDING OF PLEURAL PATHOPHYSIOLOGY AND
MANAGEMEMNT OF INTERCOSTAL CHEST DRAINS ARE SUB-OPTIMAL
R. Nagappan, A. Subramaniam, Melbourne,
Australia
0988
UTILITY, SAFETY AND COMPLICATIONS OF ULTRASOUND-AIDED
PLEURAL ASPIRATION AND CHEST DRAIN INSERTION IN MECHANICALLY
VENTILATED PATIENTS
K. Tsikritsaki, G. Koukoulitsios, I. Poularas,
I. Dimitroulis, K. Mendrinou, I. Tsiouboutariou,
I. Andrianakis, P. Dourou, N. Pentilas, P. Spyrou,
K. Tsironas, M. Paidonomos, Athens, Greece
0989
Area Coimbra
Poster Corner
PATIENT- VENTILATOR ASYNCHRONY DURING CONVENTIONAL OR
AUTOMATED PRESSURE SUPPORT VENTILATION IN DIFFICULT-TO-WEAN
PATIENTS
TECHNOLOGY FOR THE FAILING HEART & KIDNEY
10:10 - 12:00
LEFT VENTRICLE DISCHARGE DURING ECLS BY IMPELLA® MICROAXIAL
PUMP IN CARDIOGENIC SHOCK PATIENTS
P. Gaudard, J. Eliet, G. Culas, C. Legoux, P. Colson,
Montpellier, France
0990
MANAGEMENT OF HAEMODYNAMICALLY COMPROMISED PATIENTS
USING THE IMACOR CLARITEE PROBE - A FEASIBILITY STUDY
T.M. Merz, L. Cioccari, H.-R. Baur, J. Takala, Bern,
Switzerland
0991
LINEAR CORRELATION BETWEEN THE ACCURACY OF CARDIAC OUTPUT
MEASUREMENT WITH FLOTRAC/VIGILEO SYSTEM AND SYSTEMIC
VASCULAR RESISTANCE
Y. Sotomi, K. Abe, J. Yoshida, R. Okamura,
K. Iwakura, T. Masai, K. Fujii, Osaka, Japan
0992
CHANGES IN SKELETAL MUSCLE NADH REDOX STATE, TISSUE
OXYGENATION AND MICROVASCULAR BLOOD FLOW DURING GRADED
HAEMORRHAGE
N.J. Ekbal, A. Mayevsky, M. Singer, London,
United Kingdom
0993
PROGNOSIS VALUE OF TISSUE OXYGEN SATURATION RECOVERY SLOPE
DURING A VASCULAR OCCLUSION TEST IN CARDIOGENIC SHOCK
PATIENTS
P. Gaudard, A.C. Saour, J. Eliet, G. Culas, R. Coves,
P. Colson, Montpellier, France
0994
THE PAC STRIKES BACK. A STUDY OF PULMONARY ARTERY CATHETER
(PAC) USE IN THE SOUTH WEST REGION OF THE UK
C. Gibson, R. Sinclair, Truro, United Kingdom
0995
THE ESTIMATION OF CARDIAC OUTPUT BY THE NEXFIN DEVICE IS OF
POOR RELIABILITY FOR TRACKING THE EFFECTS OF A FLUID CHALLENGE
X. Monnet, F. Picard, E. Lidzborski, M. Mesnil,
J. Duranteau, C. Richard, J.-L. Teboul, Le KremlinBicetre, France
0996
THE PLETH VARIABILITY INDEX IS A WEAK PREDICTOR OF FLUID
RESPONSIVENESS IN PATIENTS RECEIVING NOREPINEPHRINE
X. Monnet, L. Guérin, M. Jozwiak, A. Bataille,
F. Julien, C. Richard, J.-L. Teboul, Le KremlinBicetre, France
0997
L I V E S 2 012
Chairs: Michael Pinsky, Pittsburgh, United States & Alain Combes, Paris, France
191
REPRODUCIBILITY OF TRANSPULMONARY THERMODILUTION CARDIAC
OUTPUT MEASUREMENTS IN CLINICAL PRACTICE: A SYSTEMATIC
REVIEW
R. Giraud, N. Siegenthaler, P. Merlani,
L. Brochard, K. Bendjelid, Genève, Switzerland
0998
GLUTAMYL AMINOPEPTIDASE IS A PREDICTIVE MARKER OF EARLY
ACUTE RENAL FAILURE IN PATIENTS UNDERGOING CARDIAC SURGERY
M. Redondo Orts, F. Manzano Manzano,
M.D.M. Jimenez, R. Wangensteen, A. Quesada,
S. Nogueras Guijarro, F. Rodríguez Alemán,
A. Osuna, Granada, Spain
0999
COMPARING INVASIVE AND LESS-INVASIVE CARDIAC OUTPUT
MEASUREMENT DEVICES DURING EXTERNAL LEG COMPRESSION
M. Helmi, R. de Wilde, J. Jansen, B. Geerts,
P. van den Berg, D. Gommers, A. Groeneveld,
1000
HAEMODYNAMIC ASSESSMENT IN CRITICALLY ILL DURING ALBUMIN
DIALYSIS
T. Zawada, W. Mielnicki, Z. Sycz, Wroclaw,
Poland
1001
NON-INVASIVE CONTINUOUS DETERMINATION OF MEAN ARTERIAL
BLOOD PRESSURE USING THE T-LINE TL-200PRO DEVICE IN CRITICALLY
ILL MEDICAL PATIENTS
B. Saugel, A.S. Meidert, A. Hapfelmeier,
R.M. Schmid, W. Huber, München, Germany
1002
A NOVEL COMPUTER-CONTROLLED HIGH RESOLUTION VIDEO
MICROSCOPY IMAGING SYSTEM ENABLES MEASURING MUCOSAL
SUBSURFACE FOCAL DEPTH FOR RAPID ACQUISITION OF ORAL
MICROCIRCULATION VIDEO IMAGES
D.M.J. Milstein, E. Romay, C. Ince, Amsterdam,
Netherlands
1003
SOME STRAINS OF HOSPITAL-ASSOCIATED METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS HAVE POTENTIALITY TO DAMAGE PRIMARY
HUMAN KERATINOCYTE TO INDUCE RECURRENT INFECTIONS
M. Fukuda, T. Baba, K. Hiramatsu, Tokyo, Japan
1004
OPTIMISATION OF PREVENTIVE INSULATION IN INTENSIVE CARE UNIT
A. Rey Perez, A. Garcia, J. Granado, R. Herrera,
C. Salvat, C. Lopez, R. Balaguer, I. Dot,
J.P. Horcajada, F. Alvarez-Lerma, Barcelona,
Spain
1005
IMPROVING ICU DOCUMENTATION AND REDUCING BLOOD STREAM
INFECTIONS
L. Ruff, T. Neal, Liverpool, United Kingdom
1006
FUNGAL INFECTION IN GASTROINTESTINAL PERFORATION
S. Dias, C. Albino, I. Moniz, C. França, Lisbon,
Portugal
1007
EPIDEMIOLOGICAL TRENDS OF FUNGAL INFECTIONS IN ADULT ICU
PATIENTS
T. Aslanidis, I. Soultati, A. Kontos, I. Chytas,
E. Anastasiou, E. Geka, K. Ethimiou,
V. Ourailoglou, M. Giannakou-Peftoulidou,
Thessaloniki, Greece
1008
CAN BIOMARKERS (CRP,WBC) DETECT INFECTION DURING MILD
THERAPEUTIC HYPOTHERMIA?
I. Voigt, C.K. Naber, Essen, Germany
1009
COMPLIANCE WITH GUIDELINES ON ANTIBIOTIC USAGE IN SEVERE
ACUTE PANCREATITIS AND ASSOCIATED OUTCOMES
K. Girgirah, A. Krige, Blackburn, United Kingdom
1010
VANCOMYCIN PHARMACOKINETICS IN CRITICALLY ILL PATIENTS
RECEIVED CRRT
D.W. Wu, H.S. Wang, T.C. Shan, R.C. Guo, Jinan,
China
1011
AUDIT AND ANTIMICROBIOGRAM OF ISOLATES OF CENTRAL VENOUS
CATHETER BLOOD STREAM INFECTIONS IN A NINE BED CRITICAL CARE
UNIT
F. Fuerstenberg, C. Spencer, M. Reay,
L. Mohankumar, S. Raybould, Dudley, United
Kingdom
1012
SYSTEMIC INFLAMATORY RESPONSE IN CRITICALLY ILL PATIENTS
M. Palomar, F. Alvarez lerma, P. Olaechea,
M.J. Lopez Pueyo, J.J. Otal, X. Nuvials, R. Jimeno,
M.P. Gracia, I. Seijas, Barcelona, Spain
1013
THE IMPACT OF A WARD BASED PERIPHERALLY INSERTED CENTRAL
CATHETER (PICC) LINE SERVICE
A.L. Sykes, M. Kyi, Sutton Coldfield, United
Kingdom
1014
AGE AND ETIOLOGY OF INFECTIONS IN CRITICALLY ILL PATIENTS
M. Palomar, P. Olaechea, F. Alvarez Lerma,
M.J. Lopez Pueyo, J.J. Otal, R. Alcaraz, I. Seijas,
M.P. Gracia, R. Jimeno, Barcelona, Spain
1015
Area Estoril
Poster Corner
BUNDLES FOR ICU INFECTIONS
Chairs: Jean-François Timsit, Grenoble, France & Arthur Kwizera, Kampala, Uganda
10:10 - 12:00
192
13-17 October 2012
L I V E S 2 012
1016
INFLUENCE OF INFECTION CONTROL IMPROVEMENT ACTIVITIES ON
MORTALITY RATE IN ICU
V. Kaloiani, Tbilisi, Georgia
1017
PROSPECTIVE IDENTIFICATION OF HIGH-RISK NEUROLOGIC PATIENTS
OUTSIDE THE CRITICAL CARE UNIT. THE BRESCIA EXPERIENCE OF AN
INTENSIVIST-LED CRITICAL CARE OUTREACH TEAM
F.A. Rasulo, N. Fagoni, S. Piva, E. Grespi, P. Turati,
A. Padovani, M. Fontanella, M. Magoni,
L. Antonini, G. Tomasoni, N. Latronico, Brescia,
Italy
1018
USE OF HIGH RESOLUTION DIFFUSION TENSOR IMAGING IN ACUTE
TRAUMATIC BRAIN INJURY: FEASIBILITY AND INITIAL CLINICAL RESULTS
V. Newcombe, M. Correia, T. Veenith, E. Carter,
J. Outtrim, J. Coles, P. Hutchinson, G. Williams,
D. Menon, Cambridge, United Kingdom
1019
EVALUATION OF VENTRICULOSTOMY MANAGEMENT PROTOCOL IN
NEURORITICAL CARE UNIT (NCCU)
D.F. Batista, T. Loza, E. Pereira, S. Barbosa,
A. Cerejo, C. Dias, J.A. Paiva, Porto, Portugal
1020
THE NEURO-PROTECTIVE EFFECT OF CITICHOLINE (CDP CHOLINE) IN
PATIENTS WITH TRAUMATIC BRAIN INJURY
E.M. El Reweny, A. Okasha, A. Hafez, Alexandria,
Egypt
1021
USE OF TRANSCRANIAL DOPPLER IN PATIENTS WITH SEVERE TRAUMATIC
BRAIN INJURY
D. Ziegler, G. Cravens, R. Gandhi, P. Cho,
M. Tellez, Fort Worth, United States
1022
CEREBROSPINAL FLUID LEVELS OF HIGH MOBILITY GROUP BOX 1 IN
PATIENTS WITH VENTRICULOSTOMY-RELATED INFECTION
S. Piva, F. Albani, E. Monti, L. Baini, L. Signorini,
F. Pecori, N. Fagoni, F. Rasulo, D. Ricotta,
B. Cesana, P. Antonelli, G. Tomasoni,
N. Latronico, Brescia, Italy
1023
RISK FACTORS FOR INFECTION OF THE EXTERNAL VENTRICULAR
DRAINAGE
G. Maria Pilar, I. Dot, A. Rey, Barcelona, Spain
1024
THE ROLE OF PLASMA D DIMER AS A PROGNOSTIC MARKER IN
E.M. El Reweny, H. Abo Khabar, S. Mourad,
Alexandria, Egypt
1025
REPEATED EVENT-RELATED POTENTIALS TECHNIQUE IN ACUTE BRAIN
INJURED PATIENTS: DIFFERENT NEUROPHYSIOLOGIC EVOLUTIONS OF
DISORDERS OF CONSCIOUSNESS
L. Prisco, M. Ganau, W. Calligaris, A. Draisci,
G. Romano, M. Semencic, F. Monti, London,
United Kingdom
1026
IS FEVER STILL A BURDEN IN NEUROINTENSIVE CARE UNIT (NICU)?
M.G. Abate, A. Vargiolu, A. Patruno, M. Fontana,
F.A. Villa, D. Bonacina, G.C. Citerio, Monza, Italy
1027
HYPOPHOSPHATEMIA IN SEVERE BRAIN INJURY
A. Pires, C. Dias, J. Pinho, I. Milet, T. Veiga, Viseu,
Portugal
1028
ADMINISTRATION OF FLUIDS TO TRAUMATIC HEAD INJURY PATIENTS IN
A NEURO-INTENSIVE CARE UNIT. ARE WE GIVING THEM TOO MUCH?
S.G. Kulkarni, S. Griffiths, G. Sundaram,
1029
DECOMPRESSIVE CRANIECTOMY FOR TRAUMA BRAIN INJURY.
FUNCTIONAL OUTCOME SIX MONTHS AFTER HOSPITAL DISCHARGE
D. Arias-Verdu, G. Seller-Perez, M. Herrera
Gutierrez, M.-J. Chaparro-Sanchez, R. RiveraFernandez, D. Fernandez-Zamora, Malaga,
Spain
1030
INTRACRANIAL PRESSURE AND BIS MONITORING CHANGES IN RELATION
TO SODIUM DECREASE IN SEVERE TRAUMATIC BRAIN INJURY
M. Horst ter, M. Jagt van der, I. Haitsma,
J. Bommel van, Rotterdam, Netherlands
1031
Area Evora
Poster Corner
Chairs: Javier Provencio, Cleveland, United States & Carole Ichai, Nice, France
10:10 - 12:00
Try the
e-posters
experience in the
exhibition
area
L I V E S 2 012
A.H.V. Andrade, S. Aparecida Eleodoro Santos,
A.C. Baruzzi, E.E. Taira, B. Taino, L.P. Vasconcelos,
R. Puzzo Bortoleto, L. Erthal de Burgo, L. Ferreira
Lima, M. Bracco, S. Abramovici, Sao Paulo, Brazil
SUCCESSEFUL STRATEGY TO REDUCE VENTILATOR-ASSOCIATED
PNEUMONIA - HOSPITAL M´BOIMIRIM - SAO PAULO
193
Area Faro
Poster Corner
QUALITY & SAFETY IN THE ICU
Chairs: Kathryn Rowan, London, United Kingdom & Akos Csomós, Budapest, Hungary
10:10 - 12:00
ANALYSIS OF THE UTILISATION OF THE NURSING ACTIVITIES SCORE IN
TWO SPANISH CRITICAL CARE UNITS
F.J. Carmona Monge, S. García Gómez,
C. Quirós Herranz, I. Uria Uranga, A. Jara Pérez,
M. Bergaretxe Bengoetxea, G. Etxabe Unanue,
A. Iribarren Martin, M. Echepetelecu Hernando,
E. Badiola Saralegui, M. Auzmendi Irazoqui,
Alcorcón, Spain
1032
IMPLEMENTATION OF SURVIVING SEPSIS CAMPAIGN IN A GROUP
OF PRIVATE HOSPITALS IN BRAZIL: EFFECTS ON OUTCOMES, COSTEFFECTIVENESS AND TEMPORAL TRENDS IN A PROPENSITY ANALYSIS
O.T. Ranzani, D.T. Noritomi, M. Barbosa,
F.R. Machado, E.M. Ferreira, I.C. Paula, F. Leibel,
Sao Paulo, Brazil
1033
STANDARDISED DRUG LABELLING IN INTENSIVE CARE - RESULTS OF AN
INTERNATIONAL SURVEY AMONG ESICM MEMBERS
F. Balzer, N. Wickboldt, C. Spies, B. Walder,
J. Goncerut, G. Citerio, A. Rhodes, M. Kastrup,
W. Boemke, Berlin, Germany
1034
PRELIMINARY ASSESSMENT OF THE FEASIBILITY AND FULFILLMENT OF
PROCESSES OF CARE IN AN ICU TO EVALUATE QUALITY IN ACCORDANCE
WITH THE DECLARATION OF VIENNA
J. Farinha, J. Ribeiro, C. França, Lisbon, Portugal
1035
CLINICAL AUDIT ON CENTRAL VENOUS CATHETER (CVC) PLACEMENT
E. Balakumar, B. Ramalingam, R. Ferguson,
P. Venkatesan, Hull, United Kingdom
1036
ROUTINE COAGULATION SCREENING IN THE INTENSIVE CARE UNIT - AN
AUDIT OF CURRENT PRACTICE
J. Bedford, E. Balakumar, M. Abdulahi, Hull,
United Kingdom
1037
ARE WE GIVING A FAST HUG ONCE A DAY?
R. Pinho, M. Fernandes, A. Dagge, P. Reis,
P. Campos, P. Marçal, P. Amaro, Santa Maria da
Feira, Portugal
1038
DAILY DATA RECORDING IN A NATIONAL COMPARATIVE CLINICAL
DATABASE TARGETING CONTINUOUS QUALITY IMPROVEMENT OF THE
UNIVERSITY HOSPITAL SINGLE INTENSIVE CARE UNIT PERFORMANCE
V. Degoricija, M. Milošević, M. Sharma, I. Šmit,
S. Šefer, Zagreb, Croatia
1039
IMPACT OF THE USE OF COMPUTERISED RECORD KEEPING ON PATIENT
CARE MANAGEMENT
E. Kadosh, L. Duchovna, J. Golan, A. Eden, S.A. Bursztein-De Myttenaere, Haifa, Israel
1040
ADULT DEPENDANCY AND ILLNESS SEVERITY SURVEY (ADISSEY) IN A
LARGE UK DISTRICT GENERAL HOSPITAL
A.J. Garland, K. Burt, G. Humphries, R. Sinclair,
Truro, United Kingdom
1041
LESSONS LEARNED FROM CRITICAL INCIDENT REPORTING: TIME FOR A
CENTRALISED CRITICAL INCIDENT REPORTING SYSTEM?
N. Jain, S. Singh, E. Christie, Chester, United
Kingdom
1042
QUALITY INDICATORS COMPLIANCE SURVEY IN INDIAN ICU
P.B. Gopal, R. Amte, K. Munta, R. Nagoria,
Hyderabad, India
1043
ANALYSING THE SAFETY CLIMATE IN THE ICU: A TOOL FOR PATIENT
SAFETY
M.E. Lugarinho, S. Reis, L. Peixoto, P.P. Castro,
Duque de Caxias, Brazil
1044
EFFECTS OF HYPEROXIA, HYPOXAEMIA AND HAEMORRHAGE ON
BLADDER TISSUE OXYGEN TENSION IN PIGS
A. Dyson, F. Simon, A. Seifritz, O. Zimmerling,
J. Matallo, E. Calzia, P. Radermacher, M. Singer,
1045
AGREEMENT BETWEEN HB AND SO2 MEASUREMENTS IN DIFFERENT
VASCULAR COMPARTMENTS USING A HUMAN HAEMOGASOMETER AND
A CALIBRATED DEVICE FOR PIGS: CALIBRATION FOR ANIMAL SPECIES
NECESSARY?
A. Pereira, S. Jakob, S. Djafarzadeh, J. Takala,
Bern, Switzerland
1046
REGIONAL ANTICOAGULATION WITH CITRATE DURING MARS
TREATMENT - PREELIMINARY RESULTS
W. Mielnicki, T. Zawada, Z. Sycz, J. Bartczak,
1047
THE ACCURACY AND PRECISION OF A DISPOSABLE NON INVASIVE CORE
THERMOMETER IN PATIENTS UNDER GENERAL OR SPINAL ANAESTHESIA
O. Kimberger, J. Koch, I.P. Sanchez, S. Dizili,
L. Saager, A. Kurz, Vienna, Austria
1048
Area Fatima
Poster Corner
TECHNOLOGY IN THE ICU
Chairs: Thomas Geeraerts, Toulouse, France & Manu Malbrain, Antwerp, Belgium
10:10 - 12:00
194
13-17 October 2012
L I V E S 2 012
K. Yamashita, T. Kawano, T. Yatabe, H. Abe,
M. Yokoyama, Kochi, Japan
1049
IMPACT OF ARTERIAL LOAD ON RELIABILITY OF PULSE CONTOURDERIVED CARDIAC OUTPUT MEASUREMENTS
M.I. Monge García, Jerez de la Frontera, Spain
1050
STUDY ON THE FEASIBILITY OF QUANTITATIVE MITOCHONDRIAL
OXYGENATION MEASUREMENTS IN THE RENAL CORTEX
R. Bezemer, J. Kramer, B. Ergin, P. van Horssen,
J. Stap, M. Heger, C. Ince, Amsterdam,
Netherlands
1051
INTEROBSERVER RELIABILITY OF THE TRANSTHORACIC
ECHOCARDIOGRAPHY IN INTENSIVE CARE UNIT
A. Snauwaert, J. Allyn, N. Allou, H. Houissa,
R. Bronchard, P. Montravers, Paris, France
1052
RELIABILITY OF PULSE CONTOUR METHOD-BASED HAEMODYNAMIC
MEASUREMENTS ASSESSED BY DIFFERENT OPERATORS
F. Franchi, A. Faltoni, V. De Palo, S. Cecchini,
L. Cubattoli, P. Mongelli, P. Giomarelli, Siena,
Italy
1053
EARLY EXPERIENCE WITH INTEGRATION OF A NOVEL CONTINUOUS
GLUCOSE MANAGEMENT SYSTEM IN HOSPITAL CRITICAL CARE
R. Joshi, R. Gottlieb, M. Kosiborod, Northridge,
United States
1054
THROMBOELASTOGRAPHY ON THE INTENSIVE CARE UNIT: AN
OBSERVATIONAL STUDY OF INITIAL USE, BENEFITS AND IMPACT ON
DIAGNOSIS AND TREATMENT
P. Davies, J. Ball, M. Cecconi, Morden, United
Kingdom
1055
COMPARISON OF TWO DIFFERENT ADSORPTIVE THERAPIES FOR THE
TREATMENT OF ENDOTOXEMIA
D. Arias-Verdu, M.E. Herrera Gutierrez, G. SellerPerez, P. Benitez-Moreno, E. Aguiar-Flores,
G. Quesada-Garcia, Malaga, Spain
1056
COMPARISON OF A UNIT-USE BLOOD GAS ANALYZER (BGA) WITH A
STANDARD LAB BGA DEVICE AS TWO OPTIONS FOR POINT-OF-CARE
TECHNIQUE (POCT) DURING ROUTINE PRACTICE ON A SURGICAL ICU DATA QUALITY, DEVIATIONS, FEASIBILITY, AND IMPACT FACTORS
S. Toussaint, D. von Wachsmann, H. Gerlach,
Berlin, Germany
1057
USE OF NOVEL NONINVASIVE CARDIAC HAEMODYNAMIC (NICHETM)
MONITORING SYSTEM IN MECHANICALLY VENTILATED PATIENTS PRELIMINARY REPORT
S. Preisman, G. Lancaster, I. Hay, M. Eldar,
H. Berkenstadt, Ramat Gan, Israel
1058
Area Funchal Poster Corner
CAN PULSE WAVE TRANSIT TIME VARIATION PREDICT A FLUID
RESPONSIVENESS MORE PRECISELY COMPARED WITH PULSE PRESSURE
VARIATION?
10:10 - 12:00
USE OF COLISTIN TO TREAT MULTIDRUG RESISTANT (MDR) GRAM
NEGATIVE PATHOGENS- A SINGLE CENTRE EXPERIENCE
K. Krishnareddy, A. Salem, M. Attia, Abu Dhabi,
United Arab Emirates
1059
PERIOPERATIVE MANAGEMENT AND EARLY OUTCOME AFTER SURGERY
FOR ACTIVE INFECTIVE ENDOCARDITIS
H. Murayama, Ichihara, Chiba, Japan
1060
COPEPTIN UTILITY IN ICU COMMUNITY-ACQUIRED PNEUMONIA (CAP)
PATIENTS
1061
CLINICAL OUTCOMES OF TIGECYCLINE MONOTHERAPY AND
COMBINATION THERAPY IN HAP/VAP WITH CARBAPENEM-RESISTANT
ACINETOBACTER BAUMANNII
J.Y. Moon, S.H. Park, Y.-P. Chong, S.O. Ha,
J.S. Park, J.W. Huh, C.-M. Lim, Y. Koh, S.B. Hong,
Seoul, Republic of Korea
1062
HAND-WASHING OBSERVATION IN AN ICU WITH CONTROLLED MRSA
CROSS-COLONISATION
D. Zafimahazo, S. Touati, F. Faibis, N. Picard,
H. Ittah-Desmeulles, P. Le Toumelin, M.C. Demachy, A. Fiacre, S. Agogue, A. Combes,
X. Forceville, Meaux, France
1063
INFLUENCE OF INFECTION DURING POST-OPERATIVE PERIOD AFTER
HEART TRANSPLANTATION IN ONE-YEAR MORBIDITY AND MORTALITY
R. Gómez-López, P. Fernández-Ugidos, P. VidalCortés, M.T. Bouza Vieiro, L. Seoane Quiroga,
A.V. Aller Fernández, J. Muñiz, J.M. Lopez
Perez, S. Fojon Polanco, M.J. Garcia Monge,
E. Rodriguez Garcia, M.J. Paniagua Martin,
E. Barge Caballero, R. Marzoa Rivas, M.G. Crespo
Leiro, Ourense, Spain
1064
ELEVATED PROCALCITONIN PREDICTS GRAM-NEGATIVE SEPSIS IN
ONCOLOGICAL CRITICAL PATIENTS
I. Ribeiro, F. Coelho, F. Faria, Porto, Portugal
1065
IMPACT OF ANTIBIOTIC APPROPRIATENESS IN OUTCOME AND EARLY
C-REACTIVE PROTEIN EVOLUTION IN ICU PATIENTS WITH BACTERAEMIA
R. Pimentel, M. Couto, A. Leitão, P. Mergulhão,
J. Paiva, Porto, Portugal
1066
L I V E S 2 012
Chairs: Fernando Bozza, Rio de Janeiro, Brazil & Claude Martin, Marseille, France (TBC)
195
THE IMMUNE STATUS OF PATIENTS WITH PROLONGED STAYING IN THE
INTENSIVE CARE UNIT
A. Kondratiev, R. Nazarov, E. Kondratieva,
N. Domnina, St. Petersburg, Russian Federation
1067
VENTILATOR ASSOCIATED PNEUMONIA CAUSED BY MULTIDRUG
RESISTANT ACINETOBACTER BAUMANNII: COLISTIN MONOTHERAPY
VERSUS COMBINATION THERAPY WITH COLISTIN AND HIGH DOSES
AMPICILLINE-SULBACTAME
F. Frantzeskaki, E. Paramythiotou, N. Nikitas,
C. Diakaki, S. Karabi, G. Dimopoulos,
A. Armaganidis, Athens, Greece
1068
ACINETOBACTER AND THE CRITICALLY-ILL PATIENT: RISK FACTORS AND
PATIENT OUTCOME- CASE SERIE’S ANALYSIS IN A SAUDI INTENSIVE CARE
UNIT
Y.S. AlMakadma, O. Shaer, T.H. Ibrahim, S. AlObeid, Riyadh, Saudi Arabia
1069
PROGRAMME CONTROL FOR VENOUS CATHETER RELATED INFECTIONS
IN A BRAZILIAN ICU: THE PURSUIT OF EXCELLENCE IN THE REAL WORLD
M.E. Lugarinho, P. Castro, L. Peixoto, Duque de
Caxias, Brazil
1070
MICROBIOLOGICAL PROFILE AND ANTIMICROBIAL SUSCEPTIBILITY OF
ISOLATES IN CULTURES IN THE INTENSIVE CARE UNIT AT A UNIVERSITY
HOSPITAL IN BRAZIL
E. Apinagés-Santos, M.G. Menegueti,
M. Auxiliadora-Martins, A.C. Teixeira,
E.A. Nicolini, J.M. Viana, G.C. Teixeira, M. Puga,
C. Ferrarini, K.T. Muniz, R. Martinez, A. BasileFilho, F. Bellissimo-Rodrigues, Ribeirão Preto,
Brazil
1071
ANALYSIS OF MORTALITY IN URINARY SEPSIS
C. Joya-Montosa, E. Trujillo-García, E. CurielBalsera, M.C. Martinez-González, V. OleaJiménez, M.P. Benítez-Moreno, E.E. AguiarFlores, Málaga, Spain
1072
Area Guarda
Poster Corner
ACUTE KIDNEY INJURY: PATHOPHYSIOLOGY
Chairs: Bernard Cholley, Paris, France & Michael Bauer, Jena, Germany
10:10 - 12:00
196
BALANCED 6% HES 130/0.4 IMPAIRED KIDNEY FUNCTION IN HEALTHY
RODENTS
W. Baar, C. Wunder, C. Held, R. Schneider,
N. Roewer, M.A. Schick, Würzburg, Germany
1073
THE IMPACT OF HYDROXETHYLSTARCH 130/0.4 ON HUMAN PROXIMAL
TUBULAR CELLS IN VITRO
R.R. Bruno, W. Neuhaus, A. Neuhoff, N. Roewer,
M.A. Schick, C. Wunder, Würzburg, Germany
1074
CONTINUED VENTILATION DURING OPEN HEART SURGERY
REDUCES SYSTEMIC SECRETION OF SOLUBLE ST2 AND INHIBITS
POLYMORPHONUCLEAR CELL ACTIVATION
L. Beer, T. Szerafin, A. Mitterbauer, T. Haider,
M. Dworschak, B. Steinlechner, G. Roth,
H.J. Ankersmit, Vienna, Austria
1075
A POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF
CARDIOVASCULAR EFFECTS OF MAGNESIUM IN PATIENTS WITH SEVERE
PREECLAMPSIA
G.G. Lugo, D.Y. Guillen, México, Mexico
1076
CONTINUED LUNG VENTILATION DURING OPEN HEART SURGERY
ATTENUATES SYSTEMIC HEAT-SHOCK PROTEIN 70 RELEASE
L. Beer, T. Szerafin, A. Mitterbauer, T. Haider,
B. Steinlechner, M. Dworschak, G. Roth,
H.J. Ankersmit, Vienna, Austria
1077
ACUTE KIDNEY INJURY (AKI) AFTER LIVER TRANSPLANTATION (LTX): A
SINGLE CENTRE EXPERIENCE
A. De Gasperi, R. Collini, F. Garrone, M. Prosperi,
E. Mazza, A. Corti, Milan, Italy
1078
NEUTROPHIL GELATINASE ASSOCIATED LIPOCALCIN (NGAL) IS A
RELIABLE BIOMARKER OF DIALYSIS-DEPENDENT ACUTE KIDNEY INJURY
AFTER INFRARENAL AORTIC SURGERY
H.K. Joergensen, J. Bisgaard, T. Gilsaa, Kolding,
Denmark
1079
ACUTE KIDNEY INJURY FOLLOWING EMERGENCY SURGERY IN A
UNIVERSITY TEACHING HOSPITAL
E. Precious, L. Blackbourn, M. Vijayakumar,
S. Halder, M. Heneghan, E. Barton, M.P. Wise,
Cardiff, United Kingdom
1080
RENAL FAILURE AND MORTALITY IN POSTOPERATIVE CARDIAC SURGERY.
WHAT FACTORS INFLUENCE? ANALYSIS ARIAM REGISTRY OF CARDIAC
SURGERY
V. Olea Jiménez, J.M. Mora Ordoñez, J. Muñoz
Bono, R. Rivera Férnandez, R. Gómez Calvo,
T. García Paredes, Málaga, Spain
1081
INCIDENCE AND OUTCOMES OF RED BLOOD CELL TRANSFUSION IN
SURGICAL INTENSIVE CARE UNIT AT SIRIRAJ HOSPITAL
A. Piriyapatsom, O. Chaiwat, J. Sak-Aroonchai,
W. Suwannasri, S. Kanavitoon, Bangkok,
Thailand
1082
CD4+/CD8+ RATIO AS A USEFUL INDICATOR FOR POSTOPERATIVE
SEVERE SEPSIS IN CRITICALLY ILL PATIENTS UNDERGOING ELECTIVE
ABDOMINAL OPERATIONS
G. Xiangdong, L. Xiaoyue, Guangzhou, China
1083
13-17 October 2012
L I V E S 2 012
1084
BLOCKADE OF LEUKOTRIENE B4/BLT1 PATHWAY PREVENTS ISCHaEMIA
REPERFUSION INJURY OF KIDNEY
Y. Kosaka, M. Majima, Y. Nara, T. Yokomizo,
Y. Yamada, Y. Kondo, M. Kuroiwa, H. Okamoto,
Sagamihara, Japan
1085
RANDOMISED CONTROLLED TRIAL OF NOVEL RECOMBINANT HUMAN
SOLUBLE THROMBOMODULIN (RTM) FOR SEPSIS WITH DISSEMINATED
INTRAVASCULAR COAGULATION PATIENTS IN JAPAN
H. Ushizawa, E. Isotani, H. Takahashi, T. Sera,
Y. Otomo, Tokyo, Japan
1086
REQUIEM FOR XIGRIS®: ITS USE IN SEPSIS-ASSOCIATED ARDS REQUIRING
ECMO SUPPORT
S. Biondi, G. Cianchi, M. Bonizzoli, S. Matano,
V. Anichini, A. Franci, G. Zagli, A. Peris, Florence,
Italy
1087
SERUM SOLUBLE ICAM-1 IS A RELIABLE BIOMARKER OF INFECTION IN
PATIENTS WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
R. de Pablo, J. Monserrat, A. Prieto, T. Carolina,
E. Reyes, M. Alvarez-Mon, Alcalá de Henares,
Spain
1088
RECOGNITION AND MANAGEMENT OF SEVERE SEPSIS: A RETROSPECTIVE
AUDIT
J.R. Richardson, R. Daniels, Birmingham, United
Kingdom
1089
THE ROLE OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN
(RHS-TM) IN SEPTIC DIC (DISSEMINATED INTRAVASCULAR
COAGULATION)
R. Nagai, M. Kang, M. Saito, M. Takeda,
T. Harada, R. Moroi, M. Namiki, A. Yaguchi,
Tokyo, Japan
1090
IMPLEMENTATION OF A SEPTIC SHOCK CODE TRACK BY A
MULTIDISCIPLINARY TEAM
C. Cabeza, E. Piacentini, M.C. Nicolás, G. Muñoz,
A. Álvarez, R. Ferrer, Terrassa, Spain
1091
THE MIS-FIRED MAGIC BULLET? RECOMBINANT ACTIVATED PROTEIN C
(RHAPC) USE IN PATIENTS WITH DECOMPENSATED LIVER DISEASE OR
GRAFT DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION
R. Roplekar, W. Bernal, C. Willars, L. Sizer,
J. Wendon, G. Auzinger, London, United
Kingdom
1092
EFFECTS OF COMBINATION THERAPY OF RECOMBINANT HUMAN
SOLUBLE THROMBOMODULIN AND ANTITHROMBIN ON DISSEMINATED
INTRAVASCULAR COAGULATION WITH SEVERE SEPSIS
K. Ikeda, Tokyo, Japan
1093
EVALUATION OF THE INITIAL ATTENTION OF SEVERE SEPSIS AND SEPTIC
SHOCK IN DAILY CLINICAL PRACTICE
P. García Olivares, J.I. Roblas, P. Santa Teresa,
J.C. Sotillo, J. Peral, M. Sancho, E. Bermejo,
J.M. Gómez, S. Arenal, A. Jaspe, Madrid, Spain
1094
OXYGEN THERAPY FOR SEPSIS PATIENTS IN THE EMERGENCY
DEPARTMENT; A LITTLE LESS?
R.M. Stolmeijer, J.C. ter Maaten, J.G. Zijlstra,
J.J. Ligtenberg, Groningen, Netherlands
1095
CORRECTION OF THE HAEMOCOAGULATION DISORDERS AND
REDUCING THE LEVEL OF THE SEPTIC COMPLICATIONS BY USING
EPIDURAL ANAESTHESIA AT PATIENTS WITH ACUTE NECROTISING
PANCREATITIS
O. Tarabrin, V. Dubinina, S. Shcherbakov,
D. Gavrychenko, G. Mazurenko, Odessa, Ukraine
1096
PROGNOSTIC FACTORS OF SEPSIS WITH DISSEMINATED INTRAVASCULAR
COAGULATION (DIC) PATIENTS UNDER ADMINISTRATION OF
ANTITHROMBIN III IN JAPAN
T. Sera, E. Isotani, H. Ushizawa, H. Takahashi,
Y. Otomo, Tokyo, Japan
1097
GLYCAEMIC CONTROL IN CRITICALLY ILL. A TERTIARY DUBLIN HOSPITAL
EXPERIENCE
H. Elfil, L. Borovickova, S.M.G. Ahmed, N. Dervan,
C. Hickey, Dublin, Ireland
1098
EARLY WARNING SCORES IN SEPSIS - UTILITY OF A SINGLE EARLY
WARNING SCORE IN THE EMERGENCY DEPARTMENT?
A.R. Corfield, F. Lees, G. Houston, I. Zealley,
S. Dickie, K. Ward, C. McGuffie, Kilmarnock,
United Kingdom
1099
Area Porto
Poster Corner
RE-EVALUATION OF SEPSIS THERAPIES
Chairs: Mitchell Levy, Providence, United States & Herwig Gerlach, Berlin, Germany
10:10 - 12:00
+
L I V E S 2 012
Visit us at the
Level 1
K. Ueta, N. Iguchi, A. Uchiyama, N. Watanabe,
K. Hosotsubo, Y. Fujino, Suita, Japan
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY
BIOMARKER FOR ACUTE KIDNEY INJURY AFTER ENDOVASCULAR STENT
GRAFT REPAIR OF AORTIC ANEURYSM
197
Poster Corner
10:10 - 12:00
198
SCORING & PROGNOSIS IN ICU PATIENTS
THE ASSOCIATION BETWEEN ELEVATED CREATINE PHOSPHOKINASE
AND ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS: A COHORT
STUDY
K.B. Christopher, G.W. Reed, T. Moromizato,
C.K. McKane, M. Mendu, F.K. Gibbons, Boston,
United States
1100
HOW WELL DO PHYSICIANS ESTIMATE MORTALITY AT DISCHARGE FROM
ICU?
S. Ley, R. Sundaram, Paisley, United Kingdom
1101
SAPS3 SCORE MULTICENTRE MORTALITY EVALUATION STUDY IN SPAIN
C. Lopez-Caler, M. García-Delgado, J. CarpioSanz, E. Aguilar-Alonso, F.J. Gómez-Jiménez,
J.-E. Barrueco-Francionni, F. Lobato-Madueño,
R. Rivera-Fernández, Málaga, Spain
1102
COMPARISON OF RANSON AND BISAP PROGNOSTIC INDICES FOR
PREDICTING ORGAN FAILURE, COMPLICATIONS AND MORTALITY IN
SEVERE ACUTE PANCREATITIS
A. Lagos, A. Rego, E. Barjas, L. Correia, A. Valente,
R. Palma, P. Alexandrino, J. Velosa, Lisbon,
Portugal
1103
AUGMENTED CREATININE RENAL CLEARANCE IN CRITICALLY ILL
PATIENTS: IS THERE A PLACE FOR A NEW PROGNOSTIC MARKER?
J.P. Baptista, L. Teixeira, L. Rodrigues, M. Neves,
J. Pimentel, Coimbra, Portugal
1104
PROSPECTIVE ANALYSIS OF CRITICAL CARE REFERRAL PATTERNS PRIOR
TO THE INTRODUCTION OF A NATIONAL EARLY WARNING SCORE (EWS)
E. Dunne, I. Conrick-Martin, F. Colreavy,
B. Marsh, Dublin, Ireland
1105
DEVELOPMENT OF A POINT OF CARE MODEL TO PREDICT INTENSIVE
CARE UNIT (ICU) ADMISSION
B. Kidane, S.A. Chadi, A. Di Labio, F. Priestap,
W. Haddara, T. Mele, J. Murkin, London, Canada
1106
THE COMPARISON OF GCS, PSS, SAPS III SCORING SYSTEMS OF
ORGANOPHOSPHATE POISONED PATIENTS, TREATED IN AN INTERNAL
CARE UNIT
T.E. Bilgin, K. Akoz, A.A. Altunkan, Z. Ozer,
Mersin, Turkey
1107
AGGRAVATING FACTORS FOR ACUTE KIDNEY INJURY IN THE INTENSIVE
CARE UNIT
J.J. Zaragoza Galvan, E.R. Vidal Andrade,
R. Martinez Zubieta, U.W. Ceron Diaz, A.F. Sierra
Unzueta, Distrito Federal, Mexico
1108
THE BUNCRE INDEX AS A PREDICTOR TOOL FOR PROLONGED INTENSIVE
CARE UNIT’S LENGTH OF STAY IN POSTOPERATIVE CARDIAC SURGERY
PATIENTS
M.G. Teixeira Junior, R.M. Hatum, Rio de Janeiro,
Brazil
1109
RISK STRATIFICATION OF PATIENTS ATTENDING TO THE EMERGENCY
HOSPITAL DEPARTMENT BY AN EPISODE OF SYNCOPE. INITIAL
EXPERIENCE OF A SYNCOPE UNIT
M.A. Ramirez-Marrero, I. Vegas-Vegas,
D. Gaitan-Roman, M. Cano-Garcia,
Malaga, Spain
1110
INTRODUCING THE NEW CARDIAC POST-OPERATIVE MORBIDITY SCORE
(C-POMS) INTO CLINICAL PRACTICE: A PILOT STUDY COMPARING POSTOPERATIVE TOTAL MORBIDITY BURDEN IN PATIENTS UNDERGOING
SURGICAL AORTIC VALVE REPLACEMENT (AVR) AND TRANS-CATHETER
AORTIC VALVE IMPLANTS (TAVI)
A. Shah, H. Brambley, M. Curtis, M. Mullen,
N. Delahunty, J. Yap, A. Smith, J. Sanders,
1111
PREDICTING OUTCOME OF PATIENTS WITH SEVERE ACUTE PANCREATITIS
A. Fernández Carmona, A. Díaz Redondo,
J.C. Frías Pareja, S. Ramos Saez, Granada, Spain
1112
SAPS3 SCORE MULTICENTRE MORTALITY EVALUATION STUDY IN
CORONARY PATIENTS IN SPAIN
C. López Caler, J.E. Barrueco-Francioni,
E. Aguilar-Alonso, M. García-Delgado,
R. Sánchez-Rico, J.A. Arboleda-Sánchez,
G. Quesada-García, R. Rivera-Fernández,
Malaga, Spain
1113
Area Setubal
Chairs: Patrick Ferdinande, Leuven, Belgium & Eric Hoste, Ghent, Belgium
13-17 October 2012
L I V E S 2 012
Poster Corner
TRAINING ICU TEAMS
10:10 - 12:00
PRE-ICU UNDERSTANDING OF RENAL PHYSIOLOGY AND MANAGEMENT
OF ACUTE RENAL FAILURE ARE SUBOPTIMAL
R. Nagappan, P. Gibson, Melbourne, Australia
1114
SURVEY OF NURSES. RECOGNITION OF CAPNOGRAPH TRACES
S. Bengeri, Darlington, United Kingdom
1115
RECENTLY GRADUATED DOCTORS’ SELF-REPORTED PREPAREDNESS
IN THE MANAGEMENT OF ACUTELY ILL PATIENTS. A 5 YEAR REVIEW
OF LONDON DEANERY´S FOUNDATION PROGRAMME SIMULATION
TRAINING - A CLINICAL CHALLENGE FOR MEDICAL EDUCATION?
G.T. Bird, C. Swampillai, O. Lacey, I. Curran,
1116
THE BENEFITS OF A SIMPLIFIED METHOD FOR CPR TRAINING OF
MEDICAL PROFESSIONALS: A RANDOMIsED CONTROLLED STUDY
K.S. Allan, N. Wong, T. Aves, P. Dorian, Toronto,
Canada
1117
PRE-ICU UNDERSTANDING OF SEPSIS AND MANAGEMENT OF SEPSIS
AND SEPTIC SHOCK ARE SUBOPTIMAL
R. Nagappan, P. Gibson, A. Subramaniam,
Melbourne, Australia
1118
VENTILATOR-ASSOCIATED PNEUMONIA PREVENTION EDUCATION IN
THE EMERGENCY DEPARTMENT
K. Grall, L.A. DeLuca, J. Peraza, W. Larson,
A. Westergard, J. Gonzaga, L. Stoneking,
J. Rosell, J. Sakles, K. Denninghoff, Tucson,
United States
1119
INTERNATIONAL COLOUR CODED SYRINGE LABELS. A PROGRAMME OF
EDUCATION AND ASSISTANCE TO IMPROVE PATIENT SAFETY AT LEEDS
TEACHING HOSPITALS (LTHT)
L. Hudman, J.K. Gordon, Leeds, United Kingdom
1120
PERCEIVED BENEFITS OF SIMULATION TRAINING FOR FOUNDATION
DOCTORS IN MANAGING MEDICAL EMERGENCIES
P. Patel, V. Fox, I. Sockalingam, Stevenage,
United Kingdom
1121
DOES THE COLLABORATOR COMPETENCY MEAN THE SAME THING
TO ALL PEOPLE? A DISCOURSE ANALYSIS OF INTERPROFESSIONAL
COLLABORATION
W. Haddara, L. Lingard, London, Canada
1122
CRITICAL INCIDENT REPORTING SYSTEMS AS FEEDERS FOR HIGH
FIDELITY SIMULATION TRAINING
M. Abu-Habsa, J. Grundlingh, Oxford, United
Kingdom
1123
DEVELOPMENT OF A NEW CRITICAL CARE AND APPLIED PHYSIOLOGY
TEACHING PROGRAMME SPECIFICALLY DESIGNED FOR THE SURGICAL
TRAINEE
C. Carle, B. Mcgrath, P. Alexander, J. Barker,
J. Moore, D. Atkinson, Peterborough, United
Kingdom
1124
DESIGNING A PERFORMANCE ASSESSMENT STRATEGY FOR A POSTGRADUATE PHARMACIST INTENSIVE CARE SPECIALIST ROTATION
C. Gowing, M. Donnelly, J. Strong, E. Deasy,
Dublin, Ireland
1125
IMPROVING COMMUNICATION SKILLS FOR JUNIOR DOCTORS THROUGH
SIMULATION: WHEN, WHOM AND HOW TO CALL FOR HELP
P. Patel, V. Fox, I. Sockalingam, Stevenage,
United Kingdom
1126
COGNITION REGARDING DO-NOT-ATTEMPT-RESUSCITATE (DNAR) OF
HEALTH CARE PROVIDER IN THE EMERGENCY DEPARTMENT OF KOREA CHANGE OF PATIENT MANAGEMENT AFTER DNAR
S.-H. Lee, S. Ryu, J.-S. Lim, Y.-C. Cho, I.-S. Yoo,
Daejeon, Republic of Korea
1127
USE OF ASSESSMENT TOOL BY CRITICAL CARE OUTREACH NURSE
PRACTITIONERS IMPROVES ASSESSMENT AND DOCUMENTATION OF
THE PHYSIOLOGICAL STATUS OF ACUTELY UNWELL PATIENTS
J. Peacock, C.E. Fox, C.A. Mukherjee,
M.A. Pittman, Basildon, United Kingdom
1128
VALIDATION OF THE CONFUSION ASSESMENT METHOD FOR INTENSIVE
CARE UNIT IN THE ITALIAN CONTEXT
I. Comisso, P. Gaspardo, L. Peressoni, Udine, Italy
1129
NURSES ATTITUDES TOWARDS THE CONDUCT OF ICU RESEARCH: A
MULTI-CENTRE SURVEY
O. Smith, C. Dale, C. Filice, J. Filice, D. Foster,
C. Jones, Y. Lee, A. Matte, E. McDonald,
K. Porretta, M. Steinberg, R. Ward, K. Wheeler,
S. Mehta, R. Pinto, L. Rose, Toronto, Canada
1130
SPIRITUAL DISTRESS ASSESSMENT TOOL A VALID INSTRUMENT FOR
ELDERLY PATIENTS IN THE INTENSIVE CARE UNIT
V. Gherghina, G. Nicolae, Constanta, Romania
1131
SLEEP IN THE ICU: PATIENTS AND NURSES PERCEPTION
S. Calvino, Grenoble, France
1132
Life-Priority
Poster Corner
Area Sintra
Chairs: Marco Maggiorini, Zurich, Switzerland & Brian Marsh, Dublin, Ireland
NURSING ASSESSMENT & TRAINING
10:10 - 12:00
L I V E S 2 012
Chairs: Ana Rosa, Lisbon, Portugal & Terry O’Reilly, London, United Kingdom
199
PTSD AND MEMORY OF SYMPTOMS DURING ICU STAY
S. Quossine, J.S. Benbenishty, Jerusalem, Israel
1133
RELATIVES’ EXPERIENCES OF CONFUSION AND AGITATION IN CRITICAL
CARE PATIENTS
M. Buckel, C. Roberts, J. Baldwin, S. Laha,
Preston, United Kingdom
1134
WORKLOAD OF REGISTRATION OF VENTILATOR-ASSOCIATED
PNEUMONIA IN THE ICU WITH AND WITHOUT THE USE OF A PATIENT
DATA MANAGEMENT SYSTEM
M. Hout van der, L. Duijn, A.M. Kaiser,
J. Peppink, C. Vandenbroucke-Grauls, A. Girbes,
1135
PREFERRED CONTENT AND USEFULNESS OF A PHOTO-DIARY
E. Åkerman, A. Ersson, B. Fridlund, K. Samuelson,
Malmö, Sweden
1136
DETERMINATION OF RELATIVES NEEDS WHOSE PATIENTS HAVE BEEN
TREATED IN ICU
A. Yava, B. Tosun, Ö. Kızılca, N. Bayram, Y. Çırak,
Ankara, Turkey
1137
THE IMPACT ON PATIENT CARE AND SAFETY OF COMPREHENSIVE
EDUCATIONAL EFFORTS AT AN INTENSIVE CARE UNIT
R. Soderlund, E.M. Wallin, Stockholm, Sweden
1138
COMPUTER APPLICATION IN INTENSIVE CARE UNIT
A. González, Manresa, Spain
1139
THE KNOWLEDGE AND ATTITUDES OF NURSES ON PHLEBITIS IN A
TRAINING AND RESEARCH HOSPITAL
A. Koyuncu, A. Yava, A. Güler, U. Demirkılıç,
Ankara, Turkey
1140
ROOM Lisbon
Thematic Session
PRESIDENT’S SESSION: SHAPING THE NEXT 30 YEARS
Chairs: Jean-Daniel Chiche, Paris, France & Andrew Rhodes, London, United Kingdom
12:00 - 12:20
Defining the specialty
12:20 - 12:40
Refining diagnostics & therapeutics
12:40 - 13:00
Redefining the ICU environment
13:00 - 13:20
Reinventing clinical trials
13:20 - 13:40
Funding research, education and bedside translation
13:40 - 14:00
Attracting and mentoring the stars
ROOM Berlin
Thematic Session
MECHANICAL VENTILATION: HOT TOPICS 2012
Chairs: Marco Ranieri, Turin, Italy & Marcelo Amato, Sao Paulo, Brazil
12:00 - 12:20
Monitoring diaphragmatic function during assisted ventilation
12:20 - 12:40
Automatised modes. Where do they fit in?
12:40 - 13:00
Is prone positioning evidence-based?
13:00 - 13:20
Should we use muscle relaxants in early ARDS?
Laurent Papazian, Marseille, France
13:20 - 13:40
What is the optimal respiratory monitoring strategy in ALI/ARDS?
13:40 - 14:00
Prevention is better than treatment. Changing the ARDS paradigm
Patricia Rocco, Rio de Janeiro, Brazil
ROOM Barcelona
Thematic Session
OPTIMAL TISSUE PERFUSION
Chairs: Can Ince, Rotterdam, Netherlands & Rupert Pearse, London, United Kingdom
200
12:00 - 12:20
Tissue perfusion: Optimising global haemodynamics
12:20 - 12:40
Tissue perfusion: Optimising microvascular flow
12:40 - 13:00
Tissue perfusion in sepsis
13:00 - 13:20
Tissue perfusion after high-risk surgery
13:20 - 13:40
Tissue perfusion in trauma
13:40 - 14:00
How do we know we are treating poor perfusion?
13-17 October 2012
L I V E S 2 012
Thematic Session
FLUID THERAPY IN SEPTIC SHOCK
12:00 - 12:20
Albumin
12:20 - 12:40
Fluid resuscitation vs. GDT: Are they the same thing?
12:40 - 13:00
HES
13:00 - 13:20
Acid base and fluids: Do they really matter?
13:20 - 13:40
CVP 8-12 mmHg for everybody?
13:40 - 14:00
So… do we know what to do with fluids?
room Rome
THE BURN PATIENT
Chairs: Stijn Blot, Ghent, Belgium & Jeff Lipman, Brisbane, Australia
12:00 - 12:20
Injury assessment
Stijn Blot, Ghent, Belgium
12:20 - 12:40
Early ICU management: What you should do
Alexandre Mebazaa, Paris, France
12:40 - 13:00
Burn wound infection
13:00 - 13:20
Metabolic needs and nutrition
13:20 - 13:40
Acute kidney injury: Anything special?
13:40 - 14:00
Discussion
room Glasgow
Thematic Session
ROOM Geneva
Chairs: Richard Beale, London, United Kingdom & Anders Perner, Copenhagen, Denmark
SEDATION, ANALGAESIA & DELIRIUM IN CRITICAL CARE
Chairs: Jean-Louis Vincent, Brussels, Belgium & Claudia Spies, Berlin, Germany
12:00 - 12:20
Altering intensive care sedation paradigms to improve patient
outcomes
12:20 - 12:40
Analgaesia in intensive care
Kathleen Puntillo, San Francisco, United States
12:40 - 13:00
Sedation and delirium: An intriguing relationship
13:00 - 13:20
Sedation in neurological patients: Any difference?
13:20 - 13:40
New drugs: Appreciable advantages?
13:40 - 14:00
New guidelines needed?
Carol Thompson, Memphis, United States
room Stockholm
Thematic Session
OXYGEN & THE BRAIN: NEW INSIGHTS
12:00 - 12:20
Basic principles: Coupling of oxygen consumption with cerebral blood
and energy flow
12:20 - 12:40
Acute brain injury: Ischaemia is not the only problem
12:40 - 13:00
Acute brain injury: Oxygen utilisation is the problem
13:00 - 13:20
Non-invasive monitoring of brain oxygen: Is it possible?
13:20 - 13:40
Invasive monitoring of brain oxygen
13:40 - 14:00
What clinical targets should we use?
+
L I V E S 2 012
Visit us at the
ESICM Booth
Exhibition Area A
Chairs: Jean-François Payen, Grenoble, France & Nino Stocchetti, Milan, Italy
201
room Paris
QUESTIONS
Thematic Session
POST-CARDIAC ARREST MANAGEMENT: ANSWERING THE IMPORTANT
Chairs: Bernd Böttiger, Heidelberg, Germany & Alain Cariou, Paris, France
12:00 - 12:20
Cooling: How early?
12:20 - 12:40
Cooling: Does the technique matter?
Kjetil Sunde, Oslo, Norway
12:40 - 13:00
Defining targets for brain perfusion and oxygenation
13:00 - 13:20
What is the optimal organ support?
13:20 - 13:40
Should we add antibiotic prophylaxis?
13:40 - 14:00
Neurological prognostication in the era of hypothermia
room Vienna
Thematic Session
THINKING GLOBALLY TO IMPROVE PATIENT CARE
Chairs: Andreas Valentin, Vienna, Austria & Rui Paulo Moreno, Lisbon, Portugal
12:00 - 12:20
Intensive care as one step in the clinical course of critical illness
12:20 - 12:40
Basic requirements for ICU structure
Patrick Ferdinande, Leuven, Belgium
12:40 - 13:00
Basic organisational requirements for ICUs
Andreas Valentin, Vienna, Austria
13:00 - 13:20
Human interaction - the key to successful intensive care
13:20 - 13:40
How to improve time-dependent processes in the ICU
Peter van der Voort, Amsterdam, Netherlands
13:40 - 14:00
Learning from others: ICU networks
room Athens
EMERGING THERAPEUTIC OPTIONS FOR AKI
Chairs: Michael Joannidis, Innsbruck, Austria & Ravindra Mehta, San Diego, United States
12:00 - 12:20
Albumin
12:20 - 12:40
Bicarbonate
12:40 - 13:00
Alkaline Phosphatase and iNOS inhibition
Netherlands
13:00 - 13:20
Renal Vasodilators
Ravindra Mehta, San Diego, United States
room Athens
Controversies Session
THE ICU PHYSICIAN IS AN ENDANGERED SPECIES
Yes
Francesca Rubulotta, London, United Kingdom
13:40 - 13:50
No
13:50 - 14:00
Discussion
13:30 - 13:40
202
Try the
e-posters
experience in the
exhibition
area
13-17 October 2012
L I V E S 2 012
Hot Topics Session
HOT TOPICS SESSION
14:15 - 14:30
Awards winners
14:30 - 14:50
Tight glycaemic control in children influences neurocognitive function
after ICU
Greet Van den Berghe, Leuven, Belgium
14:50 - 15:10
Daily sedation holidays vs. protocolised sedation: Any difference?
Sangeeta Mehta, Toronto, Canada
15:10 - 15:30
The PROSEVA trial: Effect of prone positioning in patients with severe
and persistent ARDS.
15:30 - 15:50
Albumin for volume replacement in severe sepsis. The ALBIOS trial
15:50 - 16:10
Fluid resuscitation with 6% hes (130/0.4) vs. normal saline. The CHEST
trial.
John Myburgh, Sydney, Australia
16:10 - 16:30
Standards of care and clinical outcomes for patients undergoing noncardiac surgery. The EuSOS study
room Lisbon
Chairs: Jean-Daniel Chiche, Paris, France & Howard Bauchner, Chicago, United States
L I V E S 2 012
203
ESICM Faculty List
ESICM Declaration of potential conflict of interests
The Society wishes to ensure that all those who participate in the Society’s professional, administrative, scientific and educational activities,
including speakers and chairpersons at the Annual Congress, have the opportunity to declare any interests they may have which could influence,
or might be perceived to influence, their judgement or behaviour.
Competing interests may arise from academic, financial, or professional activities and ambitions. These are inevitable, and in many instances do
not adversely affect behaviour. Similarly, research and educational relationships with industry are desirable and essential for progress in health
care. However, these tensions and relationships provide opportunities for abuse and inappropriate influence.
Faculty disclosures are listed below as of 12 September 2012.
Abuella, Gihan
Bell, Max
Chastre, Jean
Dünser, Martin
Stockholm, Sweden
Paris, France
Salzburg, Austria
Ajizian, Samuel
Bellingan, Geoffrey
Duranteau, Jacques
Winston Salem, United States
Honoraria fees for lectures from
Nektar-Bayer
Consulting, Covidien. No conflict
for session.
Benbenishty, Julie
Chew, Michelle
LFB - Fresenius Kabi.
Alonso-Iñigo, José-Miguel
Alzira, Spain
I have received funds for teaching
conferences during last year. Vygon
Amato, Marcelo
Sao Paulo, Brazil
Amrein, Karin
Graz, Austria
I am investigator in a RCT that is in
part funded by Fresenius Kabi.
Angus, Derek
Pittsburgh, United States
Berger, Mette
Chiche, Jean-Daniel
Paris, France
Unrestricted research grant.
Fresenius Kabi.
Chiumello, Davide
Bion, Julian
Cholley, Bernard
Paris, France
Blot, Stijn
Citerio, Giuseppe
Ghent, Belgium
Monza, Italy
Boemke, Willehad
Speakers Bureau. Codman
Milan, Italy
Berlin, Germany
Claassen, Jan
Bonten, Marc
New York, United States
Ferdinande, Patrick
Leuven, Belgium
Ferguson, Colin
Plymouth, United Kingdom
Flaatten, Hans
Bergen, Norway
Fletcher, Nick
Forni, Lui
Worthing, United Kingdom
Friberg, Hans
Lund, Sweden
I am PI of a multicenter NIH trial of
EGDT.NIH. I served on the DSMB of
PROWESS Shock and I was involved
in the initial evaluation of Xigris. Eli
Lilly. I study long-term follow-up of
sepsis. I have current NIH funds to
conduct this work. I conduct RCTs
in the critically ill. NIH.
Clau-Terré, Fernando
Böttiger, Bernd
Barcelona, Spain
Speaker’s bureau, Sponsor of
Nicolet Monitors. Carefusion Inc
Heidelberg, Germany
Combes, Alain
Gajic, Ognjen
Bouman, Catherine
Paris, France
Rochester, United States
PI of a study supported by MAQUET
Patent application for ICU
Dashboard, no personal financial
relationship or benefit at present
Annane, Djillali
Brochard, Laurent
Bozza, Fernando
Rio de Janeiro, Brazil
Garches, France
Geneva, Switzerland
I was a member of the experts
panel who revised the guidelines.
I’ve been the PI of one RCT on
vasopressin antagonist.
Leader Of The European Research
Reva Network. Reva.
Research Grants To The Laboratory.
Drager- Maquet- CovidienRespironics Philips- General Electric.
Research Grants For Working On
The Smartcare Algorithm- For Asv.
Drager- Hamilton.
Antonelli, Massimo
Rome, Italy
Azoulay, Elie
Paris, France
Brun-Buisson, Christian
Baatar, Otgon
Ulaanbaatar, Mongolia
Bakker, Jan
Balik, Martin
Prague, Czech Republic
Bauchner, Howard
Chicago, United States
Bauer, Michael
MOSAR coordinator. EC funded
study (FP-6).
Canivet, Jean-Luc
Liège, Belgium
Capuzzo, Maurizia
Ferrara, Italy
Cariou, Alain
Scientifc advisor. Lilly France
Baumann, Frédéric
Bern, Switzerland
Casear, Michaël
Leuven, Belgium
Beale, Richard
Beaulieu, Yanick
Montreal, Canada
Creteil, France
Paris, France
Jena, Germany
204
Jerusalem, Israel
Malmö, Sweden
Cecconi, Maurizio
Honoraria, travel expenses, advisory
board. dwards Lifesciences,
LiDCO, Cheetah, Deltex, Applied
Physiology, Masimo, Bmeye.
13-17 October 2012
Copetti, Roberto
Tolmezzo, Italy
Csomós, Akos
Budapest, Hungary
Curtis, J. Randall
Seattle, United States
Czosnyka, Marek
De Backer, Daniel
Brussels, Belgium
Gattinoni, Luciano
Milan, Italy
Geeraerts, Thomas
Toulouse, France
Gerlach, Herwig
Berlin, Germany
Girbes, Armand
Research grants and material for
studies.Edwards Lifescience /
Vytech.
Groeneveld, Arie Bastiaan Johan
de Pont, Anne-Cornelie
De Waele, Jan
Ghent, Belgium
Deutschman, Clifford
Philadelphia, United States
Dimopoulos, George
Athens, Greece
Doig, Gordon
Sydney, Australia
Dominguez-Gil, Beatriz
Madrid, Spain
Druml, Wilfred
Gruber, Pascale
Guérin, Claude
Lyon, France
Guidet, Bertrand
Paris, France
Hamilton, Mark
Haniffa, Rashan
Colombo, Sri Lanka
Harbarth, Stephan
Geneva, Switzerland
Coinvestigator of the MOSAR
consortium
Vienna, Austria
Herridge, Margaret S.
Du, Bin
Toronto, Canada
Beijing, China
Hiesmayr,Michael
Vienna, Austria
L I V E S 2 012
Hofer, Christoph
Legrand, Matthieu
Mira, Jean-Paul
Pinsky, Michael
Zurich, Switzerland
Paris, France
Paris, France
Lecturing fees & research grants.
Pulsion Medical Systems/Edwards
Lifesciences.
Leroux, Peter
Honorarium. Eli Lilly
Inventor of a US Patent held
by the University of Pittsburgh
on functional haemodynamic
monitoring. US government.
Consultant. Edwards, LiDCO,
Applied Physiology. Resuscitation
mechanisms of tissue injury.NIH
Philadelphia, United States
Molitoris, Bruce
Research Funding. Integra distributes brain oxygen monitor
in US
Indiana, United States
Sponserd Clinical Trials. Velomedix,
Philips
Levy, Mitchell
Honoré, Patrick
Providence, United States
Member of the medical advisory
board of Pulsion Medical Systems
Lipman, Jeff
Moreno, Rui Paulo
Brisbane, Australia
Lisbon, Portugal
Lojewski, Christian
Myburgh, John
Berlin, Germany
Sydney, Australia
Ma, Penglin
Navarrete Navarro, Pedro
Beijing, China
Granada, Spain
Macchiarini, Paolo
Nolan, Jerry
Florence, Italy
Bath, United Kingdom
Maggiore, Salvatore
Oddo, Mauro
Rome, Italy
I have been an advocate of the
importance of the microcirculation
and have developed tools for
monitring it which is why I have
conflict of interest
Maggiorini, Marco
Oliveira, Eduardo
Zurich, Switzerland
Lisbon, Portugal
Mai,a Paulo
O’Reilly ,Terry
Porto, Portugal
Jhanji, Shaman
Malbrain, Manu
Ostermann, Marlies
Antwerp, Belgium
I do research on inflammation
in SAH. NIH and Brain Aneurysm
Foundation
Joannes-Boyau, Olivier
Member medical advisory board
Pulsion Medical systems
Oudemans-van Straaten, Heleen
Pugin, Jérôme
Geneva, Switzerland
Pessac, France
Manara, Alexander
Joannidis, Michael
Bristol, United Kingdom
Paiva, José Artur
Puntillo, Kathleen
Innsbruck, Austria
Mancebo, Jordi
Jonas, Max
Barcelona, Spain
Southampton, United Kingdom
Marsh, Brian
Jones, Christina
Dublin, Ireland
Martin, Claude
Karantza, Maria
Marseille, France
Athens, Greece
Marz, Susanne
Kavanagh, Brian
Berlin, Germany
Toronto, Canada
Maury, Eric
Kellum, John
Paris, France
Mayo, Paul
Holzer, Michael
Vienna, Austria
Brussels, Belgium
Consultant. Gambro, Pfizer.
Horn, Peter
Berlin, Germany
Hoste, Eric
Ghent, Belgium
Ichai, Carole
Nice, France
Ince, Can
Grant support. Baxter.
New York, United States
Kentish-Barnes, Nancy
McLean, Antony
Paris, France
Sydney, Australia
Kesecioglu, Jozef
McLean, Barbara
Atlanta, United States
Knobel, Elias
McWilliams, David
Sao Paulo, Brazil
Manchester, United Kingdom
Köth, Holger
Mebazaa, Alexandre
Berlin, Germany
Paris, France
Kwizera, Arthur
Mehta, Ravindra
Kampala, Uganda
San Diego, United States
Labeau, Sonia
Mehta, Sangeeta
Ghent, Belgium
Galway, Ireland
Larsson, Anders
Uppsala, Sweden
Lassus, Johan
Helsinki, Finland
Laterre, Pierre-François
Leuven, Belgium
Advisory Board, consultant. Kenta,
AstraZeneca, Ageenix.
L I V E S 2 012
Poelaert, Jan
Brussels, Belgium
Poulakou, Garyfallia
Athens, Greece
Prat, Gwenaël
Brest, France
Preiser, Jean-Charles
Brussels, Belgium
Price, Susanna
Procaccio, Francesco
Rome, Italy
Provencio, Javier
Cleveland, United States
Porto, Portugal
San Francisco, United States
Papazian, Laurent
Quintel, Michael
Marseille, France
Payen, Jean-François
Grenoble France
Payen de La Garanderie, Didier
Paris, France
Pearse, Rupert
Research funding and honoraria.
LiDCO Ltd, Circassia Holdings,
Covidien Inc, Pulsion Medical
Systems, Edwards Lifesciences
Pelosi, Paolo
Genova, Italy
Pelucchi, Giulia
Monza, Italy
Pène, Frédéric
Paris, France
Perel, Azriel
Tel Aviv, Israel
Medical Advisory Board, PulsionConsultant to BMEYE,
Perner, Anders
Copenhagen, Denmark
Gottingen, Germany
Advisor of the Dräger, Covidien
and Philips Company. Advisor
honorarium
Ranieri, Marco
Turin, Italy
Chair of the SC of the prowess
shock study- supported by Eli-Lilly.
Member of the advisory board of
Maquet and Hemodec
Rasulo, Frank
Brescia, Italy
Reinhart, Konrad
Jena, Germany
Reintam Blaser, Annika
Tallin, Estonia
Rello, Jordi
Barcelona, Spain
Ad board or/and speaker bureau.
Pfizer, Astellas, Jansen, KENTA,
Cubicin, Novartis.
Rhodes, Andrew
Mekontso Dessap, Armand
Support for research. B Braun
Medical and Fresenius Kabi.
Steering committee. Steering
committee member of Prowess
Shock. Lilly
Creteil, France
Pesenti, Antonio
Monza, Italy
Ricou, Bara
Melot, Christian
Brussels, Belgium
Peters, Mark
Menon, David
Toronto, Canada
Laffey, John
Monnet, Xavier
Geneva, Switzerland
Rocco, Patricia
Rio de Janeiro, Brazil
Roes, Kit
Metnitz, Philipp
Vienna, Austria
Romand, Jacques-André
Michalsen, Andrej
Geneva, Switzerland
Tettnang, Germany
205
Ronco, Claudio
Sprung, Charles
Vincent, Jean-Louis
Vicenza, Italy
Jerusalem, Israel
Brussels, Belgium
Rooyackers, Olav
Stocchetti, Nino
Voga, Gorazd
Stockholm, Sweden
Milan, Italy
Celje, Slovenia
Rosa, Ana
Storti, Enrico
Walder, Bernhard
Lisbon, Portugal
Milan, Italy
Geneva, Switzerland
Rothen, Hans Ulrich
Sunde, Kjetil
Weber-Carstens, Steffen
Bern, Switzerland
Oslo, Norway
Berlin, Germany
Rouby, Jean-Jacques
Suter, Peter
Wendon, Julia
Paris, France
Geneva, Switzerland
Rowan, Kathryn
Taccone, Fabio Silvio
Wernerman, Jan
Brussels, Belgium
Stockholm, Sweden
Chief Investigator for ongoing early,
goal-directed, resuscitation trial.
Hold academic research grant for
above.
Grant Research. Benechill
Takala, Jukka
Woittiez Arend, Jan
Rubulotta, Francesca
Sander, Michael
Berlin, Germany
Sanders, Robert
United Kingdom
I have spoken on the same
topic at the canadian society of
anesthesiologists meeting. This was
supported by Hospira.
Schortgen, Frédérique
Creteil, France
Schröder, Torsten
Berlin, Germany
Sharshar, Tarek
Singer, Mervyn
Years ago I sat on a UK advisory
board and got occasional speaker’s
fees. Lilly. Have received speaker
fees and sat on advisory board from
manufacturer. Orion
UCL hold shares in the company.
I get unrestricted grants into
my research fund and I receive
consultancy fees from them.
Deltex Medical. Am a clinical PI in
the UK PROMISE multicentre trial
on EGDT. UK Dept of Health. Am
doing studies with UK Ministry of
Defence and Immunexpress on
early diagnostics in sepsis, and
Oxford Optronix for early diagnosis
of organ hypoperfusion
Sitzwohl, Christian
Vienna, Austria
Beijing, China
Zanier, Elisa
Milan, Italy
Zapol, Warren
I Receive Royalties on inhaled NO.
Linde and Ikaria Corps..
Teboul, Jean-Louis
Member of the medical advisory
board of Pulsion Medical Systems
Thiery, Guillaume
Paris, France
Memphis, United States
Timsit, Jean-François
Research grants from Astellas,
Gilead, and Merck. university
Grenoble 1
Torres, Antonio
Barcelona, Spain
Research grant from Pfizer.
Toussaint, Susanne
Berlin, Germany
Truog, Bob
Valentin, Andreas
Vienna, Austria
Valenza, Franco
Milan, Italy
Van den Berghe, Greet
Leuven, Belgium
van der Voort, Peter
Via, Gabriele
Paiva, Italy
Slama, Michel
Vieillard-Baron, Antoine
Amiens, France
Boulogne, France
Slooter, Arjen
Slowinsky, Thorsten
Berlin, Germany
Received speaking fees and grants.
Fresenius Medical Care, Germany
206
Xi Xiu, Ming
Grenoble, France
Paris, France
Berlin, Germany
My deparatment has had a research
contract on three clinical trials
on demedetomidine- I have no
personal conflict of interest, and I
have received no financial benefits
from any source in context of this
topic. Orion Pharmaceuticals (my
department’s source of research
contract)
Almelo, Netherlands
Thompson, Carol
Schultz, Marcus
Spies, Claudia
Bern, Switzerland
GE, Maquet, Lilly
Vignon, Philippe
Limoges, France
Vigué, Bernard
Loan of transcranial Doppler
machine in the departement. Atis
medical
13-17 October 2012
L I V E S 2 012
industry sponsored sessions
L I V E S 2 012
207
FACULTY LIST - INDUSTRY SPONSORED SESSIONS
208
Javier
Belda
Valencia
Spain
Max
Bell
Stockholm
Sweden
Rafael
Cantón
Madrid
Spain
Lakhmir
Chawla
Washington
United States
Pierre
Dechelotte
Rouen
France
Björn
Ellger
Munster
Germany
Luc
Foubert
Aalst
Belgium
Alexandre
Guerrini
Saint Avertin
France
Walter
Hasibeder
Ried Im Innskrels
Austria
Leo
Heunks
Nijmegen
Netherlands
Carole
Ichai
Nice
France
Samir
Jaber
Montpellier
France
Pierre
Kalfon
Chartres
France
Rudolf W.M.
Keunen
The Hague
Netherlands
Rafael
Manez
Barcelona
Spain
Ricardo
Matos
Lisbon
Portugal
Shay
McGuinness
Auckland
New Zealand
William Lancelot
Michell
Cape Town
South Africa
Andrea
MorellI
Rome
Italy
Paolo
Navalesi
Alessandria
Italy
Rachael
Parke
Auckland
New Zealand
Mathieu
Raux
Paris
France
Daniel
Reuter
Hamburg
Germany
Jean-Damien
Ricard
Paris
France
Jean-Christophe
Richard
Geneva
Switzerland
Roberto
Roncon de Albuquerque
Porto
Portugal
Alain
Rudiger
Zurich
Switzerland
Nigel
Scawn
Liverpool
United Kingdom
Alexander
Soriano
Barcelona
Spain
John
Stover
Zurich
Switzerland
Miguel
Tavares
Leça da Palmeira
Portugal
Hugo
Van Aken
Munster
Germany
Richard
Weiskopf
Tiburon
United States
Tobias
Welte
Hanover
Germany
Martin
Westphal
Munster
Germany
Wolfram
Windisch
Cologne
Germany
João
Wink
Porto
Portugal
13-17 October 2012
L I V E S 2 012
Chair: Marco Maggiorini, Zurich, Switzerland & TBA
12:30 - 12:35
Introduction
12:35 - 13:10
13:10 - 13:45
Renal Recovery After Acute Kidney Injury: Clinical and Health Economic
Considerations
Max Bell, Stockholm, Sweden
13:45 - 14:00
Discussion
ROOM Berlin
THE FUTURE OF GLUCOSE MONITORING IN THE ICU
Chairs: Carole Ichai, Nice, France & Jean-Charles Preiser, Brussels, Belgium
12:30 - 13:00
13:00 - 13:30
Nigel Scawn, Liverpool, United Kingdom
13:30 - 14:00
Clinical experience with the GlucoClear Continuous Glucose Monitoring
System
Luc Foubert, Aalst, Belgium
ROOM BARCELONA
Industry Sponsored Session Individualised nutritional strategies in ICU
Chairs: Martin Dünser, Salzburg, Austria & Jukka Takala, Bern, Switzerland
12:30 - 12:35
12:35 - 12:55
12:55 - 13:15
Jan Wernerman, Stockolm, Sweden
13:15 - 13:35
Stephan Jakob, Bern, Switzerland
13:35 - 13:55
13:55 - 14:00
ROOM Geneva
Industry Sponsored Session GOOD CLINICAL NUTRITION PRACTICE
Chairs: Pierre Dechelotte, Rouen, France & Mette Berger, Lausanne, Switzerland
12:30 - 12:35
Introduction
12:35 - 13:15
Is it worth adapting the energy and protein intake to the patient’s
13:15 - 13:55
John Stover, Zurich, Switzerland
13:55 - 14:00
Concluding remarks
ROOM Rome
SPONSORED SESSIONS
room Lisbon
Industry Sponsored Session New Clinical Perspectives on the Management of
Critically Ill Patients with Acute Kidney Injury
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
209
INDUSTRY SPONSORED SESSIONS
BRAIN MONITORING IN ICU: WHY AND HOW?
Chairs: Giuseppe Citerio, Monza, Italy & Can Ince, Rotterdam, Netherlands
12:30 - 12:40
Introduction
12:40 - 13:05
Importance of NIRS Monitoring in ICU after cardiac surgery
Rudolf Keunen, The Hague, Netherlands
13:05 - 13:30
Monitoring oxygen delivery in high risk surgery: Evidence and new
possibilities?
13:30 - 13:55
Sedation Management in ICU with processed EEG technology
Rafael Manez, Barcelona, Spain
13:55 - 14:00
Questions and Conclusion
L I V E S 2 012
209
SPONSORED SESSIONS
ROOM GLASGOW
Chairs: Jean-François Timsit, Grenoble, France & Mervyn Singer, London, United Kingdom
12:30 - 12:40
Opening Remarks
12:40 - 13:00
The physiologic basis of haemodynamics treatment in sepsis and septic
shock
Walter Hasibeder, Ried Im Innkreis, Austria
13:00 - 13:20
Preclinical data suppporting betablockers rationale in sepsis
Alain Rudiger, Zurich, Switzerland
13:20 - 13:40
Betablocker use in septic patient: Experience of a single centre pilot
Andrea Morelli, Rome, Italy
13:40 - 13:50
Panel question session
13:50 - 14:00
Concluding comments
ROOM Stockholm Industry Sponsored Session
CHANCE OF SUCCESS IN NIV
OPTIMISING PATIENT-VENTILATOR INTERACTION AND
Chairs: Massimo Antonelli, Rome, Italy & Paolo Navalesi, Alessandria, Italy
12:30 - 13:00
An overview of NIV ventilation
Paolo Navalesi, Alessandria, Italy
13:00 - 13:30
13:30 - 14:00
NIV NAVA in the post-operative setting
Mathieu Raux, Paris, France
ROOM Paris
NEW AKI BIOMARKERS: A REVOLUTION IN RISK ASSESSMENT
Chairs: Eric Hoste, Ghent, Belgium & Claudio Ronco, Vicenza, Italy
MONDAY 15 OCTOBER
12:30 - 12:40
Introduction
12:40 - 13:20
New biomarkers: A revolution in risk assessment
13:20 - 14:00
Expert panel on AKI and Risk Assessment
Lakhmir Chawla, Washington, United States
ROOM Vienna Industry Sponsored Session OPTIFLOW™ - EXTENDING THE BOUNDARIES OF OXYGEN THERAPY:
LATEST TRIAL RESULTS AND EVOLVING CLINICAL EXPERIENCE
Chairs: John Laffey, Galway, Ireland & Salvatore Maggiore, Rome, Italy
210
12:30 - 13:00
Recent advances in nasal high flow with Optiflow™
Jean-Damien Ricard, Paris, France
13:00 - 13:30
population
Rachael Parke, Auckland, New Zealand
13:30 - 13:45
population
Shay McGuinness, Auckland, New Zealand
13:45 - 14:00
Optiflow™ during bronchoscopy
João Wink, Porto, Portugal
13-17 October 2012
L I V E S 2 012
Philips
12:30 - 12:50
Bundles of joy - reducing harm on the ICU
12:50 - 13:00
Discussion
13:00 - 13:20
Breaking walls - saving lives! The impact of MET-systems
13:20 - 13:30
Discussion
13:30 - 13:50
Keep it simple, keep it safe: Early recognition of patient deterioration
and impact on ICU performance
13:50 - 14:00
Discussion
Tamas Szakmany, Llantrisant, United Kingdom
Jens-Christian Schewe , Bonn, Germany
Chris Subbe , Wrexham, United Kingdom
ROOM Geneva Industry Sponsored Session MANAGEMENT OF INTRA-ABDOMINAL HYPERTENSION: DON’T
LET THE PRESSURE TAKE CONTROL - COVATEC
Chairs: Claudia Spies, Berlin, Germany & Ricardo Matos, Lisbon, Portugal
18:15 - 18:35
Definitions and epidemiology on abdominal hypertension and
abdominal compartment syndrome: Past, present and future
18:35 - 18:55
Clinical experience on management of intra-abdominal hypertension
18:55 - 19:15
Medical management of abdominal hypertension: What is new?
ROOM Stockholm
Industry Sponsored Session EFFECTIVE GLYCAEMIA CONTROL
Chairs: Michael Hiesmayr, Vienna, Austria & Jean-Charles Preiser, Brussels, Belgium
18:15 - 18:35
Glycaemia in ICU: State of the art
Björn Ellger, Munster, Germany
18:35 - 18:55
Patient-specific glycaemic control software in the ICU setting
Alexandre Guerrini, Saint Avertin, France
18:55 - 19:15
Computer-assisted glucose regulation in critically ill patients: A proof of
concept study
Pierre Kalfon, Chartres, France
ROOM Vienna Industry Sponsored Session
THERMO FISHER
GUIDING ANTIBIOTIC THERAPY TO TACKLE RESISTANCE FORMATION
Chairs: Jean Chastre, Paris, France & Tobias Welte, Hanover, Germany
18:15 - 18:20
Introduction - Status of antibiotic resistance in ICUs
18:20 - 18:45
Antibiotic resistance: From underlying mechanisms to the patients in
the ICU
Rafael Cantón, Madrid, Spain
18:45 - 19:10
Antibiotic guidance in the ICU
19:10 - 19:15
Summary of symposium
L I V E S 2 012
SPONSORED SESSIONS
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Athens
Chairs: Tamas Szakmany, Llantrisant, United Kingdom & Hans Flaatten, Bergen, Norway
211
SPONSORED SESSIONS
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
212
ROOM Berlin
Industry Sponsored Session HAEMODYMANIC MONITORING
Chairs: Maurizio Cecconi, London, United Kingdom & Jean-Louis Vincent, Brussels, Belgium
12:30 - 13:00
Haemodynamic optimisation: Is it cost-effective?
13:00 - 13:30
Integration of haemodynamic data at the bedside
13:30 - 14:00
ROOM Barcelona Industry Sponsored Session
STRATEGIES & BENEFIT
PICCO FOR HAEMODYNAMIC MONITORING: INDICATIONS,
Chairs: Jean-Louis Teboul, Kremlin-Bicetre, France & Javier Belda, Valencia, Spain
12:30 - 13:00
Benefit of early optimised critical care patient management with PiCCO
Daniel Reuter, Hamburg, Germany
13:00 - 13:30
Consequences of haemodynamic monitoring strategies in septic shock
patients
13:30 - 14:00
Solving therapeutic conflicts in ARDS - clinical case studies
ROOM Geneva
VOLUME MANAGEMENT IN TRAUMA, SURGERY, AND ICU
Chairs: Charles Sprung, Jerusalem, Israel & Hugo Van Aken, Munster, Germany
12:30 - 13:00
Volume management in trauma
William Lancelot Michell, Cape Town, South
Africa
13:00 - 13:30
Volume management in acute resuscitation
Richard Weiskopf, Tiburon, United States
13:30 - 14:00
Volume management in ICU
Martin Westphal, Munster, Germany
ROOM Rome
EMERGING THERAPEUTIC OPTIONS FOR THE ICU PATIENT
Chairs: Miguel Tavares, Leça da Palmeira, Portugal & Mervyn Singer, London, United Kingdom
12:30 - 13:00
Dexmedetomidine and levosimendan - new studies, novel insights
13:00 - 13:30
Sedation, immunomodulation and delirium
Robert Sanders, United Kingdom
13:30 - 14:00
Pharmacological strategies to improve weaning from mechanical
ventilation
ROOM GLASGOW Industry Sponsored Session
we ensure optimal outcomes
MRSA nosocomial pneumonia today: how can
Chairs: Jean-François Timsit, Grenoble, France & Tobias Welte , Hanover, Germany
12:30 - 12:35
12:35 - 13:00
How do I ensure appropriate therapy for my patients with MRSA
nosocomial pneumonia?
Alexander Soriano, Barcelona, Spain
13:00 - 13:25
How can I avoid the pitfalls of MRSA VAP diagnosis and treatment
13:25 - 13:50
What do the MSRA nosocomial pneumonia guidelines mean for me?
13:50 - 14:00
Q&A
13-17 October 2012
L I V E S 2 012
ON THE WAY TO PERFECT SYNCHRONY
12:30 - 13:00
Diaphragm dysfunction at ICU (VIDD) - clinical implications
Samir Jaber, Montpellier, France
13:00 - 13:30
PAV+ - what European experts think about it
Jean-Christophe Richard, Geneva, Switzerland
13:30 - 14:00
Patient ventilator synchrony - intensivists daily nightmare? Case
presentation and interactive discussion
ROOM Paris
CO2 REDUCTION, SOMETHING WE SHOULD CARE ABOUT!
Chairs: Antonio Pesenti, Monza, Italy & Alain Combes, Paris, France
12:30 - 13:00
How much CO2 is too much CO2?
Wolfram Windisch, Cologne, Germany
13:00 - 13:30
CO2 Removal in early ARDS, a paradigm change?
13:30 - 14:00
CO2 Removal, the fast line in the emergency room?
Roberto Roncon de Albuquerque, Porto,
Portugal
L I V E S 2 012
SPONSORED SESSIONS
TUESDAY 16 OCTOBER
MONDAY 15 OCTOBER
SUNDAY 14 OCTOBER
saturday 13 OCTOBER
ROOM Stockholm
Chairs: Massimo Antonelli, Rome, Italy & Laurent Brochard, Geneva, Switzerland
213
O
T
T
O
N
!
S
IS
M
Highlights of the Congress
Level 0
WI-FI CAFÉS
POSTER CORNERS
Exhibition Areas (A & B)
Exhibition Area A & B
and on Level 1 and in
the LIFE-PRIORTY Area
Looking for a Wi-Fi access? Then go down to
the Exhibition Area, where you can sit down,
relax and have a coffee while using our
connection!
Berlin
Exhibition Area A
Between 10:10 until 12:00 and 14:00
until 15:50, abstract presenters will
discuss their data in Poster Corner
sessions moderated by world-class
experts. Presenters will be allowed
a 4-minutes presentation followed
by a 3-minutes time window for
comments and discussion by the
audience and the chairpersons.
Exhibition Area B
Main Entrance
LIFE-PRIORITY Connecting Area
INTERACTION
in front of the Congress Centre
Come live all the stages of the “Wheels of Life” tour in
the 3D TECHNO TENT of LIFE-PRIORITY!
An amazing tour and thousands of lives saved!
in Rooms Athens, Berlin, Rome
O
T
T
O
N
!
S
IS
M
Highlights of the Congress
Level 1
REPLAY THEATRE
OVERFLOW AREAS
In front of Room Athens,
in front of Room Rome
and on Level 2
Exhibition Area A (on the Gallery)
Start by checking out the programme of the Replay
Theatre. Then take the opportunity to watch lectures,
which have recently been given, on a large screen
with high-fidelity audio.
Replay Theatre powered by CYIM
In the interest of allowing optimal
access for all sessions, we offer overflow
spaces. When session in Rooms Paris &
Athens are full, we transmit audio/video
from these session Rooms in front of
Room Athens. The same process applies
for Rooms Rome & Berlin in front of
Room Rome and for Rooms Vienna &
Barcelona on Level 2.
e-POSTERS
Exhibition Area A
(on the Gallery)
Look into posters of your
choice or let the “most viewed”
statistics direct you to the hot
topics of the Congress. Post
comments, ask questions on
the data presented, and engage
in scientific communication
with authors through a userfriendly interface.
Rome
Level
2
Exhibition
Area A
Athens
Main Foyer
Visit the ESICM Members Lounge!
Relax, refresh and network with other members.
Special Highlight: Watch LIVE broadcasts in the
iPad Bar.
INTERACTION
in Rooms Athens, Berlin, Rome
exhibition list & guide
LIST OF EXHIBITORS
COMPANY
Area
Booth
A/B
N°
COMPANY
Area
Booth
A/B
N°
ALERE
B
48
IMDSOFT
A
1
ALUNG TECHNOLOGIES
A
40
INTEGRA
B
53
ASTELLAS FARMA
B
65
INTENSIVE CARE MONITOR
B
63
ASTUTE MEDICAL
A
19
INTENSIVE CARE SOCIETY
B
56
B. BRAUN MELSUNGEN
A
14
INTERSURGICAL
A
27
BARD
A
9
ISICEM
B
62
BAXTER HEALTHCARE
A
7
KARL STORZ
A
6
BELLCO
A
39
KIMAL
A
44
BIOTEST
B
57
KIMBERLY-CLARK HEALTH CARE
A
29
BRAEDIUS MEDICAL
B
67
LIDCO
A
33
CNSYSTEMS MEDIZINTECHNIK
A
34
LINET GROUP
A
21
CODMAN - JOHNSON&JOHNSON
B
58
MAQUET
A
30
CONVATEC
A
4
MEDTRONIC
A
35
COOK MEDICAL
A
38
MITSUBISHI PHARMA EUROPE
B
64
COVIDIEN
A
28
NESTLÉ HEALTH SCIENCE
A
12
CYTOSORBENTS EUROPE
A
43
NIHON KOHDEN EUROPE
A
22
DRAEGERWERK
A
18
NOVALUNG
B
51
EDWARDS LIFESCIENCES
A
11
ORION PHARMA
A
10
ESA
B
61
PHILIPS MEDICAL SYSTEMS
B
54
ESICM
A
5
PULSION MEDICAL SYSTEMS
A
15
ESTOR
A
36
SCCM
B
59
FISHER & PAYKEL HEALTHCARE
A
24
SIEMENS
A
45
FRESENIUS KABI DEUTSCHLAND
A
17
SPRINGER
B
52
FRESENIUS MEDICAL CARE
A
31
STARMED
A
26
GAMBRO LUNDIA
A
16
SWISSTOM
B
47
GE HEALTHCARE
A
13
TELEFLEX
A
3
GLYCOCHECK
A
32
TERUMO EUROPE
A
42
HAMILTON MEDICAL
A
23
THE JAMA NETWORK
B
49
HILL-ROM
B
55
THERMO FISHER SCIENTIFIC
A
25
HOLLISTER
A
20
TORAY MEDICAL
A
37
HOSPITECH RESPIRATION
A
41
WFSICCM CONGRESS
B
60
ICU MANAGEMENT
B
66
WISEPRESS MEDICAL BOOKSHOP
B
46
IMACOR
A
8
ZOLL MEDICAL
B
50
MAP EXHIBITION
LEVEL 0
Level 0
Exhibitor Booth
Poster Corner
Exhibitor Booth
Poster Corner
Catering
Catering
Exhibitor Helpdesk
25
24
27 26
45
Lounge Area
Faro
23
22
20 21
19
9
8
Fatima
First Aid
Evora First Aid
44
7
63 62 61
43
28 Area B18
6
10
Exhibition
Exhibition
Area
A
42
34
33
32
Cascais54
15
55
59 60
11
58
Guarda
Geneva
Coimbra
64
30
65
66
67
14
Beja
31
L I V E S 2 012
12
IM1
3
IM5
IM450
49
48
46 47
51
52 53
54
57
56
Funchal
IM2
Guarda
59 60
IM4
Geneva
55
Braga
4
61
IM3
35
58
17
57
56
16
29
51
Estoril
52 53
62
IM5 Exhibition Area B
IM3
41
40
50
39
49
48
46 47
38
37
36
63
Catering Area
Catering Area
ESICM Booth
Catering Area
Map - Exhibition
ion
Funchal
64
65
66
67
IM1
IM2
2
13
1
217
GUIDE TO EXHIBITION
BoothArea Name
It is the exhibitor’s responsability to submit a description with no errors in
grammar and spelling.
BoothArea Name
48BALERE ALERE primary areas of focus are cardiology, infectious disease, women’s
health, oncology and toxicology. We see several opportunities to
develop innovative health management programs in these areas,
supported by advanced diagnostic and monitoring tools, that will
help people look after themselves better. We also expect to acquire
technologies and products that, over time, will allow for our expansion
into new medical issues, but our efforts will continue to be focused on
enabling individuals to take charge of their health at home.
ARD pioneered the development of single-patient-use medical
products for hospital procedures; today BARD is dedicated to pursuing
technological innovations that offer superior clinical benefits while
helping to reduce overall costs.
40AALUNG TECHNOLOGIES
BARD’s core values of Quality, Integrity, Service, and Innovation
represent our reality and our aspirations. These four values prepare
us for the challenges ahead and guide our everyday activities and
align us to our mission. They are central to how we behave and want
to be viewed by our fellow co-workers, customers, shareholders and
communities.
ALung Technologies has developed the Hemolung Respiratory Assist
System (RAS), a dialysis-like alternative or supplement to mechanical
ventilation. The Hemolung RAS provides Respiratory DialysisTM, a
simple, less invasive form of extracorporeal CO2 removal. By removing
carbon dioxide and delivering oxygen directly to the blood, the
Hemolung RAS allows the patient’s lungs to rest and heal. Applications
of the device include preventing intubation in acute exacerbation of
chronic obstructive pulmonary disease (COPD) and enabling ultraprotective ventilation in acute respiratory distress syndrome (ARDS).
Baxter International Inc., through its subsidiaries, develops,
manufactures and markets products that save and sustain the lives of
people with hemophilia, immune disorders, infectious diseases, kidney
disease, trauma and other chronic and acute medical conditions. As
a global, diversified healthcare company, Baxter applies a unique
combination of expertise in medical devices, pharmaceuticals and
biotechnology to create products that advance patient care worldwide.
65 BASTELLAS FARMA
39ABELLCO
Astellas is one of the leading pharmaceutical companies in the world.
As a young, forward thinking company with a rich heritage, Astellas
is dedicated to improving peoples’ lives through the introduction of
innovative and reliable pharmaceutical products. In everything we
do we are guided by our ethos of CHANGING TOMORROW to create a
brighter future for all our stakeholders - above all for patients.
In Europe, Astellas’ strategic focus and core expertise lie in the therapy
areas of Transplantation, Urology, Dermatology, Anti-Infective and Pain
Management. In addition, Astellas is committed to growing a strong
presence in the field of Oncology.
Bellco. The right therapy way
19AASTUTE MEDICAL
Astute Medical is committed to improving patient outcomes
through the identification and validation of unique biomarkers. Our
measurement methods help rapidly assess high-risk acute conditions
and diseases. By incorporating useful clinical tools, we help healthcare
professionals provide rapid, accurate and life-saving responses.
14AB. BRAUN MELSUNGEN
New Concepts for safer Infusion Therapy and Acute Dialysis
B. Braun, a globally operating family owned company with more
than 43,000 employees. With innovative & state-of-the-art products
focused on clinical safety, B. Braun leads the changing demands in
health care around the world.
218
9ABARD
C. R. Bard, Inc. is a leading multinational developer, manufacturer, and
marketer of innovative, life-enhancing medical technologies in the
product fields of: Vascular, Urology, Oncology and Surgical Speciality.
13-17 October 2012
7ABAXTER HEALTHCARE
Bellco offers worldwide therapeutic systems for blood purification in
Dialysis, Intensive Care and Cardiology. Bellco focus is on personalised
treatments. Customised therapeutic options are common to the
three new devices: AMPLYA (Acute); FLEXYA (Chronic); CARPE DIEM
(Neonatal).
Bellco stands out for the Collaborative Research with the goal of
sharing innovation with the medical-scientific community. Upon
these premises, Bellco provides its contribution to the Collaborative
Research Club.
Complex clinical conditions, such as those of patients in Intensive Care,
require a really integrated approach. The Bellco’s all-embracing offer
provides a completely new outlook on acute patients.
57BBIOTEST
Biotest is a developing pharmaceutical and biotherapeutic company,
with headquarters in Germany, which specialises in the areas of
immunology and haematology. Biotest produces plasmaproteins
which are used in the treatment of diseases of the immune and
haematopoietic systems and has a worldwide distribution network.
As the global market leader in hyperimmunoglobulins and the
exclusive manufacturer of an IgM-enriched immunoglobulin, Biotest
considers itself as a provider of special solutions for the prevention
and therapy of life-treatment of haemophilia A and B. Currently our
research is focussed on a number of monoclonal antibodies which will
have a place in the treatment of various autoimmune diseases. Biotest
employs more than 1,600 people worldwide.
L I V E S 2 012
BoothArea Name
34A
BoothArea Name
CNSYSTEMS MEDIZINTECHNIK CNSystems is technology leader in the development of non-invasive
medical devices designed for real-time evaluation of all medical
conditions characterised by rapid and short-term changes in
haemodynamics.
With its CNAP® Monitor 500, the company succeeded in revolutionizing
the method of non-invasive continuous blood pressure monitoring
in Anaesthesiology and perioperative care. CNAP® PPV is CNSystems’
latest non-invasive development and provides essential information
on the fluid status of the patient for an even better haemodynamic
optimization during surgery.
58B
CODMAN - JOHNSON&JOHNSON
43A
CYTOSORBENTS EUROPE
CytoSorbents Corp., USA,is a therapeutic device company using blood
purification to modulate the immune system and fight multi-organ
failure in life-threatening illnesses. Its purification technology is based
on biocompatible, highly porous polymer beads that can actively
remove toxic substances from blood by pore capture and adsorption.
In 2011, CytoSorb® achieved CE approval as an extracorporeal cytokine
filter, and can now be sold under the CE Mark to be used in clinical
situations where cytokines are elevated. The goal of CytoSorb® is to
modulate the immune system by reducing “cytokine storm” in critically
ill patients that could otherwise lead to deadly inflammation, multiple
organ failure, immune dysfunction, and often death in sepsis, trauma,
burn injury, ARDS, pancreatitis and other SIRSyndromes.
Our Mission: To deliver life-saving neuro solutions and support you can
count on
18A
Codman, a division of Johnson & Johnson, is a global neuroscience
company that develops and markets a wide range of devices and
solutions for the diagnosis and treatment of neurological disorders
including:
· critical care,
· trauma and tumour,
· adult and paeditatric hydrocephalus,
· pain & spasticity,
· aneurysms and acute ischemic stroke.
Draeger. Technology for Life®
The Draegerwerk AG & Co. KGaA is an international leader in the fields
of medical and safety technology. Draeger products protect, support
and save lives. The current product range of the medical division
includes anaesthesia workstations, ventilators for emergency and
critical care as well as warming therapy for premature infants. Patient
monitoring, IT solutions, accessories and consumables, ceiling supply
units, light systems and central supply systems for medical gases
complete the portfolio. The Draeger Group is currently present in
more than 190 countries and has about 11,000 employees worldwide.
www.draeger.com
The company’s leading solutions include programmable as well as
fixed pressure shunt systems, antimicrobial impregnated catheters,
intra-cranial pressure monitoring devices, electro-surgery and cranial
closure products, drug pumps, interventional neurovascular coils,
catheters, vascular reconstruction and thrombectomy devices.
4A
CONVATEC
ConvaTec is a leading developer of innovative medical technologies
that have helped improve the lives of millions of people worldwide. In
Ostomy Care, Wound Therapeutics, Continence and Critical Care, and
Infusion Devices - ConvaTec products support health care professionals
from hospital to community health settings.
38A
COOK MEDICAL
A global pioneer in medical breakthroughs, Cook Medical is committed
to creating effective solutions that benefit millions of patients
worldwide. Today, we combine medical devices, drugs, biologic grafts
and cell therapies across more than 16,000 products serving more
than 40 medical specialties. Cook manufactures the Dolphin BT Ciaglia
Balloon-Assisted Tracheostomy Introducer, the Tiger 2Self-Advancing
Nasal Jejunal Feeding Tube and Spectrum® Minocycline/Rifampin
catheters. We look forward to meeting you at ESICM 2012.
28A
COVIDIEN
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence.
Covidien manufactures, distributes and services a diverse range of
industry-leading product lines in three segments: Medical Devices,
Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6
billion, Covidien has 41,000 employees worldwide in more than 65
countries, and its products are sold in over 140 countries.
L I V E S 2 012
DRAEGERWERK
11AEDWARDS LIFESCIENCES
At Edwards Lifesciences, we strive to provide you with the valuable
information you need for tailored perioperative optimization and
haemodynamic management of the ICU patient. From the very first
Swan-Ganz pulmonary artery catheter to the FloTrac sensor and
PediaSat oximetry catheter, to the latest VolumeView set and EV1000
clinical platform, our goal remains the same.. to provide you with the
choice in how you manage the haemodynamics of your critically ill
population.
61BEUROPEAN SOCIETY OF ANAESTHESIOLOGY (ESA)
5AEUROPEAN SOCIETY OF INTENSIVE CARE
MEDICINE (ESICM)
The European Society of Intensive Care Medicine (ESICM) is an
international non profit-making association of doctors, nurses,
physiotherapists and other allied healthcare professionals. The Society,
which has over 6,000 active members, is devoted to the promotion
of intensive care medicine, the advancement of scientific research,
as well as the provision of educational courses and professional
development in the field. More information about ESICM’s objectives
and activities (including Membership, EDIC, PACT, Educational Courses
and ongoing Research and Scientific studies / projects) is available at
the ESICM booth. All ESICM members are also welcome to visit the
ESICM Members Lounge: An exclusive meeting place reserved for
ESICM members to network, refresh and relax.
219
BoothArea Name
BoothArea Name
36AESTOR
13AGE HEALTHCARE
Estor S.p.A. is a medical device company specialised in the promotion
and sales of high-quality biomedical devices in the fields of
haemodialysis, ICU and haemodynamics.
GE Healthcare provides transformational medical technologies
and services that are shaping a new age of patient care. Our broad
expertise in medical imaging and information technologies,
medical diagnostics, patient monitoring systems, drug discovery,
biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers
to deliver better care to more people around the world at a lower cost.
In addition, we partner with healthcare leaders, striving to leverage
the global policy change necessary to implement a successful shift to
sustainable healthcare systems.
Estor S.p.A. is committed in enhancing the quality of life giving its
contribution to the clinical research in the perspective of reaching the
correct scientific and marketing positioning of the whole assortment.
Estor S.p.A. was created in 1999 with the aim to expand the offer of the
medical Supply department of Hoechst, from which it is born through
a spin-off.
ESTOR S.p.A. created ProLUNG®, an innovative extracorporeal CO2
removal system concerned for patients with acute respiratory failure.
24A
FISHER & PAYKEL HEALTHCARE
Fisher & Paykel Healthcare has been specialised in respiratory
humidification for 40 years. Based in New-Zealand, our company
develops and produces innovative solutions for both hospital care
and homecare: heated humidifiers and single use patient kits and
interfaces for respiratory therapies, from invasive ventilation to oxygen
therapy. One of our last innovations consists in the new respiratory
support system Optiflow. Optiflow is a simply better oxygen therapy
17A
FRESENIUS KABI DEUTSCHLAND
Fresenius Kabi is dedicated to the therapy and care of critically and
chronically ill patients inside and outside the hospital by providing
intravenously administered drugs, infusion therapies, clinical nutrition
and related medical devices.
The company applies its long-standing expertise in pharmaceuticals
and medical devices to support clinical staff and care professionals in
the best therapy of patients. For more information about Fresenius
Kabi, visit the company’s website at www.fresenius-kabi.com.
31A
FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world’s largest integrated provider of
products and services for individuals undergoing dialysis because of
kidney failure, a condition that affects more than 2.1 million individuals
worldwide. The company also provides a wide range of products for
hemodialysis and peritoneal dialysis such as hemodialysis machines,
dialyzers and related disposable products. With innovative dialysis
products and therapies we define highest standards for the treatment
of the patients.
16AGAMBRO LUNDIA
Gambro is a global medical technology company and a leader in
developing, manufacturing and supplying products and therapies
for Kidney and Liver dialysis, Myeloma Kidney Therapy, and other
extracorporeal therapies for Chronic and Acute patients.
For decades, Gambro has been first to market with many
groundbreaking innovations. By designing and delivering solutions
to dialysis clinics and intensive care units, Gambro offers not just
improved treatment quality, but also improved efficiency.
Gambro was founded in 1964 and has today 7 500 employees,
13 production facilities in 9 countries, and sales in more than 100
countries.
220
13-17 October 2012
For more information about GE Healthcare, visit our website at http://
www.gehealthcare.com.
32AGLYCOCHECK
GlycoCheck is a leading provider of imaging solutions based on an
innovative measurement system of the Glycocalyx layer. GlycoCheck
solutions facilitate the accurate, reliable and non-invasive selection,
detection & monitoring of patients in intensive care, cardiology and
internal medicine.
GlycoCheck ICU is an innovative software solution that measures this
Glycocalyx layer accurately, in real time. The measurement itself is
performed non-invasively with a camera device that is placed under
the patient’s tongue.
What does that mean for you?
•You will be able to assess microcirculation more accurately as well as a
patient’s response to current and new treatments
•You can perform the measurements non-invasively
•GlycoCheck ICU provides you with a unique parameter to monitor a
patient’s well-being over time
23AHAMILTON MEDICAL
HAMILTON MEDICAL was born from a passion to improve the
lives of ventilated patients and the people who care from them.
HAMILTON MEDICAL began 1983 with a new generation of intelligent
microprocessor controlled intensive care ventilators featuring
revolutionary new modes and diagnostic tools.
Today HAMILTON MEDICAL maintains this tradition with the world’s
finest ICU ventilation technologies and a total dedication to Intelligent
Ventilation by offering a full range of ventilation solutions, from clinical
to mobile ICU.
Intelligent Ventilation respiratory care solutions from HAMILTON
MEDICAL deliver a unique combination of: ease of use, improved
patient outcome and efficiency through innovation resulting into
World’s first full closed loop ventilation INTELLiVENT-ASV.
55BHILL-ROM
Hill-Rom® is a leading worldwide manufacturer and provider of
medical technologies and related services for the health care industry,
including patient support systems, safe mobility and handling
solutions, non-invasive therapeutic products for a variety of acute
and chronic medical conditions, medical equipment rentals, and
information technology solutions. Hill-Rom’s comprehensive product
and service offerings are used by health care providers across the
health care continuum and around the world in hospitals, extended
care facilities and home care settings to enhance the safety and quality
of patient care.
L I V E S 2 012
BoothArea Name
BoothArea Name
20AHOLLISTER
1AIMDSOFT
Hollister Incorporated is recognised for its innovation in the
manufacture of quality Critical Care, Ostomy, Continence Care, and
Wound Care products in over 90 countries.
iMDsoft is a leading provider of Clinical Information Systems for critical,
perioperative, and acute care environments. The company’s flagship
family of solutions, the MetaVision Suite, was first implemented in 1999.
It captures, documents, analyzes, reports and stores the vast amount
of patient-related data generated in a hospital. iMDsoft products
demonstrate a 100% customer retention rate. Hospitals worldwide including 4 of the top 10 US hospitals and 13 of the top 50 European
hospitals - use MetaVision to improve care quality, enhance financial
results, support research and promote compliance with government,
payor, and hospital protocols.
Hollister Critical Care partners with healthcare providers to help
optimise patient care and reduce costs related to skin health and
infection control. The AnchorFast® Oral Endotracheal Tube Fastener is
designed to help prevent the formation of lip ulcers and optimise oral
care. The InstaFlo® Bowel Catheter System is designed to be easy to
use, and to help minimise the need for clinician intervention.
In every line of our company’s products, our overriding goal and
commitment is to make a difference in the journey of life.
41AHOSPITECH RESPIRATION
HOSPITECH RESPIRATION focuses on developing a platform
technology and products aiming at improving the mechanical
ventilation procedure and reducing the rate of mechanical ventilation
complications.
The ANAPNOGUARD technology by Hospitech provides continuous,
closed-loop control of air leakage and optimization of the ET tube’s
cuff pressure. The control is based on CO2 monitoring above the cuff,
where high CO2 level above the cuff indicates a leak. It also provides
automated, effective evacuation of secretions from above the cuff.
The device and ET tubes are CE cleared & the tubes are FDA cleared.
1st pilot clinical study has been successfully completed in Europe, a
2nd study is ongoing and a multi centre study is planned for end of
2011 through 2012. Initial sales in Europe are expected to start in 2012.
66BICU MANAGEMENT
ICU Management is the Official Management and Practice Journal
of the International Symposium on Intensive Care and Emergency
Medicine (ISICEM) and is working in close collaboration with the
most important international associations and congresses. Based
on the most recent clinical developments, the journal focuses on
best practice, efficiency, better value-for-money investments, cost
savings, ethics, optimal patient and staff satisfaction. Produced four
times per year under the stewardship of Prof. Jean-Louis Vincent and
international editorial board, the journal has become the point of
reference in the increasingly sophisticated area of critical care and
emergency medicine.
8AIMACOR
ImaCor, an innovator in critical care solutions, has developed the
first and only haemodynamic transesophageal echocardiography
(hTEE™) device designed for management of haemodynamically
unstable patients. ImaCor’s hTEE is the only technology which
provides direct visualization and is continuously available to optimise
cardiac performance for advanced patient care and decreased
overall cost. Designed with perioperative specialists in mind, hTEE
facilitates superior utilization of hospital resources and complies with
performance-based measures of effectiveness in critical care. hTEE
has rapidly become the foremost haemodynamic assessment and
management tool by clinicians at leading hospitals around the world.
53BINTEGRA
Integra develops, manufactures and markets implants and surgical
instruments used in neurosurgery, spine surgery, reconstructive
surgery, orthopaedic surgery and general surgery. Integra was
founded in 1989, as the result of innovation in the first artificial
dermal regeneration matrix composed of collagen. From this initial
technological achievement, Integra went on to develop the first dural
regeneration matrix, a pioneer step into the domain of neurosurgery
which established Integra one of the key player in this field. With
leading products and brands in Neurosurgery and Neuro Critical Care,
(Mayfield®, Cusa Excel®, DuraGen®, OSVII®, Licox®, Camino®, Accudrain®,
Radionics®), Integra is one of the professional’s preferred partner.
63BINTENSIVE CARE MONITOR
Intensive Care Monitor is an evidence-based, current awareness journal
for the busy intensivist. Each issue has specially written, extended
abstracts of original papers which impact on critical care, mainly RCTs,
meta-analyses and systematic reviews. Papers are graded for evidence
level, with an expert comment from a leading international specialist,
summed up by a ‘bottom line’. Symbols denote papers of special
interest, such as ‘hot topic’, bright idea’ et. Every issue carries selfassessment questions, making it ideal for Journal Clubs. Now in its 19th
year, ICM is available six times a year in either a printed or e-version or a
combination of both. An index is published for each year. Subscriptions
can be taken out or renewed using our website. The journal is a must
for the clinician who wants to be better informed.
56BINTENSIVE CARE SOCIETY
The Intensive Care Society is the oldest intensive care society in the
world with a growing membership of around 3000 members. It is the
UK representative body for intensive care professionals, patients and
relatives. The Society is dedicated to the delivery of the highest quality
of critical care to patients in the UK and support and education to its
members.
27AINTERSURGICAL
Intersurgical manufacture & supply a complete range of respiratory care
products for use in Intensive Care & Emergency areas. The Intersurgical
product range covers all respiratory requirements from the patient
connection through to the equipment offering the complete solution
to your needs.
- A complete range of breathing systems for adults, paediatrics and
neonatesavailable in Smoothbore, Flextube and Compact tube
- Active humidification systems
- Patient connections
- Resuscitation systems
- Breathing Filters & Heat & Moisture Exchangers
- Oxygen & Aerosol Therapy Products
- A new range of CPAP Breathing Sytems & C-PEEP value valves
The Intersurgical range for Quality, Innovation & Choice.
L I V E S 2 012
221
BoothArea Name
BoothArea Name
62BINTERNATIONAL SYMPOSIUM ON
INTENSIVE CARE AND EMERGENCY MEDICINE (ISICEM )
LiDCO develops manufactures and markets medical devices primarily
for Critical Care and Anaesthesia patients.
The objective of this four day symposium is to review concepts and
technology and present recent advances in the management of the
critically ill patients.
The symposium includes formal presentations as well as practical
discussions such as tutorials, round tables, pro-con debates, “meet the
experts”, etc.
Original scientific posters will also be presented.
The meeting is open to all physicians, nurses and other allied health
professionals interested in intensive care and emergency medicine.
Language: English
6AKARL STORZ
KARL STORZ is a renowned manufacturer that is well established in
all fields of endoscopy and can be considered as market leader in
rigid endoscopy. The still family held company was founded in 1945
in Tuttlingen, Germany, and has grown to one with a worldwide
presence and 5800 employees. KARL STORZ offers a range of both
rigid and flexible endoscopes for a broad variety of applications.
Today’s product range also includes fully integrated concepts for the
OR and servicing.
44AKIMAL
KIMAL is a leading supplier of medical products in over 70 countries
worldwide. At ESICM we are launching our revolutionary ranges
of ALTIUS and ALTIUS Ultra Central Venous Catheters. These offer
unparalleled flexibility - higher flow rates with no increase in size or
CT capability. Our Ultra range is designed to guarantee contrast media
delivery at 10ml/sec under 300 psi. All sets come complete with the
Altius Guidewire Introducer for both adult and paediatric guidewires there is no easier or smoother introducer available. We offer sets with
a choice of guidewires made of stainless steel or Nitinol. We invite
you to see how we are moving Central Venous Catheters into the 21st
Century!
29AKIMBERLY-CLARK HEALTH CARE
Kimberly-Clark understands the complex issues you face to prevent,
diagnose and manage VAP. We are committed to help you protect
your patients from VAP, by providing effective clinical solutions to
address the risk factors:
-
Keeping the ventilator circuit closed
Promoting comprehensive & routine oral care
Lowering the risk of micro-aspiration of secretions past the ETT cuff
Facilitating a distal airway sample for the diagnosis of VAP
Kimberly-Clark* KimVent* VAP Solutions: a wide range of innovative
products & solutions, clinical education, in-service training, web-based
resources & compliance programs - all designed to help you provide
consistent & comprehensive care for your patients.
33A
LIDCO
The LiDCOplus™ monitor provides a range of haemodynamic
parameters including beat to beat cardiac output (CO), oxygen delivery
(DO2), stroke volume (SV), systemic vascular (SVR), blood pressure
(BP) and dynamic preload parameters (PPV and SVV). LiDCO also
offers the LiDCOrapid™ Haemodynamic Monitor which is designed to
facilitate fast and effective fluid management across the perioperative
environment.
LiDCO’s validated technology has been shown to reduce complications
by 40% and length of stay by an average of 12 days for high risk surgical
patients (Pearse et al Critical Care).
21A
LINET GROUP
LINET Group is a leading manufacturer and worldwide distributor
of a diverse portfolio of hospital and nursing care beds, mattresses,
furniture and complete service solutions to hospitals, nursing and
retirement homes. With a yearly production of more than 66,000
beds and sales in over 100 countries, Group belongs to leaders on the
European market. The company’s long-standing success is above all
based on its innovations, which help define the standard of quality in
modern medical care.
LINET Multicare bed for ICU & CCU ward is equipped with several
unique features and functions. It aids in the prevention of pulmonary
complications in long term immobile patients, and facilitates many
therapeutic and diagnostic procedures. It eases physically demanding
procedures, saving time and reducing caregiver workload.
30AMAQUET
MAQUET is a global leader in medical systems; surgical interventions,
cardiovascular procedures and critical care. MAQUET develops and
designs innovative products and therapeutic applications for OR,
hybrid OR/cath lab, ICU and patient transport within acute care
hospitals.
MAQUET offers CARDIOHELP as the main ICU product, used as a
platform for several disposables: HLS for veno-venous membrane
oxygenation and veno-arterial heart lung support; PALP (pump
assisted lung protection) for CO2 removal.
The Critical Care portfolio includes market-leading intensive care
ventilators SERVO-i® and anaesthesia solutions FLOW-i®.
MAQUET also equips Surgical Workplaces flexible room design for OR
and ICU.
www.maquet.com
MAQUET - The Gold Standard.
35AMEDTRONIC
Medtronic is the global leader in medical technology- alleviating pain,
restoring health, and extending life for millions of people around the
world. Medtronic develops and manufactures a wide range of products
and therapies with emphasis on providing a complete continuum of
care to diagnose, prevent and monitor chronic conditions. Every five
seconds, somewhere in the world, a person’s life is saved or improved
by a Medtronic product or therapy.
Medtronic Hospital Critical Care develops and manufactures
subcutaneous continuous glucose monitoring technology. By
utilizing 10 years of glucose management expertise and engineering
technology focused on the critical care patient, the business is well
placed to distinguish itself as a global leader in glucose management
within the hospital setting.
222
13-17 October 2012
L I V E S 2 012
BoothArea Name
BoothArea Name
64BMITSUBISHI PHARMA EUROPE
54BPHILIPS MEDICAL SYSTEMS
Mitsubishi Pharma Europe is the European Headquarters of one of
Japan’s largest pharmaceutical companies, Mitsubishi Tanabe Pharma
Corporation.
Philips is one of the world’s leading technology companies, with a long
history of practical innovation and visionary design. In healthcare, we
are committed to understanding the human and technological needs
of patients and caregivers. We believe this understanding will help us
deliver solutions that not only enable more confident diagnoses and
more efficient delivery of care, but also improve the overall experience
of care. We offer equipment, software, and services for imaging,
patient monitoring, resuscitation and much more. People focused.
Healthcare simplified.
Based in London, Mitsubishi Pharma Europe is engaged in the clinical
development of new drugs for the European markets. Mitsubishi
Pharma Europe is conducting trials in Europe in the following
therapy areas; cardiovascular, diabetes and renal conditions. The staff
include regulatory, QA, clinical, biostatistics, medical information,
pharmacovigilance, pharmaceutical technology and marketing.
12ANESTLÉ HEALTH SCIENCE
Nestlé Health Science makes a positive difference to the nutritional
health, well-being and quality of life of people through innovative,
medically recognised nutritional solutions. Our solutions help optimise
the nutritional intake of people who aim to combat disease, recover or
stay healthy. Our range addresses various nutritional needs and related
services including patient and healthcare professional education and
training. Innovations are developed with Nestlé Institute of Health
Sciences and the Nestlé R&D network. The Institute enables a deeper
understanding of interactions between chronic disease, lifestyle
and nutrition, which enables Nestlé Health Science to develop new
products.
22ANIHON KOHDEN EUROPE
NIHON KOHDEN is one of Japan’s leading players in medical
technology development and manufacturing, and has subsidiaries
and representative offices in Europe, the US, and the Middle and Far
East.
“Fighting Disease with Electronics” - our corporate philosophy - reflects
the high standards we have set ourselves in combating disease by
developing medical systems, contributing to higher quality of life for
patients. Our product range focuses on patient monitoring, cardiology
(ECG equipment and defibrillators) as well as neurology (EEG, EMG and
EP). NIHON KOHDEN electronic medical equipment is known for its
high quality, ease of use and safe, secure handling.
51BNOVALUNG
“Solutions for Lung Failure”: Novalung’s mission is to create new
solutions for the treatment of lung failure with innovative artificial
lungs that “breathe” outside the patient’s body. Imagine a world in
which many patients in the Intensive Care Unit are not placed in an
artificial coma so that they can tolerate mechanical ventilation, but
rather experience their treatment while awake and breathing easily and
spontaneously. Patients who can communicate, eat and drink. This can
become reality when an iLA® therapy is used to support the breathing
process. The new allrounder for lung failure, iLA activve®, covers the
full range of respiratory support: from highly effective carbon dioxide
elimination to complete oxygenation.
10AORION PHARMA
Orion is an innovative European R&D-based pharmaceuticals and
diagnostics company with an emphasis on developing medicinal
treatments and diagnostic tests for global markets.
Orion Pharma’s critical care product portfolio includes two own
proprietary molecules, the cardioprotective inodilator levosimendan
(Simdax®) for treatment of acute heart failure, and the alpha2-agonist
dexmedetomidine (Dexdor®) for sedation of patients in intensive care
units.
L I V E S 2 012
15APULSION MEDICAL SYSTEMS
Founded more than 20 years ago in Munich Pulsion has become a
leading specialist in haemodynamic monitoring since many years and
provides the clinician with a variety of technologies to optimise the
haemodynamic management of patients on ICU and in the OR:
· Transpulmonary thermodilution technique for cardiac output,
preload and lung water measurements (PiCCO)
· Fiberoptic continuous measurement of the central venous oxygen
saturation via standard CVC (CeVOX)
· Non-invasive evaluation of the liver function and the splanchnic
perfusion with indocyanine green dye (LiMON)
· Non-calibrated CO Trend measurement via standard arterial line
(ProAQT)
· Monitoring platform with a modular concept enables patient centred
flexibility (PulsioFlex)
45ASIEMENS
Siemens Healthcare Diagnostics is the leading clinical diagnostics
company in the world. We are committed to providing clinicians with
the vital information they need for the accurate diagnosis, treatment
and monitoring of patients.
Our comprehensive portfolio of performance-driven systems,
unmatched menu offering and IT solutions, in conjunction with highly
responsive service, is designed to streamline workflow, enhance
operational efficiency and support improved patient care.
The depth and breadth of our diagnostic solutions chemistry,
immunoassay, automation, hematology, hemostasis, microbiology,
diabetes, urinalysis, blood gas and molecular testing are designed to
meet the growing demands of our customers, today and tomorrow.
59BSOCIETY OF CRITICAL CARE MEDICINE
(SCCM)
The Society of Critical Care Medicine is the only multiprofessional,
international organization devoted to securing the highest quality care
for all critically ill and injured patients. With 16,000 members worldwide,
the Society is the only professional organization devoted exclusively to
ensuring excellence in the practice of critical care through education,
research and advocacy.
52BSPRINGER
Springer is one of the leading international scientific publishing
companies, publishing some 2,000 journals and more than 7,00 new
book titles every year in the STM sector.
Springer publishes “Intensive Care Medicine,” the official journal of the
ESICM, and many more relevant books and journals in this interesting
field.
223
BoothArea Name
BoothArea Name
26ASTARMED
25ATHERMO FISHER SCIENTIFIC
STARMED, located in the most advanced biomedical district in Europe
(the Mirandola Area / North Italy) is among the companies that have
been developing for decades high tech medical devices for the benefit
of millions of patients all over the world.
Since its foundation in 1992, the company’s mission was to develop
efficient devices for CPAP and non-invasive ventilation therapies,
continuously improving the technical / functional features of its
product: The Helmet, the most comfortable interface for CPAP therapy
and N.I.V. available in adult, children and infant models.
BRAHMS GmbH, Part of Thermo Fisher Scientific, specialises in
innovative products which facilitate earlier diagnosis of diseases and
better control of therapy, thus enabling doctors to provide more
efficient and economic patient care.
STARMED also created the “Ventumask”, an innovative device for easy
CPAP also in ambulance and emergency.
47BSWISSTOM
Swisstom´s innovative electrical impedance tomography (EIT) displays
the breathing lung directly on a monitor screen, making it visible to
everyone. Like watching a movie, caregives can, for the first time, see
precisely what is going on in their patient’s chest. Right at the bedside,
they get real-time feedback on therapeutic measures they take.
Unlike other systems, Swisstom’s EIT hugs the patient’s chest like a
second skin.
37ATORAY MEDICAL
Toray Medical is a medical device company. Major business field
is intensive care medicine, hemodialysis and cardiovascular. Our
products are originated from Toray’s polymer chemistry and nanotechnology. A medical device for acute blood purification is one of the
major products. Toraymyxin, blood endotoxin adsorption device for
the treatment of severe sepsis and septic shock has been used clinically
since 1994 in Japan. Clinical application has been progressing in
some EU countries and Asian countries. Two multicentric randomised
control studies, EUPHRATES in North America and ABDO-MIX in France
are now enrolling the patients.
60B
3ATELEFLEX
Teleflex is a leading global provider of specialty medical devices for
diagnostic and therapeutic procedures in critical care, urology and
surgery. Our mission is to provide solutions that enable healthcare
providers to improve outcomes and enhance patient and provider
safety. We specialise in devices for general and regional anaesthesia,
cardiac care, respiratory care, urology, vascular access and surgery,
serving healthcare providers in more than 130 countries.
WFSICCM CONGRESS
Newly designed NON-DEHP-free ETT, ISIS convertible ETT and laryngeal
masks with integrated Cuff Pilot complement our extensive range
in airway management (ET and tracheostomy tubes). We also offer
products for humidification & filtration; oxygen and aerosol therapy;
temperature management; regional anaesthesia and vascular access.
The 11th Congress of the World Federation of Societies of Intensive and
Critical Care Medicine which will take place in Durban, South Africa
from August 28 and September 1, 2013.
South Africa has long been a centre of excellence in the field of
Intensive and Critical Care in Africa. Our Scientific Committee has
combined the local talent with a list of international experts to create
what promises to be an exceptional programme. The focus of the
programme is “Critical Care for all - providing more for less”. We hope
to highlight the need for rational utilization of precious critical care
resources, thus making it accessible to as many patients as possible.
This will undoubtedly be one of the best medical conferences in 2013.
It will provide an unprecedented opportunity to learn more about
critical care in different contexts.
42ATERUMO EUROPE
46B
Terumo, a global medical devices company of Japanese origin, is
renowned for the high quality and technical innovation of its products.
By supplying innovative IV treatment devices with a strong emphasis
on safety, easiness-of-use and quality, Terumo Europe Medical
Products is putting healthcare professionals in the pole position when
treating their patients.
Wisepress.com, Europe’s leading conference bookseller, has a complete
range of relevant books and journals which can be purchased at the
stand or, if you would rather not carry them, posted to you - Wisepress
will deliver worldwide. We also have a comprehensive medical and
scientific online bookshop with great offers.
With a vast and innovative product range for both anaesthesia and
intensive care, Terumo Europe Medical Products supports healthcare
professionals all over Europe.
ZOLL Medical Corporation develops and markets medical devices and
software solutions that help advance emergency care and save lives,
while increasing clinical and operational efficiencies. With products
for defibrillation and monitoring, circulation and CPR feedback, data
management, fluid resuscitation, and therapeutic temperature
management, ZOLL provides a comprehensive set of technologies
which help clinicians, EMS and fire professionals, and lay rescuers
treat victims needing resuscitation and critical care. ZOLL develops
and manufactures its products in the United States. More than 400
direct sales and service representatives, 1,100 business partners, and
200 independent representatives serve our customers in over 140
countries around the globe.
Please visit Terumo’s booth for your personal appointment to learn
more.
49BTHE JAMA NETWORK
The JAMA Network is a consortium of peer-reviewed print and online
medical publications, published by the AMA Publishing Group, that
includes JAMA and 9 specialty Archives Journals, including Archives
of Internal Medicine, Archives of Paeditatrics & Adolescent Medicine,
Archives of Dermatology, Archives of General Psychiatry, Archives of
Neurology, Archives of Ophthalmology, Archives of OtolaryngologyHead & Neck Surgery, Archives of Surgery, and Archives of Facial Plastic
Surgery.
224
Major fields of activity are diagnosis of infectious and thyroid diseases,
cardiology and pneumology as well as sepsis, tumors, and Down’s
syndrome.
13-17 October 2012
50B
WISEPRESS MEDICAL BOOKSHOP
ZOLL MEDICAL
L I V E S 2 012
INTRODUCING A NEW ERA IN ICU SEDATION:
Effective sedation.
Effective response.
Depend on dexdor ®:
• Maintain light-to-moderate sedation*
• Improve patient manageability*
[dexmedetomidine hcl] injection
• Facilitate better patient communication*
• Decrease time to extubation*
* Jakob S et al. JAMA 2012;307(11):1151-1160, Riker RR et al. JAMA 2009; 301(5):489-99
Cooperative comfortable
sedation
Indication: Sedation of adult ICU patients requiring sedation level not deeper than arousal in response to verbal stimulation (RASS 0 to -3). Dosage and administration: Hospital use only, by healthcare professionals skilled in management
of patients requiring intensive care. Administer only as diluted intravenous infusion using controlled infusion device. Dexmedetomidine is very potent and the infusion rate is given per hour. Switch patients already intubated and sedated to
dexmedetomidine with initial infusion rate of 0.7 micrograms/kg/h and adjust stepwise within range 0.2 to 1.4 micrograms/kg/h to achieve desired sedation level. Consider lower starting infusion rate for frail patients. After dose adjustment, new
steady state sedation level may not be reached for up to one hour. Do not exceed maximum dose of 1.4 micrograms/kg/h. Switch patients failing to achieve an adequate level of sedation with maximum dose to an alternative sedative agent. Loading
dose not recommended. Administer propofol or midazolam if needed until clinical effects of dexdor ® established. No experience in use of dexdor ® for more than 14 days. Use for longer than this period should be regularly reassessed. Elderly:
No dosage adjustment required. Renal impairment: No dosage adjustment required. Hepatic impairment: Caution advised; consider reduced dose. Children aged 0-18 years: Safety and efficacy not established. Contraindications: Hypersensitivity
to dexmedetomidine or the excipients. Advanced heart block (grade 2 or 3) unless paced. Uncontrolled hypotension. Acute cerebrovascular conditions. Warnings and precautions: Intended for use in intensive care setting, use in other environments
not recommended. Continuous cardiac monitoring required. Monitor respiration in non-intubated patients. Do not use as induction agent for intubation or to provide sedation during muscle relaxant use. dexdor ® reduces heart rate and blood
pressure but at higher concentrations causes peripheral vasoconstriction and hypertension. Not suitable in patients who will not tolerate lack of deep sedation and easy rousability. Users should be ready to use alternative sedative for acute
control of agitation or during procedures, especially during the first few hours of treatment. Caution with: pre-existing bradycardia; high physical fitness and slow resting heart rate; pre-existing hypotension, hypovolaemia, chronic hypotension or reduced functional reserve; severe ventricular dysfunction; the elderly; impaired peripheral autonomic activity (e.g. due to spinal cord injury); ischaemic heart disease or severe cerebrovascular disease; severe hepatic impairment;
severe neurological disorders such as head injury and after neurosurgery. Reduce dose or discontinue if signs of myocardial or cerebral ischaemia. Additive effects may occur with other substances with sedative or cardiovascular actions.
Some patients receiving dexdor ® have been observed to be arousable and alert when stimulated; this alone should not be considered as evidence of lack of efficacy. Do not use as sole treatment in status epilepticus. Consider possibility
of withdrawal reaction if patient develops agitation and hypertension shortly after stopping dexmedetomidine. Not recommended in malignant hyperthermia-sensitive individuals. Discontinue treatment in event of sustained unexplained
fever. Undesirable effects: Very common (>1/10): Bradycardia, hypotension, hypertension. Common (1>100 to <1/10): Hyperglycaemia, hypoglycaemia, agitation, myocardial ischaemia or infarction, tachycardia, nausea, vomiting, dry mouth,
withdrawal syndrome, hyperthermia. Uncommon (1>1,000 to <1/100): Metabolic acidosis, hypoalbuminaemia, hallucination, atrioventricular block first degree, cardiac output decreased, dyspnoea, abdominal distension, drug ineffective,
thirst. See SPC for further details. Pack sizes: 5 x 2 ml ampoules; 25 x 2 ml ampoules;4 x 4 ml vials; 4 x 10 ml vials Marketing authorisation holder: Orion Corporation, Orionintie 1, FI-02200 Espoo, Finland. dexdor ® is a registered trademark.
Date of Prescribing Information: Sep 2011.
www.dexdor.eu
dexdor_ad-276x210-CompText.indd 1
14.08.12 10:21
For physicians, nurses and other
allied healthcare professionals.
> abStract SUbmiSSion DeaDline : 19 april 2013
for more information, contact
european society of intensive care medicine (esicm)
www.esicm.org
Congress Department
rue belliard 19 - 1040 brussels belgium
Tel: +32 (0)2 559 03 75 - Fax: +32 (0)2 559 03 79
paris2013@esicm.org

online final programme

Transcription

Similar documents

to Veiw Javier Buelna Vision Statement and Bio

Manual Doors for ICU/CCU Rooms

Community Newsletter June 2015

Victorville, CA 92395 - In Home Furniture Gallery

The Art History of Ancient Egypt

Venodyne

Initial Announcement

TCH Furniture Guide EN

Many (Mouse) Ears Ago: A Story of Life in the Disney Radio Shop

ICU/CCU Door - ASSA ABLOY Entrance Systems Canada